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Welcome Address
Dear Colleagues and Friends,
It is our great pleasure to welcome you to ICNC11, the International Conference on Nuclear Cardiology and Cardiac
CT. The ICNC meeting has been a key international scientific event for nuclear cardiology and cardiac CT imaging for
more than 20 years. It provides the opportunity for practitioners from all over the world to gather to learn about new
advances and to exchange scientific ideas and experiences in a distinctive environment.
Over the next few days the meeting will provide an exciting and diversified scientific programme which offers a full
spectrum of educational opportunities ranging from continuing education to cutting-edge presentations of new and
original scientific research. A core curriculum, as well as advanced and research tracks will be available. As in the past,
submitted abstracts will come from a wide geographical area which reinforces the message that ICNC is an important
international scientific event. Many ‘‘Read with the Experts’’ case review sessions will allow participants to improve
their interpretative skills for cardiac CT and SPECT and PET examinations.
Unique to this meeting will be an even greater emphasis on presentations by young investigators. In addition to the
awards and grants we already offer such as the ESC Working Group Travel Grants and the free registration for
presenters in the Young Investigator Awards session, this year we will be offering two new categories of grants, the
ICNC Grants and the ICNC Young Scientist Award. These 25 grants attributed to abstract presenters and young
cardiologists will be generously provided by the ICNC Organising Committee and will carry a stipend of €1 500 per
person. The Young Scientist Award will carry a stipend of €5 000. The winner will be announced at the gala dinner on
Tuesday, 6 May.
The beautiful city of Berlin is the venue for ICNC11. Germany’s capital city combines all the things necessary for a
successful congress, including a robust medical science community, a rich history, lively entertainment and afford-
ability. Indeed, the ICNC organisers have selected this city for its popularity not only within Europe but because it is a
favoured destination from the Americas, Asia and throughout the world.
Thank you for choosing to attend ICNC11. We are pleased that you are here and hope you enjoy the meeting and the
wonderful city of Berlin.
Organising Committee
Frank Bengel, DE – Organising Co-Chair
Robert Gropler, US – Organising Co-Chair
Robert Beanlands, CA – Industry Liaison
Robert Hendel, US – Meeting Services
Juhani Knuuti, FI – Scientific Advisor
Programme Committee Chairpersons
Sharmila Dorbala, US – Programme Chair
Michael Zellweger, CH – Programme Chair
Randall Thompson, US – Programme Chair
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Effects of MR contrast agents on attenuation map generation
and cardiac PET quantification in PET/MR
S. Fuerst1; M. Souvatzoglou1; C. Rischpler1; S.I. Ziegler1;
M. Schwaiger1; S.G. Nekolla1
1Hospital rechts der Isar of the TU Munich, Department of Nuclear
Medicine, Munich, Germany
Purpose: Gadolinium-based MR contrast agents (CA) do not signifi-
cantly affect PET annihilation photons. However, by enhancing the
MR signal they possibly influence the MR-derived attenuation cor-
rection in hybrid PET/MR. The aim was to assess this effect on
attenuation map (lmap) generation and PET quantification with the
Biograph mMR PET/MR.
Methods: lmaps were generated by acquiring MR data with a 2-point
DIXON sequence and segmenting them using thresholds. 22 patients
referred for viability imaging were scanned before and after CA
administration. These PET images were reconstructed: post-CA data/
lmap and post-CA data/pre-CA lmap. Volumes of lung, fat and soft
tissue in the lmaps were determined and the response to CA investi-
gated over time. Myocardial uptake in the left ventricle (LV) was
volumetrically quantified in 17 segment and regional differences
between the data sets were assessed.
Results: For all patients, the volume of lung tissue and fat in the lmaps
after injection of CA was reduced, whereas the amount of soft tissue
was increased. The changes were on average (-12.9 ± 24.9)%,
(-35.8 ± 18.4)% and (16.2 ± 8.3)% for lung, fat and soft tissue. In
none of the patients, the lmap composition recovered to the state
before CA injection until the exam finished. An effect on the SUV of
more than 10% was found in 42.9% of the segments, whereas the
respective global SUV variations ranged between -3.0% and +26.8%.
Conclusions: MR CA has both significant local and global effects in
cardiothoracic imaging. Tissue misclassifications are independent of
the investigated range of delays after CA injection, leading to ham-
pered quantification of otherwise adequate PET raw data. Thus, lmaps
should be acquired pre-CA and CA-optimized segmentation parame-
ters are needed.
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The influence of coronary artery calcium score on the
interpretation of myocardial perfusion imaging
M. Mohamed Mouden1; J.P. Ottervanger1; J.R. Timmer1;
S. Reiffers1; A.H.J. Oostdijk1; S. Knollema1; P.L. Jager1
1Isala Hospital, Zwolle, Netherlands
Purpose: We investigated the influence of coronary artery calcium
(CAC) scores on the visual interpretation of myocardial perfusion
imaging in stable patients referred for the diagnostic work-up of sus-
pected coronary artery disease (CAD).
Methods: Patients without a previous history of CAD in whom CAC
scoring was concomitantly performed with a hybrid 64-slice SPECT/
CT device were retrospectively identified. For the current analysis we
selected all 151 patients who underwent invasive angiography within
3 months after myocardial perfusion imaging. Experienced readers
interpreted myocardial perfusion images in two separate sessions with
and without knowledge of a patient’s CAC score. We compared both
readings with regard to the frequency of equivocal readings, and cal-
culated changes in diagnostic accuracy using angiography with C70%
luminal narrowing as a reference standard for obstructive CAD.
Results: The addition of the CAC score changed the interpretation of
myocardial perfusion images in 56 patients (37%) with a major effect
on diagnostic accuracy in 39 patients (26%). The frequency of
equivocal perfusion interpretations decreased from 21% to 9%
(P = .002). Sensitivity of myocardial perfusion imaging increased
from 48% to 64% (P = .019) with comparable specificity (72% to
68%, P = .628).
Conclusions: In this highly selected group knowledge of the CAC
score improved the interpretation of myocardial perfusion imaging and
reduced the number of equivocal readings.
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Comparison between 99mTc-HYNIC-AnnexinA5 and
99mTc-AnnexinA5-128 for in vivo detection of experimental
auto immune myocarditis
K. Khadija Ben Ali1; R. Ben Azzouna1; L. Louedec2;
M. Milliner1; D. Barbato3; C. Bucci3; F. Rouzet1;
M. Jean-Baptiste2; D. Le Guludec1; L. Sarda-Mantel1
1AP-HP-Hospital Bichat-Claude Bernard, Department of Nuclear
Medicine, Paris, France; 2Inserm U698-Hospital Bichat-Claude
Bernard, Paris, France; 3Advanced Accelerator Applications,
colleretto Giacosa, Italy
Objectives: 99mTc-HYNIC-AnnexinA5 (99mTc-HYNIC-Anx) has
been shown to allow in vivo scintigraphic detection of cardiomyocytes
death in experimental myocarditis, via high-affinity binding to phos-
phatidylserines. Anx-128 is a new mutant of AnnexinA5 which possesses
an endogenous peptidic chelation site at its N terminus. 99mTc-Anx-128
has been produced according to GMP procedure. The aim of this study
was to compare 99mTc-Anx-128 to 99mTc-HYNIC-Anx in a rat model
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of acute myocarditis, to determine its potential interest for further clinical
applications in patients with myocarditis.
Methods: Acute myocarditis was induced in 13 Wistar rats by
immunization with purified rat cardiomyosin (600 lg 9 2, in Freund
adjuvant). Rats were imaged 3 weeks after immunization with both
99mTc-Anx-128 then 99mTc-HYNIC-Anx or vice versa at 2 days
intervals. SPECT/CT images were acquired on a NanoSPECT/CTplus
(Bioscan Inc.) device, 1 hour after tracers injection (60 MBq). Auto-
radiography (Beta ImagerTM, Biospace Lab) and histological studies of
heart sections were performed after the second scan. All experiments
were also performed in eight control rats injected with Freund
adjuvant.
Results: All immunized rats had positive dual imaging, with similar
myocardial uptake of the two tracers in terms of topography and
intensity. Myocardial-to-background activity ratio was 2.3 ± 1.46* in
immunized rats vs 0.9 ± 0.32 in controls P = .01 using 99mTc- HY-
NIC-Anx, and 2.7 ± 1.3* vs 1.16 ± 0.18; P = .004 using 99mTc-Anx-
128 (*NS). Autoradiographic and histological data confirmed
co-localization of both tracers in myocardial areas of cardiomyocytes
death, and no uptake in normal myocardium of control rats.
Conclusions: 99mTc-Anx-128 is accurate and comparable to 99mTc-
HYNIC-Anx for in vivo detection of cardiomyocytes death in exper-
imental acute myocarditis. These results confirm potential interest of
this new tracer for clinical application in patients with myocarditis.
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Combining preoperative information from speckle tracking
echocardiography, cardiac CT scan and MRI scan adds
important information in patients receiving cardiac
resynchronization therapy implants
Z. Bakos1; H. Markstad2; E. Ostenfeld3; A. Roijer4;
M. Carlsson3; R. Borgquist1
1Lund University, Skane University Hospital, Department of
Arrhythmias, Lund, Sweden; 2Lund University, Skane University
Hospital, Department of Radiology, Lund, Sweden; 3Lund University,
Skane University Hospital, Department of Clinical Physiology,
Lund, Sweden; 4Lund University, Skane University Hospital,
The Clinic for Heart Failure and Valvular Disease, Lund, Sweden
Purpose: To evaluate the incremental value of using preoperative
cardiac CT and MRI in combination with echocardiography evaluation
of segmental mechanical delay, for guiding optimal left ventricular
lead placement in cardiac resynchronization therapy (CRT).
Methods: 23 patients (70 ± 9 years, 78% male, 86% with LBBB, 57%
with ischemic CMP, 91% C NYHA 3) eligible for CRT were included
consecutively. The left ventricular segment with latest mechanical
activation was determined using echocardiography with speckle
tracking radial strain. Cardiac CT scan was used for evaluation of
coronary sinus anatomy. Cardiac MRI was used for evaluation of
viability in each segment. A composite bulls-eye plot was constructed
for each patient, indicating the optimal site for LV lead placement
(Figure 1).
Results: The latest mechanical delay was in the mid inferolateral
segment (n = 4), base inferolateral (5), mid anterolateral (3), base
anterolateral (2), mid anterior (3), base anterior (1), mid inferior (3) or
base inferior (2). There were 2.5 ± 0.8 veins of suitable size (C1.5 mm
in diameter), and in 13 patients there was a matching vein in the
segment with the latest mechanical delay, i.e. an optimal placement
was possible. In 9/10 of those patients who had no eligible vein
anatomy at the optimal segment, an adjacent segment was available. In
the total group, MRI showed nontransmural (\50%) infarction in 24%
of all segments and transmural infarction (50-100%) in 7%. In one
patient there was transmural infarction in the optimal segment, thereby
altering the optimal LV lead placement.
Conclusions: Using cardiac CT in combination with echocardiography
and MRI makes it possible to determine if an optimal lead placement is
possible already preoperatively, and can be helpful in planning the
targeted implant procedure.
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68Ga-Siglec-9 peptide targeting VAP-1 is accumulated
in atherosclerotic plaques
J.M.U. Johanna Silvola1; H. Ahtinen1; S. Hellberg1;
T. Saanijoki1; H. Liljenback1; S. Yla-Herttuala2; S. Jalkanen3;
J. Knuuti1; A. Saraste4; A. Roivainen1
1Turku PET Centre, University of Turku & Turku University Hospital,
Turku, Finland; 2A.I. Virtanen Institute for Molecular Sciences at the
University of Eastern Finland, Kuopio, Finland; 3MediCity Research
Laboratory, University of Turku, and National Institute of Health and
Welfare, Turku, Finland; 4Turku University Hospital, Department of
Medicine, Turku, Finland
Purpose: Vascular adhesion protein-1 (VAP-1) plays a key role in
recruiting leukocytes into sites of inflammation. VAP-1 is stored in
intracellular granules of endothelial cells, but upon inflammation it is
rapidly translocated to the endothelial cell surface. Using a phage
display approach, we have recently discovered that sialic acid-binding
Ig-like lectin 9 (Siglec-9) is a granulocyte ligand for vascular adhe-
sion protein 1 (VAP-1) and a 68Ga-Siglec-9 peptide specifically
detects VAP-1 in vasculature at sites of inflammation. Since the
inflammation has a prominent role also in atherosclerosis, the novel
68Ga-Siglec-9 peptide may be a potential tracer for imaging of
inflammation associated with atherosclerotic plaques. This study
investigated the uptake of 68Ga-Siglec-9 in atherosclerotic plaques in
mice.
Methods: Six-month-old atherosclerotic low-density lipoprotein
receptor deficient mice expressing only apolipoprotein B100
(LDLR-/-ApoB100/100, n = 15) fed with high-fat diet for four
months and normally fed two-month-old C57BL/6 control mice
(n = 11) were intravenously injected with 19 ± 5 MBq of 68Ga-Sig-
lec-9. The aorta and other tissues were excised at 25 minutes after
tracer injection and measured by gamma counter to clarify biodistri-
bution of radioactivity. The uptake of 68Ga-Siglec-9 in aorta was
studied in more detailed by autoradiography and histology analyses.
Results: The six-month-old LDLR-/-ApoB100/100 mice demon-
strated highly inflamed and extensive atherosclerotic plaques after
4 months of a high-fat diet, presenting a suitable model for studying
the imaging of atherosclerotic plaque inflammation. The 68Ga-Siglec-
9 peptide was rapidly excreted through the kidneys to the urine. At
25minutes post-injection the blood radioactivity was still relatively
high. However, the uptake of 68Ga-Siglec-9 in the aorta was
Figure 1. Composite bullseye plot optimal position.
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significantly higher in the LDLR-/-ApoB100/100 mice
(0.88 ± 0.32%IA/g) than in the control mice (0.45 ± 0.11%IA/g,
P = .0003), and an autoradiography demonstrated focal uptake of
68Ga-Siglec-9 in atherosclerotic plaques.
Conclusion: Our preliminary results provide evidence that 68Ga-Sig-
lec-9 peptide is accumulated into the plaques of atherosclerotic mice
and that it might be a promising and novel PET tracer to detect plaque
inflammation. Further studies are warranted to determine the expres-
sion level of VAP-1 at different stages of atherosclerotic plaque
development.
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Dynamic computed tomography perfusion imaging for the
detection of functionally significant coronary lesions
A. Rossi1; A. Wragg2; A. Dharampal1; S.E. Petersen2;
E. Klotz3; P.J. De Feyter1; F. Pugliese2
1Erasmus MC, Rotterdam, Netherlands; 2Barts and The London NIHR
Cardiovascular Biomedical Research Unit, London, United Kingdom;
3Siemens Healthcare Sector, Forchheim, Germany
Purpose: To evaluate the performance of hyperaemic myocardial
blood flow (MBF) derived from stress computed tomography perfusion
(CTP) imaging in the detection of functionally significant coronary
lesions in a prospective cohort of patients with stable chest pain.
Lesions were defined functionally significant by fractional flow reserve
(FFR) B0.75.
Methods and Materials: Coronary computed tomography angiogra-
phy (CTCA) and CTP were performed in 80 patients (63 males/17
females; mean age 60 ± 10 years) referred for invasive angiography. A
second-generation dual-source CT scanner (Somatom Definition Flash,
Siemens) with a dynamic ECG-triggered axial shuttle mode was used.
This technique provides an arterial input function and myocardial time-
attenuation curves fitted to a two-compartment model to give MBF.
Hyperaemia was induced by infusion of adenosine (140 lg/kg body
weight). Three to four minutes into the infusion, 60 mL of contrast
were injected. Gantry rotation time was 285 ms, collimation
64 9 0.6 mm, tube voltage 100 kV and the tube current-time product
was 300 mAs/rotation.
Results: Data from 210 coronary vessels and 210 corresponding
myocardial territories were available for comparison and were included
in the analysis. Functionally significant coronary lesions were found in
56/210 vessels (27%). MBF was 62 (51-74) mL/100 mL/minute in
myocardial territories supplied by vessels with functionally significant
coronary lesions and 109 (92-136) mL/100 mL/minute in the remote
myocardium (P \ .001). The optimal cut-off value of MBF to dis-
criminate functionally significant coronary lesions was 78 mL/
100 mL/minute. MBF had 88% sensitivity and 90% specificity and an
area under the receiver operating characteristics curve (AUC) of 0.95
(95% CI, 0.92-0.98, P \ .001). By comparison, visual CTCA analysis
yielded 80% sensitivity, 76% specificity and an AUC of 0.78 (95% CI,
0.71-0.85, P \ .001).
Conclusions: MBF performs better than visual CTCA analysis to
predict functionally significant coronary lesions (FFR B 0.75).
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Diversity of high-efficiency CZT SPECT Tc-99m imaging
protocols: Results of an international survey
M. Milena Henzlova1; B. Songy2; P.L. Jager3; M.H. Cherk4;
P.A. Kaufmann5; A. Gimelli6; T.D. Ruddy7; F.P. Esteves8;
W.L. Duvall1
1Mount Sinai School of Medicine, New York, United States of America;
2North Cardiology Hospital, Paris, France; 3Isala Hospital, Zwolle,
Netherlands; 4Alfred Hospital, Melbourne, Australia; 5University
Hospital Zurich, Zurich, Switzerland; 6Gabriele Monasterio
Foundation, Department of Cardiovascular Medicine, Pisa, Italy;
7University of Ottawa, Ottawa, Canada; 8Emory University, Atlanta,
United States of America
Purpose: The introduction of high-efficiency SPECT cameras for MPI
represents one of the most important hardware developments in dec-
ades. Approximately, 30 laboratories have the multi-pinhole CZT
camera installed as of the summer of 2012. There are no current
guidelines for dosing and imaging times for these cameras.
Methods: A questionnaire was distributed to eight early adopters who
published peer reviewed papers utilizing the multi-pinhole CZT cam-
era in Europe (N = 4), Australia (N = 1) and North America (N = 3)
requesting yearly patient volume, low and high Tc-99m doses, low and
high dose imaging times, time from low and high dose injection to
imaging, and information about the use of attenuation correction.
Results: Surveyed labs perform close to 20,000 studies a year with 6 of
8 using a stress-rest protocol (rest imaging optional). The stress:rest
dose ratio varies from 1:2 to 1:3, with stress doses ranging from 3 to
10 mCi and stress imaging time from 5 to 11 minutes. The largest
variation was noted in time to rest imaging (3-60 minutes). North
American labs are more likely to perform rest-stress imaging with a 1:3
to 1:4 rest:stress dose ratio and rest doses usually of 5 mCi. Calculated
radiation dose to the patients for low-dose stress only studies was
B3 mSV per study and 3.6-9.1 mSv for a full study. All sites use either
CT or prone imaging attenuation correction.
Conclusions: Using CZT SPECT technology results in significant
decreases in radiation doses and imaging time. Sufficient data is now
available to propose unified guidelines for CZT SPECT imaging.
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Warranty periods of a normal stress-rest myocardial perfu-
sion SPECT
J.G. Romero Farina1; S. Aguade-Bruix1; G. Cuberas-Borros1;
M.N. Pizzi1; G. De Leon1; J. Castell-Conesa1;
D. Garcia-Dorado1; J. Candell-Riera1
1Hospital Universitari Vall d’Hebron, Barcelona, Spain
Purpose: To evaluate the warranty period (WP) of a normal stress-rest
myocardial perfusion SPECT for exercise stress (ES), ES plus phar-
macologic stress (PhS), and PhS and in different clinical conditions.
WP of normal SPECT is important in order to establish appropriate use
of this technique in different subgroups of patients.
Methods: A cohort of 2,922 patients (62.9 ± 13 years; 53.4% women)
with normal stress-rest myocardial perfusion SPECT was studied. WP
was defined as the time in which a patient remained at low risk (\1%
complications/year) for total mortality (TM) and for hard events (HE)
(cardiovascular death or nonfatal acute myocardial infarction. Multi-
variate Cox proportional hazards models and Kaplan-Meier curves
analysis were used to estimate the WP.
Results: 2051 patients underwent ES, 461 underwent ES plus PhS, and
410 underwent PhS. During a follow-up of 5 ± 3.3 years, a significant
(P \ .05) increased of annual TM (1.47%, 2.3% and 4%) and annual
HE (0.4%, 0.9% and 2%) were observed for ES, ES plus PhS, and PhS
respectively. A significant (P \ .05) WP reductions of TM [13.5, 9.6
and 8 months], and HE [34.8, 20.5 and 8.2 months] was observed for
ES, ES plus PhS, and PhS respectively. Clinical variables (age, gender,
diabetes and known coronary artery disease) were other determinants
of the WP. An abnormal gated SPECT (ejection fraction \ 50%)
significantly decreased WP for HE in patients underwent ES plus PhS
(P = 0.001) or PhS (P = .007).
Table of the abstract 56
Stress-
rest site
Annual
volume
Stress
dose
Stress
imaging
time
Time
to stress
imaging
Rest
dose
Rest
imaging
time
Time
to rest
imaging
Rest-stress
ratio
Attenuation
correction
Stress-only
exposure
Stress-rest
exposure
Paris 5,000 3 mCi 10–12 5–10 9 mCi 5–6 45–75 1:3 Prone 0.9 mSv 3.6 mSv
Zwolle 2,750 10 mCi 5 45–60 20 mCi 5 45–60 1:3 CT 3.0 mSv 9.1 mSv
Melbourne 1,900 5.7 mCi 8 10–15 15 mCi 4 5–10 1:2.6 Prone 1.7 mSv 6.3 mSv
Zurich 1,400 6 mCi 5 60 15 mCi 5 3 1:2.5 CT 1.8 mSv 6.4 mSv
Pisa 1,400 4–5 mCi 7 10–15 8–10 mCi 8 15–30 1:2 Prone 1.4 mSv 4.1 mSv
New York 2,300 10 mCi 5 30–60 20 mCi 3 40 1:2 Prone 3.0 mSv 9.1 mSv
Rest-stress
site
Annual
volume
Rest
dose
Rest
imaging
time
Time
to rest
imaging
Stress
Dose
Stress
imaging
time
Time
to stress
imaging
Rest-stress
ratio
Attenuation
correction
Rest-stress
exposure
Ottawa 1,600 4–5 mCi 10 30–45 12–15 mCi 6 30–45 1:3 Prone 5.5 mSv
Atlanta 1,600 5 mCi 7–9 60 20 mCi 5–7 15–60 1:4 CT 7.6 mSv
New York 1,500 5 mCi 5 30–60 15 mCi 3 40–60 1:3 Prone 6.1 mSv
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Conclusions: WP of a normal stress-rest myocardial perfusion SPECT
is very variable since it is mainly determined by the type of stress,
clinical characteristics and left ventricular ejection fraction.
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A protocol for the provisional use of perfusion imaging
with exercise stress testing
M. Milena Henzlova1; E.J. Levine1; S. Moonthungal1;
M. Fardanesh1; L.B. Croft1; W.L. Duvall1;
1Mount Sinai School of Medicine, New York, United States of America
Purpose: Previous literature suggests that the results of myocardial
perfusion imaging (MPI) add little to the prognosis of patients who
exercise C10 METS during stress testing. With this in mind, we
attempted to determine if a provisional injection protocol could be
developed in which a patient would not receive an injection of
radioisotope if adequate exercise was achieved without symptoms and
a negative ECG response. This protocol would save a substantial
amount of time, radiation exposure, and cost.
Methods: All patients who underwent a stress SPECT MPI over a
6.5 year period from 2004 to 2010 were included. Patients who would
have been considered for a standby injection protocol were: exercise
stress, age \ 65, no known CAD, and an interpretable ECG. Patients
were retrospectively divided into two groups based on whether they
would have received radioisotope or not. Criteria for not injecting
included a maximal predicted heart rate C 85%, C 10 METS of
exercise, no symptoms of chest pain or shortness of breath, and no
ECG changes (ST depression or arrhythmia). The two groups were
then compared based on MPI results and all-cause mortality derived
from the Social Security Death Index.
Results: A total of 24,689 patients underwent SPECT MPI during this
period, and 5,352 would have been eligible for a provisional injection
protocol. There were 3,791 (70.8%) who would have been injected and
1,561 (29.2%) who would not have been. Perfusion results were
abnormal in 5.9% of non-injected group compared to 14.4% in those
who would have been injected. After a mean follow-up of
60.6 ± 21.4 months, 1.1% had died in the non-injected cohort com-
pared to 2.2% in the injected group.
Conclusion: A provisional injection protocol defined as age \65,
normal rest ECG, no history of CAD, and high level exercise with a
negative ECG response and no symptoms, has a very low 5 year all-
cause mortality and low yield of MPI. If adopted it would decrease
radiation exposure, save time and health care costs without jeopar-
dizing prognosis.
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Is necessary to perform an exercise myocardial perfusion
gated SPECT in patients with D-Transposition of the
great arteries after arterial switch operation?
A single centre long-term follow-up
M.N. Pizzi1; S. Aguade-Bruix2; E. Franquet2;
G. Cuberas-Borros1; B. Manso3; J. Casaldaliga4;
G. Romero-Farina5; J. Castell-Conesa2; D. Garcia-Dorado6;
J. Candell-Riera6
1Universitary Hospital Vall d’Hebron, Cardiology Department,
Nuclear Cardiology and Cardiac CT Unit, Barcelona, Spain;
2Universitary Hospital Vall d’Hebron, Nuclear Medicine Department,
Barcelona, Spain; 3Universitary Hospital Vall d’Hebron, Paediatric
Department, Barcelona, Spain; 4Universitary Hospital Vall d’Hebron,
Cardiology Department, Adult Congenital Heart Disease Unit,
Barcelona, Spain; 5Hospital Vall d’Hebron, Cardiology Department,
Epidemiology Unit, Barcelona, Spain; 6Universitary Hospital Vall
d’Hebron, Cardiology Department, Barcelona, Spain
Objectives: Arterial switch operation (ASO) is the preferred technique
for the correction of transposition of the great arteries (TGA), but
translocation and re-implantation of the coronary arteries can produce
myocardial ischemia. There is no consensus on the need to monitor
these patients to detect abnormalities in myocardial perfusion. The
purpose of this study is to report our experience with exercise myo-
cardial perfusion gated SPECT with 99mTc-tetrofosmine to evaluate
myocardial perfusion and exercise tolerance after ASO.
Methods: We performed exercise-rest myocardial perfusion gated
SPECT in 67 patients (48 boys, 9.9 ± 3.2 years old), including five
who had referred symptoms and 62 who were asymptomatic. Myo-
cardial perfusion and left ventricular (LV) wall motion, thickening,
volumes and ejection fraction (EF) were evaluated. We compared
patients with (n: 4) and without (n: 63) peri-operative complications,
and patients with A (normal) (n: 45) and non-A (n: 22) coronary
pattern.
Results: During exercise testing 67 patients reached 9.8 ± 3.05 METs
and 73.58 ± 14.24% of the predicted peak heart rate. Fifty-nine
patients (88%) had normal myocardial perfusion while only 2 patients
(3%) had reversible defects, and 6 patients (9%) had fixed defects. All
patients with peri-operative ischemic complications had myocardial
perfusion defects (100%) while only 4 patients (6.35%) without
ischemic complications had an abnormal perfusion (P = .0005). We
did not find a significant difference between patients who had an A and
non-A coronary pattern.
Conclusions: The high rate of normality of myocardial perfusion gated
SPECT in our study suggests that myocardial perfusion gated SPECT
should be reserved for patients who have suffered peri-operative
ischemic complications, or those with symptoms, at least during the
first 10 years after the surgery.
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Time to myocardial perfusion positivity after heart
transplant
L. Longmore1; K.A. Bybee2; S. Bhatti2; K. Kennedy2;
G. Dhillon1; T.M. Bateman2
1University of Missouri-Kansas City, Kansas City, United States of
America; 2St. Luke’s Mid America Heart Institute, Kansas City, United
States of America
Purpose: Cardiac allograft vasculopathy (CAV) is common among
orthotopic heart transplant (OHT) patients and is the major factor
affecting mortality. Serial myocardial perfusion imaging (MPI) is
useful diagnostically and prognostically, and with current technology
can be performed at minimal dosimetry. However, neither the time
course to positivity nor the correlates of this are known.
Methods: Using the OHT and MPI electronic databases at a single
center, we identified 192 patients who had undergone OHT and serial
MPI’s between January 1, 2000 and December 31, 2011. Collected
data included gender, age, diabetes, hyperlipidemia, hypertension,
smoking, family history of premature CAD and time to an abnormal
MPI (AMPI) defined by a summed stress score [3.
Results: The 192 OHT patients underwent 801 MPI’s over a mean
follow up period of 5.6 (+2.7) years. A total of 54 patients (28%)
ultimately developed an AMPI. Of these 54 patients, 11% (6 patients)
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had an AMPI by 1 year, 57% (31 pts) by 3 years, 78% (42 pts) by
5 years, 93% (50 pts) by 7 years, and thereafter only 1 patient per year
had an AMPI in the final 4 years. The average time to AMPI was
6 years. Demographic and atherosclerotic risk factor data were not
statistically different between the 54 patients who developed an AMPI
vs those who did not.
Conclusions: Serial MPI is helpful in identifying CAV following
OHT, with significant conversion to abnormality even during the first
several years following OHT. Traditional risk factors do not correlate
with those OHT patients who develop early post-transplant cardiac
allograft vasculopathy.
Conversion to abnormal MPI over time
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New approach to decrease the radiation dose for CT-based
attenuation-corrected SPECT imaging using a hybrid
64-slice SPECT/CT
D. Daniel Zalkind1; V.T. Tsatkin1; Y.L. Liu1; A.S. Sinusas1;
R.R.R. Russell1
1Yale-New Haven Medical Center, New Haven, United States of
America
Purpose: The utility of CT based attenuation correction (AC) has been
shown in previous multi-center trials for SPECT cameras with sodium
iodide (NaI) detectors, although remains undefined for hybrid high-
sensitivity cadmium-zinc-tellurium (CZT) SPECT cameras with
diagnostic 64-slice CT (Discovery NMCT570c). The CZT detectors
allow imaging with decreased radiotracer dose. The aim of this study
was to further reduce the dose by applying one higher dose AC CT
scan to both rest and stress images, and to evaluate the impact on
quantification of SPECT integrated defect size (IDS, %LV volume).
Methods: Forty-four consecutive hybrid SPECT/CT rest and stress
scans were processed using the GE Xeleris software. Patient had a
mean age of 63.1 ± 15.8 years, mean BMI 29.4 ± 5.4 and 66% male
gender. IDS was calculated at rest using a gender-matched low-risk
database, after attenuation correction with either the phase-matched
rest CT (120 kV and 20 mA) or the phase mismatched stress CT
(120 kV and 80 mA) AC maps using the Yale WLCQ software. A
paired two-tail Student t-test and Pearson correlation were used to
compare IDS within each coronary distribution (LAD, LCX, and RCA)
after processing with the low and high dose CT attenuation maps.
Results: The AC CT for the stress phase resulted in a radiation dose of
2.72 mSv (high dose) and the CT for the rest phase resulted in a low
radiation dose of 0.33 mSv (low dose). There was no statistically
significant difference in IDS between the rest perfusion processed with
the low-dose CT at rest, and the rest perfusion images processed with
the high-dose stress CT within each coronary distributions (LAD:
0.39 ± 0.31, P = .9, r = 0.61; LCX: 1.2 ± 4.8, P = .93, r = 0.97,
RCA: 0.62 ± 0.77, P = .52, r = .87).
Conclusions: The application of the stress CT AC map to the rest
SPECT images did not significantly change the rest IDS. Therefore,
one can eliminate the low dose rest CT AC map without compromising
SPECT quantification, further reducing the radiation dose associated
with hybrid CZT SPECT/CT.
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Assessment of left ventricular ejection fraction (LVEF) with
hybrid solid-state cadmiun zinc telluride (CZT) SPECT
imaging with and without CT attenuation correction:
comparison to 2D echocardiography
M.J. Maria Jimena Salas P.1; V. Tsatkin1; Y. Liu1; R. Russell1;
A.J. Sinusas1
1Yale University, New Haven, United States of America
Purpose: Gated SPECT is used to calculate LVEF and provides results
comparable to other methods. However, data is limited on accuracy of
hybrid solid state CZT SPECT for estimation of LVEF using an
integrated 64-slice CT for attenuation corrected (AC). We sought to
compare the LVEF determined by gated SPECT with and without AC
(no AC) and 2D echocardiography (2DE).
Methods: We retrospectively reviewed all rest 99mTc-tetrofosmin
SPECT scans performed on a hybrid CZT SPECT/CT (Discovery
NM570c) in patients having 2DE within 24 hours of SPECT processed
with AC and no AC over a 6 month period. CT was performed using
low dose protocol and free breathing. LVEF was calculated from
SPECT with WLCQ software with and without AC. Two operators
independently processed the LVEFs. 2DE EF was measured by the
biplane disk method. Interobserver variability was defined and Pear-
son’s correlation coefficients used for comparisons.
Results: 52 patients were identified, 32 males and 20 females,
meeting the inclusion criteria. The interobserver variability for LVEF
was low (SEM = 2.7%) and correlation high (r = 0.99). There was
excellent correlation between no AC and AC LVEF (r = 0.98). 2DE
LVEF correlated with SPECT LVEF with AC (r = 0.73) and no AC
(r = 0.74). There were differences in the correlation between 2DE
and SPECT LVEF when patients were grouped by gender (females:
r = 0.90; males: r = 0.70), presence/absence of LV hypertrophy
(LVH: r = 0.89; no LVH: r = 0.81), and patients with high
([80 mL) or low (\80 ml) LVEDV (low EDV: r = 0.60; high EDV:
r = 0.78).
Conclusions: LVEF assessed using a hybrid CZT SPECT/64-slice CT
was similar with AC and no AC, and correlated highly with 2DE
LVEF. There was an improved correlation in females, high LVEDV,
and no LVH, suggesting an influence of LV wall thickness.
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Effect of spill-over from right ventricular cavity to cardiac
PET radio water perfusion study
C. Chunlei Han1; H. Merisaari1; V. Oikonen1; S. Nesterov1;
M. Teras1; J. Knuuti1
1Turku PET Centre, Turku, Finland
Purpose: In analysis of cardiac PET water perfusion data, several
studies have suggested that the spillover activity from right ventricular
cavity (RV) to the septum should be corrected. Despite this, the cor-
rection is not implemented in routine analysis. This study investigates
the bias in perfusion estimation without RV spill-over correction,
based on simulation data.
Methods: Time-active curves (TAC) from left (LV) and right ven-
tricular cavities were derived from typical clinical 15O-labelled water
studies. One-tissue compartment model (Iida et al., 1989) was
employed to simulate noise free curves according to our study proto-
col. Water model without RV spill-over correction (LVModel) as
implemented in Carimas v2.6 (a data analysis package) was compared
with a new model with RV spill-over correction (LV_RVModel),
which was implemented to Carimas v2.6 as a modeling plugin.
In LV_RVModel, the myocardial ROI TAC was expressed as:
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ROI(t) = Va_lv*LV(t) + Va_rv*RV(t) + alpha*C(t), where Va_lv
and Va_rv are spill-over fractions from LV and RV, respectively, and
alpha is perfusable tissue fraction.
Results: RV affects significantly the perfusion estimation and this
effect becomes bigger for higher perfusion values and larger Va_rv.
When ground values of Va_rv = 0.1, 0.15, 0.2, 0.25 mL/mL, for
ground flow value of 0.98 mL/g/minute (as rest condition), estimated
flow values with LVModel were 0.94(-13%), 0.85(-20%), 0.78(-27%)
and 0.72(-33%) mL/g/minute, respectively; for ground flow value of
3.2 mL/g/minute (as stress condition), estimated values with LVModel
were 2.66(-17%), 2.34(-27%), 2.07(-36%) and 1.84(-43%) mL/g/
minute, respectively. Meanwhile, estimated flow values from
LV_RVModel were very close to ground values (error \ 2%).
Conclusions: Simulations confirm that spill-over from RV leads to
severe underestimation of perfusion in septum, unless correction is
applied in the analysis tool.
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Simultaneous acquisition in 64 3 64 and 128 3 128 matrix
of Gated SPECT myocardial perfusion (GSPECT) and
comparison of parameters of image quality in coronary
patients
I. Casans-Tormo1; R. Diaz-Exposito1; A.C. Orozco-Molano1;
E. Plancha-Burguera2
1Nuclear Medicine, Hospital Clı´nico Universitario, Valencia, Spain;
2Cardiology, Hospital Francisco de Borja, Gandia, Spain
Purpose: To assess the influence of 128 3 128 acquisition matrix in
GSPECT image quality analyzed in function of patients
(p) characteristics.
Material and Methods: We have studied a prospective group of 71 p
(31 women-43.7%), mean age 65 ± 10 (42-82 y/o, more than 70 (28/
71-39.4%) with known or suspected CAD, submitted to detect possible
myocardial ischemia. GSPECT was performed 1 hour after injection of
a 99mTc-tracer (2 day-protocol, 20 mCi-70 kg), obtaining two
simultaneous acquisitions with 64 3 64 and 128 3 128 matrix at
stress and at rest in 52 p and stress only in 16 p, with a total of 240
explorations, 120 with each matrix size (68 stress and 52 rest), But-
terworth filter (order 5, cutoff 0.56 (64)-0.30 (128), pixel size mm 6.3
(64)-3.1(128), QGS program. We perform visual semi-quantitative
analysis of global image quality (IQ), delimitation of ventricular cavity
(VC) and of perfusion defect (PD) considering 1-poor, 2-middle,
3-good, 4-excellent, analyzing differences between the two matrix size
studies respect to age, gender, body mass index (BMI), rest end-sys-
tolic volume (ESV) existence of perfusion defects or rest FE \ 50%,
obtained from usual 64 3 64 GSPECT, and also assessing possible
interference of intestinal activity.
Results: Mean BMI was 31.2 ± 6.5 (22.5-58.6), with 21/71 (29.6%)
more than 30. 31/71 p (43.7%) with ESV \ 25 mL, 32/71 (45.1%)
with PD, 18/71 (25.3 %) with FE \ 50% and 15/71 (21.1%) with
intestinal interference. Visual parameters graded 2-4. Global Q was in
general better in 128 than 64, without age differences. Better IQ at S
and R in 128 than 64 in women and p with ESV \ 25 mL (24/31-
77.4% of women had ESV \ 25 mL), higher IQ and PD in 128 than 64
at R in p with BMI more than 30 (80.9%) vs lower than 30 (32%)
p:0.03, better VC in 71.8% p without perfusion defects or attenuation
only vs 40.6% with perfusion defects (p:0.04) and in p with FE C 50%
than \50% (p:0.002). Better delimitation with intestinal activity in
11/15 (73%) of p that showed intestinal interference.
Conclusion: In this study with simultaneous acquisition in 128 3 128
and 64 3 64 matrix size, we obtained higher quality images in general
with 128 than 64, specially in patients with BMI [ 30, ESV \ 25 ml
(77% were women), without perfusion defects, with FE [ 50%, and
also better delimitation with intestinal activity, all of that could
improve interpretative certainly and diagnostic accuracy.
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Rapid SPECT MPI using 128 3 128 matrix acquisition with
iterative resolution recovery and attenuation correction
A. Amelia Jimenez-Heffernan1; A. Ortega-Carpio2;
C. Salgado-Garcia1; E. Sanchez De Mora1; J. Lopez-Martin1;
C. Ramos-Font1; R. Lopez-Aguilar1; S. Aguade-Bruix3
1Hospital Juan Ramo´n Jime´nez, Department of Diagnostic Imaging,
Huelva, Spain; 2Centro de Salud El Torrejon, Huelva, Spain; 3Hospital
Vall d’Hebron, Department of Nuclear Medicine, Barcelona, Spain
Purpose: To assess the contribution of 128 3 128 matrix acquisition
to improving the diagnostic quality and reducing LVEF overestimation
of rapid SPECT/CT reconstruction with ordered subset expectation
maximum and resolution recovery (OSEM-RR) with attenuation cor-
rection (AC).
Methods: We studied 461 consecutive patients (54% male, age:
64.5 ± 11.7 years, weight: 79.5 ± 15.2 kg) referred for 99mTc
SPECT/CT MPI using a 128 3 128 matrix and OSEM-RR recon-
struction with AC. For comparison we used a group of 572 patient who
underwent rapid SPECT with the usual 64 3 64 matrix, all other
parameters identical. 60 frames of 12 second duration were acquired
over 908 using a standard hybrid system. Our protocol performs 12
iterations with a maximum number of 10 subsets. A 2-day stress/rest
protocol was used. Stress was exercise combined with adenosine in 365
and regadenoson in 96 patients respectively. Image quality (poor,
medium, good or very good), diagnostic performance (normal,
abnormal and normalcy rate) and LVEF quantification were assessed.
Results: Images were of very good quality, clearly showing or sug-
gesting the papillary muscles in all cases. MPI was reported as normal
in 46.7%, abnormal in 51.3% and equivocal in 2% of patients
respectively. Normalcy rate using a very low pretest likelihood of
disease (Miller’s score modified) was 57.8%. In the 64 3 64 matrix
group reports were normal in 55%, abnormal in 43.6% and equivocal
in 1.4% of patients respectively and the normalcy rate was 68.6%. The
lower normalcy rate and increment of abnormal studies with the
128 3 128 matrix was mostly due to small basal inferolateral defects,
which we hypothesize could be related to the higher activity of the
adjacent posteromedial papillary muscle. Mean LVEF in normal per-
fusion patients was 63.3% for 128 3 128 and 67.2% for 64 3 64
matrix respectively, a significant difference (P \ .05).
Conclusion: The 128 3 128 matrix produces higher quality images
with lower overestimation of LVEF, nevertheless careful attention
must be paid to the area basal to the posteromedial papillary muscle in
order to avoid false positive readings.
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Towards sub-mSv radiation dose for myocardial perfusion
SPECT
R. Conwell1; C. Chuanyong Bai1; L. Abreu1; J. Maddahi2
1Digirad Corporation, Poway, United States of America;
2UCLA-David Geffen School of Medicine, Los Angeles, CA,
United States of America
Purpose: Patient radiation dose in conventional myocardial perfusion
SPECT (MPI) is approximately 11.4 mSv using the standard one-day
rest/stress protocol with 370 MBq rest and 1017.5 MBq stress Tc-99m
sestamibi injection. In this work, we evaluated the potential of sub-
mSv (\1 mSv) patient radiation dose through the use of high-
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sensitivity SPECT systems, advanced reconstruction algorithms, and
modified imaging protocols.
Methods: Sixty-six consecutive patient studies with list-mode data
acquisition were performed on a triple-head dedicated cardiac SPECT
camera with solid-state detectors. The average injection was 340.4 and
1306.1 MBq and the average acquisition time was 11.4 and 4.2 min-
utes for rest and stress studies, respectively. For each patient, a full
time dataset and a 1/3 time dataset were generated from the list-mode
data with the latter using every third of the list-mode events. The full
time data was reconstructed using a 3D-OSEM algorithm with reso-
lution recovery (nSPEED). The 1/3 time data was reconstructed with
an improved 3D-OSEM algorithm (nSPEED2) that incorporated a 3D
maximum a posteriori technique and a weighted-Gaussian filter
for better noise/resolution trade-off. Images were interpreted by a
blinded expert nuclear cardiologist for quality and diagnostic
equivalence.
Results: The 1/3 time nSPEED2 images showed diagnostic agreement
with the full time nSPEED images in 64/66 (97%) of the studies. The
quality of the 1/3 time nSPEED2 images was better than or equivalent
to that of the full time nSPEED images in 65/66 (99%) stress and 62/66
(94%) rest studies. The 1/3 time data corresponded to 3.8-minutes rest
and 1.4-minutes stress acquisitions; hence, if using longer acquisition
time, the patient dose can be reduced to \1 mSv at 15 minutes (see
Table).
Conclusion: Patient studies showed potential sub-mSv rest and stress
radiation dose when using a high-sensitivity camera for data acquisi-
tion and an advanced algorithm (nSPEED2) for image reconstruction.
Overall sub-mSv MPI radiation dose can be achieved for patients with
normal stress diagnosis when using stress-only protocols.
Patient dose vs acquisition time
Stress Rest
Acq. time
(minutes)
Injection
(MBq)
Radiation
dose (mSv)
Injection
(MBq)
Radiation
dose (mSv)
10 183.2 1.49 131.0 1.06
15 122.1 0.99 87.3 0.71
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Caution is required when comparing left ventricular
function calculated using newer gated SPECT iterative
reconstruction algorithms to the previously used filtered
backprojection reconstruction method
D. Doumit Daou1; C. Coaguila2; M. Tawileh1
1APHP, Cochin Hospital, Department of Nuclear medicine, Paris,
France; 2Hospital Sud-Francilien, Corbeil-Essonnes, France
Purpose: Gated SPECT myocardial perfusion (GSPECT) has been
extensively validated for the quantification of left ventricular (LV)
function especially with QGS. This was done with filtered backpro-
jection reconstruction method (FBP). Recent developments in nuclear
medicine technologies allow simple application of iterative recon-
struction with and without resolution recovery. We aimed to compare
the performance of the QGS software for the quantification LV func-
tion when using FBP as compared to iterative reconstruction (OSEM)
and iterative reconstruction combined to resolution recovery (3D-
Flash, Siemens).
Methods: Our study included 51 consecutive patients addressed for
myocardial perfusion scintigraphy. Studies were acquired on a two-
headed gamma-camera (Symbia, Siemens). GSPECT studies were
reconstructed using three different methods (FBP, OSEM, and 3D-
Flash) and then processed with the QGS software. LV end diastolic
volumes (EDV), end systolic volumes (ESV) and LVEF were
compared.
Results: LVEF was higher with FBP (72 ± 13%) than OSEM (70 ± 11%,
P \ .0001) and 3D-Flash (69 ± 12%, P \ .0001), respectively.
LV EDV was lower with FBP (70 ± 23 mL) than OSEM (74 ± 25 mL,
P \ .0001) and 3D-Flash (80 ± 26 mL, P \ .0001), respectively.
LV ESV was lower with FBP (22 ± 14 mL) than OSEM (24 ± 16 mL,
P \ .0001) and 3D-Flash (27 ± 17 mL, P \ .0001), respectively.
Bland-Altman analysis for the combined EDV and ESV (n = 102)
between FBP and 3D-Flash showed that the difference in LV volumes
between the two methods increased with their average LV volumes
(r = 0.61, P \ .0001). This also was also verified for FBP and OSEM:
r = 0.44 (P \ .0001).
Conclusions: Newer iterative reconstruction methods (OSEM, 3D-
Flash) give significantly different LVEF and volumes than those
obtained with FBP. This should be considered when adopting newer
reconstruction algorithms in clinical practice.
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Correlation of myocardial ischemia with contraction
asynchrony measured by single photon emission computed
tomography synchronized with electrocardiogram
C. Carlos Guizar1; E. Alexanderson1; S. Hernandez1;
M. Jimenez1; H. Hernandez1;
1National Institute of Cardiology ‘‘Ignacio Chavez’’, Mexico City,
Mexico
Objective: To establish the correlation between regional changes in
the synchrony of ventricular contraction and the presence of moderate
to severe ischemia on gated-SPECT.
Methods: We included men and women over age 40 who underwent gated-
SPECT in the period from January 1, 2006 to January 1, 2008 and had
moderate to severe myocardial ischemia, expressed as a summed difference
score (SDS) C 9 points, with no evidence of infarction. For the image
analysis we used Emory Cardiac ToolboxTM 3.1 (Emory University Atlanta
Georgia) software. Myocardial perfusion was analyzed in 17-segment polar
maps, obtaining the summed stress score (SSS), the summed rest score
(SRS) and the summed difference score (SDS). End diastolic volume, end
systolic volume and ejection fraction of the left ventricle were also obtained.
The sequential activation of the left ventricle was assessed in visual form
from the polar map, thereby detecting the territories in which the activation
occurred delayed. Synchrony indices were obtained as the standard devia-
tion of timing phase angles and bandwidth.
Results: We included 34 patients, with a mean age of 67.5 ± 9.2 years,
67% were male patients (n = 23) and 33% female (n = 11). The 47%
had severe ischemia and 53% moderate ischemia. The mean SSS was
14.12 ± 5.77, whereas for the SRS was 0. The mean ejection fraction
was 66.21 ± 12.31%, the end diastolic volume of 84.85 mL, and the
end systolic 32.84 ± 33.03 ± 23.89 mL. Ischemia was observed on the
anteroseptal region in 38% of cases, on the inferior wall in 29%, on the
lateral wall in 21% and on the apex in 12%. The synchrony polar map
showed contraction delay in the ischemic region in 58.8% of cases.
Patients with asynchrony in the polar map had a significantly larger
bandwidth than those without delay in the polar map, with 60 ± 22
and 44 ± 16, respectively (P = .02). There was no significant dif-
ference in the standard deviation (21.5 ± 10 vs 21.44 ± 9, P = .94).
There was also no association between the degree of ischemia and the
presence of asynchrony in the polar map (P = .315).
Conclusions: Moderate to severe ischemia was associated with the
presence of delay in the contraction of the same region with consid-
erable frequency (58.8%), but the delay was slight. Only the bandwidth
measurement was significantly increased in these cases, so this index is
probably more sensitive than the standard deviation to detect slight
delays in contraction associated with myocardial ischemia.
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Coronary stent evaluation with MDCT: comparison between
low-osmolar, high-iodine concentration iomeprol-400 and
iso-osmolar, lower-iodine concentration iodixanol-320
S. Mushtaq1; D. Andreini2; G. Pontone1; E. Bertella1; E. Conte1;
A. Baggiano1; S. Cortinovis1; G. Ballerini1; M. Pepi1;
C. Fiorentini2
1Cardiology Center Monzino (IRCCS), Milan, Italy; 2Cardiology
Center Monzino (IRCCS), Department of Cardiovascular Sciences,
University of Milan, Milan, Italy
Purpose: To compare Iomeprol-400 with Iodixanol-320 for multide-
tector computed tomography coronary angiography (MDCT-CA)
evaluation of coronary stents. Appropriateness of MDCT-CA stents
evaluation is still a matter for debate and is unknown if contrast
medium characteristics may affect MDCT-CA diagnostic performance.
Methods: We randomized 254 patients undergoing MDCT-CA coro-
nary stent follow-up to Iomeprol-400 at 5.0 mL/second flow rate
(group 1, n = 83), Iodixanol-320 at 6.2 mL/second flow rate (group 2,
n = 87) and Iodixanol-320 at 5.0 mL/second flow rate (group 3,
n = 84). Heart rate (HR) before and after scanning, HR variation,
premature heart beats (PHB) and heat sensation by visual analog scale
(VAS) during scanning were recorded. Mean attenuation was measured
in the aortic root and coronary arteries. Image quality score and type of
artifacts were assessed.
Results: In group 3, VAS was significantly lower than in groups 2 (4.3
vs 5.3 mm) and 1 (4.3 vs 8 mm) and HR after imaging was signifi-
cantly lower than in groups 2 (53.7 vs 56.7 bpm) and 1 (53.7 vs
56.2 bpm). Number of patients with PHB during the scan was signif-
icantly lower in group 3 than in other groups. Mean attenuation was
significantly lower in group 3 than in other groups. In group 3, stent
evaluability was significantly higher and artifact rate was significantly
lower than in group 2 (99% vs 91% and 4% vs 15%) and 1 (99% vs
92% and 4% vs 17%), respectively.
Conclusions: Iodixanol-320 provides better image quality of coronary
stents, allowing higher MDCT-CA evaluability in comparison with
Iomeprol-400.
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Clinical evaluation of Monte Carlo and triple energy
window-based scatter correction in myocardial perfusion
scintigraphy
V. Vitaliy Androshchuk1; L. Hossen1; E. Reyes1;
K. Wechalekar1; J. Bailey1; S. Gregg1; S.R. Underwood1
1Royal Brompton Hospital, London, United Kingdom
Background: Myocardial perfusion scintigraphy (MPS) is degraded by
scattering of photons, which can reduce diagnostic accuracy. Scatter
correction (SC) using the triple-energy-window (TEW) technique can
correct for the degradation but Monte Carlo (MC) simulation is thought
to be more accurate. We have compared a MC-based SC reconstruction
(Hybrid recon, Hermes Medical Solutions) with a TEW technique
(Xeleris, GE Healthcare).
Methods: Twenty consecutive patients with known or suspected cor-
onary disease and a clinical referral for MPS were selected
retrospectively. MPS was performed using 99mTc-tetrofosmin
(250 + 750 MBq 1-day stress-rest protocol) with a dual detector
camera and CT attenuation correction (Infinia Hawkeye, GE Health-
care). Tomograms were reconstructed using iterative reconstruction
alone (NC) and were compared with reconstructions using MC cor-
rection with attenuation and resolution recovery (AR-MC), and TEW
correction with attenuation correction (A-TEW). The studies were
reviewed by an experienced observer blinded to the reconstruction
technique and to the previous clinical report. Parameters recorded were
diagnostic interpretation (normal, reversible, fixed or mixed defects),
interpretative confidence (3-high to 0-absent), image quality score
(3-0), artefact scores (3-0), summed segmental scores, left ventricular
ejection fraction (LVEF) and end-diastolic volume (EDV). The
reconstructions were then viewed in pairs for observer preference.
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Results: There was no difference in diagnosis between NC, AR-MC,
A-TEW (P = .98). Also, there was no difference in diagnostic confi-
dence scores between NC, AR-MC and A-TEW (1.90 ± 0.72,
2.00 ± 0.73, 1.95 ± 0.89, respectively; P = .68). Stress image quality
was higher with AR-MC (2.30 ± 0.66) and NC (2.25 ± 0.64) than
A-TEW (1.65 ± 0.59) (P = .0029 and P = .0018, respectively). AR-
MC had less stress low count artefact than A-TEW (0.25 ± 0.55 vs
0.75 ± 0.55, P = .0066). AR-MC and NC were both preferred over
A-TEW but were equally preferred to each other. Left ventricular
functional data and summed perfusion scores were not significantly
different between techniques.
Conclusion: Imaging performance of MPS with iterative reconstruc-
tion (NC) can be improved more by AR-MC than by A-TEW.
Although the advantage of AR-MC over NC is small at conventional
doses of tracer, it may allow reduction of dose without loss of diag-
nostic performance, but this application remains to be studied.
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Impact of image processing in the detection of ischemia using
CZT-SPECT/CT
D. Danielle Koopman1; J.A. Van Dalen2; C.H. Slump1;
D. Vink3; D. Lots3; P.L. Jager3
1University of Twente, MIRA-Institute for Biomedical Technology
& Technical Medicine, Enschede, Netherlands; 2Isala
Hospital-Department of Clinical Physics, Zwolle, Netherlands; 3Isala
Hospital-Department of Nuclear Medicine, Zwolle, Netherlands
Introduction: The new multipinhole cardiac SPECT/CT cameras with
cadmium zinc-telluride (CZT) detectors are highly sensitive, produce
high image quality but rely on dedicated reconstruction algorithms.
The influence of image processing steps may be different as compared
to standard SPECT protocols. We determined the intra- and inter-
operator variability of these processing steps on the final result of
myocardial perfusion imaging studies.
Methods: The population consisted of 20 consecutive patients (7
women and 13 men, BMI 22-40, age 34-79) who underwent a one-
day protocol stress- and rest CZT-SPECT/CT (GE Discovery NM/
CT 570c) using Tc99m-tetrofosmin. Data were processed twice by
three experienced operators. Processing steps include determining of
myocardial axes and boundaries, masking of the myocardium and
manual SPECT/CT co-registration for attenuation correction. We
used a 17-segment cardiac model and calculated the difference
between stress and rest of % segmental uptake values (after nor-
malisation of peak activity to 100%) for non-corrected (NC) and
attenuation-corrected (AC) image sets. AC includes one extra pro-
cessing step, i.e. SPECT/CT co-registration. Operator variation was
considered significant for the diagnosis of ischemia when greater
than 5%.
Results: As a measure of inter-operator variation, the mean operator
variation across all 340 segments was 2.5% (Q1-Q3: 1.8-2.8%) for the
NC—and 4.2% (Q1-Q3: 3.2-5.1%) for AC images (P \ .01). In more
than 3% (NC) and 28% (AC) of the cases, inter-operator variation was
greater than 5%. The mean intra-operator variation across all 680
segments was 2.2% (Q1-Q3: 1.6-2.2%) for the NC—and 3.4% (Q1-Q3:
2.6-3.9%) for AC images. In more than 5% (NC) and 13% (AC) of the
cases, intra-operator variation was greater than 5%.
Conclusion: Intra- and inter-operator variation in image processing of
SPECT-CT CZT gamma camera data is significant and may influence
the final diagnosis of ischemia. Especially the use of attenuation cor-
rection significantly increases this variation. Clearer guidelines for
image processing are necessary in order to improve the reproducibility
of the results and to obtain a more reliable diagnosis of ischemia.
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How reliable is left ventricular parameters measured by
QGS?
A. Alp Notghi1; G. James1; A. Jennings1; J. O’brien1
1Sandwell and West Birmingham Hospitals NHS Trust, Birmingham,
United Kingdom
We have looked at repeatability of LV function parameters in the same
patient using gated myocardial perfusion scan (MPS).
16 patients (6 male, 10 female) were entered into this study, median
age of 69 (range 34-69 years), mean weight of 76 kg (range 44-90 kg).
Each patient had three consecutive MPS. Rest MPS (400 MBq tetro-
fosmin) was followed on the same day with stress MPS (800 MBq),
pattient then returned for a second rest MPS (400 MBq) the next day.
On each occasion two consecutive MPI acquisitions were performed
(180 degrees, 60 projections 18 seconds/projection, 8 bin gating). The
two consecutive studies were added to obtain the equivalent of a
standard full time acquisition for each occasion. Cedar Sinai QGS
(Autoquant7 Philips Medical Systems) was used to obtain EDV, ESV
and LVEF. Paired t-test (P) and Pearson correlation (r) was calculated
to compare data.
There was a wide range of EDV (76-333 mL), ESV (7-226 mL) and
EF (21-73%). The full-time stress data were analysed twice (n = 16),
to establish the repeatability of the QGS calculations. There was no
significant difference in the EDV, ESV and EF when same data were
analysed twice (Pearson correlation 0.993, 0.998 and 0.971 respec-
tively, mean difference 0.38 mL, 0.68 mL, 0% respectively, P NS).
Then day one and day two rest studies were compared (n = 16). This
compared results obtained at separate occasions from the same patient.
There was no significant difference in calculated EDV, ESV or EF
between the two separate rest studies (Pearson correlation 0.989, 0.992
and 0.938 respectively, mean difference 0.44 mL, 0.81 mL, 0.37%
respectively, P NS).
Finally the half-time consecutive studies where compared (n = 32) to
see if the QGS calculations are reliably reproducible in low count
acquisitions when conceivable the ventricular wall delineation may be
difficult. There was again no difference in the results of paired EDV,
ESV, and EF (Pearson correlation 0.996, 0.996 and 0.961 respectively,
mean difference 0.61 mL, 1.00 mL, 0.82% respectively, P NS).
Conclusion: QGS gives reproducible parameters for consecutive
measurements of left ventricular function. The results suggest very
high accuracy of reproducibility for individual patients even with very
low count studies.
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Gated blood pool SPECT: QBS software performs better
with iterative reconstruction combined to resolution
recovery than with filtered backprojection
D. Doumit Daou1; C. Coaguila2; C. Meyer1; F. Amegassi1
1APHP, Cochin Hospital, Department of Nuclear Medicine, Paris,
France; 2Hospital Sud-Francilien, Corbeil-Essonnes, France
Purpose: Gated blood pool SPECT (GSPECT RNA) radionuclide
angiography (RNA) is interesting for the evaluation of cardiac func-
tion. We previously validated the use of QBS software (Cedars Sinai)
for the quantification of both left ventricular (LV) and right ventricular
(RV) function. This was done with filtered backprojection recon-
struction method (FBP). We aimed to study the performance of the
QBS software for the quantification LV and RV function when using
FBP as compared to iterative reconstruction with resolution recovery
(3D-Flash, Siemens).
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Methods: Our study included 83 patient addressed for LV and RV
function evaluation with planar (left anterior oblique view, planar-
LAO) and GSPECT RNA. Studies were acquired on a two-headed
gamma-camera (Symbia, Siemens). PlanarLAO studies were processed
with the NXT program (Vision, GEMS) and provided both planarLAO
LVEF and RVEF. GSPECT RNA studies were reconstructed using two
different methods (FBP and 3D-Flash) and then processed with the
QBS software. Results provided with the maximal activity threshold
method (MAT) method of QBS were noted for both FBP and 3D-
Flash: LV and RV end diastolic volumes (EDV), end systolic volumes
(ESV) and stroke volumes (SV), as well as LVEF and RVEF (ratio of
activities of MAT method). For comparison of the performance of FBP
vs 3D-Flash, planarLAO LVEF and RVEF were considered gold
standard. And for RV and LV volumes, we hypothesized that the best
reconstruction method would be the one providing the highest corre-
lation between RV-SV and LV-SV.
Results: LVEF provided by planarLAO (58 ± 10%) is highly corre-
lated to LVEF measured with QBS-FBP 69 ± 16%, r = 0.8;
P \ .0001) and QBS-3D-Flash (68 ± 16, r = 0.82; P \ .0001). On
Bland Altman analysis, the limits of agreement of LVEF for QBS-FBP
vs planarLAO (mean ± sd = -11.2% ± 10.5%) are slightly wider
than those for QBS-3D-Flash vs planarLAO (-10.5% ± 9.6%). RVEF
provided by planarLAO (45 ± 9%) was better correlated to RVEF
measured with QBS-3D-Flash (53 ± 12%, r = 0.45; P \ .0001) than
QBS-FBP (49% ± 13%, r = 0.28; P \ .05).
Linear correlation between LV-SV and RV-SV is higher with QBS-
3D-Flash (80 ± 22 mL and 91 ± 27 mL, r = 0.6; P \ .0001) than
with QBS-FBP (86 ± 26 and 116 ± 36 mL, r = 0.2; P \ .05).
Conclusions: QBS performs better when using 3D-Flash than FBP for
the quantification of cardiac function particularly for the RV.
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The effect of a beta-blocker on myocardial blood flow under
adenosine quantitatively measured with N-13-ammonia PET
O. Oliver Lindner1; R. Preuss1; R. Weise1; W. Burchert1
1HDZ NRW, Ruhr-University Bochum, Institute for Radiology, Nuclear
Medicine & Molecular Imaging, Bad Oeynhausen, Germany
Purpose: Despite maximal vasodilation by pharmacologic vasodilators
such as dipyridamol, adenosine or regadenoson an interaction with
beta-blockers has been suggested. However, the results of some recent
SPECT studies on the impact of beta blockers on the results of stress
testing with adenosine in myocardial perfusion imaging are
contradictory.
Methods: We studied seven male patients with history of CAD with
N-13-ammonia PET-CT (Siemens mCT) under adenosine infusion
(infusion time 6 minutes, injection of N-13-ammonia 2 minutes after
onset of the infusion) with beta blockers and after withdrawal of the
individual beta blocker for at least three half-lives. Myocardial blood
flow (MBF) was quantified based on an irreversible two-compartment
model.
Results: MBF under beta blockade was 195.4 ± 51.6 mL/100 g/min-
ute and significantly lower than after withdrawal of the individual beta
blocker (215.5 ± 47.6 mL/minute/100 g). RRsys did not change and
was 109 ± 13 mmHg with beta blocker and 112 ± 14 without beta
blocker (P = .23). RRdia and heart rate increased significantly after
withdrawal of beta blocker (51 ± 7 mmHg vs 55 ± 6 mmHg and
65 ± 10/minute vs 80 ± 6/minute, P \ .05). Coronary resistance was
0.40 ± 0.12 mmHg 9 100 g 9 minute/mL with beta blocker and
0.36 ± 0.09 mmHg 9 100 g 9 minute/mL without beta blocker.
Related to a rate pressure product of 10,000 mmHg/minute MBF with
beta blocker was 290.6 ± 112.0 mL/minute/100 g and without beta
blocker 245.2 ± 72.3 mL/minute/100 g (P = .07).
Conclusions: Beta blockers have a significant impact on MBF which is
decreased by about 10%. This effect is not exclusively related to
hemodynamic changes. However, we conclude that the impact on the
accuracy of SPECT imaging with adenosine under beta blockade is
small due to the uptake-flow characteristics of the current radiophar-
maceuticals. Nevertheless, we recommend to withdraw a beta blocker
in myocardial perfusion imaging if possible.
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Reduced radiation exposure in patients with new cadmium-
zinc-telluride cardiac cameras
B. Bernard Songy1; M. Guernou1; D. Lussato1; M. Queneau1
1Centre Cardiologique du Nord (CCN), Paris, France
Purpose: Myocardial perfusion imaging is an essential tool for man-
agement of coronary artery disease but leads to relative high radiation
exposure and contributes up to 20% of the estimated annual collective
radiation dose and could potentially result in additional cancers. The
American Society of Nuclear Cardiology recommends that laboratories
use imaging protocols that achieve a radiation exposure of no more
than 9 mSv in 50% of studies by 2014. Cadmium-zinc-telluride (CZT)
cardiac cameras have high myocardial counting efficiency that allows
to decrease injected activities.
Methods: We explored 20,000 patients with CZT cameras (GE DNM
530c) since 2009. We study here the feasibility of low dose protocols
and the consequences on effective dose in clinical practice.
Results: For patients without known coronary artery disease, we use
Tc99m-sestaMIBI or tetrofosmin. We inject activity from 1.5 to
2 MBq/kg, i.e., 3 mCi for 70 kg weight. Effective dose is thus less
than 1 mSv. Myocardial raw counts are higher with CZT cameras
(343 ± 87 kcounts) than with conventional Anger cameras and regular
injected activities (209 ± 40 kcounts). We observe fewer artifacts with
the CZT cameras leading to fewer equivocal results. Thus more
patients can undergo only stress imaging, leading to an even more
important decrease in radiation exposure. For patients with known
coronary artery disease, we use thallium-201 because its high uptake,
especially at stress. Additionally, it offers an alternative to molybde-
num–technetium shortage. Because radiation exposure is an important
concern with thallium-201, we dramatically decrease injected activities
down to 0.66 MBq/kg, i.e. 1.2 mCi for 70 kg weight, leading to an
effective dose of 7 mSv. Myocardial raw counts are higher with CZT
cameras (446 ± 53 kcounts) than with conventional myocardial per-
fusion imaging. We observe fewer artifacts (P \ .01), especially in
inferior (-78%) and anterior territories (-45%). The diagnostic
agreement between CZT and cardiac cameras is high (97%).
When a dual isotope protocol is used, with stress thallium and rest
technetium agent, the effective dose remains lower than 9 mSv.
Conclusions: The CZT cardiac cameras allow very low dose protocols
with high myocardial imaging quality and high diagnosis
performances.
Stress only protocols with technetium agents lead to an effective dose
lower than 1 mSv.
Thallium-201 or dual isotope protocols achieve a radiation exposure of
no more than 9 mSv, complying with the recommendations of the
American Society of Nuclear Cardiology.
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Monte Carlo simulations of a small animal PET system for
small rodent heart imaging
M.J. Park1; M. Lassmann2; R. Dominik2; L. Lemeunier3;
T. Yamane2; F. Kaiser1; T. Higuchi1
1Wu¨rzburg University, CHFC/Nuclear Medicine, Wu¨rzburg, Germany;
2University Hospital of Wu¨rzburg, Department of Nuclear Medicine,
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Wu¨rzburg, Germany; 3Siemens healthcare, Imaging & Therapy divi-
sion, Erlangen, Germany
Purpose: A combination of a realistic digital phantom of anatomical
structure and Monte Carlo methods based on high-energy physics
allows simulating realistic PET projections of anatomy and physiol-
ogy. The aim of this study is to develop and validate the simulation
platform to study image degradation and compensation methods in
rodent cardiac PET imaging.
Methods: We built a simulation platform using a MC simulation
method (Geant4 Application for Emission Tomography, GATE) and
Software for Tomographic Image Reconstruction (STIR) based on the
scanner configuration and the data collecting system of a dedicated
small animal PET system (SIEMENS Inveon). In order to validate the
simulation platform, the simulation was compared to the measurement
on the real scanner using a line source filled with 16.4 MBq F-18.
Moby phantom was used to simulate heart images of mouse and rat.
Attenuation and partial volume artifacts were measured on the
reconstructed images.
Results: The difference of average full width at half maximum
(FWHM) between simulated and measured sinograms was less than
1% for spatial resolution. Rat and mouse heart images were success-
fully obtained on the simulation platform. Photon attenuation reduced
the counts of the left ventricular wall by 36% and 20% in rat and mice,
respectively. Modifications of the left ventricular wall thickness to
2.6 mm (rat, end-diastolic), 1.8 mm (rat, end-systolic), 1.0 mm (mice,
ED), and 0.7 mm (mice, ES) resulted in count losses of 22%, 44%,
77%, and 87%, respectively, reflecting partial volume artifacts.
Conclusions: We established a computer simulation platform to study
small rodent heart micro PET images. The potential use is to study
various image degradation artifacts, as well as to develop and test new
compensation algorithms.
Partial volume effect on rodent hearts
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Reducing patient radiation exposure: A novel method of
coronary artery calcium scoring using images derived from
CT angiography
C.W. Chris Pavitt1; A.C. Lindsay1; R. Ray1; S. Zielke1;
S. Padley1; M. Rubens1; E. Nicol1
1Royal Brompton National Heart & Lung Hospital, London,
United Kingdom
Introduction: Coronary artery calcium scoring (CACS) requires an
additional acquisition prior to coronary CT angiography (CTA). We
hypothesised that the CACS can be accurately derived from CTA using
a novel analysis technique.
Methods: 120 consecutive patients undergoing CACS and CTA
between January and May 2011 were included. A 0.1 cm2 region of
interest was used to determine the mean contrast density on CTA in the
left main (LM), or the right coronary (RC) artery if the LM was
significantly calcified (n = 8). From this, a new attenuation threshold
was calculated as: mean LM/RC contrast density + 2SD (HU).
Applying this threshold CACS was calculated from axial CTA images
using conventional CACS software. Results were compared to con-
ventional CACS (130HU threshold). Agatston risk categories (0, 1-10,
11-100, 101-400 and [400) were derived from both methods. Linear
regression and Bland-Altman analysis (Figure) were performed.
Results: The mean traditional CACS was double (2.0; 95% CI 1.84-
2.14) the mean CTA-derived CACS (108.3 vs 55.4, respectively).
CTA-derived CACS correlated well with traditional CACS
(R2 = 0.86; P \ .001) representing 18.5 ± 10.3% of the total radiation
dose.
Conclusion: CACS can be accurately quantified from coronary CTA
images using a semi-automated method that reduces acquisition time
and radiation exposure. At higher CACS values correlation is less
robust but remains clinically valuable in its ability to identify high risk
patients.
80
Bismuth breast shield and adaptive statistical iterative
reconstruction (ASIR) in coronary CT angiography: lower
dose without loss in image quality
J.O. Jussi Oskari Tuomi1; S. Kajander1; A. Saraste1; J. Knuuti1
1Turku PET Centre, University of Turku & Turku University Hospital,
Turku, Finland
Purpose: To compare the effects of bismuth breast shield and image
reconstruction method on image quality in coronary CT angiography.
Background: Despite efforts to contain irradiation, collective dose
due to CT continues to grow. Therefore, new ways to combine diag-
nostic image quality and acceptable radiation dose are important.
Female breast is one of the tissues most prone to harmful biological
effects of irradiation and is within field-of-view in CT coronary
angiography. The breast dose may be reduced by 26.9-52.4% by using
a bismuth shield but the effects of such protection on diagnostic image
quality remains disputed. New reconstruction techniques, now feasible
due to improvements in data handling, are available and reduce patient
dose.
Methods: 30 women underwent scheduled coronary CT angiography.
After randomization, 15 women were scanned with a bismuth breast
shield and 15 without. Each patient’s BMI was calculated and raw CT
data was reconstructed with standard filtered back projection (FBP)
and various degrees (20%, 40%, 60% and 80%) of adaptive statistical
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iterative reconstruction (ASIR). Two experienced physicians graded
the created images using a 4-point scaling system according to their
apparent diagnostic quality. In addition, image signal and noise was
recorded at predetermined areas from each reconstruction.
Results: There was a statistically significant difference in subjective
image quality between reconstructing with filtered back projection
(=ASIR 0%) and ASIR 40 %: ASIR 0 % results worse image quality
than ASIR 40% (P = .002). Further increase of ASIR percentage
seemed to impair subjective image quality. Bismuth breast shield does
not deteriorate the subjective diagnostic quality of images (P = .70).
However, bismuth breast shield decreases image signal approximately
by 14.9 HU and causes more noise in predetermined areas
(P = .027).
Conclusions: Moderate (40%) ASIR reconstruction improves image
quality in CT angiography. Use of bismuth breast shield in women is
possible without sacrificing diagnostic image quality.
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Gated SPECT phase analysis in LBBB
H. Pena1; G. Cantinho1; A. Veiga2; J. Monteiro3; F. Godinho3
1Faculdade de Medicina de Lisboa, Instituto de Medicina Nuclear,
Lisbon, Portugal; 2Hospital Lisbon North, Hospital Santa Maria,
Lisbon, Portugal; 3Atomedical, SA, Lisbon, Portugal
Introduction: Cardiac resynchronization therapy (CRT) has shown
benefits in patients with severe heart failure. However, 20-30% of the
patients selected by conventional criteria show no response. Predicting
which ones will respond is a challenge.
Methods based on cardiac cycle analysis from myocardial perfusion
(gSPECT) have proved to be promising.
To assess the sensitivity of the technique, we used it in the charac-
terization of individuals with LBBB, selected by QRS duration.
Material and Methods: From the patients investigated because of
coronary heart disease (CHD), without evidence of MI, we selected:
– 60: QRS \ 90 ms and gSPECT normal, 30 women (68 ± 11 years)
and 30 men (65 ± 12);
– 150: LBBB and QRS [ 120 ms, 85 women (69.5 ± 10.5) and 65
men (69.5 ± 9.7).
According to the result of gSPECT, they were divided in three groups:
(1) dilated (without coronary disease), (2) normal LV size and perfu-
sion and (3) evidence of coronary disease (CD).
All underwent 30 mCi 99mTc-MIBI gSPECT (rest and pharmaco-
logical stress), reconstructed iteratively by WBR. Germano’s QGS and
QPS methods were used to quantify LV function and perfusion. To
analyze the onset of LV mechanical contraction, we used Garcia’s
method: phase histogram by Fourier analysis with determination of:
peak phase (PP), standard deviation (SD), bandwidth (HB), skewness
(HS) and kurtosis (HK) of the histogram.
We calculated the mean, the standard deviation and non-paired Student
t test was applied. These parameters were then correlated with the QRS
duration.
Cases were calculated with 1 SD, as used in the theoretically normal
phase parameters
Results: We found no statistically significant differences in the vari-
ables age and heart rate.
The parameters of LV function revealed differences in the population
with LBBB.
The diastolic parameters showed erratic changes (weak robustness of
the methodology).
There was no correlation between the histogram variables, QRS
duration and sex.
In the phase histogram, 4 of the 5 parameters were abnormal in indi-
viduals with LBBB (P \ .05), with greater significance in dilated
LBBB with CD (P \ .0001). Over 90% of cases showed abnormal
values in four parameters.
Conclusions: This gSPECT phase analysis revealed a strong dis-
criminative power on four parameters that quantify desynchrony in
patients with LBBB, reinforcing its promising capacity to select
patients for CRT. It permits to determine the later contraction location,
excluding areas of necrosis, which can guide therapy. It requires
however further studies of correlation with conventional parameters.
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Bolus administration of ultra-short acting esmolol is safe and
effective for heart rate control during coronary computed
tomography angiography
M. Karolyi1; A. Bartykowszki1; N. Pinter1; C.S. Csobay-Novak1;
G.Y. Balazs1; B. Merkely1; P. Maurovich-Horvat1
1Semmelweis University, Heart Center, Budapest, Hungary
Purpose: Heart rate (HR) control of patients undergo coronary CT
angiography (CCTA) to achieve diagnostic image quality is optimally
limited to the time of scan. Thus, intravenous administration of ultra-
short acting esmolol may be an alternative to iv metoprolol for safe HR
control during CCTA.
Methods: iv esmolol or metoprolol was administered on alternating
days to patients referred to CCTA (Brilliance iCT 256, Philips
Healthcare) if HR was C60 bmp before scan. Ascending doses of es-
molol (100-200-200 mg independent of patient’s weight; maximum
500 mg) or metoprolol (5-10-15-20 mg according to SCCT recom-
mendations; maximum 25 mg) were administered. HR and blood
pressure (BP) was recorded at arrival (T0), prior (T1), during (TS),
immediately after (T2) and 30 minutes after examination (T3).
Results: 572 consecutive patients were scanned (306 male, mean age
58 ± 11, BMI 28.3 ± 5.3). 202 received iv esmolol (E), 208 iv meto-
prolol (M) and 162 no iv drug. Median HR of the E and M group were
similar at T0 (76.5 bpm [69-87] vs 76 bpm [69-84], P = .79) and at
T1 (67 bpm [62-74] vs 68 bpm [63-73], P = .55). However HR at TS,
T2 and at T3 was significantly higher in the E group (58 bpm [54-61]
vs 60 bpm [56-64], P = .00009; 67 bpm [63-72] vs 65 bpm [60-70],
P = .0025; 65 bpm [60-69] vs 62 bpm [57-69], P = .0013, respec-
tively). BP showed no difference between the E and M group at T0, T1,
T2 and T3. HR B 60 was reached in 72.8% (147/202) of the E vs
56.7% (118/208) of the M group (P = .0009); HR B 65 was reached
in 89.6% (181/202) of the E vs 78.4% (163/208) of the M group
(P = .002). No side effects were registered.
Conclusion: Intravenous bolus administration of esmolol with a novel
administration protocol independent of body weight is safe and
effective for heart rate control in patients assigned to CCTA.
83
Aortic annulus area assessment by multidetector computed
tomography for predicting paravalvular regurgitation in
patients undergoing balloon-expandable transcatheter aortic
valve implantation
G. Gianluca Pontone1; D. Andreini1; E. Bertella1; S. Mushtaq1;
S. Cortinovis1; A.D. Annoni1; A. Formenti1; G. Ballerini1;
M. Pepi1
1University of Milan, Foundation Monzino (IRCCS), Center
Cardiology, Department of Cardiology, Milan, Italy
Purpose: Transcatheter aortic valve implantation (TAVI) is a valid
alternative to surgery in high risk patients with severe aortic stenosis
(AS). Aortic annulus (AoA) sizing is crucial for TAVI success. The
aim of the study is to compare AoA dimensions measured by mul-
tidetetctor computed tomography (MDCT) vs those obtained with
transthoracic (TTE) and transesophageal echocardiography (TEE) for
predicting paravalvular aortic regurgitation (PVR) after TAVI.
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Materials and Methods: AoA maximum diameter, minimum diameter
and area were assessed with MDCT and compared to TTE and TEE
diameter and area for predicting PVR after TAVI in 151 patients (45
men, age 81.2 ± 6.4 years).
Results: AoA maximum, minimum diameter and area detected by
MDCT were 25.04 ± 2.39 mm, 21.27 ± 2.10 mm, and 420.87 ±
76.10 mm2, respectively. AoA diameter and area measured by TTE
and TEE were 21.14 ± 1.94 mm, 353.82 ± 64.57 mm2, 22.04 ±
1.94 mm and 384.33 ± 67.30 mm2, respectively. A good correlation
was found between AoA diameters and area evaluated by MDCT vs
TTE and TEE (0.61, 0.65 and 0.69, and 0.61, 0.65, and 0.70, respec-
tively) with a mean difference of 3.90 ± 1.98 mm, 0.13 ± 1.67 mm
and 67.05 ± 55.87 mm2, and 3.0 ± 2.0 mm, 0.77 ± 1.70 mm and
36.54 ± 56.43 mm2, respectively. Grade C 2 PVR occurred in 46
patients and was related to male gender, higher BMI, pre-procedural
aortic regurgitation and lower mismatch between the nominal area of
the implanted prosthesis and AoA-AMDCT.
Conclusions: Mismatch between prosthesis area and AoA area
detected by MDCT is a better predictor of PVR as compared to
echocardiography mismatch. Specific MDCT-based sizing recom-
mendations should be developed.
84
Cardiac and respiratory dual-gated PET imaging of the rat
heart
T. Yamane1; M.J. Park2; F. Kaiser2; S. Samnick1; R. Dominik1;
T. Higuchi2
1University of Wu¨rzburg, Department of Nuclear Medicine, Wu¨rzburg,
Germany; 2University of Wu¨rzburg, Comprehensive Heart Failure
Center, Wu¨rzburg, Germany
Purpose: Movement of the heart from cardiac contraction and respi-
ration potentially causes degradation of the myocardial PET images.
The purpose of this study is to characterize these motion artifacts in a
setting of rat heart and small animal PET system using dual-gated
imaging approach.
Methods: Dual-gated PET acquisition for ECG cardiac and respiratory
cycles was performed after an administration of approximately
74 MBq F-18 FDG in the male Wister rats (27 scan sessions in 10
animals) using high-resolution dedicated small animal PET system
(Siemens Inveon) and external trigger system (BioVet). The acquired
list mode data were sorted and reconstructed into 64 frames of dual-
gating images consisted with 8 frames per ECG cycles and 8 frames
per respiratory cycle. Non-gated single frame images were also
reconstructed. Movement of the hearts and myocardial activity distri-
bution were evaluated for both cardiac and respiratory cycles.
Influence on respiratory motion by the animal position during the scan
session (spine or prone) and presence of myocardial infarction were
analyzed.
Results: The mean and standard deviation of ventricular wall move-
ments estimated from the gated PET images were 1.0 ± 0.4, 1.2 ± 0.4,
0.5 ± 0.2, 0.5 ± 0.2 and 0.5 ± 0.2 for respiratory gating, and 1.4 ± 0.4,
0.9 ± 0.3, 0.7 ± 0.2, 1.5 ± 0.5 and 1.7 ± 0.5 for cardiac cycle at the
apex, septal, lateral, anterior and inferior walls, respectively. Measured
ventricular activity increased in the systolic phase due to the less
partial volume effects compare to diastolic phase and non-gated ima-
ges. Respiratory motion caused count reduction significantly (P \ .01)
at non-gated image with 6.0 ± 5.4%, 3.1 ± 5.7%, 2.6 ± 4.3% and
3.0 ± 6.4% in septal, anterior, lateral and inferior walls, respectively.
Animal position during the scan and presence of a myocardial
infarction did not change the respiratory motion effects significantly.
Conclusions: Dual-gated imaging with small animal PET system
allows estimating motion artifacts of the rat hearts for both cardiac
and respiratory cycles. There was a minimal but significant
count reduction caused by the respiratory motion in the myocardial
walls.
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Phase gated SPECT in LBBB heart failure
H. Pena1; G. Cantinho1; A. Veiga2; F. Godinho3
1Faculdade de Medicina de Lisboa, Instituto de Medicina Nuclear,
Lisbon, Portugal; 2Hospital Lisbon North, Hospital Santa Maria,
Lisbon, Portugal; 3Atomedical, SA, Lisbon, Portugal
Aim: Phase analysis applied to gated SPECT myocardial perfusion
studies (GMPS) allows determining the regional onset timing evalua-
tion of mechanical left ventricular contraction.
This method (E. Garcia) uses 5 indices in its normal database, four of
which are consistently abnormal in LBBB patients without heart fail-
ure (HF). In our study, we pretend to evaluate how powerful these
indices are to discriminate LBBB patients with and without HF,
allowing a more accurate selection of potential candidates for cardiac
resynchronization therapy (CRT).
Material & Methods: G1: 21 men (65 ± 10 y/o) (G1 m) and 11
women (67 ± 11 y/o) (G1w) with LVEF B 35%, EDV C 130 ml,
QRS C 120 ms and no CAD.
G2: 36 men (65 ± 10 y/o) (G2 m) and 66 women (67 ± 11 y/o) (G2w)
with LVEF [ 35%, EDV \ 130 ml, QRS C 120 ms and no CAD.
All were submitted to GMPS rest and gated stress with 20 mCi 99mTc-
Tetrofosmin, reconstructed iteratively by WBR Xpress3. Germano’s
QGS and QPS were used to quantify LV function and perfusion.
E. Garcia’s Phase Analysis was used to evaluate LV dyssynchrony
with determination of peak phase (PP), phase standard deviation (SD),
as well as histogram bandwidth (HB), skewness (HS) and kurtosis
(HK).
We calculated the mean and its standard deviation and applied
unpaired student t test for G1 and G2 subgroups comparison. These
parameters were also correlated with QRS duration, LVEF and
volumes.
We used 1 and 2 SD from the normal mean database values to
determine the percentage of patients outside that range.
Results: In the phase histogram, all the indices (except PP) were
consistently different (P \ .01).
All the HF patients (G1) had SD and HB above normal range and 95%
showed low HS (even with 2SD), while the same doesn’t happen for
G2. LV functional parameters (LVEF, EDV and ESV) were statisti-
cally different (P \ .005)
We found no statistically significant differences in age, heart rate or
QRS duration.
There were no significant differences between sexes, except for the
functional parameters in dilated LVs (G2).
Conclusions: GMPS phase analysis of in HF seems to be a useful
method to evaluate LV dyssynchrony.
HB, phase SD and HS are the most consistently and greater abnormal
variables, depicting a greater dyssynchrony (independently of LVEF or
QRS duration), as a potential independent discriminative parameter.
The lower number of patients with low HK (2SD) is yet to be
explained. These 4 GMPS phase analysis parameters may therefore
play a potential adjuvant role in the future to select HF patients for
CRT.
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Accuracy of aortic root annulus assessment with cardiac
magnetic resonance in patients referred for transcatheter
aortic valve implantation: A comparison with multi-detector
computed tomography
G. Gianluca Pontone1; D. Andreini1; E. Bertella1; S. Mushtaq1;
P. Gripari1; S. Cortinovis1; A.D. Annoni1; A. Formenti1;
G. Ballerini1; M. Pepi1;
1University of Milan, Foundation Monzino (IRCCS), Center
Cardiology, Department of Cardiology, Milan, Italy
Purpose: To compare the accuracy of cardiac magnetic resonance
(CMR) evaluation of the aortic root as compared to multi-detector
computed tomography (MDCT) in patients referred for transcatheter
aortic valve implantation (TAVI).
Materials and Methods: In 50 patients, the following parameters were
assessed with CMR and compared with those obtained with MDCT: aortic
annulus (AoA) maximum diameter (AoA-Dmax), minimum diameter
(AoA-Dmin), and area (AoA-A), length of the left coronary, right coro-
nary, and non-coronary aortic leaflets, degree (grades 1 to 4) of aortic
leaflet calcification and distance between AoA and coronary artery ostia.
Results: AoA-Dmax, AoA-Dmin and AoA-A were 26.45 ± 2.83 mm,
20.17 ± 2.20 mm, 444.88 ± 84.61 mm2 and 26.45 ± 2.76 mm,
20.59 ± 2.35 and 449.78 ± 86.22 mm2 by MDCT and CMR, respec-
tively. The length of left coronary, right coronary, and non-coronary
leaflets were 14.02 ± 2.27 mm, 13.33 ± 2.33 mm, 13.39 ± 1.97 mm,
and 13.95 ± 2.18 mm, 13.30 ± 2.14 mm, 13.46 ± 1.80 mm by
MDCT and CMR, respectively, while the scores of aortic leaflet cal-
cifications were 3.4 ± 0.7 vs 2.97 ± 0.77. Finally, the distance between
AoA and left main and right coronary artery ostia was 16.21 ±
3.07 mm, 16.02 ± 4.29 mm and 16.14 ± 2.83 mm, 16.14 ± 4.36 mm
by CCT and CMR, respectively. There was close agreement between
CMR and MDCT measurements, whereas aortic leaflet calcifications
were underestimated by CMR.
Conclusions: Aortic root assessment with CMR including AoA size,
aortic leaflet length and coronary artery ostia height is accurate in
comparison to MDCT. CMR may be a valid imaging alternative in
patients unsuitable for MDCT.
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Comparison of two different strategies of intravascular
ultrasound guidance during percutaneous coronary
intervention
J.B. Jae Bin Seo1; H.S. Kim2
1Boramae Hospital, Seoul, Republic of Korea; 2Seoul National
University Hospital, Seoul, Republic of Korea
Background: Intravascular ultrasound (IVUS) is helpful during per-
cutaneous coronary intervention (PCI), because we can confirm the
good apposition or optimal expansion of stents. In DES era, there has
been one study to show the utility of IVUS guidance compared with
no-guidance. In this study, we compared the angiographic result as
well as clinical outcome between the two different strategies of IVUS-
guidance, the selective vs the routine.
Methods and Results: For this study, we have divided physicians for
3 years into two groups; doctors to do PCI under ‘routine’ IVUS-
guidance vs PCI under ‘selective’ IVUS-guidance. Among total 279
patients (384 lesions) who underwent PCI with TAXUS stent, 87
patients underwent it under the strategy of ‘routine’ IVUS-guidance
whereas 192 patients under ‘selective’ IVUS-guidance where IVUS
was used only when it is judged to be necessary by physicians.
Baseline clinical features of the patients are similar between two
groups. The actual rate of IVUS usage was 89.2% in the routine group
whereas 68.2% in the selective group (P \ .01). Remarkable proce-
dure-related parameter was the high rate of adjunctive ballooning,
which was comparable between the two groups (72.5 vs 76.1% in
routine vs selective, P = .57). We analyzed serial angiographic data,
pre-PCI, immediate post-PCI, and follow-up at 6-9 months. The
minimal lumen diameter at the immediate post-PCI was significantly
wider in routine IVUS group than in selective one (2.58 vs 2.48 mm in
routine vs selective, P = .03). But the difference disappeared at fol-
low-up period (1.98 vs 1.98 mm in routine vs selective, P = .94).
Clinical outcomes at 1 year were not different between the two groups,
including death, myocardial infarction, target lesion revascularization,
or composites.
Conclusions: PCI under the strategy of ‘selective’ IVUS-guidance was
comparable to PCI under ‘routine’ IVUS-guidance in terms of angio-
graphic and clinical outcomes when we frequently use adjunctive
ballooning after stenting.
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Application of a new left ventricular edge-detection
algorithm to small hearts: Effects of correction in Japanese
patients
K. Nakajima1; K. Okuda1; K. Nystrom2; J. Richter2; S. Matsuo1;
S. Kinuya1; L. Edenbrandt3
1Kanazawa University, Kanazawa, Japan; 2EXINI Diagnostics,
Lund, Sweden; 3University of Gothenburg, Gothenburg, Sweden
Purpose: In gated SPECT, determination of volume and ejection
fraction (EF) in small hearts has been considered inaccurate. In a
Japanese female population, in particular, more than half of the
patients showed an end-systolic volume (ESV) B 20 mL as calculated
by QGS software (Cedars Sinai Medical Center, USA). The aim of this
study was to develop a new edge-tracing method for the left ventricular
myocardium in small hearts.
Methods: The 3D-segmentation of the left ventricle was based on a
heart shaped model and the active shape algorithm (EXINI Diagnos-
tics, Sweden) (ExH). The model contained statistical information of
the variability of left ventricular shape. In small hearts, due to the
partial volume effect and the short distance to the opposite ventricular
wall, the endocardial and the epicardial surfaces were shifted in the
epicardial direction. The correction was dependent on the volume of
the left ventricle. This algorithm was tested in two groups of patients:
(1) normal databases created by multi-center working group activity in
Japan (n = 47, m/f = 29/18, ESV \ 10 excluded), and (2) consecu-
tive Japanese patients (n = 116, m/f = 79/37) who underwent stress-
rest gated SPECT. The end-diastolic volume (EDV), ESV and EF were
calculated and compared with the results by QGS. The small heart was
defined as ESV B 20 mL: ESV of 0-10 mL (Group SH10) and ESV of
11-20 mL (Group SH20) and compared to ESV C 20 mL (Group NH).
Results: In normal databases, small heart was observed in 43% of the
subjects. In the small-heart subjects, EF was 74 ± 4% and 71 ± 7% for
QGS and ExH (P = n.s. between QGS and ExH), EDV was 62 ± 8 and
85 ± 11 mL (P \ .0001), and ESV was 16 ± 3 and 24 ± 4 mL
(P \ .0001), respectively. In consecutive 116 patients, frequency of the
small heart was 84% for female (43% and 41% in Groups SH20 and
SH10), and 37% for male (27% and 10% in Groups SH20 and SH10). With
QGS software EFs were 55 ± 16%, 72 ± 7% and 83 ± 5% for Groups
NH, SH20 and SH10, respectively (P = .0001). In contrast, with ExH
software, EFs were 64 ± 14%, 69 ± 11% and 69 ± 7% for the same ESV
groups, respectively (P = n. s.). Particularly in subjects with small hearts
(SH10) defined by QGS, EDV was 40 ± 7 and 57 ± 7 mL for QGS and
ExH, respectively and ESV was 7 ± 2 and 18 ± 3 mL.
Conclusions: In a Japanese population the incidence of small hearts
was high particularly in consecutive female patients (approximately
80%). The optimal technical correction is required to overcome errors
in calculation. The algorithm of ExH provided uniform EFs for a wide
range of ESV, and common standard EF values might be used in
patients with normal and small hearts.
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Individual determination of lesion-associated left ventricular
segments on the basis of coronary angiography: Validation
by fractional flow reserve measurements and stress perfusion
SPECT studies
C.S. Csaba Jenei1; B. Kracsko1; I. Racz1; G.T. Szabo1;
F. Gyory1; G. Vajda1; I. Edes1; Z.S. Koszegi1
1University of Debrecen, MHSC-Faculty of Medicine, Institute of
Cardiology, Department of Cardiology, Debrecen, Hungary
Background: According to the current guideline the 17 myocardial
segments can be assigned to the 3 major coronary arteries. However,
the individual coronary artery variation can differ significantly from
the standardized assignment. This can explain the recently published
disagreements between the results of the fractional flow reserve (FFR)
and the perfusion abnormality on the scintigrams (SPECT).
Objectives: To generate an algorithm about the concordance between
the individual epicardial coronaries and the left ventricular segments
on the basis of the coronary angiography. To compare the overlap
between the FFR-predicted ischemic segments and the segments with
reversible perfusion defect on the SPECT according to the assignment
in our algorithm and on the basis of the guideline.
Methods: Data of 29 patients with at least one angiographically sig-
nificant lesion ([50% diameter stenosis) and with FFR measurements
by intracoronary pressure wire and stress perfusion studies were ana-
lyzed. The distribution of the ischemia defined by 1 reversibility score/
segment (RSc) on the perfusion polar map was correlated with the
individual lesion-associated (L-A) left ventricular segments defined by
our algorithm called Holistic Coronary Care (HCC) program. The
software used the modified Syntax segmentation for defining the L-A
left ventricular region in the 17 segment model.
Results: In the HCC program 2-11 left ventricular segments (alto-
gether 87) were assigned to the 14 FFR positive (\0.80) stenoses on
the basis of the coronary angiography. Out of these segments, 56
showed reversible perfusion defect. From these data the per-vessel
analysis using the regional ischemia criteria (C2 RSc) showed 65%
sensitivity and 100% specificity for the prediction of ischemia by the
HCC and 59% sensitivity and 82% specificity for the prediction of
ischemia by the standard alignment. Per-segment analysis revealed
78% sensitivity and 84% specificity, by the HCC and 44% sensitivity
and 86% specificity for the prediction of ischemia by the standard
alignment, respectively.
Conclusion: The myocardial segments affected by significant epicar-
dial lesions can be defined with higher sensitivity by the HCC program
than on the basis of the standard alignment. During a patient follow up
in coronary heart disease, if anatomical information of coronary
arteries is known (from coronary CT or from coronary angiography),
the HCC software is useful to interpret correctly the SPECT images
and to determine the ischemic region helping the plan of
the revascularization.
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Low-dose axial CT in patients with atrial fibrillation:
Is simultaneous assessment of the left atrium and coronary
arteries feasible?
P. Pal Maurovich-Horvat1; R. O’connor2; M. Kolossvary1;
M. Karolyi1; G. Szeplaki1; A. Bartykowszki1; L. Geller1;
B. Merkely1
1Heart Center, Semmelweis University, Budapest, Hungary;
2Erasmus Medical Center, Rotterdam, Netherlands
Atrial fibrillation (AF) is considered a relative contraindication to
coronary CT angiography due to irregular heart rates (HR). Aim of our
study was to evaluate image quality (IQ) of coronaries in patients who
underwent CT angiography to assess the left atrium for electroana-
tomical mapping and radiofrequency catheter ablation.
Hundred consecutive patients (66 male, 61.3 ± 11.2 years) with AF
were examined with a 256-slice CT-scanner (80-140 kV,
200-300 mAs/rot, 0.27 seconds rotation time, 2 9 128 9 0.625 mm
collimation, Philips Brilliance iCT) using prospective ECG trigger-
ing—’’Step-and-shoot’’—mode to evaluate left atrial anatomy.
Patients were divided into low/medium HR-group [LHR] (mean
HR \ 80 bpm, n = 55) and high HR-group [HHR]-(mean
HR C 80 bpm, n = 45). Coronary segment based IQ assessment was
performed using four-point Likert-type scale.
1403 coronary segments were analyzed. Mean IQ score was
1.88 ± 1.05 and 88.8% (1246/1403) of segments had diagnostic IQ
(49.2% [690/1403] excellent, 25.5% [358/1403] good and 13.3% [186/
1403] moderate IQ). IQ of LHR-group was better than of HHR (mean
score 1.59 ± 0.89 vs 2.24 ± 1.11; P \ 0.0001). Mean HR of the LHR
and HHR group were 68.3 ± 8.7 bpm and 92.7 ± 12.2 bpm
(P \ 0.0001). The HR variation was lower in LHR group than in HHR
group (42.5 ± 24.3 vs 55.0 ± 25.1 bpm; P = .014). Average radiation
dose was 4.9 ± 1.6 mSv (range: 0.8-9.5 mSv). Out of 100 patients we
identified 22 patients with severe coronary artery disease (CAD), in 13
cases invasive angiography was performed and 7 patients underwent
PCI. Axial image acquisition with 256-slice CT provides diagnostic IQ
for coronary evaluation. Simultaneous imaging of the left atrium and
coronaries is feasible with axial scan mode and provides extra infor-
mation regarding coronary artery disease in patients who have AF and
are scheduled for left atrial ablation procedure.
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Improvement of overall feasibility of multidetector computed
tomography angiography using snap shot freeze
G. Gianluca Pontone1; D. Andreini1; E. Bertella1; S. Mushtaq1;
S. Cortinovis1; E. Conte1; A.D. Annoni1; A. Formenti1;
G. Ballerini1
1University of Milan, Foundation Monzino (IRCCS), Center
Cardiology, Department of Cardiology, Milan, Italy
Purpose: Recently, GE SnapShot Freeze (SSF) technology (GE
Healthcare, Milwaukee, WI) has been introduced to reduce coronary
motion artifacts. The aim of the study is to compare the overall fea-
sibility of MDCT using standard post-processing reconstruction
algorithm vs SSF.
Methods and Materials: Twenty-one patients with at least proximal
or mid segment or more than 3 segments classified as not evaluable for
motion artifacts were enrolled in this study. Image MDCT datasets
were analyzed using standard reconstruction (Group 1) and SSF
algorithm (Group 2) by two blinded expert reader. The overall number
of artifacts (Art), image quality score (QS: 1 no artifacts; Qs: 4 for
severe artifacts), the overall feasibility (Fe: evaluable segments/total
number of coronary segments) and the prevalence of CAD including
all segments with not-evaluable segments censored as positive.
Results: Thirteen patients (62%) received intravenous metoprolol
(mean dose 9.62 ± 3.8 mg). The HR during the scan was
67.9 ± 6.6 bpm. Sixteen (76%) and 5 (24%) were performed using
retrospective and prospective ECG-triggering, respectively. Group 2 vs
Group 1 showed lower incidence of artifacts (17% vs 34%, P \ .01),
better QS (1.24 ± 0.64 vs 1.84 ± 1.2, P \ .01) and Fe (93% vs 83%,
P \ .01). The prevalence of CAD including all segments with not-
evaluable segments censored as positive was higher vs vessel-based
analysis including diagnostic segments only in Group 1 (63% vs 20%,
P \ .01) and not in Group 2 (25% vs 17%, P: not significant).
Conclusions: Given these promising results in this preliminary expe-
rience, this novel SnapShot Freeze technology may be a useful tool to
freezing coronary motion in higher heart rate variability.
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Comparison of a qualitative interpretation of stress MRI to a
SPECT quantitative approach for the segmental evaluation
of myocardial perfusion
N. Nicolas Piriou1; B. Laporte1; K. Warin-Fresse1; M. Caza1;
F. Valette1; G. Fau1; J. Helias1; D. Crochet1
1University Hospital of Nantes—Hospital Guillaume & Rene Laennec,
Nantes, France
Background: Stress magnetic resonance imaging (MRI) evaluates
myocardial perfusion (MP).The analysis is most commonly limited to a
pure qualitative evaluation of segmental MP, whereas SPECT, the
gold-standard for MP imaging, is routinely analyzed with a full auto-
mated quantitative approach. We aimed to compare the two methods of
analysis with SPECT as a reference.
Methods: We retrospectively analyzed stress MRI and SPECT data of
ten patients that had both examinations for myocardial ischemia
detection between 2009 and 2012 in our center. MP on stress MRI was
analyzed on a 16 segments model, excluding apical segment from the
usual AHA segmentation. Each segment was classified as normal
perfusion (N), non-transmural sub-endocardial perfusion defect (NT)
or transmural perfusion defect (T) after adenosine stress and at rest.
SPECT data were analyzed with the QPS software and average per-
centage of tracer uptake was reported for each segment, at stress and
rest. During MRI, late gadolinium enhancement (LGE) sequences were
also analyzed and classified as normal (LG-) or positive for LGE
(LG+). After stress MRI, each segment was classified as non ischemic
(NI : N at stress, N at rest and LG-), ischemic (I: NT or T at stress, N
at rest and LG-) or infarcted (INF : LG+).
Results: At stress, 114 on 160 segments (71.25%) were correctly
classified by MRI, taking SPECT as the reference. 132 segments were
classified N on MRI, whereas 31 (23.5%) had a percentage of tracer
uptake \70% on SPECT. The mean percentage of tracer uptake was
75.5 ± 11% for segments classified N on stress MRI perfusion
sequences, 67.7 ± 16% for segments classified NT, and 48.7 ± 8% for
segments classified T (P \ .05 vs N and NT segments). Among the
117 segments classified as NI on MRI, 92 (78.6%) were NI on SPECT
(Chi2 for association: P \ .001). Only 2 on the 10 segments classified I
on MRI were I on SPECT (Chi2:NS), and 10 on the 33 segments INF
on MRI were INF on SPECT (Chi2: P \ .001).
Conclusion: As previously described in the literature, pure qualitative
interpretation of MP with stress MRI is less sensitive than SPECT
quantitative analysis for the detection of mild to moderate segmental
perfusion defects. This seems to be due in our study to non-significant
differences of mean SPECT tracer fixation uptake in segments classi-
fied N and NT on MRI. Thus, semi-quantitative or multi-parametric
analysis of stress cardiac MRI, involving cine-imaging and LGE, must
be preferred to reach the diagnostic performance of SPECT in daily
practice.
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A hybrid method using two-dimensional echocardiography
and myocardial perfusion scintigraphy (MPS) for assessment
of myocardial ischaemia
C. Szmigielski1; P. Wood2; J. Newton3; S. Pavlitchouk3;
S. Zielke3; H. Becher2; N.K. Nik Sabharwal3
1Medical University of Warsaw, Department of Internal Medicine,
Hypertension & Vascular Diseases, Warsaw, Poland; 2Mazankowski
Alberta Heart Institute, University of Alberta, Edmonton, Canada;
3John Radcliffe Hospital, Department of Cardiology, Oxford,
United Kingdom
Objective: We hypothesized that in patients with stable angina, normal
LV function at rest assessed by echocardiography is synonymous with
normal perfusion. Thus the normal resting echocardiogram could be
used instead of a normal rest MPS scan.
Design: Patients with normal LV function who were referred for MPS
because of stable chest pain underwent a comprehensive 2D echocar-
diogram prior to their nuclear procedure. Rest and stress scans were
reviewed with the ECG and clinical data. A second reader analyzed only
the stress scans with the ECG, clinical data and resting echocardiogram.
Patients: 94 consecutive patients with chest pain suggestive of
ischaemic heart disease were enrolled in this prospective study.
Interventions: Patients underwent an additional transthoracic echo-
cardiogram in addition to the clinical stress-rest MPS.
Main outcome measure: To compare the results of reading stress only
MPS with standard reading of both stress and rest MPS in patients with
normal LV function on resting 2D echocardiography.
Results: Both readers agreed in calling the studies normal or abnormal
in 82 out of 94 patients (kappa = 0.6). In 12 patients there was a minor
disagreement between the two readers. There was good agreement in
assessing the size of the perfusion defects (kappa = 0.63).
Conclusions: In patients with normal resting LV function resting MPS
could be avoided even in the presence of a perfusion defect on the
stress MPS scan. This should lead to decreased radiation doses and
higher throughput. These findings warrant further investigation in a
larger clinical trial.
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Factors influencing the level of apical LV myocardial
perfusion tracer uptake in SPECT/CT attenuation
correction: A normal population study
D. Doumit Daou1; C. Meyer1; O. Kotbi1; F. Amegassi1;
C. Coaguila2; M. Tawileh1
1APHP, Cochin Hospital, Department of Nuclear Medicine, Paris,
France; 2Hospital Sud-Francilien, Corbeil-Essonnes, France
Purpose: Attenuation correction (AC) of myocardial perfusion SPECT
allows better quantification of cardiac tracer uptake. In normal patients,
the apical left ventricular (LV) tracer uptake with SPECT-AC is var-
iable with frequently observed reduced relative tracer uptake as
compared to filtered backprojection without AC. The factors influ-
encing the level of LV apical tracer uptake with SPECT-AC are not
well defined. In this study, we aimed to determine in normal patients
the factors potentially influencing the level of LV apical tracer uptake
with SPECT-AC.
Methods: Our study included 154 consecutive patients with no pre-
viously known CAD addressed for myocardial perfusion scintigraphy
(MPI) and having clinically and electrically negative stress tests
(exercise, dipyridamole, combined) and normal filtered back-projec-
tion (FBP) stress MPI (without AC). All patients had SPECT/CT MPI
acquisitions (Myoview-Tc99m, Symbia, Siemens) allowing the
reconstruction of both FBP (non-AC) and SPECT-AC. These were
processed with QPS software and allowed the quantification of LV
apical uptake (segment 17): seg17_FBP and seg17_AC. Stepwise
regression analysis was used to determine the factors influencing the
level of seg17_AC uptake: age, sex, weight, height, type of stress test,
LV axis angle in the sagittal plane (angle_S, in degrees), LV axis angle
in the transaxial plane (angle_T, in degrees), exercise work level
(watts), maximal stress heart rate expressed as percent of age-predicted
maximal heart rate, presence of coronary calcification on the CT part
used for attenuation correction, and seg17_FBP.
Results: 40% of patients were male and mean age was Seg17_AC was
much lower than seg17_FBP: 68.45 ± 7.02% (minimum = 49%;
maximum = 87%) vs 83 ± 6.05% (minimum = 72%; maxi-
mum = 96%) (P \ .0001). On stepwise regression analysis,
seg17_AC was only correlated to angle_S (F = 82) and seg17_RPF
(F = 74): seg17_CA = 16.301 + 0.559*seg17_FBP—0.406*angle_S
(r = 0.729; P \ .0001).
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Conclusions: The level of normal apical LV tracer uptake with
SPECT-AC depends on both its level on FBP and the angle of the LV
in the sagittal plane.
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Automatic segmentation of CT perfusion of the left ventricle
J. De Geer1; M. Gjerde1; E. Olsson1; A. Persson1;
J.E. Jan E. Engvall1
1Linkoping University Hospital, Linkoping, Sweden
Purpose: To compare the average global blood flow value obtained by
manual AHA-segmentation to that obtained by automated AHA-seg-
mentation in dynamic myocardial perfusion.
Method: Eight patients with manifest cardiovascular disease were
included in the study. CT images were acquired under adenosine-
induced stress, using a dual source/dual energy CT scanner in single
energy dynamic perfusion mode.
The wall of the left ventricle was manually segmented according to the
AHA 17-segment model. Each segment (except segment 17) consisted
of three sub-segments along the long axis. The blood flow value for
each segment was taken as the sum of the values for each sub-segment
divided by three (for segments 1-16). The average global blood flow
value was taken as the sum of all segment blood flow values divided by
17.
The average global blood flow obtained by manual segmentation was
compared to that obtained by using dedicated, automated software,
using Student’s t-test.
Results: The average, manually obtained global blood flow value was
127 mL /100 g tissue/minute. The average, automatically obtained
global blood flow value was 132.8 mL/100 g tissue/minute. The mean
difference was -5, 8 or 4, 4%.
Conclusion: The use of automated segmentation resulted in a slightly
higher average global blood flow value. However, the difference was
small.
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Evaluation of left and right ventricular ejection fraction and
volumes from Gated Blood-Pool SPECT with new Cadmium-
zinc-telluride (CZT) camera: Comparison with cardiac MRI
D. Goulon1; N. Piriou1; A. Pallardy1; K. Warin-Fresse1;
M. Caza1; F. Kraeber-Bodere1; F. Valette1
1University Hospital of Nantes—Hospital Guillaume & Rene Laennec,
Nantes, France
Objective: New cardiac CZT camera, widely more performant in
resolution, dose exposure and acquisition time, has not been evaluated
in gated blood-pool single-photon emission computed tomography
(GBPS). GBPS with camera CZT was compared with cardiac magnetic
resonance (CMR) for the measurement of left ventricular (LV) and
right ventricular (RV) ejection fractions (EF) and volumes [end-dia-
stolic volume (EDV) or end-systolic volume (ESV)] in a mixed
population.
Methods: Ten successive patients (80% men; mean age:
48 ± 19 years) referred for various symptoms or heart diseases
underwent a fast GBPS acquisition (9 minutes) with CZT camera and
CMR. GBPS data were analyzed using fully automated gradient soft-
ware. CMR images were acquired for both ventricles at the same time
using a steady-state-free precession sequence and short-axis views.
LVEF and RVEF and volumes were assessed with GBPS and CMR
and were compared.
Results: We found no statistical difference between GBPS and CMR
in the assessment of LVEF (P = .033) and RVEF (P = .769), who
were correlated in regression analysis (r = 0.89 for LVEF; r = 0.633
for RVEF; all P \ .001). Regarding biventricular volumes, there was
no statistical difference between these 2 methods (P = .002 for LV
EDV, 0.005 for LV ESV, 0.263 for RV EDV and 0.402 for RV ESV),
but there were not significantly correlated (due to the low number of
patients included).
Conclusion: GBPS with new camera CZT is a simple, faster and
available technique that can assess biventricular EF and volumes with
comparable results to CMR.
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Interpretation of ischemia in myocardial perfusion scintig-
raphy by two computer aided diagnosis systems
E. Tragardh1; M. Lomsky2; L.B. Johansson2; S.E. Svensson1;
L. Edenbrandt1
1Skane University Hospital, Clinical Physiology and Nuclear Medicine
Unit, Malmo, Sweden; 2Sahlgrenska University Hospital, Department
of Clinical Physiology, Gothenburg, Sweden
Purpose: Visual interpretation of myocardial perfusion scintigrams
(MPS) is dependent on the knowledge of the physician, and subject to
inter- and intra-observer variability. Inexperienced physicians could
benefit from getting ‘‘second opinion’’ from a computerized interpreta-
tion. To compare the diagnostic performance for the detection of ischemia
of two computer aided diagnosis software packages (EXINI heart 5.0 and
PERFEX Emory Cardiac Toolbox 3.0) for interpretation of MPS.
Methods: 1052 consecutive patients, 499 (47.4%) men and 553
(52.6%) women, who underwent 2-day stress/rest 99mTc-sestamibi
MPS were included. Patients were stressed using either maximal
exercise or pharmacological test with adenosine. The gold standard
was obtained from three physicians, with more than 25 years each of
experience in nuclear cardiology, who evaluated all MPS images on
the presence or absence of ischemia. The majority rule was applied in
cases of disagreement. No quantitative results from software packages
were available during this evaluation. Automatic processing was done
using EXINI (artificial neural networks based) and PERFEX (rule
based expert system) software packages.
Results: Ischemia was found in 257 patients according to gold stan-
dard. The sensitivity for detecting ischemia was 69.7% for EXINI and
62.6% for PERFEX (P = .045). The specificity was 93.1% for EXINI
and 82.4% for PERFEX (P \ .0001).
Conclusions: EXINI showed significantly higher sensitivity and
specificity for the detection of ischemia compared to PERFEX. The
difference in performance should be considered when software pack-
ages are used in clinical routine.
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The impact of advanced reconstruction on myocardial image
noise in rubidium myocardial perfusion PET
I.S. Ian Armstrong1; C.M. Tonge1; P. Arumugam1
1Central Manchester University Hospitals NHS Foundation Trust,
Manchester, United Kingdom
Purpose: The benefit of advanced PET reconstruction algorithms, that
include resolution modelling and time-of-flight, has been widely
demonstrated in FDG oncology PET scanning. However, the assess-
ment of these algorithms in myocardial perfusion PET is currently very
limited. This study compared image noise in the left ventricular
myocardium in rubidium cardiac PET using standard and advanced
reconstruction algorithms.
Methods: Resting rubidium perfusion PET scans from 74 patients
(mean [range] body mass index: 33.3 [20.8-55.8]; 34 male) that were
reported as normal were used for analysis. Images were acquired on a
Siemens Biograph mCT and reconstructed with the standard OSEM
and advanced OSEM, which included resolution modelling and time of
flight. As a measure of image noise, the coefficient of variation (COV)
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of pixel values was measured in polar plot data from the two sets of
images. COV data were compared against a range of patient related
factors—weight, body mass index, cross-sectional chest area, and size
of the myocardium.
Results: The COV was overall found to be significantly lower
(P \ .001) when using the advanced reconstruction. The reduction in
COV was correlated most strongly to patient weight, with the greatest
reduction occurring at the highest weights. COV was greater in some
cases with the advanced reconstruction, which was suspected to be due
to subtle perfusion reductions becoming more apparent. COV was less
dependent of either patient weight or BMI when using the advanced
algorithm.
Conclusion: This study demonstrates the benefit of using advanced
reconstruction in rubidium cardiac PET. The effect of patient size is
less influential on image noise when using the advanced algorithm.
Differences in image appearance are seen with subtle defects becoming
more apparent, highlighting the importance of a clinicians’ under-
standing of the impact of moving from standard to more advanced PET
reconstruction algorithms. Further evaluation using data with clinical
follow up to assess the impact of image interpretation on patient
management is needed.
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Coronary vein anatomy; exploring the possibilities with
preoperative CT evaluation for planning the left ventricular
lead placement in cardiac resynchronization therapy
H. Markstad1; Z. Bakos2; E. Ostenfeld3; A. Roijer4;
M. Carlsson3; R. Rasmus Borgquist5
1Lund University, Skane University Hospital, Department of Radiology,
Lund, Sweden; 2Lund University, Skane University Hospital,
Department of Arrhythmias, Lund, Sweden; 3Lund University, Skane
University Hospital, Department of Clinical Physiology, Lund, Sweden;
4Lund University, Skane University Hospital, The Clinic for Heart
Failure and Valvular Disease, Lund, Sweden; 5Lund University
Hospital, Department of Arrhythmias, Lund, Sweden
Purpose: To introduce a novel way of evaluating the coronary sinus
vein anatomy, focusing on relevance in the context of left ventricular
(LV) lead implantation in cardiac resynchronization therapy (CRT).
Accumulating evidence suggests that targeting specific segments with
late mechanical or electrical activation in the left ventricle is superior
to non-targeted LV lead placement. It is therefore less relevant to
discuss the number of veins in preoperative evaluation, but more
appropriate to describe which segments can be reached with an LV
electrode.
Methods: 23 patients (70 ± 9 years, 78% male, 86% with LBBB, 57%
with ischemic CMP, 91% C NYHA 3) eligible for CRT were included
consecutively and evaluated prospectively. Cardiac CT scan was per-
formed using a prospective (39%) or retrospective (61%) low-dose
protocol. For identification of venous branches in the different cardiac
segments, the standard 17-segment bulls-eye plot of the left ventricle
was used. To facilitate interpretation, MPR-reconstruction was per-
formed providing a standard short axis view of the left ventricle (LAO
45 projection). The AV plane was identified and in the long axis
projection (RAO 45) the ventricle was divided into basal, mid, apical
and apex segments.
Results: The average DLP was 416 ± 217 mGycm and contrast vol-
ume was 99 ± 21 mL. All patients had acceptable image quality for
detection of clinically relevant venous branches C1.5 mm in diameter.
On average, 2.5 vein branches were identified excluding the main
stems of the middle and the great cardiac veins in the interventricular
grooves. An average of 3.9 segments had a suitable vein branch of
sufficient diameter. Veins with very short length (\2 cm) or with very
acute angles ([150) from the main stem were excluded as clinically
not relevant for lead placement. For all patients, a bulls-eye plot was
constructed indicating which segments had suitable veins. Patients
with ischemic cardiomyopathy (CM) had 4.1 segments compared to
3.8 for patients with dilated CM (P = n.s). Male patients had 3.8
segments compared to female patients with 4.2 (P = n.s.).
Conclusions: Using cardiac CT preoperatively for CRT is feasible
with low radiation doses and sufficient image quality to identify
clinically relevant vein branches in the coronary sinus. There are no
significant differences between different heart failure etiologies or sex.
Presenting data in a bulls-eye plot allows for comparison with echo-
cardiographic data regarding segmental activation times, facilitating a
comprehensive preoperative evaluation for optimal LV lead electrode
placement.
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Novel method of attenuation correction of CZT camera
myocardial perfusion images with CT scans from stand-alone
hybrid SPECT/CT
M.A. Dziuk1; S. Piszczek1; A. Mazurek1; A. Budzynska1
1Military Institute of Medicine, Nuclear Medicine Department,
Warsaw, Poland
Purpose: Dedicated cardiac CZT scanners are more frequently used
for myocardial perfusion SPECT imaging. Not all CZT devices are
coupled with the CT. Some imaging centers are equipped with both
CZT and standard SPECT/CT cameras. The goal of this study was to
assess whether attenuation correction of CZT images can be performed
with the CT scans (CTAC) taken from the stand-alone SPECT/CT
device.
Methods: We retrospectively estimated 39 patients (24 men, 15
women) in the age of 51-73 years with perfusion abnormalities
mostly located in inferior wall and therefore attenuation correction
was performed. Three patients had a history of inferior MI. SPECT
myocardial perfusion acquisitions were obtained from CZT gamma
camera and CT scans from hybrid SPECT/CT scanners. Subsequently
SPECT and CT acquisitions were fused with QGS/QPS dedicated
software.
33 stress and 21 rest studies before and after attenuation correction
were assessed. We performed SPECT imaging 60 minutes after radi-
otracer injection, mean 99mTc-sestamibi dose was 9.2 mCi
(8-10.4 mCi). CT scans were obtained on the day of the SPECT study.
Myocardial perfusion was evaluated on the long axis slices before and
after CTAC—semiquantitative evaluation was performed in basal, mid
and apical segments of inferior and lateral walls as well as in apex with
5-graded scale. We also performed visual analysis for presence or
absence of diaphragmatic attenuation.
Results: In 51 from 54 studies there was perfusion improvement in
at least 1 segment of inferior wall after CTAC. The most frequent
variability was achieved in basal and the least in apical segment of
inferior wall, we observed image improvement in 88%
(P\ 0.05) and 11% segments after CTAC, respectively. There were
also image improvements in basal (50%, P\ 0.05) and apical (6%)
segments of lateral wall. Conversely, image impairment was
observed in apex in 50% studies. In visual analysis we revealed
perfusion abnormalities typical for diaphragmatic attenuation in 50%
studies, all of the patients were men. Beside three patients, who had
had myocardial infarction of inferior wall, no significant left ven-
tricular contractility abnormalities were observed: ESV 10-73 mL
(median 35 mL), EDV 58-152 mL (median 108 mL), EF 44-85%
(median 68%).
Conclusions: The method of attenuation correction presented here is
feasible and promising in the interpretation of inferior wall perfusion
abnormalities. A new artifact, specific to CZT scanner, the basal lateral
wall attenuation defect was found in half of scans.
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When prone SPECT imaging is needed to exclude
diaphragmatic attenuation, should we gate the study?
A.A. Sadek1; M. Mohamed Mandour Ali1; S. Sharara2;
D. Helmy3; E. Hegazy3; A.H. Allam1;
1Al-Azhar University, Department of Cardiology, Cairo, Egypt;
2Ain Shams University, Cairo, Egypt; 3Alfa scan radiology center,
Cairo, Egypt
Background: Male patients undergoing myocardial SPECT imaging
are frequently imaged in the prone position following supine imaging
to exclude diaphragmatic attenuation. As gated SPECT imaging allow
evaluation of ejection fraction (EF), end diastolic volume (EDV) and
end systolic volume (ESV) we thought that comparing these functional
indices in the prone vs (Vs) supine position could answer the question
whether gating both studies is needed.
Methods: We compared EF, EDV and ESV obtained from a com-
mercially available software QGS, in 54 male consecutive patients
undergoing routine stress gated supine SPECT followed by gated prone
SPECT imaging.
Results: EF 59 ± 6 vs 59.7 ± 5.4% P = .096 and ESV 39.8 ± 13.7 vs
40.8 ± 13.1 mL P = .089 were not significantly different for prone vs
supine imaging respectively. While, EDV 94.7 ± 21.1 vs 99.5 ±
21.5 mL was significantly lower in the prone position compared to the
supine position (P \ .000).
Conclusion: EDV obtained in the prone position is different compared
to the supine position. Hence, when prone SPECT imaging is needed,
the study should be gated.
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Accurate estimation of radiation exposure in patients
undergoing Tc99m-sestamibi myocardial perfusion tests
M. Massimiliano Szulc1; A.M. Collins1; F.J. Wong1
1Weill Cornell Medical College, Greenberg Division of Cardiology,
New York, United States of America
Hypothesis: Published data of radiation exposure in patients under-
going a nuclear myocardial perfusion (MP) stress test may be
significantly overestimated. Radiation exposure in these patients is
commonly calculated on the amount of activity in the isotope syringe
as opposed to the actual amount of activity received by the patient.
Although it is the standard practice to assay the amount of activity
prior to injection, it is not standard to assay the amount of activity in
the syringe after injection. We hypothesized that there may be sig-
nificant amounts of residual activity.
Method: We analyzed the 389 dose syringes used to inject 201 patients
undergoing SPECT MP stress tests at our institution. All patients
underwent either one day (low dose rest/high dose stress) or two day
(high dose rest/high dose stress) imaging protocols with Tc99m
Sestamibi. The activity in the syringe containing Tc99m Sestamibi
before injection was assayed using a dose calibrator and the activity
and time of assay recorded. Each patient was injected for either a rest
scan or a stress scan and the time of injection was recorded. The
syringe was then re-assayed in the dose calibrator and the residual
activity and time of assay recorded. The residual activity was sub-
tracted from the pre-injection activity to determine the actual activity
injected into the patient. The pre-injection activity and the activity
actual injected were multiplied by the Tc99m Sestamibi ICRP dose
factor to estimate the nominal and actual effective doses, respectively.
Conclusion: Based in our analysis there is a significant residual
activity remaining in the syringe after injection of Tc99m Sestamibi.
Therefore, calculation of radiation exposure using the activity in the
syringe prior to administration overestimates the actual exposure. As
we are looking for ways to reduce the amount of dose a patient receives
from MP imaging procedures, we should be aware of exactly how
much activity the patients have received, in order to precisely calculate
their exposure. This is especially important if one is calculating total
cumulative dose that a patient receives from a MP study, as part of the
patient’s cumulative radiation burden from multiple imaging
procedures.
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Quantification of myocardial blood flow with Tc-99m tetro-
fosmin dynamic SPECT using a semiconductor detector
Y. Yasuyuki Takahashi1; M. Miyagawa2; H. Ishimura2;
Y. Nishiyama2; T. Mochizuki2; K. Murase3
1Gunma Prefectural College of Health Sciences, Maebashi, Japan;
2Ehime University, Toon, Japan; 3Osaka University, Suita, Japan
Purpose: SPECT systems based on the cadmium-zinc-telluride (CZT)
solid-state semiconductor detector have better energy resolution and
sensitivity than conventional Anger type systems. Due to improved
sensitivity, dynamic SPECT acquisition with good time resolution of a
few seconds has become possible. However, acquisition conditions and
kinetic analysis in dynamic SPECT has remained controversial. In this
study, we attempted the quantification of myocardial blood flow using
a semiconductor detector.
Methods: A semiconductor detector, Discovery NM 530c (GE
Healthcare corp.) was used. Dynamic SPECT method was carried out
for the initial 10 minutes after bolus injection of 259 MBq of Tc-99m
tetrofosmin. We compared analytical parameters based on window
width, slice thickness, and acquisition times.
In the process of kinetic analysis, the image transformation process of
dynamic data used for compartment analysis includes the creation of a
transaxial image by multi-file (10 seconds), unit time (per second)
image transformation, single-file transformation, and format conver-
sion (from 70 matrix to 64 matrix). The time activity curve of our
dynamic SPECT data was conducted as described below. The left
ventricle was segmented into the left ventricle myocardial wall and the
left ventricle lumen. Blood counts within the former, converted to
activity measures served as the output function, whereas blood counts
within the lumen converted to activity measures served as the input
function. Using compartment analysis (creation of myocardial blood
flow, MBF, Transracial data), K1 (unidirectional transfer constant) was
calculated by the 3 compartment, 3 parameter model and the 2 com-
partment model. The K1 to MBF conversion formula was approxi-
mated by the 5th polynomial. The Bull’s eye map of MBF (mL/g/
minutes) and myocardial perfusion reserve (MPR) is displayed.
Results: Window width variations between 140.5 keV ± 5% to 10%
and 15% yielded a count rate increase by a factor of 1.2 and 1.35
respectively. The data was examined with a slice thickness of 4 and
8 mm. The accuracy of the input function on TAC depended and
preferred SPECT images consisted of a slice thickness of 4 mm. The
kinetic-analysis condition leading to increased accuracy consisted of
140.5 keV ± 10% window width, with a slice thickness of 4 mm, and
an acquisition time of 10 seconds.
Conclusion: Extremely high-time-resolution dynamic SPECT using a
semiconductor detector is possible. The kinetic analysis yielded a
myocardium time activity curve with a clear accumulation process.
Moreover, the quantification of myocardial blood flow with Tc-99m
tetrofosmin was stabilized.
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Simultaneous ECG-gated cardiac PET of multiple mice
in a single scan: A feasibility study
I. Ichiro Matsunari1; H. Aoki2; W. Fujita2; Y. Miyazaki1;
K. Kajinami1
1Medical & Pharmacological Research Center Foundation, Hakui,
Japan; 2Kanazawa Medical University, Kanazawa, Japan
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Purpose: Although ECG-gated cardiac PET of small animals is
promising for simultaneous assessment of a molecular process such as
glucose metabolism and function, it can usually image only one single
animal/scan. The purpose of this study was to develop a preclinical
PET system, which enables simultaneous ECG-gated acquisition of
three mice in a single scan.
Methods: The system was based on a commercially available small
animal PET/CT scanner (Triumph II, Gamma-Medica) with an
increased bore size of 15 cm in diameter. A custom made animal bed
along with instruments for anesthesia lines for 3 mice was also
developed. ECG signals were processed using a multi-channel ECG-
triggering system (SAII). For feasibility study, we used 6 mice (ddY,
body weight 38-45 g) with myocardial infarction created by ligation of
left coronary artery. Approximately 40-60 MBq of FDG was injected
(i.p.) 30 minutes after intra-peritoneal injection of glucose and insulin
to stimulate myocardial FDG uptake. An ECG-gated acquisition of 3
mice were performed in list-mode for 20 minutes with ECG-leads
attached to each mouse (3 mice scan). After completion of the 3 mice
scan, each mouse was set-up on a normal bed for single mouse, and
was scanned one-by-one (single mouse scan). The 3 mice scan data
were reconstructed for each mouse using the ECG-signal of that
mouse, resulting in 3 data sets. The single mouse scan data were
reconstructed normally using ECG-gating. End-diastolic (EDV), end-
systolic volumes (ESV), and left ventricular ejection fraction (LVEF)
were calculated using MunichHeart software.
Results: The EDV, ESV, and LVEF could be obtained for each mouse
using the 3 mice scan data. As compared to the single mouse scan, the
3 mice scan tended to underestimate left ventricular volumes (EDV:
51 ± 8 vs 59 ± 8 lL, P = .07; ESV: 22 ± 7 vs 28 ± 9 lL, P \ .05),
and to overestimate LVEF (58 ± 11 vs 53 ± 12%, P \ .01) probably
because of larger distance from the center and thereby worse spatial
resolution in the 3 mice scan. However, there was a significant cor-
relation of LVEF between the 3 mice and single mouse scan
(r = 0.93, P \ .01).
Conclusions: Although more validation is necessary, our preliminary
results indicate that simultaneous ECG-gated PET acquisition of 3
mice is feasible, and may facilitate a high throughput cardiac imaging
in animal research.
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Gender differences in myocardial blood flow with
Regadenoson dynamic Rubidium-82 PET/CT
S. Suman Tandon1; J. Moody2; B.C. Lee2; A.V. Srivastava3;
R. Fazzone-Chettiar4; E.P. Ficaro5; A.J. Sinusas1;
1Yale University School of Medicine, New Haven, United States of
America; 2INVIA Medical Imaging Solutions, Ann Arbor, United States
of America; 3University of California San Francisco, School of
Medicine, Fresno, United States of America; 4Yale New Haven
Hospital, New Haven, United States of America; 5University of
Michigan, Ann Arbor, United States of America
Purpose: This study evaluates the impact of gender on myocardial
blood flow (MBF) dynamics in patients undergoing routine evaluation
for myocardial ischemia with Regadenoson stress/rest Rb-82 PET/CT.
Methods: 91 women and 59 men referred for a clinically indicated Reg-
adenoson stress/rest dynamic Rb-82 PET/CT without perfusion defects
formed the study cohort. Absolute MBF and myocardial vascular resistance
(MVR) were calculated at rest and during Regadenoson stress using factor
analysis. Linear regression analysis was performed to evaluate the relation-
ship between global stress and rest MBF and cardiovascular (CV) risk factors.
Results: Resting heart rate (HR), systolic blood pressure (SBP) and rate
pressure product (RPP) were similar between women and men, however,
women had a higher peak HR (95 ± 17 bpm vs 90 ± 16 bpm, P = .037)
and RPP (12679 ± 3332 vs 11418 ± 3032, P = .02) with Regadenoson
stress. Women had significantly higher rest global MBF without RPP
correction (1.10 ± 0.35 mL/g/minute vs 0.83 ± 0.26 mL/g/minute,
P \ .0001) and with RPP correction (1.13 ± 0.38 vs 0.86 ± 0.27 mL/g/
minute, P \ .0001). Regadenoson-induced hyperemic MBF was signifi-
cantly higher in women (2.51 ± 1.00 vs 1.85 ± 0.76 mL/g/minute,
P \0.0001) and RPP correction for stress MBF did not alter the findings.
No significant difference was noted in coronary flow reserve (stress MBF/
rest MBF RPP corrected) (2.31 ± 0.87 women vs 2.26 ± 0.93 men).
Prevalence of CV risk factors [age, body mass index (BMI), hypertension,
hyperlipidemia, diabetes, tobacco use, family history of coronary artery
disease], coronary artery disease and coronary calcium were not signifi-
cantly different between genders. Regression analysis using the above
mentioned covariates showed gender and BMI to be the strongest predic-
tors of hyperemic MBF (adjusted mean difference in flow between women
and men 0.70, P \ .0001) and rest MBF (adjusted mean difference in flow
between women and men 0.28, P \ .0001). Gender remained a significant
predictor of hyperemic and rest MBF even after adjusting for BMI.
Conclusion: Gender is an independent strong predictor of Regadenoson-
induced hyperemic and rest MBF in patients undergoing Regadenoson
dynamic Rb-82 PET/CT in a routine clinical setting. Although the risk
factor profile and coronary flow reserve were similar between genders,
women had a significantly higher resting blood flow and hyperemic
response to Regadenoson. Correction for gender and BMI may need to be
considered when establishing reference limits for myocardial flow, and
when interpreting hyperemic blood flow responses.
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Regadenoson in Europe: First-year experience of
regadenoson stress combined with submaximal exercise in
patients undergoing MPS
M. Brinkert1; E. Reyes1; S. Walker1; K. Latus1; R. Mizumoto1;
Q. Nkomo1; K. Standbridge1; K. Wechalekar1; S.R. Underwood2
1Royal Brompton Hospital, London, United Kingdom;
2Royal Brompton and Harefield NHS Trust Hospital, Imperial College
London, London, United Kingdom
Purpose: Regadenoson is a selective adenosine A2a receptor agonist
that was developed to avoid the side effects associated with the unse-
lective adenosine receptor agonists. Since approval in Europe in 2011
regadenoson has become the default form of stress at our institution. The
aim of this study was to assess its side effect profile and tolerability in
consecutive patients undergoing MPS between July 2011 and July 2012.
Methods: We studied 1764 consecutive patients referred to our institution
for clinically indicated MPS. Clinical, stress and imaging data were
recorded prospectively and analysed using the Excel data analysis toolpak
and SPSS. Symptoms during stress were defined as mild, moderate or
severe. An adverse event was defined as any symptom that persisted for
more than 30 minutes or that required investigation or treatment.
Results: Of 1764 patients, 1581 (90%) received regadenoson com-
bined with sub-maximal exercise unless contraindicated. Symptoms
were common (63%) but transient and well-tolerated. The severity of
symptoms was recorded in most of the patients as mild (84%).
Dyspnoea (36%) and chest discomfort (12%) were the commonest side
effects. Adverse events were reported in 8 (0.5%) patients, 7 of these
thought to be vaso-vagal. Three events were moderate and two severe,
the latter with sinus arrest and asystole lasting 30 and 10 seconds and
requiring CPR. All patients recovered fully without sequelae. There
were no deaths, myocardial infarction or hospital admissions. Two-
hundred and six asthma/COPD patients (12%) received regadenoson
without bronchospasm or any other major side effect.
Conclusion: We have studied 1764 stress tests for MPS over a twelve-
month period in order to assess the symptom profile of regadenoson in
the largest European cohort to date. Regadenoson combined with
exercise is well tolerated, notably also in patients with asthma/COPD.
The majority of adverse events were vaso-vagal episodes without
sequelae. There is no clear direct mechanism by which regadenoson
might cause vaso-vagal syncope.
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A comparative study of the safety of Regadenoson in patients
with mild or moderate asthma and chronic obstructive
pulmonary disease
C. Carlos Salgado1; E. Sanchez De Mora1; A. Jimenez-Heffer-
nan1; J. Lopez-Martin1; C. Ramos1; I. Ynfante2
1Hospital Juan Ramon Jimenez, Department of Diagnostic Imaging,
Huelva, Spain; 2Hospital Juan Ramon Jimenez, Department of
Pharmacy, Huelva, Spain
Purpose: We aim to assess the safety of Regadenoson (REG), a
selective agonist of A2A adenosine receptors, in subjects with mild or
moderate asthma or chronic obstructive pulmonary disease (COPD)
referred for myocardial perfusion imaging (MPI) and to compare the
side effect profile. REG is not marketed in Spain, so the Spanish
Agency of Medicines and Health Products (AEMPS) must authorize its
use on an individual patient basis.
Methods: 82 patients (60.98% male, mean age 67.7 ± 11.5 years,
range 31-87 years) were studied. Group A comprised 48 COPD and
Group B 34 asthma patients respectively. Stress was 4 minutes of low-
level exercise with bolus intravenous injection of 0.4 mg REG at 1.5
minutes and 99mTc-MPI agent injection at 2 minutes. Patient
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demographics, past medical history, treatment, clinical symptoms
during stress and changes in blood pressure were evaluated. Continu-
ous variable are expressed as mean ± SD and compared using the
paired Student’s t-test, whereas Chi-square testing was used for com-
parison of dichotomous variables.
Results: Both groups were comparable (P = ns) with regards to age,
gender, hypertension, dyslipidemia and medication type with the excep-
tion of anticholinergic use (Group A 62.5% vs Group B 23.5%, P \ .001).
Asthmatic patients showed a higher incidence of feeling hot (Group A
10.42% vs Group B 29.41%, P = .028) and dry mouth sensation
(Group A 12.50% vs Group B 35.29%, P = .014). On the other hand
COPD patients had a higher incidence of dyspnea (Group A 39.58% vs
Group B 14.71%, P = .015). There was no difference between both
groups in the incidence of the following side effects: Fatigue (41.67%
vs 58.82%), dizziness (18.75% vs 26.47%), chest discomfort (8.33% vs
11.76%), nausea (6.25% vs 5.88%), headache (4.17% vs 14.71%) and
flushing (2.08% vs 5.88%). Side effects began soon after dosing and
resolved within approximately 3-5 minutes. We didn’t observe sig-
nificant changes in blood pressure following REG administration
(mean baseline systolic pressure was 152.51 mmHg ± 29.88 vs
158.48 mmHg ± 30.89 following REG).
Conclusion: REG combined with low-level exercise shows a good
safety profile in our series of COPD and asthma patients undergoing
MPI. REG was well tolerated by all patients; with dyspnea, feeling hot
and dry mouth sensation showing differences between groups.
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Is regadenoson safe in patients on N-acetylcysteine
undergoing stress MPS?
E. Eliana Reyes1; S. Walker1; R. Mizumoto1; Q. Nkomo1;
S.R. Underwood1; K. Wechalekar1
1Royal Brompton Hospital, London, United Kingdom
Background: The safety profile of regadenoson is similar to that of
other coronary vasodilators with no cardiac death or non-fatal myo-
cardial infarction reported in the largest clinical trials. Life-threatening
events appear unlikely after regadenoson. However, an episode of
asystole following regadenoson injection was published recently
(Grady EC. J Nucl Cardiol 2011;18:521) and a potential interaction
between regadenoson and N-acetylcysteine (NAC, an inhibitor of
adenosine deaminase) in patients with interstitial lung disease (ILD)
was suggested. We investigated the tolerability and safety profile of
regadenoson in patients with ILD on NAC undergoing clinically
indicated MPS.
Methods: Regadenoson was approved for clinical use at our institution
in July 2011. Clinical, stress, graded symptoms and imaging data were
collected prospectively as part of a departmental patient database.
Symptoms during stress were recorded and classified as mild, moderate
or severe. An adverse event was defined as any symptom that persisted
for more than 30 minutes or required investigation or treatment.
Results: Between July 2011 and July 2012, out of 1764 patients who
underwent stress MPS, 1581 (90%) received regadenoson and of these
10 patients were on NAC at the time of the test (male, n = 7;
mean ± SD age, 64 ± 12 years). The main indication for stress MPS
was chest pain (70%) followed by worsening dyspnoea. Regadenoson
(400 mcg) was coupled with exercise in 6 patients. Side effects were
reported in 7 patients (dyspnoea, n = 6; abdominal pain, n = 2; and
light-headedness, n = 1). All side effects were mild to moderate in
severity and well-tolerated. There were no complications or adverse
events. The side effect profile and safety was similar to that of the
entire patient population. Three out of ten MPS studies were reported
as abnormal with all showing mild myocardial ischaemia.
Conclusion: In a small series of ILD patients on NAC undergoing
stress MPS, regadenoson administration was not associated with an
increased risk of adverse events or severe side effects.
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Impact of diabetes mellitus on iodine-123 meta-iodobenzylgua-
nidine (I123MIBG) cardiac uptake in patients with heart failure
S. Stefania Paolillo1; G. Rengo2; G. Pagano1; T. Pellegrino3;
A. Boemio3; E. Attena4; D. Leosco1; B. Trimarco1; A. Cuocolo3;
P. Perrone Filardi1
1Department of Internal Medicine, Cardiovascular and Immunological
Sciences, Federico II University, Naples, Italy; 2Division of
Cardiology, ‘‘Salvatore Maugeri’’ Foundation—IRCCS—Institute of
Telese Terme (BN), Telese Terme, Italy; 3University of Naples
Federico II, Department of Biomorphological and Functional
Sciences, Naples, Italy; 4Department of Cardiology Fatebenefratelli
Hospital, Naples, Italy
Purpose: Patients with heart failure (HF) and diabetes mellitus (DM)
have worse prognosis compared to HF patients without DM. Impaired
sympathetic nervous system activity has been demonstrated in DM
patients without HF and correlated to worse prognosis but few data are
available on the effect of DM on cardiac sympathetic nerve activity in
patients with HF. The aim of the present study was to assess cardiac
sympathetic nerve activity in HF patients with and without DM.
Methods: We evaluated 75 patients with severe HF (left ventricular
(LV) ejection fraction 31.03 ± 7.15) with and without DM. HF patients
underwent Iodine-123 meta-iodobenzylguanidine (I123MIBG) scin-
tigraphy from which early and late heart to mediastinum (H/M)
I123MIBG ratio and washout rate were calculated. Clinical, echocar-
diographic and biochemical data, including serum NT-proBNP levels
and HbA1c, were measured. Patients were assigned to two groups with
(n = 37) and without DM (n = 38).
Results: The two groups were matched for cardiovascular risk factors
and drug therapy, demography, HF etiology, LV systolic function,
NYHA functional class, and serum NT-proBNP. I123MIBG early H/M
ratio (1.65 ± 0.21 in DM vs 1.75 ± 0.21 in non DM patients; P \ .05)
and late H/M ratio (1.46 ± 0.22 in DM vs 1.58 ± 0.24 in non DM
patients; P \ .03) were significantly lower in DM compared to non
DM patients. In all patients a significant inverse correlation between
early H/M ratio and HbA1c levels (Pearson = -0.473, P = .001) and
between late H/M ratio and HbA1c levels (Pearson = -0.382,
P = .001) was observed. In diabetic patients, by multivariate analysis,
HbA1c and LV ejection fraction remained the only significant pre-
dictors of early H/M ratio, whereas HbA1c remained the only
significant predictor of late H/M ratio. No correlation between either
early or late H/M ratio and HbA1c was found in non diabetic patients.
Conclusions: DM is associated to reduced cardiac sympathetic activity in
HF patients, and the status of glycemic control over the last 1-2 months
correlates to I123MIBG uptake. These findings may contribute to explain
the adverse prognostic impact of DM in patients with HF.
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Correlation between cardiac sympathetic function, gated
SPECT and phase histogram parameters in patients with
systolic heart failure
S. Santiago Aguade-Bruix1; G. Romero-Farina1; M.N. Pizzi1;
C. Espinet Coll1; J. Perez-Rodon1; E. Galve-Basilio1;
J. Candell-Riera1; J. Castell-Conesa1
1Hospital Vall d’Hebron, Barcelona, Spain
Purpose: Cardiac sympathetic function plays an important role in the
regulation of left ventricular function and the pathophysiology of LV
dysfunction. The aim of this study was to evaluate the correlation
between early and late heart-to-mediastinum ratio (H/M ratio) with
123I-metaiodobenzylguanidine (123I-MIBG) and left ventricular (LV)
end-diastolic volume (EDV), end-systolic volume (ESV), ejection
fraction (EF), peak phase (PPh), standard deviation (SD), bandwidth
(B), skewness (S) and kurtosis (K) of phase histogram.
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Methods: 37 consecutive patients (62.9 ± 13 years; 53.4% women)
with heart failure and LVEF \ 50% were included. Same day early
(15 minutes) and late (4 hours) 123I-MIBG and followed by 99mTc-
Tetrofosmin gated-SPECT was performed. Early and late 123I-MIBG
H/M ratio, gated SPECT (EDV, ESV, and EF), and histogram phase
(PPh, SD, B, S, and K) parameters were related by Pearson correlation
coefficient statistics and linear regression.
Results: All patients had an abnormal early and late H/M ratio. There
were a significant differences (Wilcoxon test, Z: -3.426; P = .001)
between early (mean 1.4 ± 0.17) and delayed (mean 1.3 ± 0.20) H/M
ratio. Gated-Spect and phase analysis results in Table 1.
Conclusions: In patients with systolic heart failure, early and late 123I-
MIBG H/M ratio are related not only with LV volumes and EF but also
with phase histogram parameters except peak phase.
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The incremental prognostic value of cardiac 123i-mIBG
scintigraphy in predicting serious arrhythmic events in heart
failure patients
F. Al Badarin1; A. Wimmer1; K. Kennedy1; T. Bateman1;
1Mid America Heart Institute, Kansas City, United States of America
Purpose: Whereas implantable cardiac defibrillators (ICD) are con-
sidered the mainstay of sudden cardiac death (SCD) prevention in
patients with heart failure (HF), the current paradigm for selecting ICD
candidates is fraught with limitations. The shortcomings of left ven-
tricular ejection fraction (LVEF) in accurately assessing arrhythmic
risk in HF patients underscore the need for additional risk assessment
tools in this population. Prior studies have shown the role of cardiac
mIBG scintigraphy in predicting life-threatening arrhythmias in HF
patients. However, existing literature focused mainly on identifying HF
patients at higher risk for serious arrhythmias. Moreover, little is
known about the incremental benefit of combining mIBG imaging with
other clinical, ECG and imaging variables in improving assessment of
arrhythmic risk in this population. Accordingly, we examined the
incremental value of mIBG imaging in predicting life-threatening
arrhythmias among patients with LVEF \ 35%.
Methods: Using data from the ADMIRE-HF study, we identified 778
patients with LVEF \ 35% and NYHA II-III symptoms who did not
have an ICD at the time of enrollment. At baseline, all patients
underwent early and late anterior planar imaging following injection of
123I-mIBG (AdreView, GE Healthcare). Late heart/ mediastinum ratio
(HMR) was determined as a measure of relative myocardial sympa-
thetic nerve activity. In addition, 99mTc-Tetrofosmin (MyoView, GE
Healthcare) resting myocardial perfusion imaging was performed.
Patients were followed prospectively for a median of 17 months. The
endpoint for this analysis was the first occurrence of serious arrhythmic
events (SAE); a composite of SCD, appropriate ICD therapy, resus-
citated cardiac arrest or sustained ventricular tachycardia. Multivariate
regression was used to determine independent predictors of SAE.
Integrated discrimination improvement (IDI) was assessed after
inclusion of HMR to a multivariate model that includes other SAE
predictors.
Results: SAE occurred in 54 patients (6.9%). After adjusting for age,
LVH, BNP and summed-rest score, independent predictors of SAE,
were HMR \ 1.6 (HR 3.48, 95% CI [1.52-8], P .02), LVEF \ 25%
(HR 1.97, 95% CI [1.28-3.05], P .04) and SBP \ 120 (HR 1.19, 95%
CI [1.03-1.39], P .02). Combining HMR with EF and SBP resulted in
45% improvement in the ability to predict SAE (relative IDI 45%,
P = .03).
Conclusion: HMR provides incremental prognostic value beyond SBP
and LVEF. Knowledge of findings on mIBG imaging helps identify
higher- and lower-risk patients among those with LVEF \ 35%.
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123I-mIBG Scintigraphy for the assessment of cardiac
sympathetic innervation and the relationship to cardiac
autonomic function in healthy adults using standardized
methods
O. Omar Asghar1; P. Arumugam2; I. Armstrong2; U. Alam1;
C. Miller3; M. Schmitt3; S.G. Ray3; R.A. Malik1;
1Univeristy of Manchester, Cardiovascular Research Group,
Biomedical Sciences, Manchester, United Kingdom; 2Department of
Nuclear Medicine, Central Manchester Foundation Trust, Manchester,
United Kingdom; 3University Hospitals of South Manchester NHS
Trust, Wythenshawe Hospital, Manchester, United Kingdom
Background: 123I-mIBG scintigraphy has been proposed as an
independent prognostic indicator for lethal arrhythmic events and
mortality in patients with heart failure. However, normal variations in
regional and global innervation are not accurately established nor is
their functional relevance clear. The purpose of this study was to
quantitatively and qualitatively define global and regional cardiac
sympathetic innervation and functional associations in healthy adults,
according to recommended guidelines.
Methods: We performed 123I-mIBG scintigraphy and cardiac mag-
netic resonance imaging (adenosine stress and late gadolinium
enhancement (LGE)) to exclude structural, functional and ischaemic
heart disease in 15 healthy adults. Using planar and single photon
emission computed tomography (SPECT) imaging, we assessed global
uptake via the late heart mediastinum ratio (HMR) and sympathetic
turnover by determining the washout rate (WR). Regional innervation
was assessed semi-quantitatively using a 17 segment left ventricular
model by grading tracer uptake according to a scale (0 = normal,
1 = mild, 2 = moderate 3 = severe). Cardiac autonomic function was
assessed using established tests of heart rate variability.
Results: One subject was excluded due to structural heart disease.
The remaining 14 participants (mean age 54.6 ± 5.3 years, M:F 9:5)
had structurally (mean LV Mass 101 ± 25.4 g) and functionally
(LVEF 61 ± 6.39%) normal hearts, with no evidence of previous
myocardial infarction on LGE and no evidence of perfusion abnor-
malities on rest or stress MR. Mean late HMR was 1.73 ± 0.16
(1.37-2.08) and WR was 19.09 ± 7.63% (4.20-31.30). Tracer uptake
was reduced in all subjects at the apex, apical anterior segment and
the inferior wall, predominantly in the basal inferior, inferoseptal and
inferolateral segments. HMR correlated with E:I ratio (-0.609,
P = .035) and sympatho-vagal balance (LFa/RFa) (0.647, P = .023).
WR did not correlate with any functional tests of sympathetic
function.
Conclusion: Using standardized methodology for 123I-mIBG scin-
tigraphy in a well-defined group of healthy adults, we confirm HMR
values comparable with control data from the ADMIRE HF study. We
Table 1. Gated-SPECT and phase analysis results: correlation and
P-value
N 5 37
H/M Early H/M Late
r P value r P value
EDV -0.51 .019 -0.38 .019
ESV -0.57 \.001 -0.43 .008
EF 0.63 \.001 0.53 .001
Peak phase -0.20 .229 -0.14 .423
SD -0.44 .007 -0.31 .063
Bandwidth -0.42 .011 -0.33 .050
Skewness 0.39 .016 0.39 .015
Kurtosis 0.35 .31 0.36 .029
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also confirm a heterogeneous pattern of cardiac innervation affecting
the inferior wall and apex. Although WR has wide variability, perhaps
limiting its use as an additional prognostic marker, HMR is associated
with indices of cardiac sympathetic a function suggesting it might not
only be a useful prognostic marker but may also provide insight into
the functional integrity of the cardiac autonomic nervous system.
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Association of global and segmental strain abnormalities in
sarcoidosis patients with inflammation and scar by 18F-FDG
PET
B. Tamarappoo1; T. Negishi1; K. Negishi1; R. Brunken1;
T. Marwick1
1Cleveland Clinic, Department of Cardiovascular Medicine,
Cleveland, United States of America
Background: Detection of subclinical cardiac sarcoidosis may be
important in preventing arrhythmias and sudden death. Diagnosis of
subclinical disease using echocardiography, PET and MRI can be
challenging; however, global longitudinal strain (GLS), a highly sen-
sitive measurement of altered left ventricular (LV) function, may be
able to improve diagnostic accuracy. Our aim was to examine the
relationship between GLS, segmental strain and myocardial inflam-
mation or scar in patients with sarcoidosis.
Method: We identified patients with systemic sarcoidosis with an
echocardiogram and 18F-FDG PET performed within 60 days at the
Cleveland Clinic, between 2007 and 2012. Patients with cardiac sur-
gery, valvular disease and coronary artery disease were excluded.
Segments with inflammation and scar by PET were identified by a
single observer. Global (GLS) and segmental longitudinal strain by
echocardiography was quantified by an independent observer in blin-
ded fashion. Abnormal segmental strain was defined as [ -14%.
Result: Among 35 patients (age 51 ± 11, 60% male), 27 had scar,
inflammation or both on 18F-FDG PET. GLS was normal in patients
without scar or inflammation, -21.6 ± 2.7%. GLS was significantly
reduced in patients with scar (-13.1 ± 4% P \ .0001) and
scar + inflammation (-12.8 ± 4.8% P \ .0001) and unchanged in
patients with inflammation alone (18 ± 3.9 P = .08). There was a
strong correlation between GLS and the amount of scar (scar, r = 0.64
P \ .0001; scar + inflammation; r = 0.72 P \ .0001). The area under
the receiver operating characteristic curve (AUC) for presence of scar
by GLS was 0.881 (sensitivity 72.7%, specificity 92.3%) with a cut-off
of -14.8%; and for scar, inflammation or scar + inflammation was
0.918 (sensitivity 85.7% specificity 85.7%) with a cut-off at -18.7%.
AUC for detection of scar based on the number of segments with
abnormal segmental strain was 0.832 for scar (sensitivity 68.2%,
specificity 84.6%) with a cut-off of 4 abnormal segments and 0.895 for
detection of scar, inflammation or both (sensitivity 67.9%, specificity
100%) with a cut-off of 3 abnormal segments. Segmental longitudinal
strain was significantly increased in segments with scar or scar and
inflammation compared to segments without abnormalities on PET (-
11.9 ± 6.1% vs -18.4 ± 6.7% vs P \ .001).
Conclusion: Myocardial scar and inflammation due to sarcoidosis
detected by 18FDG PET are strongly associated with abnormal GLS
measured by echocardiography. Further studies are required to exam-
ine the incremental value of GLS and segmental strain for the
diagnosis of cardiac sarcoidosis.
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Integrated Dual Exercise and Lexiscan (IDEAL): Differing
effects on myocardial blood flow in normal and in abnormal
PET
V. Lanka1; D. Vangala1; J. Bruyere1; M.F. Di Carli1;
S. Sharmila Dorbala1;
1Brigham and Women’s Hospital, Boston, United States of America
Immediate post-exercise vasodilator stress may maximally vasodilate
normal coronaries with minimal additional vasodilation of diseased
vasoconstricted coronaries.
Objective: To test the hypothesis that exercise + vasodilator compared
to vasodilator alone results in lower stress myocardial blood flow
(MBF) in patients (Pts.) with defects and higher stress MBF in Pts.
without defects.
Methods: Pts. with clinical PET (Rb82/ammonia, IV Regadenoson),
underwent a repeat study in 2 weeks (Treadmill exercise + IV Reg-
adenoson, L-exercise). MBF (mL/gm/minute) and global coronary
flow reserve (CFR, stress/rest MBF) were computed.
Results: We studied 13 Pts. (age 60 ± 10 years, 54% females, 77%
hypertension, 23% diabetes, LVEF 57 ± 11%). Stress hemodynamics
were higher with L-exercise (Figure A). Stress MBF was lower with
L-exercise only in Pts. with defects; Pts. without defects demonstrated
a trend toward higher stress MBF (Figure B).
Conclusions: In this pilot study, stress MBF was lower with exer-
cise + vasodilator in Pts. with perfusion defects. Exercise +
vasodilator may be better than vasodilator alone to identify flow
changes from coronary disease.
117
Usefulness of MDCT coronary angiography in the evaluation
of patients after arterial switch operation for transposition of
the great arteries
V. Silvestri1; B. Leonardi2; G. Pongiglione2; P. Toma’2;
A. Secinaro2
1Catholic University of the Sacred Heart, Rome, Italy;
2Bambino Gesu Children’s Hospital, Rome, Italy
Background: The arterial switch operation (ASO) has become the
surgical approach of choice for transposition of the great arteries
(TGA). There is, however, an incidence of adverse sequelae (coronary
stenosis, distortion of the pulmonary arteries, dilatation of the neo-
aortic root and aortic regurgitation) in some survivors. At present,
cardiac catheterization is recommended. New CT scans are becoming a
useful option to evaluate the congenital heart disease anatomy with
acceptable radiation exposure and few risks.
Objective: To evaluate the clinical usefulness of MDCT angiography
in the evaluation of coronary anatomy, besides the right and left
ventricle outflow in pediatric patients after ASO for TGA.
Methods: At the Children’s Hospital, between May 2011 and July
2012, 24 asymptomatic children after ASO, 19 male (79%), mean age
of 12.6 ± 6.8 years, underwent a CT. Examinations were performed on
a 2nd generation dual-source CT scanner, using low-dose acquisition
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protocols (high-pitch spiral or sequential mode). We evaluated the
coronary arteries in regard to rule out possible complication at the
reimplantation site or at proximal vessel segments, such as looping,
stretching, compression, kinking or stenosis. Multiplanar reformation
(MPR), maximum intensity projection (MIP) and volume rendering
(VR) were used for image interpretation. Image quality was expressed
by a numerical value, according to a five points Likert scale from 5
(excellent), to 1 (inestimable), depending on vessel contrast and the
presence/absence of motion or ‘‘stair-step’’ artifacts (the latter
occurring in sequential examinations). Coronary angiography was
reserved to the patients with coronary abnormalities on CT
evaluation.
Results: Scanning time was short (approximately 0.25 seconds in
high-pitch spiral mode) and acquisition was performed without seda-
tion, with patients breathing freely. The average heart rate variability
didn’t show to influence vessel evaluation on ostia and proximal seg-
ments, which were always assessable. The diagnostic quality of the
images was from moderate to excellent (mean value 4.7) and the
diagnostic confidence high. Mean radiation dose was 1.36 ± 1.37 mSv.
Conclusion: CT could be a valid alternative to coronary angiography
in the follow up of pediatric patients after ASO. Latest generation of
scanner make examination feasible even in patients with high cardiac
frequency and non-cooperative, reducing radiation dose, risks related
to anesthesia, hospitalization and the stress experienced by children
and their family.
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Myocardial perfusion imaging using dual-energy computed
tomography: First experience
G. Gianluca Pontone1; D. Andreini1; E. Bertella1; S. Mushtaq1;
E. Conte1; A.L. Bartorelli1; L. Grancini1; A.D. Annoni1;
G. Ballerini1; M. Pepi1;
1University of Milan, Foundation Monzino (IRCCS),
Center Cardiology, Department of Cardiology, Milan, Italy
Purpose: Dual-energy computed tomography (DECT) may allow
improved quantitative analysis of myocardial CT perfusion (CTP) in
comparison with single-energy CT by reducing the beam hardening.
We present the first human case of stress-CTP using DECT.
Methods and Materials: A 61-year-old man was evaluated by stress-
CTP with adenosine using DECT and compared with invasive coro-
nary angiography (ICA). A new stress-CTP was repeated after
coronary angioplasty and stent implantation (PCI + stent).
Results: The DECT showed chronic occlusion (CTO) of the left
anterior descending artery (LAD) (Panel A-C, circle) with a perfusion
defect in the anterior wall of the left ventricle after stress (Panel D-F,
with arrow) involving 32 g of myocardial mass (18% of overall
myocardial mass). The ICA confirmed the CTO of LAD that was
treated by PCI + stent. A stress-DECT performed 3 day later showed a
reduction of perfusion defect up to 2 g of myocardial mass corre-
sponding to 1.2% of overall mass (Panel G-I, red arrow). The total
amount of contrast agent and overall effective radiation dose for each
DECT were 120 cc and 4.4 mSv, respectively.
Conclusions: This is the first human case in which DECT has been
used for the quantitative analysis of perfusion defect.
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Quantitative analysis of stress-rest myocardial perfusion
SPECT using solid state gamma camera: Validation and
usefulness to facilitate stress-only low-dose protocol
T. Tali Sharir1; M. Pinskiy1; V. Prochorov1; V. Gottfried1;
A. Bojko1; K. Merzon1; M. Motro1
1Assuta Medical Center, Tel Aviv, Israel
Purpose: To validate quantitative analysis of myocardial perfusion
imaging (MPI) acquired with a solid state technology having dedicated
normal limits, and use it for standardized interpretation of stress only
protocol.
Methods: Forty four patients with low likelihood of CAD and 86
patients with intermediate-high likelihood and perfusion defects
underwent MPI using a solid state camera. MPI protocol comprised of
stress (10 mCi)/ rest (25 mCi) Tc-99m sestamibi, 5 minutes stress
supine acquisition, 3:20 stress prone and 3 minutes rest supine. Visual
summed stress score (SSS) was determined using a 17 segment model
(0-4 score) and converted to %SSS by dividing by 68. Quantitative
%SSS and total perfusion deficit (TPD) were derived using a com-
mercial software. Custom new normal limits (NNL) were developed
for the new technology from data of another 30 females and 30 males
with low CAD likelihood. Results of quantitative analysis using NNL
were compared to those based on standard (commercial)normal limits
(SNL) with visual %SSS as gold standard. Stress-only protocol was
performed in 24 low CAD likelihood patients with NNL %SSS.
Results: Among patients with low pretest CAD likelihood mean stress
NNL TPD was close to zero and significantly lower compared to SNL
TPD (0.95% ± 0.99 vs 3.5% 1 ± 1.9, p4% (normalcy rate 100%),
while 15 had TPD [ 4% using SNL (normalcy rate 65.9%). Of the 44
patients 24 (54.5%) had a low-dose stress only protocol (10 mCi Tc-
99m sestamibi, patient exposure \ 3 mSv) with NNL SSS% B 4% in
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all cases. Of these 24 patients only 7 (29%) had SNL TPD B 4%.
Among the 86 patients with intermediate-high likelihood quantitative
%SSS was similar to visual %SSS using either NNL or SNL (NNL:
23.6% ± 11.6, SNL: 22.4% ± 11.0, vs visual: 21% ± 9.3, P = NS).
Quantitative %SSS (both NNL and SNL) highly correlated to visual
%SSS (R = 0.84 for both, P \ 0.0001).
Conclusion: Quantitative analysis of solid state SPECT using custom
normal limits and commercial software provided very high normalcy
rate among patients with low CAD likelihood, and correctly detected
the amount of perfusion abnormality among patients with intermediate-
high likelihood. This standardized analysis may facilitate the use of
low-dose, stress only protocol with very low patient radiation exposure
(\3 mSv).
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Angiographic coronary stenosis versus (15)O-water PET
myocardial blood flow
A. Anders Thomassen1; P.E. Braad1; A. Johansen1; H. Petersen1;
A. Diederichsen2; H. Mickley2; L.O. Jensen2; P. Thayssen2;
B. Blomberg1; P.F. Hoilund-Carlsen1
1Odense University Hospital, Department of Nuclear Medicine,
Odense, Denmark; 2Odense University Hospital,
Department of Cardiology, Odense, Denmark
Purpose: To examine which of stress myocardial flow (MBF) and
coronary flow reserve (CFR) determined by (15)-water-PET (PET)
correspond most closely with diameter stenosis assessed by quantita-
tive coronary angiography (QCA).
Methods: Twenty-three patients with a C40% QCA stenosis under-
went baseline and adenosine stress PET. Baseline MBF measures were
corrected for myocardial workload and stress MBF and CFR calculated
in 17 standard AHA myocardial segments and reassigned to respective
feeding vessels. If multiple stenoses, only the most severe stenosis was
considered. Pearson’s correlation coefficients were calculated and
compared using Fisher r-to-z transformation.
Results: A total of 35 QCA stenoses were identified with a mean
diameter stenosis of 75% ± 18%, range 45-100%. Stress MBF and
CFR in corresponding vascular territories were: 1.84 ± 0.78 and
1.86 ± 1.05 mL/minute/g, respectively. MBF was significantly corre-
lated to QCA stenosis severity: r = -0.46, P = .006, whereas CFR
was not, r = -0.28, P = .097. These two r values did not differ sig-
nificantly, P = .42. In contrast, stress MBF and CFR were significantly
correlated (C): r = 0.86, P \ .001.
Conclusions: The correlation between anatomic and functional ste-
nosis was poor, suggesting that the hemodynamic consequences of
angiographically proven coronary stenoses should be examined by
functional imaging like PET.
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99mTc-HMDP and 99mTc-DPD have similar performance
for the detection of cardiac involvement in patients with
TTR-familial amyloid polyneuropathy
F. Francois Rouzet1; V. Algalarrondo2; R. Chequer1;
L. Eliahou2; F. Hyafil1; I. Corman1; E. Sorbets1; D. Adams3;
M. Slama2; D. Le Guludec1
1AP-HP—Hospital Bichat-Claude Bernard, Paris, France;
2AP-HP—Hospital Antoine-Beclere-University Paris-Sud, Clamart,
France; 3AP-HP—Hospital Bicetre, Department of Neurology, French
Reference Center for Familial Amyloidosis, Le Kremlin-Bicetre,
France
Background: Familial amyloid polyneuropathy (FAP) is a severe
hereditary disease, due to liver production of a genetic variant trans-
thyretin (TTR) resulting in amyloidosis. Diphosphonate scintigraphy
has been proposed as a diagnostic tool for TTR-related cardiac amy-
loidosis, so we compared the relative accuracy of radiolabelled
hydroxymethylene diphosphonate (HMDP) and diphosphono-propa-
nedicarboxylic acid (DPD) scintigraphy in this setting.
Methods and Results: We prospectively evaluated 50 consecutive
patients with proven TTR-FAP. Cardiac involvement was assessed by
EKG, echocardiography, right heart catheterization, 123I-MIBG scin-
tigraphy, cardiac MRI, and classified as absent, moderate, or severe.
Patients characteristics are presented in Table. Acquisitions were per-
formed 3 hours (planar and SPECT) after i.v. injection of 740 MBq of
tracer (HMDP in the first 24 patients). Myocardial uptake was visually
scored on planar images (absent, moderate, or intense), and quantified
(myocardium to lung ratio [MLR]) on tomographic slices. In patients
with cardiac amyloidosis, 9/21 (43%) were positive with HMDP and
14/24 with DPD (58%; P = .4), all but one with severe forms. The main
determinant of a positive scan was LV wall thickness assessed by echo,
and MLR was correlated to relative wall thickness both with HMDP
(r = 0.6; P = .05) and DPD (r = 0.6; P = .04). In patients without
cardiac amyloidosis, none was positive whatever the tracer.
Conclusion: In TTR-FAP, diphosphonate scintigraphy was positive in
about half of the patients with cardiac involvement, all but one with
severe forms. The major determinant of tracer uptake was wall
thickness. There was no significant difference in diagnostic accuracy
between HMDP and DPD. Since it failed to detect moderate forms,
diphosphonate scintigraphy seems unfit to be used as a screening tool,
but mostly as marker of severity.
Study population
99mTc-HMDP
(n 5 24)
99mTc-DPD
(N 5 26) P value
Age (year) 56 ± 14 61 ± 13 .2
Sex (males) n (%) 11 (46%) 17 (65%) .2
MET 30 n (%) 17 (71%) 18 (70%) 1
Relative wall thickness
(Echo)
0.48 ± 0.20 0.49 ± 0.15 .7
Cardiac involvement no/
moderate/severe (n)
3/8/13 2/9/15 .9
Positive scan 0/0/9 0/1/13 [.4
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The assessment of myocardial blood flow in patients with
cardiac X syndrome using positron emission tomography
D.V. Ryzhkova1; M.V. Kolesnichenko2; S.A. Boldueva2;
I.S. Kostina3; S. Nesterov4
1Russian Research Center of Radiology & Surgical Technology,
Almazov Federal Center of Blood & Endoc, Saint Petersburg, Russian
Federation; 2State Medical Academy named after I. I. Mechnikov
(SPSMA), Saint Petersburg, Russian Federation; 3Almazov Federal
Center of Heart, Blood and Endocrinology, St-Petersburg, Russian
Federation; 4Turku PET Centre, Turku, Finland
Purpose: The myocardial blood flow and coronary flow reserve were
studied by positron emission tomography (PET) in patients with car-
diac syndrome X (CSX).
Material and Methods: Sixteen patients with the typical triad of CSX:
pain in the chest, ST segment depression during stress ECG test and
angiographically normal coronary arteries were included. Patients with
coronary heart disease (CHD) (n = 12) and volunteers without car-
diovascular disease (n = 12) were served as the control groups.
Cardiac PET with 82Rb-chloride was performed at rest, during cold
pressor test (CPT) and dipyridamole hyperaemia (DH). Absolute val-
ues of myocardial blood flow (MBF) was calculated using the software
package ‘‘Carimas 2.2’’. Coronary flow reserve (CFR) was calculated
based on the values of MBF at rest and during DH.
Results: We did n’t find any significant differences between values of
CFR in patients with CSX and volunteers. In patients with CHD there
was observed a significant decrease in CFR compared with control
groups. In patients with CSX PET during CPT revealed an insignificant
increase of MBF compared to baseline values (6 pts.), or decrease of
MBF (10 pts.), suggesting an absence of EDPR or microvascular
spasm. MBF during CPT was significant increase (more than 25% of
baseline values) in volunteers.
Conclusion: Disturbance of endothelium-dependent vasodilatation
plays a role in the pathogenesis of myocardial ischemia in patients with
coronary syndrome X.
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Incremental value of Rubidium PET myocardial blood flow
measurement over relative perfusion assessment in the
detection of coronary artery disease
P. Arumugam1; M. Agelaki1; M.A. Khan1; R.S. Khattar1
1Central Manchester University Hospitals NHS Foundation Trust,
Manchester, United Kingdom
Myocardial perfusion imaging using Positron Emission Tomography
(PET) is currently regarded as the most accurate non-invasive method for
quantifying Myocardial Blood Flow (MBF). It is well known that relative
perfusion assessment with both Single Photon Emission Tomography
(SPECT) and PET could potentially underestimate the extent of ischaemia
and coronary artery disease in a proportion of patients. We assessed the
performance of Rubidium-82 PET against angiographic coronary artery
disease. The aim was to assess the additional value of PET MBF over
relative perfusion assessment using Siemens’ MBF Circulation software.
Methods: We retrospectively studied 57 consecutive patients who
underwent a clinically indicated PET scan and coronary angiography
within three months. Coronary angiograms were reviewed by two
independent operators and a C50% stenosis in a major epicardial
coronary artery was considered significant. The patients were dichot-
omized into those in whom relative perfusion assessment matched
coronary stenosis on angiography (concordant group) and those in
whom the results lacked agreement (discordant group).
We then compared the Coronary Flow Reserve (CFR = Stress MBF/
Rest MBF) data in the standard three coronary vascular territories of
the discordant group to determine whether it concurred with the degree
of coronary stenosis and location of disease. CFR of less than 1.5 was
used as a cut off for significant reduction in blood flow.
Results: A total of 57 patients were studied (46 male, 11 female) with
a mean age of 64 years. Fourteen patients (24%) had multivessel
disease. The total number of concordant cases was 40 (70%) in whom
relative perfusion assessment matched coronary angiographic findings.
Among the 17 discordant results, CFR findings corresponded to cor-
onary angiography in 8 patients (48%). Therefore the use of CFR
improved the overall concordance rate to 84%. CFR was still discor-
dant in 9 cases of whom 7 had single vessel disease and 2 had
multivessel disease.
Conclusions: In this study, relative perfusion assessment was con-
cordant with coronary angiography for the detection and location of
coronary artery disease in 70% of cases. The use of CFR with
Rubidium-82 PET had incremental diagnostic value showing agree-
ment in disease detection in approximately half of the patients with
previously discordant results. We plan to clinically follow up the
discordant patient group to assess cardiac event rate in an 18-month
follow up period.
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Low dose ‘‘stress-only’’ gated-myocardial perfusion SPECT
scintigraphic protocol: Solid state detector imaging reduces
the need for rest injection imaging
A. Atul Verma1; S. Pandey1
1Fortis Escorts Heart Institute, New Delhi, India
Objective: To find out the efficacy of semiconductor detector gamma
camera to reduce the need of rest injection imaging on a’’ Stress-only’’
gated SPECT myocardial perfusion scintigraphy when compared with
the conventional gamma camera using low dose Tc99m-MIBI.
Materials & Methods: 65 subjects irrespective of age and sex with
atypical symptoms and normal LVEF were chosen for the study. Each
were subjected to stress (treadmill/pharmacological) and were injected
5-10 mCi of Tc99m-MIBI according to the weight . The gated SPECT
imaging were performed under both Discovery NM530C (Solid state)
and Symbia S (conventional) gamma cameras with the imaging times
of 5 and 12 minutes respectively. The resting imaging was performed
under both the cameras after injection of 20-25 mCi of Tc99m MIBI.
The acquired images were processed using 3D-iterative reconstruction
(No of iterations = 70) for discovery NM530C and backprojection
reconstruction using butterworth filter of 5 & order of 5 for symbia S.
The images were compared using both the segmental distribution &
Myocardial contractility.
Observations: The processed images were divided into:
Group A: 26 cases showed maintained myocardial radiotracer
distribution in both the cameras.
Group B: 29 cases showed photopaenicity in the inferior/inferobasal
wall during both stress and rest images with symbia S. The
DiscoveryNM530C showed maintained radiotracer uptake and ade-
quate myocardial contractility.
Group C: 10 cases showed reduced radiotracer uptake in both the
cameras with hypocontractility on a gated SPECT study. These
showed a near total refilling during stress imaging with improved
myocardial contractility.
Inference: From the above observations, 26 subjects with no perfusion
defects and maintained myocardial contractility during post stress
imaging do not require rest injection imaging; 29 cases where photo-
paenicity were seen in the inferior/inferobasal wall by a conventional
camera. A gated SPECT due to low count images were not able to dif-
ferentiate low perfusion area from diaphragmatic photon attenuation.
However Discovery NM530c showed adequate perfusion with relatively
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maintained myocardial contractility. The photopaenicity may be
ascribable to diaphragmatic photon attenuation and does not require rest
injection. 10 cases showed reduced radiotracer distribution in both the
cameras with hypokinesia on gated study required rest imaging.
Discussion: The direct energy conversion, increased spatial and energy
resolution and pin hole detectors improves low dose image quality
which showed increased efficacy over conventional camera on a low
dose stress only protocol.
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Prognostic value of circulating matrix metalloproteinases
and brain natriuretic peptide in patients after q-wave
myocardial infarction
A. Alexander E. Berezin1; A. Kremzer1; T. Samura1
1State Medical University, Zaporozhye, Ukraine
Background: Following acute myocardial infarction (MI), myocytes
and the interstitium are changed immediately. Extracellular matrix
reposition after MI is considered as a one of powerful integral mech-
anisms of cardiac remodeling that determinates individual cardio-
vascular risk value. Recently clinical trials have been shown that both
early post-MI dilatation of left ventricular cavity and spherical trans-
formation of one are tightly associated with poor short-term and long-
term prognosis as well. Matrix metalloproteinases (MMPs) play an
important and pivotal role in processes around heart architectonic
disorders in subjects after acute MI.
The objective of this study was to compare of prognostic value of
MMP-3, MMP-9 and NT-pro-BNP for fatal and non-fatal complica-
tions in Q-wave myocardial infarction patients in acute MI and post-MI
periods.
Materials and methods: 120 patients (male and female) with docu-
mented Q-wave myocardial infarction (MI) were observed during
1 year after hospitalization period. Clinical endpoints were identified
through the hospital patient tracking system, with review of medical
records for each recorded endpoint. LV ejection fraction (LVEF) and
wall motion index (WMI) were calculated accordingly conventional
methods. Measurements of MMP-3, MMP-9, and NT-pro-BNP con-
centrations were performed by ELISA.
Results: In the ROC curves, a cut-off value for MMP-3 (9.7 ng/mL)
showed the best discriminatory power (sensitivity = 77.8%, specific-
ity = 90.8%). We found also that optimal cut-off for MMP-9 was
18.1 ng/mL (sensitivity = 70.5%, specificity = 75%), and cut-off for
NT-pro-BNP was 885 pmol/l (sensitivity = 58%, specificity = 68.6%).
Combination MMP-3 and MMP-9 had positive prognostic value of 70%
(sensitivity and specificity y are 84% and 82% respectively).
Conclusion: We predispose, that obtained data can be helpful for
further stratification of the patients into high cardiovascular mortality
risk group.
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Added value of Rb-82 cardiac PET quantitation of
myocardial blood flow over semi-quantitative analysis to
select patients eligible for invasive coronary angiography
J.A. Jean-Aibert Collinot1; E. Deshayes1; V. Michiels2;
O. Muller2; J.O. Prior1
1CHUV and University of Lausanne, Department of Nuclear Medicine,
Lausanne, Switzerland; 2CHUV and University of Lausanne, Depart-
ment of Cardiology, Lausanne, Switzerland
Aim: To determine whether myocardial blood flow (MBF) quantitation
derived from Rb-82 cardiac PET could improve the selection of
patients eligible for invasive coronary angiography (ICA) as compared
to semi-quantitative analysis using summed difference score (SDS).
Methods: We enrolled 40 consecutive patients with suspected or
known CAD who performed cardiac Rb-82 PET/CT and ICA within
60 days, without cardiovascular events in between. Rest and adeno-
sine-induced stress MBF (sMBF) were computed, as well as
myocardial flow reserve (MFR = stress/rest MBF) using the 1-com-
partment Lortie model (FlowQuant) for the whole LV, as well as for
each coronary artery territories (vessel-based analysis). Flow parame-
ters were divided in 3 groups: G1 = abnormal MFR \ 1.5 &
sMBF \ 2 mL/minute/g; G2 = intermediate abnormalities
1.5 B MFR \ 2 & sMBF \ 2 mL/minute/g and G3 = normal
MFR C 2 or sMBF C 2 mL/g/minute. Stenosis severity was classified
as non-significant (\50% or FFR C 0.8), intermediate (50% B ste-
nosis \ 70%) and severe (C70%).
Results: In patients with abnormal or intermediate flow abnormalities,
21/22 (95%) and 6/7 (86%) had at least one vessel with severe stenosis,
respectively. Among patients without perfusion abnormalities, 9/11
(82%) had no significant coronary lesion. Moreover using semi-
quantitative analysis criteria only (SDS C 7), 10 patients would benefit
from ICA (all in G1 or G2) against 27 patients with sMBF & MFR
quantitation. At ICA, 29/40 (73%) patients had at least one vessel with
severe stenosis, with 27/29 (93%) in abnormal or intermediate
abnormalities groups. Likewise, 52/84 (62%) of vessels analysed in
patients of abnormal or intermediate abnormalities groups had a sig-
nificant stenosis.
Conclusion: Patients with normal flow parameters (MFR C 2 &
sMBF [ 2 mL/minute/g) could avoid ICA. Patients with 3-vessels low
MFR and sMBF would benefit from ICA, as they are likely to present a
severe stenosis (C70%) in at least one vessel. MBF and MFR quan-
titation improves patient referral to ICA as compared to semi-
quantitative analysis alone.
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The influence of hypoxic preconditioning on the levels of
s-NGAL (lipocalin-2) during myocardial revascularization
under extracorporeal circulation
Z.H. Vesnina1; S.I. Sazonova1
1Research Institute for Cardiology, Tomsk, Russian Federation
Purpose: To evaluate the effect of hypoxic preconditioning (HPC) on
the levels of s-NGAL (lipocalin-2) during myocardial revascularization
under extracorporeal circulation (EC).
Methods: We examined 40 patients with CAD (mean age
57.6 ± 1.2 years) who underwent coronary bypass surgery (CABG)
under EC. The patients were divided into 2 groups: patients (n = 20)
with HPC, conducted during CABG (study group), and 20 patients
without preconditioning (comparison group). Preconditioning was
performed in single-cycle 10-minute hypoxemia followed by the
5-minute period of reoxygenation before global ischemia. The con-
centration of serum lipocalin before and 5 hours after CABG was
determined in all patients using a test-system Human Lipocalin-2
NGAL, ELISA.
Results: Baseline levels of lipocalin did not differ significantly
between groups. We found a reverse correlation between the levels of
s-NGAL and left ventricular ejection fraction (R = -0.37, P = .02),
and also between the glomerular filtration rate (according to the
radionuclide renoscintigraphy) and level of lipocalin (R = -0.28,
P = .046). Five hours after CABG has been a significant increase in
the concentration of s-NGAL vs pre-operative value in the study group,
and in the comparison group (127.58 ± 22.59 vs 70.65 ± 10.72 ng/mL
and 171.65 ± 20.10 vs 65.01 ± 8.64 ng/mL, respectively). We found
a direct relationship between the duration of the EC and the dynamics
of s-NGAL levels in both groups. However, increasing of the NGAL
concentration in the comparison group was more significant compar-
atively to the study group (P = .02). The average value of the
difference between pre- and postoperative lipocalin levels in study
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group was 56.94 ± 19.76, and 106.64 ± 18.94 ng/mL—in comparison
group (P = .004).
Conclusion: Hypoxic preconditioning during myocardial revasculari-
zation under extracorporeal circulation prevents a critical increasing of
serum lipocalin-2.
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Effectiveness and safety of increasing target clamp serum
glucose during the hyperinsulinemic euglycemic clamp for
PET viability imaging
J. John Askew1; D. Mihalkova1; T. Miller1;
M. Rodriguez-Porcel1; P. Chareonthaitawee1;
1Mayo Clinic, Rochester, Minnesota, United States of America
Purpose: Positron emission tomography (PET) with F-18 fluorode-
oxyglucose (FDG) is an important tool in the identification of viable
myocardium in patients with ischemic left ventricular (LV) systolic
dysfunction. The hyperinsulinemic-euglycemic clamping (HEC) is a
well-proven technique for optimizing glucose metabolic conditions and
FDG PET image quality. Prior to June 2010, the HEC serum glucose
(SG) goal in our practice was set at 90 (range 85-95) mg/dL. However,
using this protocol, a number of patients experienced significant
hypoglycemia (defined as SG \ 70 during HEC). The goals of this
study were (1) to increase the SG goal to 95 (range 90-100) mg/dL, (2)
to measure the incidence of hypoglycemia and (3) assess FDG PET
image quality with the new HEC SG goal.
Results: Please see table for details.
Methods: From January 1, 2009 to December 27, 2009, 72 consecutive
patients underwent FDG PET viability studies with an HEC SG goal of
85-95 mg/dL. New SG goals (90-100 mg/dL) were implemented from
June 1, 2010 to December 31, 2011. During this time, 84 consecutive
patients underwent FDG PET viability studies. Data were collected and
analyzed for mean blood glucose, episodes of asymptomatic and
symptomatic hypoglycemia, and image quality. Image quality was
determined by consensus of two experienced readers.
Conclusions: Raising the HEC SG goal from 85-90 to 90-100 mg/dL
during FDG PET viability studies significantly reduced hypoglycemic
episodes without affecting FDG PET image quality.
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Cardiac metaiodobenzylguanidine scintigraphy in patients
with spinocerebellar ataxia type 2
T. Pellegrino1; S. Pappata’1; S. De Luca1; A. De Rosa1;
M. De Leva1; M. Tuccillo1; A. Boemio1; A. Filla1;
G. De Michele1; A. Alberto Cuocolo1
1University Federico II, Napoli, Italy
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neu-
rodegenerative disorder characterized by progressive cerebellar ataxia,
slow saccadic eye movements, and peripheral neuropathy. Autonomic
nervous system dysfunction represents also a significant component of
SCA2 clinical picture. The aim of this study was to evaluate cardiac
autonomic innervation in patients with SCA2 using cardiac I-123
metaiodiobenzylguanidine (MIBG) scintigraphy, a marker of post-
ganglionic sympathetic cardiac nerve terminals integrity, in compari-
son with patients with Parkinson’s disease (PD), usually showing
reduced myocardial MIBG uptake.
Methods: Cardiac autonomic innervation was assessed in 8 patients
with SCA2 (5 men and 3 women, mean age 40 ± 12 years) and 5
patients with PD (3 men and 2 women, mean age 53 ± 7 years). None
of these patients had diabetes mellitus, cardiac disease, or took drugs
that may affect MIBG myocardial uptake. All patients underwent I-123
MIBG scintigraphy. Following thyroid gland blocking with potassium
iodide, 111 MBq of I-123 MIBG was intravenously injected. Planar
scintigraphic imaging in the anterior view was obtained 15 minutes
(initial) and 4 hours (delayed) after the tracer injection using a dual-
head gamma camera equipped with a low-energy, high-resolution
collimator. A preset time of 10 minutes was used for image acquisition
with a 159 ± 10 keV of energy window. Region of interest analysis
was used to calculate the initial and delayed heart to mediastinum (H/
M) ratios. The H/M ratio for both initial and delayed images and the
background corrected myocardial washout rate were calculated. Two
observers, blinded about patients’ disease, performed data analysis.
Results: Initial H/M ratio and delayed H/M ratio in patients with PD vs
patients with SCA2 were 1.6 ± 0.3 vs 1.9 ± 0.2 and 1.4 ± 0.4 vs
1.8 ± 0.1, respectively. In patients with PD, the initial H/M ratio and
delayed H/M ratio were significantly lower compared to patients with
SCA2 (P \ .05). Washout rate in patients with PD vs patients with
SCA2 were 63.3 ± 24.5% vs 33.9 ± 7.4%, respectively. In patients
with PD, washout rate was significantly higher than in patients with
SCA2 (P \ .01).
Conclusions: Our preliminary findings show that myocardial I-123
MIBG uptake is reduced more markedly in PD than in SCA2 patients,
suggesting a more severe and/or a different sympathetic autonomic
dysfunction in patients with PD as compared to those with SCA2.
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Correlation between perfusion abnormalities and myocardial
blood flow using 13N-ammonia PET/CT in patients with CAD
E. Erick Alexanderson Rosas1; L.V. Torres-Araujo1;
E.A. Penarrieta-Daher1; L.E. Juarez-Orozco1;
S. Hernandez-Sandoval1; C.A. Guizar-Sanchez1;
A. Meave-Gonzalez1; M. Jimenez-Santos1;
M.M. Martinez-Aguilar1
1Instituto Nacional de Cardiologı´a ‘‘Ignacio Cha´vez’’,
Mexico City, Mexico
Introduction: PET/CT provides anatomical information of the coronary
arteries, along with objective evidence of its functional impact. New
software provide an automated perfusion scoring of the 17 left ventric-
ular segments, calculating perfusion scores: Summed Rest Score (SRS),
Summed Stress Score (SSS), Summed Differential Score (SDS), and the
quantification of Myocardial Blood Flow (MBF), Coronary Flow
Reserve (CFR) and the quantification of Total Perfusion Defect (TPD).
Old HEC SG
goal (n 5 72
patients)
New HEC SG
goal (n 5 84
patients) P
Age (years) 68 65 .05
Males 64 (89%) 75 (89%) .94
Patients achieving HEC
SG goal during steady
state
56 (78%) 65 (77%) .95
SG during HEC (mg/dL) 88 92 \.01
Patients with
hypoglycemia
7 (10%) 1 (1%) .02
Patients with
symptomatic
hypoglycemia
4 (6%) 0 (0%) .04
Lowest SG (mg/dL)
during HEC
78 83 \.01
Time to FDG injection
(minutes)
95.4 95.5 .79
Patients with
unsatisfactory FDG
PET image quality
1 (2%) 1 (1%) .91
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Methods: We studied 30 patients with known CAD determined by
CCTA, who underwent a 13N-Ammonia Gated PET study. The patients
were divided, by the severity of ischemia based on visual interpretation
of the 13N-Ammonia PET perfusion images, into three groups: mild,
moderate and severe ischemia. Ten patients were included in each
group. The SRS, SSS, SDS, rest and stress TPD (rTPD and sTPD), rest
and stress MBF (rMBF and sMBF) and CFR were calculated, using the
CSI Software. The one factor ANOVA test was used to determine if
there is a significant correlation in any of the above mentioned values
proportional to the severity of the ischemia.
Results: Table 1.
Conclusions: We found an inversely significant proportional relation
between the degree of ischemia and the absolute MBF values. Coro-
nary flow reserve was decreased in patients with high score of SDS and
sTPD. sTPD can help to identify a patient with low CFR in the absence
of flow evaluation.
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Radionuclide renoscintigraphy in evaluation of the
nephroprotective effectiveness of hypoxic preconditioning
Z.H. Vesnina1; Y.U. Podoksenov1; Y.U. Lishmanov1
1Research Institute for Cardiology, Tomsk, Russian Federation
Purpose: Using radionuclide renoscintigraphy to evaluate the effec-
tiveness of hypoxic preconditioning (HPC) during myocardial
revascularization under extracorporeal circulation (EC).
Methods: We examined 51 patients (mean age 52.8 ± 1.4 years) who
underwent coronary bypass surgery (CABG) under EC condition.
Patients were randomized into 2 groups: 20 patients with HPC, con-
ducted during CABG (study group) and 31 patients without
nephroprotection (comparison group). The precondition was performed
in single-cycle 10-minute hypoxemia followed by the 5-minutes period
of reoxygenation before global ischemia. Dynamic radionuclide ren-
oscintigraphy with 99m Tc-DTPA were performed before and 6-7 days
after surgery with the calculation of the parameters of filtration and
evacuation function of the kidneys.
Results: Patients of comparison group after CABG had the negative
dynamics of renal filtration function parameters. Thus, there was a
significant decrease in the mean values of total and separately for each
kidney GFR, combined with a slowing of blood clearance. In addition,
in patients of this group there was a significant increase of the radio-
pharmaceutical clearance from the collecting system of the left kidney
and from the parenchyma of both kidneys.
In the study group average values of kidney filtration activity did not
change in comparison with the initial data, except for the right kidney
GFR. A reduction in the filtration function of one or both kidneys
under the influence of non-pulsed blood flow was observed in only 3
patients (19%) and was not significant. Indicators of the kidneys
evacuation function in the study group also didn’t changed
significantly.
Conclusions: Radionuclide renoscintigraphy allows objectively and
with high informativeness to determine the extent and nature of the
impact of CABG on the kidney function. HPC has nephroprotective
activity in patients undergoing open-heart surgery under EC.
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Impact of diabetes mellitus on cardiac sympathetic
denervation in patients with heart failure
T. Pellegrino1; P. Gargiulo1; G. Rengo1; G. Pagano1;
S. De Luca1; M. Tuccillo1; A. Boemio1; D. Leosco1;
P. Perrone-Filardi1; A. Alberto Cuocolo1
1University Federico II, Napoli, Italy
Patients with heart failure (HF) and diabetes mellitus (DM) have worse
prognosis compared to HF patients without DM. Impaired sympathetic
nervous system activity has been demonstrated in DM patients without
HF and correlated to a worse prognosis but few data are available on
the effect of DM on cardiac sympathetic nerve activity in patients with
HF. The aim of the present study was to assess cardiac sympathetic
nerve activity in HF patients with and without DM.
Methods: We evaluated 75 patients with severe HF (left ventricular,
LV, ejection fraction 31 ± 7) with and without DM. HF patients
underwent I-123 MIBG scintigraphy from which early and late heart to
mediastinum (H/M) ratio and washout rate were calculated. Clinical,
echocardiographic and biochemical data, including NT-proBNP levels
and HbA1c, were measured. Patients were assigned to two groups with
(n = 37) and without DM (n = 38).
Results: The two groups were matched for cardiovascular risk factors
and drug therapy, demography, HF etiology, LV systolic function,
NYHA class, and serum NT-proBNP. MIBG early H/M ratio
(1.65 ± 0.21 in DM and 1.75 ± 0.21 in non-DM) and late H/M ratio
(1.46 ± 0.22 in DM and 1.58 ± 0.24 in non-DM) were significantly
(P \ .01) lower in DM compared to non DM patients. In DM patients,
a highly significant inverse correlation between early H/M ratio and
HbA1c levels (Pearson = -0.697, P \ .000) and between late H/M
ratio and HbA1c levels (Pearson = -0.579, P \ .000) was observed.
Early H/M and late H/M ratios significantly correlated to age, LV
ejection fraction, NYHA class, HF etiology, NT-proBNP, presence of
DM and HbA1c at univariate analysis. However, in multivariate
analysis, HbA1c and LV ejection fraction remained the only significant
predictor of early H/M ratio, whereas HbA1c remained the only sig-
nificant predictor of late H/M ratio.
Conclusions: DM is associated to a more severe impairment of cardiac
sympathetic activity in HF patients and the status of glycemic control
strictly correlates to cardiac autonomic imbalance. These findings
likely contribute to explain the adverse prognostic impact of DM in
HF, and should prompt prospective studies to assess whether a strict
glycemic control in HF diabetic patients leads to improvement of
cardiac sympathetic innervation and of clinical outcome.
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Elevation of high-sensitivity c-reactive protein levels as a
predictor of cardiovascular events in patients with arterial
hypertension during 1 year after ischemic stroke
A. Alexander E. Berezin1; O. Lisovaya2
1State Medical University, Zaporozhye, Ukraine;
2City Hospital 6, Zaporozhye, Ukraine
Table 1. Comparison of PET/CT parameters
PET
parameters
Mild
ischemia
(mean ± SD)
Moderate
ischemia
(mean ± SD)
Severe
ischemia
(mean ± SD) P
SRS 1 ± 1.55 2.1 ± 2.47 24.1 ± 11.12 \.001
SSS 5.7 ± 1.1 10.9 ± 1.45 38.9 ± 12.05 \.001
SDS 4.7 ± 2.15 8.8 ± 2.89 14.8 ± 11.75 .01
rTPD 5.11 ± 4.01 8.43 ± 7.31 36.5 ± 18.38 .0007
sTPD 9.78 ± 0.05 15 ± 6.26 43.25 ± 16.01 .0004
rMBF 0.85 ± 0.25 0.68 ± 0.13 0.74 ± 0.33 .387
sMBF 2.43 ± 0.88 1.84 ± 0.40 0.95 ± 0.25 \.001
CFR 2.90 ± 0.74 2.73 ± 0.57 1.66 ± 0.49 \.001
PET, Positron emission tomography; SRS, summed rest score; SSS,
summed stress score; SDS, summed difference score; rTPD, rest total
perfusion defect; sTPD, stress total perfusion defect; rMBF, rest
myocardial blood flow; sMBF, stress myocardial blood flow; CFR,
coronary flow reserve.
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Background: C-reactive protein (CRP) is considered as a sensitive
indicator of systemic inflammation and direct mediator of atherogen-
esis that has been shown to be a powerful predictor of future recurrent
coronary and cerebral ischemic events in subjects after stroke. How-
ever, the pathogenic and clinical significance of these associations is
controversial.
The aim of the study was to evaluate the relationship between CRP
plasma level and risk of recurrent coronary and cerebral ischemic
events in arterial hypertension patients after ischemic stroke.
Methods: 102 mild-to-moderate arterial hypertension patients (67 male,
56-68 aged) were enrolled to the scrutiny at baseline in 3 weeks after
ischemic stroke and then they were studied prospectively for 12 months
period regarding survival rate and cardiovascular clinical outcomes.
Hemispheric location of ischemic focus as leucoareosis was provided by
contrast-enhanced computer tomography at baseline. Serum high-sen-
sitivity CRP level was determined study entry only. Clinical interviews
were performed every 3 months during 1 year after blood sampling. End
point events included the following: certainly diagnosed ischemic stroke
or TIA; coronary ischemic events, sudden death, and all cardiovascular
events including hospitalization due to ones.
Results: Patients in the highest quartile of high-sensitivity CRP level
had a significantly higher adjusted odds ratio for cardiovascular events
when compared with those in the first quartile (odds ratio = 7.46; 95%
CI = 1.55-19.6; P = .001). A ROC curve detected a cut-off point of
high-sensitivity CRP level of 2.47 mg/dL (63.3% sensitivity, 78.3%
specificity), which was used to include the variable into the multi-
variate model. Obtained results clarified that cut-off point closely
associated with risk of end point events (hazard ratio = 5.14; 95%
CI = 1.27-18.66; P = .005). After adjustment for age, sex, and other
conventional risk factors cut-off point of high-sensitivity CRP more
2.47 mg/dL became a significant predictor of clinical outcomes
(P = .006).
In conclusion, we predisposed that high-sensitivity CRP levels provide
prognostic information in patients with arterial hypertension during
1 year after ischemic stroke.
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Correlation of Fractional Flow Reserve with stress perfusion
scintigraphy for the detection of ischemia to intermediate
coronary artery stenosis
V. Viktor Solomyanyy1
1A.L. Myasnikov Institute of Cardiology, Moscow, Russian Federation
Objectives: To compare ischemia assessment by Fractional flow
reserve (FFR) SPECT scanning by using cardiac gating testing in
patients with intermediate coronary artery stenosis.
Background: FFR it is now frequently used to determine the man-
agement of intermediate coronary artery stenosis. A cut-off value of
0.75 is used in clinical practice to guide revascularisation supported by
long-term outcome data, but a ‘grey zone’ of 0.75-0.8 with uncertain
clinical significance exists. Advances in non-invasive imaging tests
(gated SPECT) warrant a re-evaluation of FFR at intermediate stenosis
severity against non-invasive imaging.
Methods and Results: In this study 50 patients (mean age,
60 ± 9.1 years; 13 women) with coronary artery disease and a 50% to
70% coronary stenosis (target vessel). SPECT by using cardiac gating
was performed as a single-day stress (bicycle testing) /rest protocol by
use of technetium 99m-MIBI. Within 4 (±9) days, coronary angiog-
raphy was performed and FFR was calculated by use of a pressure wire
(normal FFR, [ or =0.8). The mean FFR of all patients was
0.79 ± 0.15. Overall sensitivity of SPECT was 77% whereas speci-
ficity reached 92%.
Conclusion: SPECT cardiac gating showed reasonable combination of
sensitivity and specificity in patients with intermediate coronary artery
stenosis and may thus be the more useful additional test to determine
the significance of ‘grey’ lesions on FFR.
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Conformity of ‘‘Appropriate Use Criteria for cardiac
radionuclide imaging’’ in Japan
N. Nobuyuki Kuroiwa1; S. Fukuzawa1; M. Inagaki1;
J. Sugioka1; S. Okino1; A. Ikeda1; J. Maekawa1; S. Maekawa1;
S. Ichikawa1; S. Okamoto1
1Funabashi Municipal Medical Center, Division of Cardiology,
Heart and Vascular Institute, Funabashi City, Japan
Background: Myocardial perfusion SPECT is widely used as a
screening test for ischemic heart disease. However appropriate use
criteria were not well established in Japan.
Purpose: According to ACC/ASNC/ACR/AHA/ASE/SCCT/SCMR/
SNM ‘‘2009 Appropriate Use Criteria for Cardiac Radionuclide
Imaging’’, we have evaluated the appropriate use of Radionuclide
Imaging in our facility which is located in Japan.
Methods and Results: We reviewed 513 patients (age 69.2 ± 9.2,
male 339) who underwent stress myocardial SPECT imaging between
1 Dec 2010 to 31 Jan 2012. Purpose of performing SPECT imaging
were detection of cardiac artery disease (CAD) n = 310, Post revas-
cularization risk assessment n = 144 and perioperative evaluation
n = 59. Among 310 cases of detecting CAD, 192 (61.9%) met
appropriate use criteria (AUC) but 118 (38.1%) did not. Summed stress
score 3 & over were shown 67 (34.9%) in appropriate group, 47
(39.8%) in inappropriate group and 7 & over were shown 42 (21.9%)
in appropriate group, 30 (25.4%) in inappropriate group. Coronary
angiography was performed in 61 cases in appropriate group, 32 cases
in inappropriate group and significant stenosis were detected 36
(61.0%) and 20 (62.5%) respectively. The characteristics of this 20
patients were all asymptomatic and mostly male age over 60 and
classified as low pretest probability. Post revascularization risk
assessment met AUC for 79.2% but perioperative evaluation met only
6.8%.
Conclusion: CAD was detected from group not meeting AUC for
cardiac radionuclide imaging in relatively high probability. Changing
pretest probability for asymptomatic, over 60 years old male from
‘‘low’’ to ‘‘intermediate’’ will resolve this problem.
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Estimate of myocardial perfusion’s disorders in patients with
rheumatoid arthritis
D. Denis Shulgin1; V. Sergienko1
1Cardiology Research and Production Center, Institute of Clinical
Cardiology, Moscow, Russian Federation
For patients with rheumatoid arthritis (RA) plural lesion of coronary
vessels, early occurrence of an acute coronary syndrome, rising of a
lethality after the first myocardial infarction (MI), high frequency of
occurrence of painless myocardium ischemia, of «painless» MI are
typical. The connection of these complications with hyperactivity of an
inflammation should be noted particularly.
The purpose: Studying of myocardium perfusion by means of SPECT
method with application of 99mTc-MIBI (4,2-metoksiizobutilizonitril)
in patients with RA depending on the basic therapy carried out.
Materials and methods: 99mTc-MIBI is a compound which visual-
izes the perfusion of myocardium, and it has been offered for
estimation of the myocardium perfusion’s condition in patients with
RA. 20 persons at the age from 18 to 65 years old with reliable
diagnosis RA were included in the research. Patients were divided into
two groups by the randomizing ‘‘envelopes’’ method: group I—not
receiving treatment by Methotrexatum, group II—receiving treatment
by Methotrexatum. All patients with RA received pulse-therapy by
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glucocorticoids. The estimation of perfusion’s condition was made on
ten standard deviations (10 sd), meanwhile values exceeding 2 sd are
considered to be clinically significant. Scale DAS28 was applied for
estimation of RA activity at the patients.
Results: During the analysis of the received results no authentic signs
of a transient ischemia were noted at patients receiving therapy by
Methotrexatum. At the same time significant defects of depth of per-
fusion of the myocardium exceeding 2sd were detected at the
overwhelming majority of patients who had not take over therapy by
Methotrexatum (that corresponds to sites of a transient ischemia of a
myocardium (P \ .05)). During the interrelation analysis between
defect of perfusion at patients with RA and index of illness activity
(DAS28) a correlation dependence has been noted, however, statisti-
cally significant reliability was not reached (P = .024). On the average
the area of defect of perfusion of a myocardium made up
30.7% ± 22.6% in group of patients who were not taking over Met-
hotrexatum, while in group of patients who were taking over the
treatment this index was much more low—10.6% ± 6.4%.
The conclusion: SPECT of myocardium is a modern and extremely
informative method of estimation which subsequently will help to
throw light on the occurrence of cardiovascular complications at
patients with RA.
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Association between serum adrenomedullin and coronary
atherosclerosis in mild renal insufficiency nondiabetics:
MDCT study
A. Racekova1; J. Gonsorcik1; C. Gibarti2; E. Zemberova3
1Department of Cardiology, East-Slovak Institute for Cardiolvascular
Diseases, Kosice, Slovak Republic; 2Department of Radiology and
Imaging Techniques-Cardiac CT, Kosice, Slovak Republic;
3RIA Laboratory, Kosice, Slovak Republic
Purpose: Plasma adrenomedullin (ADM) levels are elevated in various
pathological states including cardiovascular and inflammatory diseases
in the general population. Its plasma levels or its precursors have not
been evaluated in population of patients chronic kidney diseases. The
present study investigated whether an increased ADM level is a marker
of vascular complications in nondiabetics with mild renal
insufficiency.
Methods: The study group consisted of 67 patients. Fifty-eight percent
(39 of 67) of the study group were men, with mean age of 66.7 ± 9.8,
and 42% (28 of 67) were women, with mean age of 65.8 ± 11.1. We
determined plasma mid-regional pro-adrenomedullin (MR-proADM)
levels in patients without documented coronary events in stage 2 and 3
chronic kidney disease. Coronary artery calcification (CAC) and
noninvasive coronary angiograms were obtained using a 64 slice
scanner (Somatom, Siemens) and a standard protocol using prospective
triggering. Coronary artery stenosis of at least 50% was considered
significant. Laboratory data MR-proADM were collected and analysed
to CT findings.
Results: The mean MR-proADM plasma levels was 0.78 nmol/L, and
the mean CAC score was 370.58. Coronary artery calcifications were
observed in 86.6% of the patients, with significant coronary artery
stenosis in 37.2%. Plasma adrenomedullin correlated with total CAC
(r = 0.36; P = .007), glomerular filtration rate (r = -0.59; P = .007)
and age (r = 0.41; P = .002). We also found that CAC associated
significantly better with significant coronary stenosis (P \ .001) than
plasma adrenomedullin (P = .03). A receiver operating characteristic
(ROC) curve analysis predicting significant coronary stenosis revealed
that the area under the curve (AUC) CAC was significantly larger than
MR-proADM (0.83 vs 0,68, P \ .05). High levels of the plasma
peptide mid-regional pro-adrenomedullin was able to detect significant
coronary stenosis in mild renal insufficiency nondiabetics with sensi-
tivity and specificity of 85 and 73%, respectively.
Conclusions: Our findings suggest the possibility that plasma ADM is
a novel sensitive marker for the presence of vascular lesions in patients
with coronary kidney disease.
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Feasibility of 18F-RGD for ex vivo imaging of atherosclerosis
in detection of alpha5beta3 integrin expression
R. Reza Golestani1; L. Mirfeizi1; C. Zeebregts1; H. Boersma1;
J. Westra1; R. Tio1; R. Dierckx1; P. Elsingha1; R. Slart1
1University Medical Center Groningen, Groningen, Netherlands
Background: Given the fact that angiogenesis plays an important role
in atherosclerotic plaque vulnerability, molecular imaging of angio-
genesis can be used for determination of rupture-prone atherosclerotic
plaques. avb3 integrin is a key player in the process of angiogenesis.
Targeted imaging of avb3 integrin has been shown to be possible in
previous studies on tumor models, using radiolabeled arginine-glycine-
aspartate (RGD).
Our aim was to investigate feasibility of ex vivo detection of avb3
integrin in human carotid endarterectomy (CEA) specimens.
Methods: CEA specimens, immediately after excision, were incubated
in 5 Mbq 18F-RGD for one hour followed by 1 hour emission mi-
croPET scan. The results were quantified in 4 mm wide segments as
percent incubation dose per gram (%Inc/g). A segmental-to-total ratio
was calculated by dividing segmental %Inc/g by total specimen’s
%Inc/g. Presence of avb3 integrin and endothelial cells in each seg-
ment was confirmed by immunohistochemical staining for CD31 and
avb3 integrin, respectively.
Results: 18F-RGD uptake was heterogeneous in CEA specimens and
was localized within the vessel wall. Significant correlations were
observed between segmental-to-total ratio with avb3 integrin staining
score (r = 0.58, P = .038) and CD31 staining score (q = 0.67,
P \ .002).
Conclusion: This study, for the first time showed the feasibility of
integrin imaging in determination of avb3 integrin expression and
angiogenesis in human atherosclerotic plaques.
Picture Caption: Saggital view of [18F]-RGD k5 microPET image of
an excised carotid endarterectomy specimen (left). Transversal images,
109 magnitude of CD31 staining (arrows), and avb3 integrin staining
(arrows) of corresponding slices are shown.
RGD microPET and histology
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Plasma myeloperoxidase level can help to determine high
risk patients after Unstable Angina
I. Inga Markava1; A. Miadzvedzeva1; L. Helis1; M. Kaliadka1;
I. Russkikh1; I. Lazareva1
1Republican Scientific and Practical Centre of Cardiology, Minsk,
Belarus
Purpose: It is assumed that platelet activation has the significant role
in the onset of atherothrombosis and that usually precedes acute cor-
onary syndromes. We addressed the role of plasma myeloperoxidase
(MPO) level as a marker of oxidative stress and plaque instability in
the development of atherothrombotic events in patients with unstable
angina (UA).
Materials and Methods: We investigated the prognostic importance
of plasma MPO levels in UA at a 1-year follow-up, and we analyzed
the correlations between plasma MPO levels and other biochemical
values. We evaluated 90 consecutive patients (60 men; mean age,
56 ± 11 years) diagnosed with UA and 36 age- and sex-matched
healthy control participants. Patients were monitored for the occur-
rence of major adverse cardiovascular events (MACE), which were
defined as cardiac death; reinfarction; new hospital admission for
angina; heart failure; and revascularization procedures.
Results: The mean follow-up period was 18 ± 5 months. Plasma MPO
levels were higher in UA patients than in control participants
(284 ± 14.3 vs 90 ± 15 pmol/L; P = .001). Composite MACE
occurred in 36 patients with UA. In multivariate analysis, plasma MPO
level was independent predictor of MACE (OR = 4.7; 95% CI, 2.9-
7.7; P = .003). High plasma MPO level identify patients with a worse
prognosis after unstable angina at 1-year follow-up.
Conclusion: Evaluation of plasma myeloperoxidase levels might be
useful in determining patients at high risk of death and MACE who can
benefit from further aggressive treatment and closer follow-up.
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Impact of early morning plasma catecholamines on left
ventricular size during viability study with thallium 201
A.A.A. Abdelaty1; T.H.E. Elzawawy1; A.H.Y. Yosry2;
A.S.A. Samir3
1Cardiology Department, Faculty of Medicine and Clinical Chemistry
Department, Institute of Medical Research, A, Alexandria, Egypt;
2Microbiology Department, High Institute of Public Health, Alexan-
dria University, Alexandria, Egypt; 3Cardiology Department, Faculty
of Medicine, Alexandria University, Alexandria, Egypt
Purpose: We noticed transient ischemic dilatation (TID) in patients
(pts.) submitted for resting (R) viability (V) study with Thallium (Tl)
201 in the initial R. study in early morning compared to late R. study
with reinjection. Is this phenomenon related to the early morning cir-
cadian rhythm of ischemia, serum catecholamines (catec.) and plasma
cortisol (Co.) or due to anxiety of the pt. about the SPECT study.
Methods: Pts were seen at nuclear cardiology lab. during 6 month
period from January to July 2010 coming for post myocardial infarc-
tion (MI.) V. study. Every pt. was subjected to a questionnaire; adopted
from the American Institute of Stress to evaluate their anxiety, mea-
suring plasma Co, serum Adrenaline(AD) and Noradrenaline(NAD)
‘‘before each image’’ one at 7:30 AM and the second 3 hours later, and
Tl 201 R. SPECT with delayed R. with reinjection protocol.
Results: 40 Pts (34 M, 6 FM) mean age 54.88 Y; 40% (16/40)
developed TID; they had significantly higher mean NAD, AD, and Co.
in the initial study (311.38 ng/L, 100.25 ng/L, 30.44 mcg/dL), com-
pared to (237.29 ng/L, 65 ng/L, 18.71 mcg/dL) (P value = .0021,
.0013 and .0001), 40% (16/40) were proved to be anxious about the
test, 12 (75%) of them developed TID (P value = .00013)
Conclusion: TID in pts. with IHD in the early morning during resting
thallium 201 SPECT viability study is associated with higher cate-
cholamines.,Cortisol and anxiety which are triggering factors for
worsen myocardial ischemia. These factors should be considered in the
total ischemic burden for these patients.
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Prognostic evaluation of 123I-MIBG cardiac scintigraphy
in ischemic and nonischemic heart failure previous to
resynchronizer implant: Preliminary results
A. Ana Abreu1; L. Oliveira2; M. Goncalves3; M. Carrola3;
H. Santa-Clara3; S. Silva1; M. Carmo1; P. Cunha1; M. Oliveira1;
R. Ferreira1
1Hospital Santa Marta, CHLC, Lisbon, Portugal; 2Quadrantes, Lisbon,
Portugal; 3Technical University of Lisbon, Human Kinetics Faculty,
Lisbon, Portugal
Background: Cardiac MIBG imaging has been used for noninvasive
evaluation of autonomic nervous system. Several MIBG cardiac
scintigraphy parameters have been negatively correlated to prognosis.
Aim: To correlate MIBG cardiac scintigraphy parameters with clinical
severity, functional capacity, left ventricular ejection fraction (LVEF)
and short-term prognosis in patients (P) with Chronic Heart Failure
(CHF) disease and indication to cardiac resynchronization (CRT).
Methods: 34 consecutive CHF P, mean age 68.6 ± 14.37 (34-82 years
old), 74% male, LVEF \ 35%, referred to CRT were included. 12 P
(35%) had ischemic cardiomyopathy (ICM) and 22 P (65%) nonis-
chemic cardiomyopathy (NICMP). 35% P were diabetic and 97% had
at least one coronary artery disease risk factor. Clinically, 27% P were
class I, 31% class II and 42% class III (NYHA).
All P performed echocardiogram, cardiopulmonary testing and cardiac
scintigraphy with 123 I-MIBG.
Cardiac events such as cardiac re-hospitalization, severe arrhythmia or
cardiac death were evaluated (8 months mean time follow up).
Results: Our preliminary results showed: LVEF \ 30% in 62% P;
oxygen peak consumption (VO2p) mean value 14.8 ± 5.5 mL/kg/
minute; exercise test duration mean value 6.81 ± 4.19 minutes. 4 P
(12%) had at least one cardiac event during follow-up (1 P, 8% ICM; 3
P, 13% NICM).
MIBG scintigraphic parameters: Early Heart-Mediastinum rate
(HMR) \ 1.6 in 74% P; Late HMR \1.6 in 94% P and Washout (WO)
mean value 40.6 ± 27.3.
Between ICM and NICM, WO was not statistically different, however
HMR were: Early HMR 1.6 ± 0.15 vs 1.4 ± 0.15 (P = .016); Late
HMR 1.5 ± 0.19 vs 1.3 ± 0.12 (P = .006), respectively. No significant
difference in systolic dysfunction severity was present in ischemic vs
nonischemic: LVEF 29% ± 9% ICM vs 25% ± 7% NICM (P [ .05).
HMR and WO were not significantly different between: diabetic vs
nondiabetic; LVEF0.05).
In the 4 P with events, mean Early HMR and mean Late HMR were not
significantly different from the P without events (1.37 vs 1.52) and
(1.34 vs 1.42), respectively, however with a tendency for inferior Early
HMR in P with events (P = .09 and P = .30).
Conclusion: In this preliminary study, we found in nonischemic
patients significantly lower early and late HMR, translating a more
severe autonomic dysfunction, as well as a tendency for worst prog-
nosis. There was a high percentage of cardiac events at 8 months
follow up (12%), especially in nonischemic patients. Patients with
events had lower early HMR, needing a larger population to confirm
statistically this difference.
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The role radionuclide assessment of cardiac sympathetic
activity in patients with atrial fibrillation
Y. Lishmanov1; S. Stanislav Minin1; Y. Saushkina1; I. Efimova1;
S. Popov1; I. Kisteneva1
1Institute of Cardiology, Tomsk, Russian Federation
Introduction: The mechanisms underlying the majority of cardiac
arrhythmias are unclear. The disturbance sympathetic innervation of
the heart may be the cause of atrial fibrillation (AF), but also reason of
myocardial dysfunction of the left ventricle (LV).
The aim of this study was to assessment of cardiac sympathetic activity
in patients with atrial fibrillation by planar scintigraphy with 123I-
metaiodbenzilguanidine (123I-MIBG).
Materials and Methods. The study included 20 (17 men and 3
women, average age 57.4 ± 11.6 years) patients with suspected coro-
nary artery disease, hypertension 2-3 class. All patients to divide 3
groups: 8 patients (group 1) with paroxysmal AF (ParAF), 5 patients
(group 2) with persistent atrial fibrillation (PerAF) and 7 patients with
no signs of AF (group 3).
Planar imaging was performed to study initial (imaging started 10
minutes after MIBG injection 148 MBq 123I-MIBG) and delayed
(imaging started 4 hours after 123I-MIBG injection). For the anterior
planar 123I-MIBG images, regions of interest were constructed for the
heart and upper mediastinum, and the heart-mediastinal ratio (HMR)
and corrected 123I-MIBG washout were calculated.
Results: The delayed HMR in patients with ParAF and PerAF was
significantly lower compared that in patients third group (1.56 ± 0.16,
1.58 ± 0.17 and 1.82 ± 0 19, respectively, P \ 0.05). There were
statistically significant differences in the washout rate of 123I-MIBG
between all treatment groups (44.8 ± 4.9, 38.9 ± 11.81 and 27.8 ± 7.8,
respectively, P \ 0.05). In this study, the highest washout rate was
observed in the group with paroxysmal AF.
Conclusion: Results of this study indicated, that the patients with atrial
fibrillation has of regional LV myocardial, according with 123I-MIBG
imaging. More sympathetic innervation abnormality was observed in
the group with paroxysmal AF.
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Predictive value of brain natriuretic peptide and c-reactive
protein in diabetes mellitus patients with symptomatic heart
failure due to ischemic reason
A. Alexander E. Berezin1; A. Kremzer1
1State Medical University, Zaporozhye, Ukraine
The aim of the study was to investigate the nature of the relationship
between NT-pro-BNP and C-RP on the one hand and severity and
prevalence of coronary atherosclerosis on the other in patients with
chronic heart failure due to ischemic reason depending on diabetes
mellitus.
Methods: The study included 82 patients of both sexes with chronic
heart failure FC II-III (NYHA), which developed as a result of coronary
artery disease and 36 healthy individuals. Each patient with chronic
heart failure, appropriate criteria for inclusion/exclusion, with verified
diabetes mellitus 2 type (DM) in accordance with the criteria IDF
(2003) was picked up by the patient without the disease. All patients
underwent transthoracic echocardiography, visualization and evalua-
tion of the severity of coronary artery lesions with multislice computed
tomography with the calculation of Vessel index and Gensini index as
well as measurement of circulating levels of NT-pro-BNP and C-RP.
Results: Analysis of the data showed that the group of patients with
chronic ischemic heart failure variance with DM (OR = 5.40, 95%
CI = 2.60-9.70, and OR = 4.92, 95% CI = 2.40-8.85, respectively),
the level of NT-pro-BNP (OR = 2.88, 95% CI = 1.34-4.56, and
OR = 2.59, 95% CI = 1.18-5.02 respectively) and C-RP (OR = 3.02,
95% CI = 1.40-5.20, and OR = 2.90, 95% CI = 1.27-5.80, respec-
tively) had the highest value as predictors of the severity of
atherosclerotic coronary artery lesions, evaluated on scales Vessel
score and Gensini score. In a cohort of DM patients an excess of cut-
off points for both NT-pro-BNP and C-RP plasma level to 812.2 fmol/
mL and 5.6 mg/L, respectively, predictive sensitivity and specificity of
these biological markers as indicators of the prevalence and severity of
coronary atherosclerosis.
In conclusion, we noted that the data support the hypothesis that in
stable patients with chronic ischemic heart failure elevation of NT-pro-
BNP and C-RP may be due to the severity and prevalence of coronary
arteries atherosclerosis
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The utility of 99mTc-PYP-SPECT in diagnosis
of myocarditis in patients with rhythm disorders
I. Svetlana Sazonova1; Y.U.N. Ilyushenkova1; R.E. Batalov1;
Y.U.B. Lishmanov1
1Research Institute of Cardiology, Tomsk Scientific Center, Tomsk,
Russian Federation
Aim: To compare results of 99mTc-pyrophosphate myocardium
SPECT with histology data in patients with suspected myocarditis with
rhythm disorders.
Materials & Methods: We examined 15 patients (10 males and 5
females, mean age 44.3 + 5.2) with rhythm disorders (atrial fibrilla-
tion, extrasystole) and suspected myocarditis. All patients underwent
SPECT with 99mTc-pyrophosphate (99mTc-PYP) at 3 and 18 hours
post injection (delayed SPECT), following by SPECT with 99mTc-
MIBI at the rest condition. Both images were then combined to define
more exactly the localization of 99mTc-PYP uptake in the heart and to
exclude ventricles blood pool. Accumulation of 99mTc-PYP was
accepted as pathological when focus localized in myocardium area,
focus/background ratio exceeded 1.4. Endomyocardial biopsy (EMB)
samples were taken during angiography procedure. Scintigraphic
results were correlated with the EMB findings.
Results: At 3 hours post injection in all patients the ventricles blood
pool of 99mTc-PYP was visualized. The intensity of these accumu-
lations was high (heart to lung ratio 3.2 ± 0.5) that impeded
visualization of heart walls. At 18 hours post injection visualization of
99mTc-PYP blood pool remained, but its intensity significantly
decreased (heart to lung ratio 1.2 ± 0.2) that allowed to estimate the
myocardium. The pathological uptake of 99mTc-PYP was found only
in 4 patients. The EBS confirmed intramyocardial inflammation at 5 of
15 patients. The number of true-positive results of delayed 99mTc-
PYP SPECT was 4, true negative 8, false-positive—0, false negative 3.
The sensitivity was 50%, specificity 100%, accuracy 46%
Conclusion: The results of our pilot study have shown that the diag-
nosing of myocarditis with 99mTc-PYP SPECT is possible only when
delayed studies are performed (at 18 hours post injection), because of
significant blood pool effect on early imagings. The sensitivity of
99mTc-PYP SPECT is seemed to be low, in the same time high
specificity shows the opportunity of 99mTc-PYP SPECT usage in
diagnosing of myocarditis.
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Osteoprotegerin as independent predictor of coronary
vasculature damage severity in type 2 diabetic patients
A. Alexander E. Berezin1; A. Kremzer1; T. Berezina2
1State Medical University, Zaporozhye, Ukraine;
2Private Medical Center VitaCenter, Zaporozhye, Ukraine
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Background: Osteoprotegerin (OPG) is a bone-related glycopeptide
produced by vascular smooth muscle cells due to arterial damage. OPG
is considered as an independent predictor of cardiovascular disease in
diabetic populations.
Aim of the study: To investigate the interrelation between OPG
plasma level and coronary artery disease (CAD) in type 2 diabetic
patients.
Methods: 126 subjects with stable diabetes mellitus 2 type with pre-
viously angiographic documented CAD were enrolled to the study. All
patients were graduated into two groups depended calculating very
high risk cardiovascular events and other. Assessment of risk was
performed with contrast multispiral CT-angiography and NT-pro-brain
natriuretic peptide (NT-pro-BNP) measurement. Patients with circu-
lating NT-pro-BNP plasma level [ 440 fmol/mL and/or Agatston’
coronary calcium score (CCS) C 400 units were stratified as high risk
(n = 72) and all other patients as low risk patients (n = 54). Severity
of coronary vasculature damage was verified with Gensini score index.
NT-pro-BNP and OPG plasma levels were measured with ELISA.
Results: Circulating OPG level in high risk subjects was higher than in
low risk patients (5581 pg/mL [95% confidence interval (CI) = 3975-
6280 pg/mL] and 2880 pg/ml; 95% CI = 745-3740 pg/ml; P \ .01).
Among high risk patients increased OPG in plasma was an independent
predictor of significant CAD for third and fourth quartile vs first A-
gatston’ CCS valuesrespectively (adjusted odds ratio (OR) = 2.96
[95% CI = 1.12-9.80] and OR = 3.42 [1.50-11.2]). High circulating
OPG was also associated with presence of [70% coronary artery
stenosis (adjusted OR = 8.80 [2.96-19.44] for fourth vs first quartile
OPG). Gensini score index correlated well with circulating OPG
(R = 0.62; P = .012) and was higher in high risk subjects when it had
been compared with low risk patients (adjusted odds ratio (OR) = 5.10
[95% CI = 2.90-10.30]; P = .002).
Conclusions: We believe that elevated OPG in plasma can be con-
sidered as independent predictor of severity of coronary vasculature
damage in type 2 diabetic patients.
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Failure to predict viability in Takotsubo-cardiomyopathy
with cardiac 18F-FDG-PET
T.E. Christensen1; M. Lyngby Lassen1; F. Andersen1;
L. Holmvang2; L.E. Bang2; P. Grande2; A. Kjaer1; P. Hasbak1
1Rigshospitalet—Copenhagen University Hospital, Clinical
Physiology, Nuclear Medicine & PET, Copenhagen, Denmark;
2Rigshospitalet—Copenhagen University Hospital, Heart Centre,
Department of Cardiology, Copenhagen, Denmark
Introduction: Current guidelines assign class I recommendation to 18F-
Fluorodeoxyglucose (FDG) PET viability assessment in chronic heart
failure patients. The combined evaluation of rest blood-flow and FDG-
uptake is assumed to distinguish most reliably between viable and non-
viable myocardium. Myocardial viability refers to a state of reversible
impairment of contractile function. Thus, the Takotsubo cardiomyopa-
thy syndrome with acute but reversible heart failure represents a unique
human heart failure model to test FDG as a cardiac viability marker.
Method: From 2010-2012, as a part of a multimodality cardiac imaging
research project in Takotsubo-cardiomyopathy, a total of 22 (1 male, 21
females) patients were included. All the patients were admitted for acute
coronary angiography (CAG) on the suspicion of acute myocardial
infarction and were included in the study if (a) CAG showed no signif-
icant coronary artery disease and (b) left ventriculography or
echocardiography showed ‘‘apical ballooning.’’ The patients were
examined with echocardiography, cardiac SPECT and FDG-PET within
7 days upon admission and again 3 months after discharge.
Results: Of the 22 patients originally included, 17 (16 females, 1 male)
fulfilled the Mayo Clinic Diagnostic Criteria for Takotsubo-cardio-
myopathy. The FDG-PET scans were evaluated, Standardised Uptake
Value (SUV) within the diseased area was correlated to the non-dis-
eased area, and a ‘‘Takotsubo/basilar region activity ratio’’ (T/B-ratio)
was calculated. On acute examinations the normal tissue was based on
a Volume of Interest (VOI) placed over the entire heart, with a
threshold value of 60% of the SUVmax measured in the VOI. The
diseased area was manually drawn with threshold offset which fol-
lowed the contours of the myocardial tissue. On follow-up
examination, since there was no clearcut diseased area, a VOI was
manually drawn on the prior Takotsubo-area and compared to a
manually drawn VOI on the basilar region.
Acute and follow-up T/B-ratios were 2.06 ± 0.2 vs 1.05 ± 0.03,
P \ .0001
Acute cardiac SPECT showed apical perfusion defect of 16 ± 7% with
normalization at follow-up.
Conclusion: In the presented data, FDG-PET completely failed to
visualize viability in the area of the left ventricle involved in the acute
state of Takotsubo-cardiomyopathy, despite complete recovery of left
ventricle function. Thus, it is important not to rule out viability based
on reduced/absent FDG uptake in regions of the left ventricle in these
patients.
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123I-mIBG scintigraphy for the assessment of cardiac
sympathetic innervation and the relationship to Cardiac
Autonomic Function in Individuals with Impaired Glucose
Tolerance using standardized method
O. Omar Asghar1; P. Arumugam2; I. Armstrong2; U. Alam1;
M. Schmitt3; C. Miller3; S.G. Ray3; R.A. Malik1
1Univeristy of Manchester, Cardiovascular Research Group,
Biomedical Sciences, Manchester, United Kingdom; 2Department of
Nuclear Medicine, Central Manchester Foundation Trust, Manchester,
United Kingdom; 3University Hospitals of South Manchester NHS
Trust, Wythenshawe Hospital, Manchester, United Kingdom
Background: Individuals with impaired glucose tolerance (IGT) are at
increased risk of developing type 2 diabetes and cardiovascular disease
(CVD). Previous studies in subjects with IGT have confirmed the
presence of sub-clinical CVD and microvascular complications how-
ever data on cardiac sympathetic imaging and their functional
associations in these cohorts is currently lacking. The purpose of this
study was to quantitatively and qualitatively assess global and regional
cardiac sympathetic innervation and function in individuals with IGT
using 123I-mIBG scintigraphy and standard cardiac autonomic func-
tion tests.
Methods: We performed 123I-mIBG scintigraphy in 18 subjects with
IGT (mean age 57.5 ± 9.6 years, M:F 10:8) and 14 age-matched
healthy controls (54.6 ± 5.4 years, 9:5). In addition, subjects under-
went cardiac magnetic resonance imaging (CMR) to assess LV mass,
systolic function, rest and stress perfusion and late gadolinium
enhancement (LGE). Using planar and single photon emission com-
puted tomography (SPECT) imaging, we assessed indices of global
(late HMR) and regional innervation respectively. Sympathetic turn-
over was determined by the washout rate (WR) and cardiac autonomic
function was assessed using standard tests of heart rate variability
(HRV).
Results: There were no significant differences in LV mass index
(47.3 ± 9.0 vs 51.0 ± 11.0 g/m2, P = .349), LVEF (61% ± 6.4% vs
61% ± 1.0%, P = .98) or indices of HRV between the IGT and control
groups. There was no evidence of previous myocardial infarction or
perfusion abnormalities on LGE and on stress MR in either group
respectively. Mean late HMR (1.73 ± 0.18 vs 1.73 ± 0.16, P = .97)
and WR (18.6% ± 4.2% vs 19.09% ± 7.6% P = .84) did not differ
between groups. Semi-quantitative SPECT analysis revealed reduced
tracer uptake in all subjects at the apex and inferior wall however there
were no significant differences in total or segmental innervation
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between groups. HMR correlated with sympatho-vagal balance (LFa/
RFa) in both IGT and controls (r = 0.500, P = .013, r = 0.48,
P = .024) although WR did not correlate with any functional tests of
sympathetic function.
Conclusion: In a well phenotyped cohort of adults with IGT, global
and regional measures of 123I-mIBG uptake and washout and
functional parameters of cardiac sympathetic function are comparable
to healthy controls. Furthermore, HMR correlates with measures of
sympatho-vagal balance suggesting it might not only be a useful
prognostic marker but may also provide insight into the functional
integrity of the cardiac autonomic nervous system.
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Mechanistic insights into early post-infarct inflammation:
A clinical study using quantitative F-18 FDG PET-CT
T. Wollenweber1; P. Roentgen2; A. Schaefer2; C. Zwadlo2;
I. Schatka1; T. Brunkhorst1; G. Berding1; J. Bauersachs2;
F.M. Bengel1
1Hannover Medical School, Department of Nuclear Medicine,
Hannover, Germany; 2Hannover Medical School, Department of
Cardiology and Angiology, Hannover, Germany
Purpose: Myocardial infarction triggers an inflammatory response
which determines subsequent healing and remodeling. Recent pre-
clinical studies of post-infarct inflammation showed that progenitor
cells are released from bone marrow, hosted in spleen, and migrate to
infarct and, to a lesser degree, remote myocardium. Insights into this
systemic interaction in the clinical setting are scarce, but relevant for
the development of strategies to support cell recruitment for possible
regeneration.
Methods: We performed dynamic 18FDG-PET/CT in 10 patients
within the first week after acute myocardial infarction as their first
cardiovascular event. All had transmural infarct on CMR. Heparin was
given before PET to suppress myocyte glucose metabolism. Using
Patlak analysis, metabolic rate of glucose (MRGlc) was quantified and
used as a marker of immune cell activity. Measurements were obtained
for infarct and remote myocardium, for bone marrow and spleen.
Results: MRGlc was significantly elevated in infarct vs remote myo-
cardium (9.4 ± 4.7 vs 2.9 ± 3.2 lmol/100 g/minute; P \ .001), but
did not correlate with concomitantly measured perfusion defect size,
LVEF or CKmax. The magnitude of MRGlc in the infarct correlated
with that in remote myocardium (r = 0.783; P = .013) and spleen
(r = 0.776; P = .014), but not in the bone marrow.
Conclusions: Using FDG after heparin, noninvasive imaging suggests
a strong inflammatory response in the infarct region, which is associ-
ated with inflammatory cell recruitment to remote myocardium and
with activity of the spleen as a cell depot. Bone marrow activation
seems to not occur in the same phase. These clinical observations are
consistent with preclinical work. They may serve as a foundation for
further studies aiming at therapeutic support of myocardial healing.
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Cardiac rehabilitation improves coronary endothelial
function in patients with dilated idiopathic cardiomyopathy:
A (15)-O water positron emission tomography study
D. Legallois1; A. Belin2; D. Agostini1; P. Milliez3; J.J. Parienti4;
A. Manrique1
1Department of Nuclear Medicine, CHU de Caen, Universite´ Caen
Basse-Normandie; EA4650, Caen, France; 2Department of
Cardiology, CHU de Caen, Universite´ Caen Basse-Normandie, Caen,
France; 3Department of Cardiology, CHU de Caen, Universite´ Caen
Basse-Normandie; EA4650, Caen, France; 4Department of Biostatistic
and Clinical Research, CHU de Caen, Universite´ Caen
Basse-Normandie, Caen, France; 5Department of Nuclear Medicine,
CHU de Caen, Universite´ Caen Basse-Normandie; GIP Cyceron;
EA4650, Caen, France
Purpose: Endothelial function is altered in patients with heart failure.
Prior studies have demonstrated the ability of exercise training to
improve survival and functional capacity in patients with heart failure
but its impact on coronary endothelial function is not known. We
conducted a prospective study to assess the effect of cardiac rehabil-
itation on coronary endothelial function using (15)O-water positron
emission tomography (PET) in patients with nonischemic heart failure.
Methods: Myocardial blood flow (MBF) was measured before and after
cardiac rehabilitation, at rest and during cold pressor test (CPT) using
dynamic (15)O-water PET in 16 patients with angiographically proven
idiopathic dilated cardiomyopathy (52 ± 12 years; 13 men and 3 women;
left ventricular ejection fraction (LVEF): 29 ± 7%). Patients with coro-
nary risk factors that potentially impair endothelial function (diabetes,
hypertension, current smoking and hypercholesterolemia) were excluded.
The flow response to cold pressor test was evaluated using (i) percent
increase in MBF from baseline (%MBF) and (ii) increase in absolute units,
i.e., the difference of flow between CPT and baseline (DMBF). Statistical
analysis were performed using paired Student’s t-test and Spearman
correlation test. All tests were two-sided and performed using R statistical
software with a P \ .05 significance level.
Results: Cardiac rehabilitation significantly improved MBF at rest
(0.710 ± 0.193 mL/minute/g at baseline vs 0.824 ± 0.209 mL/minute/g
after cardiac rehabilitation; P = .02). After rehabilitation, coronary endo-
thelial function was also significantly improved. %MBF increased from
105.8% ± 12.0% to 118.9% ± 17.2% (P\ .01). DMBF increased from
0.028 ± 0.094 to 0.156 ± 0.148 mL/minute/g (P\ .01). LVEF improved
significantly from 28% ± 7% to 44% ± 11% (P\ .001); peak oxygen
consumption raised from 18.3 ± 4.3 to 22.3 ± 4.7 mL/kg/minute
(P\ .01). Plasma brain natriuretic peptide decreased from 793 ± 193 to
193 ± 267 pg/mL (P\ .01). The Minnesota Living with Heart Failure
Questionnaire improved by an average of 20 points (63% of baseline;
P\ .01). There was no correlation between %MBF or DMBF and the
parameters listed above.
Conclusion: MBF response to CPT, reflecting the functional state of
the coronary endothelium was significantly improved by cardiac
rehabilitation in patients with idiopathic dilated cardiomyopathy.
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Value of flurpiridaz F 18 myocardial SUV analysis in clinical
assessment of intermediate to severe coronary stenosis
M. Ming Yu1; M. Kagan1; B. Hsu1; P. Hsu1; S.G. Nekolla2;
J. Lazewatsky1; G. Bhat1; D. Washburn1; D. Onthank1;
S.P. Robinson1
1Lantheus Medical Imaging, N Billerica, United States of America;
2Technical University of Munich, Department of Nuclear Medicine,
Munich, Germany
Purpose: Flurpiridaz F 18 is an investigational PET myocardial per-
fusion imaging agent, currently in phase III clinical trial. Its
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myocardial standardized uptake value (SUV) ratio of pharmacologic
stress and rest has been indicated to reflect myocardial flow reserve
(MFR) in animals. Since MFR measurement has demonstrated an
added value in coronary disease diagnosis and SUV calculation is
relatively simple, we investigated the utility of flurpiridaz myocardial
SUV in assessment of coronary stenosis comparing with image-reader
findings.
Methods: Flurpiridaz F 18 data of 22 patients receiving rest and
pharmacologic stress imaging from 6 of our phase II sites were
included. The time frames for SUV calculation were 5-10 minutes for
the rest image and 5-10 or 2-8 minutes for the stress depending on
imaging files reconstructed by each sites. Standard 17-segment polar
maps at both rest and stress were constructed and aligned using Mu-
nichHeart. SUV of each segment was generated for analysis. Two SUV
ratios, the stress and rest SUV ratio of each segment (SUVstrs/rst ratio,
index of segmental MFR) and the SUV ratio of each individual seg-
ment to the segment with maximal SUV at the stress image (SUVindv/
max ratio, index of homogeneity of flurpiridaz LV uptake), were cal-
culated. The cutoff values of the two SUV ratios were determined
using ROC curve analysis. Cardiac images were analyzed either by
SUVstrs/rst ratio only or by initially the SUVindv/max ratio at stress
and then further using the SUVstrs/rst ratio in patients with the
SUVindv/max ratio [ the cutoff value. Patients with at least one
segmental SUV ratio \ the cutoff value were considered abnormal.
The image findings by the 3 readers from the same patient group were
summarized for comparison. Angiography was used as the standard
with luminal narrowing C40% as abnormal.
Results: The cutoff values of SUVstrs/rst ratio and SUVindv/max ratio
at stress were 1.56 and 0.54. The sensitivity, specificity, positive pre-
dictive value (PPV) and negative predictive value (NPV) were 87%,
71%, 87% and 71% when flurpiridaz images were analyzed by the
SUVstrs/rst ratio only. These values were same as that of the readers
(87%, 71%, 87% and 71%). However, when both the SUVindv/max
ratio and SUVstrs/rst ratio were applied, the sensitivity and NPV were
better than that of the readers (sensitivity, specificity, PPV and NPV:
100%, 71%, 88% and 100%).
Conclusions: Flurpiridaz F 18 myocardial SUV quantification dem-
onstrates a potential in detection of coronary stenosis. Diagnostic
sensitivity and NPV are improved by application of both the SUVindv/
max ratio at stress and the SUVstrs/rst ratio.
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Inflammatory capacity of peri-coronary adipose tissue
measured in PET affects plaque destabilization in patients
with non ST segment myocardial infarction
T. Tomasz Mazurek1; M. Kobylecka1; R. Wilimski1;
J. Kochman1; K. Filipiak1; L. Krolicki1; G. Opolski1
1Medical University of Warsaw, Warsaw, Poland
Background: Extravascular expression of inflammatory mediators
may adversely influence coronary lesion formation and plaque stability
through outside-to-inside signaling. It has been previously shown, that
maximal standardized uptake value (SUV) of 18-fluorodeoxyglucose
(FDG) detected by positron emission tomography in peri-coronary
adipose tissue (PVAT) is greater in patients with stable coronary artery
disease (CAD), than in controls. It also correlates with % of coronary
stenosis. We sought to investigate, whether PVAT may influence
plaque composition in Non ST Segment Myocardial Infarction
(NSTEMI) patients.
Methods: 42 coronary arteries (LM, RCA, LCX, LAD) have been
investigated in non-diabetic patients with moderate and low risk
NSTEMI (GRACE \ 140). SUV was measured in fat surrounding
coronary arteries on the sections corresponding to proximal and medial
segments. PVAT thickness was measured in two perpendicular
dimensions on axial cuts separately for the LM, RCA, LAD and LCX,
using steady state free precession cine imaging. Additionally SUV was
measured in subcutaneous fat (SC), visceral thoracic fat (VS), epi-
cardial fat over right ventricle (EPI). Conventional and virtual
histology intravascular ultrasound (VH-IVUS) was performed to assess
plaque composition, which were classified as calcified, fibrous, fibro-
fatty, or necrotic core. PET/CT sections were further examined in
segments corresponding to coronary plaques.
Results: PVAT SUV in NSTEMI patients was significantly greater
than in other fat locations (LM SUV: 1.59; RCA SUV: 1.53; LCX
SUV: 1.93 LAD SUV: 2.36 vs SC SUV: 0.57; VS SUV: 0.76; EPI
SUV: 0.98, P \ .001; ANOVA). There was no significant correlation
between PVAT thickness and plaque composition. In contrast PVAT
SUV positively correlated with necrotic core plaque rate (r = 0.68,
P \ .05), and negatively correlated with fibrous plaque rate (r =
-0.53, P \ .05). There was also positive correlation between PVAT
SUV and % plaque volume (r = 0.41, P \ .05).
Conclusions: Inflammatory activity of peri-coronary adipose tissue
reflected by SUV is greater than in subcutaneous, visceral thoracic, or
epicardial tissue in NSTEMI patients; There is no association between
amount of pericoronary fat and plaque composition; PVAT SUV
correlates with necrotic core component of coronary plaque and plaque
volume in patents with NSTEMI; In conclusion, pro-inflammatory
activity of PVAT in patients with NSTEMI may contribute to plaque
formation, vessel narrowing and plaque rupture, supporting the
hypothesis of the outside-to-inside signaling.
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Abnormal interventricular septal displacement reflects
increased oxidative metabolism in right ventricular free wall
in patients with PH using cardiac magnetic resonance and
C-11 acetate PET
K. Keiichiro Yoshinaga1; Y. Mori1; T. Sato1; C. Katoh1;
Y. Tomiyama1; H. Ohira1; O. Manabe1; N. Oyama-Manabe1;
I. Tsujino1; N. Tamaki1
1Hokkaido University Graduate School of Medicine, Sapporo, Japan
Background: Echocardiographic measurements of abnormal inter-
ventricular septum displacement toward left ventricle (LV) reflects
right ventricle (RV) volume or pressure overload. Cardiac magnetic
resonance (CMR) is considered the standard of reference for cardiac
anatomy and function. However, the association between CMR mea-
sured this change in shape and myocardial physiological condition has
not been studied. The aim of the study was to evaluate the association
between the interventricular septum displacement and oxidative
metabolism in RV free wall and interventricular septum in patients
with pulmonary hypertension (PH) using CMR and 11C-acetate PET.
Methods: Twenty-two patients with WHO functional class II to III PH
[mean PAP 38.1 ± 9.3 mmHg, pulmonary vascular resistance (PVR)
583.0 ± 221.4 dynes/second/cm5] and 8 controls prospectively under-
went C-11acetate PET. An eccentricity index, which reflects abnormal
interventricular septum displacement, was obtained by echocardiogra-
phy and CMR in PH patients. C-11 acetate PET was used to
simultaneously measure oxidative metabolism (kmono) for LV and RV.
Results: The diastolic eccentricity index (DEI) was similar between
CMR and echocardiography (1.28 ± 0.20 vs 1.26 ± 0.22, NS) and
showed good correlation (R = 0.95, P \ .001). PH patients showed
higher RV free wall kmono compared to control (0.049 ± 0.01/minute
vs 0.029 ± 0.005/minute, P \ .01). However, there was no difference
in LV kmono in patients with PH compared to control (0.056 ± 0.007
vs 0.050 ± 0.06, NS). DEI was correlated with PVR (R = 0.64,
P = .015) and RV free wall kmono (R = 0.44, P = .042). However,
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DEI was not correlated with interventricular septum (R = 0.12) or LV
lateral wall kmono (R = .11).
Conclusions: CMR measurements of abnormal interventricular septum
displacement toward left ventricle is associated with increasing
pulmonary vascular resistance and increased oxidative metabolism in
RV free wall but not interventricular septum. This CMR index might
be useful in predicting elevated oxygen consumption in RV free wall.
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Incremental prognostic value of myocardial perfusion
imaging in patients with renal dysfunction
M. Al-Mallah1; F. Khalid2; W. Qureshi2;
K. Ananthasubramaniam2
1National Guard Hospital, King Abdulaziz Cardiac Center (KACC),
Riyadh, Saudi Arabia; 2Henry Ford Hospital, Detroit, United States of
America
Background: Coronary artery disease is the main cause of mortality
and morbidity in patients with impaired renal function. The aim of this
study is to evaluate the prognostic implications of single-photon
emission computed tomography myocardial perfusion imaging
(SPECT-MPI) in patients with impaired renal function.
Methods: We included 11,829 consecutive patients (mean age,
65 ± 12 years; 52% men) referred for SPECT-MPI between April
2004 and May 2009. Renal function was estimated using the estimated
glomerular filtration rate (GFR) formula. Patients were followed up for
a composite endpoint of all-cause mortality and nonfatal myocardial
infarction (D/MI). Multiple nested Cox proportional hazard models
were used to determine the incremental prognostic value of SPECT-
MPI over clinical features and renal function.
Results: A total of 916 (8%) and 3,565 (31%) patients had GFR less 30
and between 30-60 mL/minute/1.73 m2 respectively. Patients with
decreased GFR were more often older, with higher prevalence of con-
ventional risk factors (P \ .001). After a median follow-up of 5 years
(25th to 75th percentiles, 3-6.5 years), 2578 (22%) patients experienced
D/MI (764 MI and 2113 dead). The risk of death increased with wors-
ening kidney function. At each stage of impaired renal function, patients
with abnormal SPECT-MPI had increased hazard of adverse events
(P \ .0001). Using Cox regression, total perfusion defect offered
improved discriminatory ability beyond traditional risk factors (area
under the receiver operator curve [AUC] 0.742 vs 0.759, P \ .0001).
Conclusions: SPECT-MPI adds incremental prognostic information to
identify patients at higher relative risk of D/MI across a wide spectrum
of renal function.
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Which is the best method of risk stratification for coronary
artery disease in octogenarians able to exercise?
A. Athanasios Katsikis1; A. Theodorakos1; A. Kouzoumi1;
E. Kitziri1; N. Kollaros1; V. Tsapaki1; G. Kolovou2;
M. Koutelou1
1Nuclear Cardiology Laboratory OCSC, Athens, Greece;
2Onassis Cardiac Surgery Center, 1st Department of Cardiology,
Athens, Greece
Background: Although the elderly represent the fastest growing part
of the population in developed countries, the best way to risk stratify
them is yet to be determined. As this is especially true for octoge-
narians, we aimed at evaluating the relative value of two basic non
invasive risk stratification methods for CAD in this population.
Methods: 183 patients (37 women, 146 men) aged [79 years with
LVEF C 40%, and interpretable ECGs, underwent exercise stress
myocardial perfusion imaging (ESMPI) with the Bruce protocol. Duke
treadmill score (DTS = duration of exercise in minutes -4 9 angina
index -5 9 ST depression in mm) and summed stress score (SSS) in a
17 segments LV model graded in a 4 point scale were calculated and
mortality and morbidity follow up data were collected per patient.
Kaplan Meier analysis was used to determine survival free of death,
myocardial infarction (MI), late revascularization (LR,[60 days after
ESMPI) or combinations of these end points, by risk groups formed
according to DTS and SSS.
Results: After a median duration of 7.4 years of follow up there were
36 deaths, 10 cardiac deaths (CDs), 5 MIs and 14 LRs. Neither DTS nor
SSS was able to risk stratify for total or cardiac death. However SSS
achieved to stratify the different risk groups for the composites of CD,
MI or LR (P = 0.002) and MI or LR (P = 0.008) as well as for LR
alone (P = 0,003). DTS was effective only in risk stratifying patients
for LR (P \ 0.001). Figure demonstrates curves of survival free of CD,
MI or LR for SSS categories (low 0-2, medium 3-12, high[12).
Conclusions: Simple exercise testing provides limited risk stratifica-
tion data in octogenarians with mildly reduced to normal systolic
function in contrast to ESMPI which should be the preferred risk
stratification method for this population.
KM survival free of CD, MI or LR
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Prediction of five-year cardiac death by I-123
meta-iodobenzylguanidine imaging based on a Japanese
multi-center prognostic database
K. Kenichi Nakajima1; T. Nakata2; S. Yamashina3; S. Matsuo1;
S. Kasama4; T. Yamada5; M. Momose6; T. Matsui7; M. Travin8;
A. Jacobson9
1Kanazawa University Hospital, Kanazawa, Japan; 2Sapporo Medical
University, Sapporo, Japan; 3Toho University Omori Medical Center,
Tokyo, Japan; 4Cardiovascular Hospital of Central Japan, Gunma,
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Japan; 5Osaka General Medical Center, Osaka, Japan; 6Tokyo
Women’s Medical University, Tokyo, Japan; 7Shiga Hospital, Otsu,
Japan; 8Albert Einstein College of Medicine, New York, United States
of America; 9GE Healthcare, Princeton, United States of America
Purpose: I-123 meta-iodobenzylguanidine (MIBG) imaging has been
widely used for assessment of prognosis in patients with chronic heart
failure (HF). However, a robust model incorporating MIBG results for
prediction of long-term occurrence of lethal cardiac events has not yet
been developed. The aim of this study was to create a prediction model
for lethal cardiac events in patients with HF using a Japanese multi-
center MIBG database.
Methods: Data from 6 prospective MIBG studies performed in Japan
between 1990 and 2009 were combined to make a pooled database of
1322 HF patients. Primary outcome event during extended follow-up
was cardiac death, which included HF death, sudden cardiac death
(SCD) and acute myocardial infarction (MI). Cardiac MIBG accu-
mulation was quantified using early and late heart-to-mediastinum ratio
(HMR) and washout rate (WR) calculated from anterior planar images.
Kaplan-Meier survival and Cox proportional hazard analyses were
performed. Based upon the latter, which showed HMR, NHYA class
and age as significant variables, selected univariate logistic regression
analyses of the subpopulation with known survival status at 5 years or
later (n = 993) were performed to create prediction models for cardiac
death.
Results: Kaplan-Meier survival analysis (n = 1322) showed that late
HMR = 1.7 was the optimal threshold for discriminating high-risk
patients for cardiac death (P = .0022,\.0001,\.0001 and .05 between
HMR C 1.7 and \1.7 for NYHA classes 1 to 4, respectively). In the
subpopulation for logistic regression analysis, the average time of
follow-up was 7.7 ± 4.3 years (range 0.08-14.6 years). A total of 205
cardiac deaths (22%) occurred including HF death (n = 132, 64%),
SCD (n = 61, 30%) and acute MI (n = 12, 6%); mean ejection frac-
tion and HMR were 36% ± 13% and 1.71% ± 0.33%, respectively.
Using a univariate logistic regression prediction model for each NYHA
class, estimated 5-year cardiac death rate in patients with late
HMR = 1.2 was 26%, 38%, 52% and 62% for NYHA class 1 to 4,
respectively, and that for HMR = 2.0 was 5%, 5%, 28% and 34%,
respectively. The area under the receiver-operating characteristic
curves for the prediction models was better in NYHA classes 1 and 2
(0.71, 0.71) compared with class 3 and 4 (0.61, 0.60).
Conclusion: The MIBG HMR provided improved cardiac mortality
risk stratification in all NYHA classes. However, performance of the
prediction model was better in patients with NHYA class 1 and 2 HF.
This NYHA-based prediction model might be of value in the long-term
management of HF patients.
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The prognostic value of normal stress cardiac magnetic
resonance in patients with known or suspected coronary
artery disease: A meta-analysis
P. Paola Gargiulo1; S. Dellegrottaglie2; D. Bruzzese3; O. Scala1;
D. Ruggiero1; C. D’amore1; G. Savarese1; S. Paolillo1;
A. Cuocolo4; P. Perrone Filardi1
1University of Naples Federico II, Department of Clinical Medicine,
Cardiovascular & Immunological Science, Naples, Italy; 2‘‘Villa dei
Fior’’ Hospital, Department of Cardiology and ICU, Naples, Italy;
3University of Naples Federico II, Department of Preventive Medical
Sciences, Naples, Italy; 4University of Naples Federico II, Department
of Biomorphological and Functional Sciences, Naples, Italy
Objectives: Aim of this study was to define the prognostic value of
stress cardiac magnetic resonance (CMR) for prediction of adverse
cardiac events in patients with known or suspected coronary artery
disease (CAD).
Background: With stress CMR, ischemia detection is typically based
on induction of myocardial perfusion defect (PD) and/or of wall
motion abnormality (WMA). Single-center studies have shown the
high value of stress-CMR for risk stratification.
Methods: Studies published between January 1985 and April 2012
were identified by database search. A study was included if used stress
CMR to evaluate subjects with known or suspected CAD and provided
primary data on clinical outcomes of non-fatal myocardial infarction
(MI) or cardiac death with a follow-up time C3 months.
Results: Eleven studies (11,513 subjects) met inclusion criteria. The
negative predictive value (NPV) for MI and cardiac death of normal
CMR was 98.2% (95% confidence interval [CI], 97.3-98.9%) over a
mean follow-up of 28.5 months, resulting in estimate event rate after
negative test (ERNT) equal to 1.81% (95% CI, 1.06-2.74%). The
corresponding annualized ERNT was 1.03%. Comparable NPVs for
major coronary events were obtained in studies considering the
absence of inducible PD compared with those evaluating the absence
of inducible WMA (97.5% vs 94.7%, respectively; P = 0.225).
Conclusions: Stress CMR has a high negative predictive value for adverse
cardiac events and the absence of inducible PD or WMA show a similar
ability to identify low-risk patients with known or suspected CAD.
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Coronary flow reserve assessment provides incremental
prognostic value over clinical factors in subjects without
perfusion defects on Rubidium-82 PET/CT
S. Sharmila Dorbala1; V.L. Murthy1; M. Naya1; C. Foster1;
M. Gaber1; J. Hainer1; J. Klein1; R. Blankstein1; M.F. Di Carli1
1Brigham and Women’s Hospital, Boston, United States of America
Objective: To test the hypothesis that coronary microvascular dys-
function predicts progression of atherosclerosis and major adverse
cardiac outcomes (MACE) in patients (Pts) without perfusion defects
on Rubidium-82 MPI.
Methods: Consecutive Pts. with no known CAD, no perfusion defects
and left ventricular (LV) ejection fraction (EF) [40% were included.
Myocardial blood flow (MBF in mL/gm/minute) and coronary flow
reserve (CFR, stress/rest MBF) were computed. The study endpoints
included a composite of MACE (N = 87) over 2.0 ± 1.3 years (car-
diac death, hospitalization for MI, unstable angina, CHF, new
obstructive CAD/revascularization, new drop in LVEF).
Results: We studied 1176 Pts. (age 61.8 ± 12.6 years, 68% women,
BMI 31.3 ± 9 kg/m2, LVEF 62% ± 9%), with hypertension (74%),
dyslipidemia (55%), diabetes (29%) and chest pain or dyspnea (83%).
Pts. with MACE had lower stress MBF (2.3 ± 0.97 vs 2.1 ± 0.96,
P = .04) and lower CFR (2.0 ± 0.67 vs 1.7 ± 0.61, P \ .0001) com-
pared to those without MACE.
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The middle and lower CFR tertiles independently predicted MACE
(Figure). Addition of CFR improved the model C-statistic (0.74-0.84,
P = .005). Net reclassification improvement (\1% and [2%/year
event rates) was 0.19 (95% CI, 0.077-0.293), the integrated discrimi-
nation improvement was 0.144 (95% CI 0.022-0.270).
Conclusions: Abnormal CFR provides incremental prognostic value in
predicting progression of atherosclerosis and MACE by appropriately
reclassifying risk in 19% of Pts. without perfusion defects.
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Short-Term statin fails to suppress plaque inflammation in
acute coronary syndrome: Evaluation by fluorodeoxyglucose
positron emission tomography/computed tomography
B.-H. Byung-Hee Hwang1; J.H. O1; C.-J. Kim1; E.-J. Han1;
E.-H. Chu1; K.-B. Seung1; J.H. Narula2; K.-Y. Chang1
1The Catholic University of Korea, St. Mary’s Hospital, Seoul,
Republic of Korea; 2Mount Sinai School of Medicine, Cardiovascular
Institute, New York, United States of America
Objectives: We assessed the effect of early statin therapy on plaque
inflammation in patients with acute coronary syndrome (ACS) by serial
18F-fluorodeoxyglucose positron emission tomography/computed
tomography (FDG PET/CT).
Background: Recurrent adverse ischemic events frequently occur
within the first month after ACS despite adequate statin therapy.
Methods: We enrolled twenty statin-naı¨ve patients with ACS and non-
calcified carotid plaques on ultrasound. After obtaining FDG PET/CT
of carotid arteries, all patients received atorvastatin, followed by a
second FDG PET/CT of carotid arteries after one month of therapy. 13
patients completed initial and follow-up FDG PET/CT of carotid
arteries. Maximum standardized uptake values (SUVmax) of given
carotid plaques as well as plasma cholesterol levels were measured and
compared.
Results: We quantified and tracked the statin-modulated alterations in
inflammation of FDG-positive plaques in 13 patients. Statin therapy
failed to reduce plaque inflammation at 1 month after ACS (mean
SUVmax 2.2 ± 0.5 at baseline vs 2.0 ± 0.3 after therapy; P = .174),
while it significantly reduced plasma low-density lipoprotein choles-
terol (LDL-C) (mean LDL-C 101.2 ± 21.1 mg/dL at baseline vs
70.7 ± 12.4 mg/dL after therapy; P \ .001). Notably, statin reduced
carotid FDG uptake in nine patients but did not in four patients.
Changes in SUVmax and plasma LDL-C levels were not correlated
(r = -0.15, P = .62).
Conclusions: Serial FDG PET/CT demonstrates that statin alone fails
to consistently suppress plaque inflammation within one month in
patients with ACS.
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Impact of cardiac fatty acid metabolism in sub-acute phase
on left ventricular functional recovery After Myocardial
Infarction
Y. Yukio Arita1; S. Kihara2; H. Hiraoka3; Y. Matsuzawa3
1Department of Cardiology, Toyonaka Municipal Hospital, Toyonaka,
Japan; 2Department of Biomedical Informatics, Graduate School of
Medicine, Osaka University, Suita, Japan; 3Department of Cardiology,
Sumitomo Hospital, Osaka, Japan
Left ventricular (LV) remodeling after acute myocardial infarction
(AMI) is an important predictor of mortality. Cardiac fatty acid
metabolism is associated with left ventricular function in heart failure.
Here we investigated the association of cardiac fatty acid metabolism
in sub-acute phase and functional recovery in chronic phase after AMI.
In 95 consecutive patients with AMI successfully treated with primary
percutaneous coronary intervention (PCI), I-123 beta-methyliodophe-
nyl pentadecanoic acid scintigraphy was performed 15 minutes and
3 hours after tracer injection within 10 days after AMI. Heart to
mediastinal ratio (H/M), wash out rate in whole heart (WOR), WOR in
non MI region (non-MI-WOR), and WOR in MI region (MI-WOR)
were estimated from the polar map. LV ejection fraction (EF) and LV
end-diastolic volume index (EDVI) was assessed with 99m-Tc-tetro-
fosmin quantitative gated single-photon emission computed
tomography performed six months after AMI.
LVEF was correlated with peak CK (r = -0.54, P \ .01), H/M
(r = 0.29, P \ .01), and MI-WOR (r = 0.19, P \ .01). LVEDVI was
correlated with peak CK(r = 0.49, P \ .01), H/M (r = -0.42,
P \ .01), WOR (r = -0.26, P \ .01), and MI-WOR (r = -0.24,
P \ .05). Multiple regression analyses revealed that LVEF was inde-
pendently correlated with peak CK (r = -0.48, P \ .01), H/M
(r = 0.19, P \ .05) and MI-WOR (r = 0.17, P \ .05). Multiple
regression analyses revealed that LVEDVI was independently corre-
lated with peak CK(r = 0.40, P \ .01) and H/M (r = -0.24,
P \ .05).
Altered cardiac fatty acid metabolism in sub-acute phase can predict
LV functional recovery in AMI patients.
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Detection of myocardial ischemia-reperfusion injury using
vascular adhesion protein-1 targeting imaging agent
A. Anu Autio1; S. Uotila1; V. Kyto2; M. Kiugel1; H. Liljenback1;
T. Saanijoki1; J. Knuuti1; S. Jalkanen3; A. Saraste1;
A. Roivainen1
1Turku PET Centre, University of Turku & Turku University Hospital,
Turku, Finland; 2Turku University Hospital, Turku, Finland;
3University of Turku, MediCity Research Laboratory, Turku, Finland
Purpose: Vascular adhesion protein-1 (VAP-1) mediates leukocyte
trafficking into the sites of inflammation. Recently, we have shown that
sialic acid-binding Ig-like lectin 9 (Siglec-9) is a granulocyte ligand for
VAP-1 and 68Ga-Siglec-9 peptide can be used as a positron emission
tomography (PET) tracer for in vivo imaging of inflammation. We
hypothesized that 68Ga-Siglec-9 peptide would facilitate monitoring of
the inflammatory processes associated with myocardial ischemia-
reperfusion (I-R) injury.
Methods: The myocardial uptake of 68Ga-Siglec-9 was evaluated in
rats subjected to temporary myocardial ischemia by transient surgical
ligation of the left coronary artery (LCA). The LCA was ligated for
8-12 minutes (group 1, n = 3) or 20 minutes (group 2, n = 5) fol-
lowed by a reperfusion of 24 hours. In addition, group 3 consisted of
rats with 8 minutes ligation and 4-6 hours reperfusion (n = 3). The
animals were injected with 36 ± 12 MBq of 68Ga-Siglec-9. Thirty
minutes after injection, heart was excised, cut in short-axis slices and
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stained with triphenyltetrazolium chloride (TTC) for detection of
infarcted myocardium. 68Ga-Siglec-9 uptake was measured from
cryosections of the left ventricle with autoradiography. Luminal VAP-
1 induction was evaluated by immunohistochemical staining of intra-
venously injected anti-VAP-1 antibody.
Results: All group 2 animals with 20 minutes ligation of LCA showed
large TTC positive area of myocardial infarction and increased 68Ga-
Siglec-9 uptake in the damaged myocardium compared to preserved
myocardium (3.5-fold, P = .002). Although hearts of rats with
8-12 minutes ligation were TTC negative, there was increased 68Ga-
Siglec-9 uptake in the area supplied by the left coronary artery. The
immunohistochemical staining showed VAP-1 positive vessels in the
left ventricle.
Conclusion: The 68Ga-Siglec-9 peptide accumulates in damaged
myocardium after transient occlusion of LCA in rats. Further studies
are warranted to clarify the value of 68Ga-Siglec-9 PET for the
evaluation of I-R severity and recovery.
215
Evidence of systemic plaque vulnerability in acute coronary
syndromes with FDG-positron emission tomography and
computed tomographic angiography in the BIOCORE-2
study
F. Hyafil1; V. Duchatelle2; E. Sorbets1; F. Rouzet1;
L. Mehanaoui2; G. Ducrocq2; D. Le Guludec1; L. Feldman2
1AP-HP—Hospital Bichat-Claude Bernard, Department of Nuclear
Medicine, Paris, France; 2AP-HP—Hospital Bichat-Claude Bernard,
Department of Cardiology, Paris, France
Purpose: Atherosclerotic plaque vulnerability is a systemic phenom-
enon and is often associated with a high plaque density of
inflammatory cells. 18Fluoro-deoxyglucose (FDG) accumulates in
inflammatory cells of atherosclerotic plaques where it can be measured
by positron emission tomography (PET), providing an opportunity for
non-invasive functional imaging of atherosclerosis. High FDG uptake
has been reported in carotid arteries of patients with recent strokes. The
aim of this study was to assess whether FDG uptake in the aorta and
carotid arteries is associated with morphological markers of plaque
instability detected with computed tomography angiography (CTA);
and is higher in patients with acute coronary syndromes (ACS) than in
patients with stable coronary artery disease (CAD).
Methods: Patients with ACS (n = 50) or stable CAD (n = 28)
underwent a PET 90 minutes after iv injection of 5 MBq/kg FDG
followed by a CTA of the thoracic aorta and carotid arteries. Tissue-to-
background ratios (TBRs) were calculated by dividing maximal stan-
dard uptake value (SUV) of the arterial wall by the mean SUV of
blood. A global TBR was calculated in each patient as the average of
the TBRs from the thoracic aorta and the 2 carotid arteries. Athero-
sclerotic plaques were classified with CTA as non-calcified/mixed/
calcified, and smooth/irregular.
Results: Aortic, carotid and global TBRs were higher in patients with
ACS than in patients with stable CAD (1.78 ± 0.19 vs 1.61 ± 0.18;
1.84 ± 0.35 vs 1.64 ± 0.17; 1.81 ± 0.23 vs 1.62 ± 0.16; P \ .05 for
all). Patients in the highest quartile of global TBR had a higher per-
centage of non-calcified and irregular plaques in the thoracic aorta and
carotid arteries as compared to patients in the lowest quartile of global
TBR.
Conclusions: FDG uptake in the thoracic aorta and carotids correlates
with morphological markers of plaque instability as assessed by CTA
and is higher in patients with ACS. Further studies are required to
determine whether PET-FDG of the thoracic aorta and carotid arteries
could be used as a surrogate marker for plaque instability in the cor-
onary arteries.
216
Evaluation of myocardial perfusion, metabolism and
sympathetic may offer further risk stratification in the
management of patients with Takotsubo cardiomyopathy
S. Shinro Matsuo1; K. Nakajima1; K. Okuda1; H. Wakabayashi1;
J. Taki1; M. Tobisaka1; S. Kinuya1; M. Yamagishi1;
1Kanazawa University, Kanazawa, Japan
Backgrounds: Takotsubo cardiomyopathy is a heart syndrome with an
acute onset defined by chest symptoms, ST segment elevation on elec-
trocardiograms. The entity was named because of the left ventricular
apical ballooning event on coronary ventriculography, the shape of which
looks like a Takotsubo, a vessel that is used in Japan to trap octopus.
Octopus is tako, and pot is tsubo in Japanese. Patients with Takotsubo
cardiomyopathy are sometimes misdiagnosed as having acute myocardial
infarction. Several studies reported the utility of nuclear imaging including
I-123-iodophenyl-3(R,S)methylpentadecanoic acid (BMIPP), I-123-
metaiodobenzylguanidine (MIBG), and perfusion scintigraphy (thallium-
201, Tc-99m-sestamibi, Tc-99m-tetrofosmin). However, few data exist
regarding the clinical impact of nuclear imaging on diagnosis and follow-
up of Takotsubo cardiomyopathy.
Methods: We examined 25 patients (aged 69 ± 14) with Takotsubo
cardiomyopathy. All patients were studied with resting BMIPP or
MIBG in comparison to perfusion imaging. MIBG myocardial scin-
tigraphy was performed 15 minutes and 3 hours after the injection.
BMIPP were imaged after 20 minutes after the injection.
Results: Coronary angiography showed the absence of stenotic regions
in the subjects. Regional abnormal BMIPP uptake of the myocardium
was seen in patients with Takotsubo cardiomyopathy (86%), with
complete or partial agreement with perfusion imaging. Abnormal
BMIPP uptake was observed more frequently than wall motion
abnormalities. Regional 123I-MIBG abnormality was observed in
patients with Takotsubo cardiomyopathy (100%) and the abnormalities
were observed exclusively in the apical region (total defect score
(TDS); 13 ± 4). The discrepancies between myocardial MIBG uptake
and perfusion suggest the stunned myocardium in the apical region. The
MIBG abnormality recovers later than the improvement of perfusion.
Global MIBG uptake shown by the heart-to-mediastinum ratio was
lower in patients with Takotsubo cardiomyopathy than that of normal
control subjects (2.3 ± 0.3 vs 2.6 ± 0.2, P \ .05). The degree of
damage in BMIPP ranged from moderate to severe at sub-acute phase,
but had almost normalized at chronic phase in patients with Takotsubo
cardiomyopathy (total defect score; 6.6 ±4 vs 1.4 ± 1, P \ .05). High
total defect score is associated with recurrence of hospital admission.
Conclusion: The serial changes in myocardial fatty acid metabolism
and sympathetic nerve function could give us information on the
severity and risk of patients with Takotsubo cardiomyopathy.
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Tc-99m-Annexin-V Uptake correlates with Left Ventricular
Remodeling in Rats with Ischemia and Reperfusion
J. Junichi Taki1; H. Wakabayashi1; A. Inaki1;
F.G. Blankenberg2; J.F. Tait3; I. Matsunari4; S. Kinuya1
1Kanazawa University Hospital, Kanazawa, Japan; 2Lucile Salter
Packard Children’s Hospital, Stanford, United States of America;
3University of Washington, Seattle, United States of America; 4Medical
and Pharmacological Research Center Foundation, Hakui, Japan
Background: Tc-99m-Annexin-V (Tc-Annex) imaging has been
proved to be feasible to detect phosphatidylserine which externalize on
the outer cell membrane in the early process of apoptosis. To deter-
mine whether apoptotic process correlates with left ventricular (LV)
remodeling after myocardial infarction, we studied Tc-Annex uptake in
rat model of myocardial ischemia and reperfusion.
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Methods: In 15 rats, the left coronary artery was occluded for
20-30 minutes followed by reperfusion for 2 weeks. At the time of
study, Tc-Annex (80-150 MBq) were injected, and 1 hour later, to
verify the area at risk, Tl-201 (0.74 MBq) was injected intravenously
just after the left coronary artery re-occlusion and the rats were sac-
rificed 1 minute later. Dual tracer autoradiography was performed to
assess Tc-Annex uptake and area at risk demonstrated by perfusion
defect by Tl-201. Tc-Annex uptake ratio was calculated by dividing the
Tc count density of the area at risk by that of the non-ischemic area. In
short axis LV slices, LV cavity dilatation index was calculated by
dividing the area of LV cavity by that of the LV muscle area. LV wall
thinning ratio was calculated by dividing the LV wall thickness in the
area at risk by that of the non-ischemic LV area.
Results: In visual analysis, significant Tc-Annex uptake was observed in
the area at risk in 10 rats. In the rest of 5 rats, no significant Tc-Annex
uptake was observed. Area at risk was not different in rats with and without
Tc-Annex uptake (Area ratio of area at risk to whole LV area were
0.52 ± 0.09 and 0.41 ± 0.18, respectively, P = ns). However, LV cavity
dilatation index was significantly higher in rats with Tc-Annex uptake than
in rats without (0.22 ± 0.088 vs 0.068 ± 0.039, respectively, P \ .005).
LV wall thinning ratio was more smaller in rats with Tc-Annex uptake than
in rats without (0.66 ± 0.10 vs 1.08 ± 0.048, respectively, P \ .0001). LV
cavity dilatation index and wall thinning ratio were positively and nega-
tively correlated with Tc-Annex uptake ratio, respectively (r = 0.69
(P = .0045) and r =-0.81 (P = .0002), respectively).
Conclusions: These data suggested that Tc-99m-Annexin-V uptake in
injured myocardial area correlates with LV remodeling at 2 weeks
after myocardial ischemia and reperfusion.
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The assessment of intramural fibrosis in hypertrophic
cardiomyopathy. A new indication for Cardiac CT?
C. Langer1; M. Hohnhorst1; M. Lutz1; M. Eden1; C. Gierloff2;
P. Schaefer2; M. Both2; C. Prinz3; L. Faber3; N. Frey1;
1University Hospital of Schleswig-Holstein, Campus Kiel, Department
of Cardiology, Kiel, Germany; 2University Hospital of
Schleswig-Hostein, Campus Kiel, Department of Radiology, Kiel,
Germany; 3Heart and Diabetes Center NRW, Ruhr-University of
Bochum, Department of Cardiology, Bad Oeynhausen, Germany
Background: Hypertrophic cardiomyopathy (HCM) is associated with
a certain risk of sudden cardiac death (SCD). SCD usually due to
ventricular fibrillations is caused by intramural fibrosis (IF). The ref-
erence standard for the detection of IF is magnet resonance imaging
(MRI) by showing late enhancement (LE) in such areas. But: there is
the need of alternative methods. Computed tomography (CT) was
shown to reliably demonstrate scar after myocardial infarction. There
is very scarce data about CT in the diagnosis of HCM. This study was
initiated to prove CT to detect IF in unselected HCM patients.
Methods: This ongoing validation study was approved by the local
ethics committee and the German Federal Office for Radiation Pro-
tection. At the time of abstract submission we had successively
recruited patients echocardiographically suspected HCM (interven-
tricular septum, IVS; C 15 mm). All patients undergo cardiac CT (64
slices) followed by cardiac MRI (Avanto, 1.5T) for assessment of
ventricular configuration, volumetry and IF. In cardiac CT the scan is
run 7 minutes after injection of contrast medium (2 mL/kg body
weigh) in order to detect IF by showing late enhancement (LE). Car-
diac MRI for detection of IF is done according to an established
protocol. CT based LE is identified visually proved by a significant
increase of the regional average HU value when compared to remote
myocardium measured in the opposite LV-segment. For analysis of LE
presence, distribution and intensity we use the established 17 segment
LV model (polar map). For this statistical analysis we only considered
patients presenting with LE.
Results: At the time of abstract submission 24 patients
(64.0 ± 14.5 years of age; male n = 14) had been recruited diagnosed
in echo (IVS 18.1 ± 2.0 mm; E/A 0.8 ± 0.3). So far, of these patients
n = 15 presented with LE in both modalities. IF distribution is con-
gruent is observed more often in the basal and mid-ventricular
segments as demonstrated in the established 17-segment-model (po-
larmap). In the areas of suspected IF cardiac CT based LE presented
with an average HU value of 154.4 ± 30.9 which is similar to the value
left ventricular cavum (158. 3 ± 35.0; P .73) but significantly higher
when compared to normal myocardium (92.0 ± 18.0; P \ .005). The
effective dose using our protocol was 3.43 ± 0.57 mSv for men and
4.98 ± 1.06 mSv for women.
Conclusion: Cardiac CT can detect intramural fibrosis in HCM. Thus,
in case of MRI contraindications cardiac CT may be an alternative
method for the assessment of HCM patients. However the applied scan
protocol needs to be further optimized.
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Impaired myocardial glucose uptake assessed by 18F-FDG
PET under hyperinsulinemic-euglycemic clamp correlate
with reduced level of hexokinase 2 expression in a rat model
of type 2 diabetes mellitus
F. Franz Kaiser1; T. Pelzer2; P. Arias-Lloza3; M. Kreissl4;
T. Higuchi5
1University Hospital Wu¨rzburg, Department of Nuclear Medicine,
Wu¨rzburg, Germany; 2University Hospital Wuerzburg, Department of
Internal Medicine I, Pneumology, Cardiology, Wu¨rzburg, Germany;
3University Hospital Wuerzburg, Department of Internal Medicine I,
Cardiology, Wu¨rzburg, Germany; 4Hospital Augsburg, Department of
Nuclear Medicine, Augsburg, Germany; 5University Hospital Wuerz-
burg, Comprehensive Heart Failure Center, Wu¨rzburg, Germany
Myocardial insulin resistance, an impaired ability to invoke glucose
uptake by insulin stimulation, has been suggested to be an important
etiologic factor for diabetic cardiomyopathy. A combination of 18F-
FDG PET and hyperinsulinemic-euglycemic clamp allows analyzing the
status of the local cardiac insulin resistance. Using the Zucker diabetic
fatty (ZDF) rat, a model of type 2 diabetes mellitus, we assessed the
cardiac glucose uptake under hyperinsulinemic conditions and examine
correlation with gene expression of glucose metabolism biomarkers.
Methods: ZDF rats and control (ZL) rats were studied at age 13 weeks.
Under hyperinsulinemic and euglycemic conditions, 37 MBq of 18F-
FDG were administered via the tail vein, followed by a dynamic 60
minutes PET acquisition. Cardiac 18F-FDG uptake was determined and
compared with biomarkers of glucose metabolism in the heart including
GLUT4, hexokinase II, insulin receptor substrate (IRS) 1 and IRS2.
Results: Cardiac 18F-FDG uptake under hyperinsulinemic-euglycemic
conditions decreased in ZDF rats compared to ZL controls (SUV:
3.81 ± 2.12 vs 8.05 ± 2.26, P \ .01). Expression of IRS1 and IRS2 in
the heart showed a significant increase in ZDF rats compare to ZL
controls (0.98 ± 0.07 vs 0.71 ± 0.33, P \ .05 and 0.75 ± 0.16 vs
0.42 ± 0.27, P \ .01, respectively) and GLUT4 and hexokinase II
expression showed a significant decrease (1.50 ± 0.21 vs 1.76 ± 0.31,
P \ .05 and 0.41 ± 0.29 vs 0.81 ± 0.26, P \ .01, respectively). There
was a positive correlation between 18F-FDG uptake and hexokinase II
expression (y = 0.10x + 0.02 R2 = 0.56, P \ .01), but not for the
expression of GLUT4, IRS1 and IRS2.
Conclusion: 18F-FDG PET non-invasively visualized altered myo-
cardial glucose metabolism of insulin resistance in a rat model of type
2 diabetes mellitus. Furthermore, an important role of cardiac hexo-
kinase II expression for the glucose intake reduction under insulin
stimulation was emphasized.
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In asymptomatic patients a score of carotid plaque higher
than 6 is a strong predictor of myocardial ischemia assessed
by SPECT
V.D. Victor Daniel Martire1; E.R. Pis Diez1; M.V. Martire1;
1CESALP, Fundacio´n Horacio Corrada, La Plata, Buenos Aires,
Argentina
Objective: To assess the incidence and severity of inducible myo-
cardial ischemia in patients (P) with different degrees of carotid
vascular disease (CVD), using data from the neck carotid Doppler
ultrasound (CDU) and from the functional imaging study of de
radioisotope myocardial perfusion (SPECT).
Method: A number of 397 asymptomatic P were consecutively stud-
ied, 251 men and 146 women with a mean age of 65 ± 9 years old,
with multiple cardiovascular risk factors and high pre-test probability
of coronary artery disease according to clinical scores. CDU and
SPECT were used and P were divided into 5 groups according to the
degree of CVD (quantitatively assessed by the sum of intima-media
and/or plaque thickness in mm: Plaque Score (PS): G1 (Control, n: 50
P): With no carotid alterations: PS: \1.1 mm, G2 (n: 150 P): With
intima/media thickness: between 1.1-1.5 mm, G3 (n: 88 P): PS:
between 1.5-6, G4 (n: 62 P): PS: between 6-12, G5 (n: 47 P): PS:[12.
Determination of ischemia incidence in each group and correlation
between PS was performed by means of CDU and the summed dif-
ferential score (SDS) by means of SPECT.
Result: Incidence: among all 397 P, 169 evidenced inducible myo-
cardial ischemia (42%): G1: 14 P (28%), G2: 41 P (26%). G3: 30 P
(34%). G4: 45 P (72%), G5: 39 P (83%). Correlation between SDS/PS:
r: 0.93, P \ 0.008.
Conclusion: In asymptomatic patients with multiple risk factors
myocardial ischemia was evidenced in all the groups, with high inci-
dence and severity in those P with more extensive carotid artery
disease quantified by Plaque Score using carotid Doppler ultrasound.
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Appropriate use criteria for stress myocardial perfusion
SPECT: Applicability and analysis of temporal trends in
compliance
A. Alfonso Dos Santos1; J.D. Peirano1; M. Montivero1; G. Rank1
1Sanatorio Mater Dei, Buenos Aires, Argentina
Purpose: Appropriateness Use Criteria (AUC) for Myocardial Perfu-
sion Imaging (MPI) provide information about the best current use of
tests and procedures in specific indications. The aim of our study was
to assess the applicability in daily practice of the AUC, and to evaluate
temporal trends in compliance.
Methods: We prospectively applied the 2009 version of AUC to 836
consecutive patients (P) who underwent SPECT MPI between July
2009 and June 2010 (Group A), and compare them to a second cohort
of 693 consecutive P collected between July 2011 and June 2012 in the
same single clinical center (Group B). Two experienced nuclear car-
diologists assigned, whenever possible, a specific scenario from the
AUC that was classified as appropriate, uncertain, or inappropriate.
Results: Of the 1529 P enrolled, only 10 (0.01%) were unclassifiable.
Overall, 824 P (54%) were judged as appropriate, 288 (19%) as
uncertain and 407 (27%) as inappropriate. We found a significant
decrease in the number of inappropriate indications in the temporal
comparison, with 243 studies (29%) in Group A and 164 (24%) in
Group B (P = 0.02). Table shows the most frequent indications and
temporal trends in each one. Risk assessment less than 2 years after
percutaneous coronary intervention was the only indication that
showed a significant decrease in the temporal comparison.
Conclusions: Application of AUC was feasible in daily practice, with
very few P unclassifiable. The number of inappropriate studies
observed remains high, although showing a significant decrease in the
temporal trend. Analysis of performance measures under this instru-
ment may help identify areas where educational efforts are needed
towards a more rational use of technology.
224
Incremental prognostic value of myocardial perfusion
SPECT in asymptomatic diabetic patients
E. Zampella1; W. Acampa1; S. Daniele1; R. Assante1;
M. Plaitano1; M. Tuccillo1; N. Frega1; A. Boemio1; M. Petretta1;
A. Alberto Cuocolo1
1University Federico II, Napoli, Italy
Stress myocardial perfusion single-photon emission computed
tomography (MPS) variables are robust estimators of prognosis. No
data are available on the comparative ability of stress MPS risk
markers using varied iterative and risk classification approaches in
asymptomatic diabetic patients. We compared analytical approaches to
estimate the added value of MPS variables in estimating coronary
artery disease (CAD) outcomes in asymptomatic diabetic patients. We
also evaluated the temporal characteristics of cardiac risk according to
MPS findings.
Methods: A total of 436 asymptomatic diabetic patients who underwent
stress/rest gated MPS were prospectively enrolled. Multivariable Cox
proportional hazards model were employed to estimate CAD death or
myocardial infarction (MI). Risk reclassification was calculated and
parametric survival analysis was used to predict time to events.
Results: At multivariable analysis summed stress score and post-stress
left ventricular ejection fraction (LVEF) were significant predictors of
CAD death or MI. The net reclassification improvement (NRI) by
adding MPS results to a model including pre-test CAD likelihood was
0.26 (95% confidence interval 0.7 to 0.45; P \ .001). The parametric
Indications in order of frequency
Indication Group A Group B P AUC
1
Ischemic equivalent in patient with intermediate pretest
probability of CAD, electrocardiogram interpretable and able
to exercise
127 (15%) 116 (17%) ns A
2
Asymptomatic patient, more or equal than 2 years after PCI 104 (12%) 93 (13%) ns U
3
Detection of CAD in patient with intermediate risk (ATP III
criteria)
76 (9%) 52 (7.5%) ns I
4
Evaluation of ischemic equivalent in patient
postrevascularization (PCI or CABG)
67 (8%) 52 (7.5%) ns A
5
Asymptomatic patient \2 years after PCI 62 (7.5%) 33 (4.8%) .02 I
6
Asymptomatic patient, more or equal than 5 years after
CABG
43 (5.1%) 47 (6.8%) ns A
CAD, Coronary artery disease; AUC, appropriateness use criteria; A, appropriate; U, uncertain; I, inappropriate;
PCI, percutaneous coronary intervention; ATP III, adult treatment panel III; CABG, coronary artery bypass graft
surgery.
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survival analysis showed the highest probability of CAD death or MI
and the major acceleration in time in patients with abnormal MPS and
post-stress LVEF \ 45%.
Conclusion: In asymptomatic diabetic patients, analytical approaches
that establish the reclassification of events may serve as a quality
imaging methodology for estimation of improved health outcomes for
stress MPS. Stress-induced ischemia and post-stress LVEF by gated
MPS also influence the temporal characteristic of the patient’s risk at
long-term follow-up.
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Prognostic significance of negative myocardial single photon
emission computed tomography studies among patients with
chronic renal impairment
M. Mohamed Mandour Ali1; A.H. Allam1
1Al-Azhar University, Department of Cardiology, Cairo, Egypt
Background: Prognostic value of a negative myocardial single photon
emission computed tomography (SPECT) study is well established in
literature. We thought to investigate for the prognostic value of a neg-
ative SPECT study among patients with chronic kidney disease (CKD).
Methods: Study cohort consisted of 193 consecutive patients with
CKD referred for a clinically indicated myocardial SPECT imaging. 5
patients were excluded due to non-cardiac deaths during the follow up
period. 92 (48.9%) out of the study cohort were on regular hemodi-
alysis (group I), 27 (14.4%) had uncomplicated renal transplantation
surgery after variable period of hemodialysis (group II) and 69 (36.7%)
out of them had chronic renal impairment (CRI) (GFR \ 45) required
neither regular dialysis nor renal transplantation (group III). SPECT
studies were reported as negative for myocardial ischemia in all study
population. End points (cardiac death, STEMI/NSTEMI, HF and
documented arrhythmia) at 6 months; 1 and 2 years were traced.
Results: Total cardiac events at one year were 17 (18.5%); one (3.7%) and
3 (4.3%) in groups I, II and III respectively (P value \ .05). Total cardiac
events at 2 years were 21 (22.8%); 3 (11.1%) and 7 (10.1%) in groups I, II
and III respectively (P values\ .005). Hard cardiac events (cardiac death,
STEMI/NSTEMI) were 2 (2.1%), 0% and 0% in groups I, II and III
respectively (P value = .5) at one year; and 9 (9.7%), 1 (3.7%) and 2
(2.9%) at 2 years in groups I, II and III respectively (P value\ .05).
Conclusion: CKD patients on regular hemodialysis have a higher total
cardiac event rate at one and 2 years, and still have a higher hard cardiac
event rate at 2 years of follow up even after a negative SPECT study. This
group of patients should be followed up more closely, however, a large
scale study is needed in this area to clarify and state applicable guidelines.
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Myocardial viability assessment by rest-redistribution
thallium-201 myocardial perfusion scintigraphy in acute left
ventricular failure: Improved efficacy by solid state detector
gamma camera
A. Atul Verma1; S. Pandey1; R. Jeyachandran1; S. Balani1;
M. John1
1Fortis Escorts Heart Institute, New Delhi, India
Purpose: To find out the efficacy of solid state detector over the
conventional gamma camera using low dose Tl-201 for myocardial
hibernation by Gated Rest-Redistribution study (G-RRT) in cases with
increased lung uptake interfering with exact estimation of myocardial
hibernation due to over subtraction and normalization.
Materials and Methods: 37 subjects with gross left ventricular dys-
function(LVEF B 25%) and increased lung uptake during immediate
post injection phase of the study were subjected to scanning under both
Siemen’s-Symbia S (dual head conventional gamma camera) & GE’s
dicovery NM 530C (solid state detector). All the subjects were injected
low dose(1.5 mci of Tl201) and were imaged under both the cameras
with scanning times of 12 and 5 minutes each for symbia-S & Dis-
covery NM 530C respectively. The acquired images were processed
using butterworth filter of 4.5 & order of 5 for Symbia-S & 3D iterative
reconstruction for Discovery NM 530C. The processed images were
compared using the segmental LV myocardial distribution as well as
myocardial contractility and centripetal excursion on a gated study.
Observations: All the 37 patients with increased lung uptake and scanned
under Symbia S gamma camera, showed photopenicity in anterior/ante-
roseptal & apical walls during immediate rest imaging with diffuse synergy
(Low count images). On redistribution, 15 subjects showed no redistribu-
tion, 13 showed partial refilling and 9 showed a near total refilling. These
findings were compared with the processed images of Discovery NM-
530C. The results were found to be comparable in cases with fixed or partial
refilling but with improved image quality of gated SPECT showing definite
Akinesia/hypokinesia. Of the remaining 9 cases which showed a near total
refilling, 5 showed the same results inferred as myocardial hibernation; 4
showed maintained myocardial uptake with akinesia in 2 cases inferred as
Stunned myocardium; and the rest 2 cases showed maintained contractility
& photopenicity may be ascribable to over subtraction by lung uptake and
inferred as non ischaemic cardiomyopathy.
Discussion: The improved image quality including gated SPECT by
Semiconductor detector gamma camera infers increased efficacy over
conventional cameras in detection of myocardial hibernation in cases
with significant lung uptake even at low doses of Tl201. This is
because of small field of view and direct conversion of energy into
counts and high energy and spatial resolution of solid state technology.
Also quality gated study helps in demarcation of myocardium from
lung uptake & thus negates the use of Tc99m reinjection for the same.
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Prognostic value of multidetector computed tomography and
exercise electrocardiography in patients with suspected
coronary artery disease: A long-term follow-up
G. Gianluca Pontone1; D. Andreini1; E. Bertella1; S. Mushtaq1;
S. Cortinovis1; A.D. Annoni1; A. Formenti1; A. Baggiano1;
G. Ballerini1; M. Pepi1;
1University of Milan, Foundation Monzino (IRCCS), Center Cardiol-
ogy, Department of Cardiology, Milan, Italy
Purpose: To perform a comparison of the prognostic performance of
multidetector computed tomography (MDCT) vs exercise electrocardiog-
raphy (ex-ECG) in patients with suspected coronary artery disease (CAD).
Methods and Materials: We enrolled 681 patients (age 61.3 ±
10.4 years, 461 men) with atypical or typical angina and no history of CAD.
All patients underwent ex-ECG and MDCT and were followed-up for
44 ± 12 months. The endpoints were ‘‘all cardiac events’’, defined as non-
fatal myocardial infarction, cardiac death and revascularization, and ‘‘hard
cardiac events’’, defined as all cardiac events excluding revascularization.
Results. Ex-ECG and MDCT were rated as positive in 419 (61%) and
274 (40%) out of 681 patients, respectively. In univariate analysis, both
ex-ECG and MDCT were predictors of all cardiac events (HR: 2.09
[1.5-2.8], P \ .0001 and HR: 21.1 [14.6-30.5], P \ .0001, respec-
tively) and hard cardiac events (HR: 1.9 [1.1-3.2], P = .02 and HR: 6.8
[3.9-12.0], P \ .0001, respectively), while in a multivariate analysis
CAD 50% stenoses detected by MDCT was the only independent
predictor of hard cardiac events. Stratifying our population on ex-ECG
and MDCT findings, Kaplan-Meier curves showed that ex-ECG pro-
vides only a further risk stratification in the subset of patients with low
to intermediate likelihood of CAD and positive MDCT.
Conclusions: MDCT may show a higher prognostic value as compared
to ex-ECG in patients with suspected CAD, mainly in those with a low-
to-intermediate pre-test likelihood of CAD. In this clinical setting,
MDCT may be a better diagnostic tool and may play a key role for
prognostic stratification in a combined anatomical and functional
assessment workflow.
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18F-FDG PET/CT evaluation of carotid plaque: Correlation
to histological status
A. Artor Niccoli Asabella1; A. Di Palo1; A. Notaristefano1;
C. Ferrari1; M. Fanelli1; G. Rubini1;
1Universitary PolIclinic of Bari—Nuclear Medicine—D.I.M.,
Bari, Italy
Purpose: Inflammation, plaque erosion and consequent embolism are
the main cause of acute cardiovascular events which usually result
from the sudden rupture of macrophage-rich atherosclerotic plaques.
The interior of a plaque is an anaerobic area, so glucose is the major
substrate for macrophages. The aim of this study was to evaluate a
relationship between 18F-FDG uptake in PET/CT and histology in
carotid artery plaques.
Materials and Methods: We studied 31 patients, with ultrasound
diagnosis of carotid plaque with stenosis of although 70% and candi-
dated to endoarterectomy, who performed 18F-FDG PET/CT. Plaques,
removed during carotid endarterectomy, were histologically analyzed.
Arterial 18F-FDG uptake in the neck was measured by drawing a
region of interest (ROI) around the artery on every slice of the co-
registered transaxial PET/CT images. On each image slice, the SUV
max and SUV mean of 18F-FDG in the ROI (containing the arterial
wall and the lumen) was calculated as the maximum pixel activity. We
calculated also the Target Backround Ratio max (TBR max) as the
SUV max normalized to venous SUV max (measured by drawing a
ROI around the superior cava vein). We calculated also the Target
Backround Ratio mean (TBR mean) as the SUV mean normalized to
venous SUV mean.
Results: A statistically significant difference was observed in TBR
mean value in relation with presence or absence of fibro-fatty infil-
tration (1.50 vs 1.25; t = 2.05, P = .05). A statistically significant
difference was observed in TBR mean value in relation with value of
BMI between 25 and 29 (1.47 vs 1.12; t = 2.57; P = .02). A statis-
tically significant Pearson’s correlation was observed between SUV
max of carotid plaque and SUV max of aortic arch (r = 0.793, P = 0)
and between SUV mean of carotid plaque and SUV mean of aortic arch
(r = 0.838, P = 0).
Conclusions: Our results find an association between plaque FDG
uptake, evaluated in particular with TBR mean, and fibro-fatty infil-
tration and underline vascular inflammation, predominantly in the form
of macrophages. We confirm the role of PET imaging has as a bio-
marker of the metabolic activity of atherosclerosis. 18F-FDG PET/CT
is able to identify symptomatic lesions and should help the identifi-
cation of patients at high risk of cardiovascular events.
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The relationship between serum PAPP-A concentration with
plaque morphology and coronary artery perfusion
V. Valtteri Uusitalo1; A. Saraste2; S. Wittfoot3; S. Kajander1;
H. Ukkonen2; M. Pietila2; J. Airaksinen2; K. Pettersson3;
J. Knuuti1
1Turku PET Centre, University of Turku & Turku University Hospital,
Turku, Finland; 2Turku University Hospital, Department of Internal
Medicine, Division of Cardiology, Turku, Finland; 3Department of
Biotechnology, Turku, Finland
Purpose: Pregnancy-associated plasma protein-A (PAPP-A) is a
metalloproteinase that is highly expressed in atherosclerotic plaques.
Elevated circulating PAPP-A level in acute coronary syndromes or
stable coronary artery disease (CAD) has been proposed as a biomarker
of risk for future cardiac events. We wanted to study the relationship
between circulating PAPP-A level and atherosclerotic plaque mor-
phology or myocardial blood flow as assessed by computed
tomography angiography (CTA) and positron emission tomography
(PET).
Methods: 76 patients with intermediate likelihood of CAD (age
63 ± 7 years) underwent coronary CTA and myocardial perfusion PET
with O15 water using hybrid scanner. Blood sample was obtained for
measurement of serum PAPP-A concentration with immunofluoro-
metric assay. All patients underwent invasive coronary angiography
(ICA) to detect haemodynamically significant CAD defined as stenosis
[70% or FFR \0.80. Coronary arteries were divided to 17 segments
and plaques in these segments labeled as soft (non-calcified), mixed or
calcified plaques by CTA. For summed stenosis score (SSS) stenoses
were scored as 1 (\30%), 2 (30-49%), 3 (50-69%) and 4 ([70%).
Coronary calcification was quantified by Agatston coronary calcium
score (CCS).
Results: PAPP-A concentration was comparable in patients with and
without haemodynamically significant CAD by ICA (1.52 ± 3.38 vs
0.95 ± 0.66 mIU/L, P = .82). PAPP-A concentration was not associ-
ated with global coronary flow reserve by PET (r = -0.09, P = .52),
SSS by CTA (r = 0.09, P = .46) or CCS (r = 0.12, P = .31). There
were also no correlations between the number of mixed or calcified
plaques and PAPP-A (r = 0.07, P = .48 and r = 0.08, P = .57).
However, in a subgroup of patients without haemodynamically sig-
nificant coronary stenosis (n = 46), patients with soft plaque (n = 15)
had greater PAPP-A concentration than patients without (n = 31) soft
plaques (1.12 ± 0.58 vs 0.88 ± 0.70 mIU/L, P = .045).
Conclusions: PAPP-A concentration was comparable in patients with
and without flow-limiting coronary artery stenosis. However, PAPP-A
concentration was higher in patients with non-calcified plaques as
detected by CTA. In addition to soft plaque phenotype by CTA, ele-
vated PAPP-A could be useful risk marker of coronary events in
patients with non-obstructive CAD.
230
Significance and outcomes of strongly positive stress test in
the setting of low risk myocardial single photon emission
computed tomography scans; highlights from Egyptian
population
M. Mohamed Mandour Ali1; A.H. Allam1
1Al-Azhar University, Department of Cardiology, Cairo, Egypt
Background: Stress test and myocardial SPECT studies are very
widely utilized tools in CAD evaluation. We thought to investigate for
cardiac outcomes of positive stress test in the setting of negative
SPECT study.
Methods: 415 consecutive patients were enrolled, 202 (48.7%)
patients had a negative stress test and perfusion scan (group I) and 213
(51.3%) patients had positive stress test and negative perfusion scan
(group II). Significantly positive stress test was defined as [1 mm of
horizontal ST depression 80 ms. after J point. Patients with prior PCI/
CABG, pre-excitation syndromes, pacemakers, baseline/rate dependent
LBBB and/or positive SPECT scans were excluded. Coronary calcium
score was done in all patients. 246 patients underwent either coronary
angiography or CT angiography based on the clinical decision of the
referring MD. ‘‘117 in group I and 129 in group II’’.
Results: Mean interventricular septal (IVS) thickness (mm) was
1.21 ± 0.15 and 1.29 ± 0.1 in groups I and II (P value \ .05). Coro-
nary stenosis ([50%) was seen in 3 (1.5%) and 5 (2.3%) patients in
groups I and II (P value = .5). At one year, 1 (0.5%) and 3 (1.4%) hard
cardiac events (cardiac death, STEMI/NSTEMI) happened in groups I
and II respectively (P value = .5). At 2 years 3 (1.5%) and 6 (2.8%)
hard events happened in groups I and II respectively (P value = .5).
Conclusion: Positive stress test in the setting of negative SPECT study
neither correlates with significant coronary stenosis nor hard cardiac
event rate at one and two years of follow up.
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Risk stratification and prognostication of acute coronary
syndrome patients by combined MPI SPECT and TIMI risk
scores
P.S. Shanmuga Sundaram Palaniswamy1; S. Padma1
1Amrita Institute of Medical Sciences, Cochin, India
Aim: Risk stratification of ACS pts (unstable angina & Non ST MI) is
very useful in assessment of myocardium at jeopardy and to optimize
pt management. Our retrospective study aims to correlate stress MPI
findings, TIMI risk scores and their prognostic implications.
Methods: 110 pts (M:F = 83:27, age range 47 ± 9 years) proven/
suspected MI undergoing risk stratification MPI during 2009-2010
were analyzed. Pts with previous revascularization and normal MPI
were excluded. A TIMI risk score 0-7 were assigned, one point for
each variable i.e. age [ 65 years, [3 CAD risk factors, stenosis
[ 50%, last 1 week aspirin use, recent angina, elevated cardiac
enzymes, ST in rest images. Segment with near normal tracer uptake,
good wall thickening but significant hypokinesia in gated study said to
be hibernating. 1 year follow-up data obtained.
Results: MPI studies were interpreted visually and with a 20 segment
model. 72 pts had Transmural MI and 38 (35%) had NSTMI. TMI pts
were excluded for further analysis. Images were evaluated for perfusion
defects (reversible, irreversible), wall thickening/motion and other find-
ings like TID, lung uptake. Pts were risk categorized using TIMI score as
low (0-2 score), intermediate (3-4) and high (5-7) i.e. 11:4:23 pts.
High risk 23/38 (60%) pts showed 6.2 ± 2.2 myocardial segments at
risk (ischemia ± hibernation) when compared to 2.0 ± 1.1 segments in
low risk (P \ .01).
11/23 (48%) high risk pts showed LAD territory perfusion abnormal-
ities. 9/23 (39%) high risk pts showed other non perfusion high risk
MPI findings (TID, lung uptake). As high as 80% of high risk pts (18/
23) had revascularization during the follow-up period. Good correla-
tion was observed in high risk pts between MPI findings and TIMI
score (r = 0.8).
Out of 11 low risk pts, only 1 had LAD perfusion defects and 5/11 pts
(45%) had insignificant CAD or normal angiogram. None of low risk
pts had any revascularization and any cardiac hard events during
1 year followup.
Conclusion: Stress MPI and TIMI scoring together helps to risk stratify
ACS pts. Low risk pts were found to have less cardiac events. MPI, TIMI
correlated moderate/high risk pts need to undergo revascularization.
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Ischemic ST-segment depression only during recovery after
ETT: Correlation with stress gated-perfusion SPECT data
A.F. Falcao1; W.C. Challela1; J.C.M. Meneghetti1;
J.R. Ramirez1; R.K. Kallil1; L.A. Azouri1;
S. Salvador Borges-Neto2
1Heart Institute (InCor)—University of Sao Paulo Faculty of Medicine
Clinics Hospital (HC-FMUSP), Sao Paulo, Brazil; 2Duke University,
Durham, United States of America
Purpose: The diagnostic and prognostic value of ST-segment depres-
sion (;ST) occurring during the recovery period is less well defined as
compared with that appearing during exercise testing (ET). Only few
studies have investigated the clinical significance of this finding.
Objective: The aim of this study was to compare ;ST only in recovery
with the gated-SPECT imaging incidence of the severity and extent of
ischemic changes.
Methods: Seventy patients (pts) with ;ST only during recovery, who
underwent gated-SPECT associated with ET and Bruce protocol, were
analyzed. Mean age was 60.1 ± 9.8 years, 56 (78%) male, with previous
myocardial infarction in 27.5%, coronary artery bypass graft in 21%, and
percutaneous coronary intervention in 34%. Qualitative analysis of
imaging used 5-point score (0-normal; 4-no uptake) for perfusion (17
myocardial segments), and 6-point score (0-normal; 5-diskinesia) for
motility. Left ventricular ejection fraction (LVEF) was assessed after ET.
;ST, blood pressure (BP), heart rate (HR), time of tolerance to exercise
(TTE), functional capacity (MET), appearance time to ;ST (AT;ST),
and presence of arrhythmias were evaluated during ET.
Results: Severe and extensive perfusion abnormalities was found in 57
pts (81.5%), 47% with transient defect and 11.4% associate with
persistent defect; wall motion abnormalities seen in 23 pts (33%);
mean LVEF was 58% ± 11%, with a mean of 10.6 ± 3 MET of
functional capacity. A borderline significant relationship were found
between AT;ST vs TTE (P = .09) as well as between an abnormal
perfusion vs MET (P = .09).
Conclusion: This study suggests that ;ST occurring solely during
recovery after ET is a relevant finding due to the high prevalence of
severe and extensive myocardial ischemia in the gated-SPECT. A
larger prospective study evaluating this relationship, the prognostic
value and the ability to risk stratify patients with those ischemic
parameters developed only after exercise stress is warranted.
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Can lower heart rate response to adenosine stress myocardial
perfusion imaging predict future cardiovascular events?
S. Satoko Yamasaki1; A. Goda1; S. Taniai1; A. Nagae2;
K. Shimoyama3; T. Nishimura4; K. Sakata1; T. Satoh1;
H. Yoshino1
1Kyorin University, Tokyo, Japan; 2Jukoukai Hospital, Saitama,
Japan; 3Minamidai Hospital, Tokyo, Japan; 4Towers Clinic for
Internal Medicine, Tokyo, Japan
Background: Myocardial perfusion imaging (MPI) using adenosine
widely applies for detection of coronary ischemia as well as exercise
MPI. However, little is known about heart rate response (HRR) to
adenosine. The objectives of this study are to determine which factors
affect to HRR to adenosine and whether HRR has an incremental
prognostic value to MPI.
Methods: A total of 1,247 consecutive patients (male/female 795/452,
age 71 ± 11 years) underwent adenosine MPI. An HRR \ 10%
(change from baseline) was considered lower HRR. The outcome of
interest was cardiovascular death and events (heart failure worsening
and acute coronary syndrome).
Results: A total of 22 cardiovascular deaths and 40 cardiovascular
events occurred over 368 ± 250 days of follow-up. The patients with
lower HRR (n = 819) were characterized by more male (66.8% vs
58.6%, P = .011), higher presence of hypertension (75.8% vs 68.3%,
P = .015), CKD (16.9% vs 10.7%, P = .040), and lower resting
LVEF (62.3 ± 16.4% vs 66.2 ± 15.3, P \ .001) than those with higher
HRR (n = 428). However, summed difference score was not different
between lower HRR and higher HRR group (1.09 ± 3.65 vs
1.14 ± 3.75, P = .816). Univariate Cox proportional hazards analysis
identified age, lower HRR (hazard ratio, 2.88; 95% CI 1.21 to 6.87;
P = .017), resting LVEF, exercise LVEF and presence of CKD, as
independent prognosis indexes of events. Kaplan-Meier survival
analysis revealed that patients with lower HRR had increased cardio-
vascular events compared with patients that had higher HRR
(v2 = 7.77, P = .005). In multivariate analysis, resting LVEF (hazard
ratio, 0.96; 95% CI 0.95 to 0.98; P \ .001), presence of CKD (hazard
ratio, 2.75; 95% CI 1.41 to 5.40; P = .003) and age (hazard ratio, 1.04;
95% CI 1.01 to 1.08; P = .015) predicted cardiovascular events, but
lower HRR (hazard ratio, 2.12; 95% CI 0.88 to 5.09; P = .094) did
not.
Conclusions: Lower HRR to adenosine is associated with gender,
presence of HT, CKD, and lower EF, but not with presence of myo-
cardial ischemia. Predictive value of lower HRR in cardiovascular
events does not go beyond the presence of CKD and resting LVEF.
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Cost savings associated with the use of selective stress-only
and CZT SPECT myocardial perfusion imaging
M. Milena Henzlova1; T. Naib1; G. Greco1; P. Vaishnava1;
J. Berman1; D. Ascheim1; W.L. Duvall1
1Mount Sinai School of Medicine, New York, United States of America
Purpose: Selective stress-only myocardial perfusion imaging (MPI)
and high efficiency cadmium zinc telluride (CZT) camera technology
both shorten test time and tracer dose. The cost savings of either
strategy has not been established.
Methods: Two Tc-99m SPECT imaging strategies at a tertiary medical
center were modeled using either a CZT or conventional attenuation
correction equipped Anger camera: stress-first and rest-stress. Fixed
costs (purchase price), annual operating costs (maintenance) and var-
iable costs per study (personnel time and supplies) were calculated
assuming one SPECT camera was used with a daily capacity of 10
studies. Overhead (rent, utilities, administrative costs) was not inclu-
ded as it was considered identical among all strategies.
Results: Purchase costs of the CZT camera exceed that of a conven-
tional camera (28% higher annuitized 10 year capital cost) but yearly
maintenance was 9% lower. Yearly variable costs were 5% less with a
CZT camera compared to conventional camera by decreasing per-
sonnel time. A stress-first strategy results in a 24% annual savings with
both cameras based on decreased personnel time and isotope cost. The
proportion of normal stress studies and imaging volume determined
whether the CZT camera overcame the higher initial up-front costs.
Conclusions: Cost savings can be seen with selective stress-only
imaging and new CZT camera technology compared to traditional rest-
stress imaging and conventional SPECT cameras.
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How often did we underestimate extent of ischemia by gated
SPECT myocardial perfusion imaging in patients with severe
coronary artery disease?
S. Shigeru Fukuzawa1; J. Sugioka1; A. Ikeda1; S. Okino1;
J. Maekawa1; S. Ichikawa1; N. Kuroiwa1; S. Okamoto1;
M. Inagaki1
1Funabashi Municipal Medical Center, Funabashi, Japan
Background: Since left main alone or in combination with triple vessel
coronary artery disease (CAD) are categorised as representing potentially
life-threatening variants of CAD, a screening test with high sensitivity,
low negative likelihood ratio or higher discriminatory capacity would be
desirable for risk stratification. There have been limited data regarding the
value of gated single photon emission computed tomography (SPECT)
myocardial perfusion imaging (MPI) for the detection of triple vessel or
left main coronary artery disease in clinical practice.
Methods and Results: We studied 72 patients with angiographic triple
vessel/left main CAD and no prior myocardial infarction or coronary
revascularization who underwent gated exercise or adenosine stress
SPECT MPI by one-day stress and rest protocol. The extent and
severity of perfusion abnormalities were assessed using a 4-point
system and 17-segment model. By perfusion assessment alone, high-
risk disease with moderate to severe defects ([10% myocardium at
stress) was identified in only 53% of patients visually. However, by
combining visual perfusion data and nonperfusion variables, especially
low ejection fraction, 69%, and transient ischemic dilation, 85% of
patients were identified as high risk.
Conclusion: The findings of this study demonstrate that assessment of
perfusion data alone by visual SPECT MPI analysis underestimates the
magnitude of triple vessel or left main CAD. The combination of
perfusion and nonperfusion abnormalities on gated MPI identifies high
risk in most patients with triple vessel or left main CAD. This limi-
tation can be overcome, to a certain extent, by incorporating other
imaging findings as well as clinical and stress testing parameters that
help identify individuals at an increased risk of adverse cardiac events
and hence those with severe and extensive coronary disease.
236
Left ventricular hypertrophy influences the association
between ST segment changes and ischemia in stress
myocardial perfusion SPECT
F. Mut1; M. Kapitan2; A. Damian2; M. Lujambio2; R. Ferrando2
1Nuclear Medicine, Spanish Association, Montevideo, Uruguay;
2University Clinical Hospital, Montevideo, Uruguay
Purpose: Specificity of ST segment changes on exercise testing (ET)
for diagnosis of myocardial ischemia and coronary artery disease
(CAD) in patients with left ventricular hypertrophy (LVH) remains
controversial. The aim of this study was to determine whether the
presence of LVH influences the association between ST segment
changes and ischemia in SPECT myocardial perfusion studies
(MPS).
Methods: Retrospective analysis of 175 consecutive patients (37-
83 years, mean 61.7 years, 50.3% females) evaluated stress/rest MPS
with 99mTc-sestamibi who presented exercise-induced horizontal or
downsloping ST depression C1 mm in two or more consecutive leads,
either with normal baseline ECG or with LVH pattern. We excluded
patients with LBBB, pacemaker, WPW, and those receiving digitalics.
Patients were assigned to two groups: GI) without LVH (n = 121) and
GII) with LVH (n = 54). MPS images were assessed by two inde-
pendent observers, blinded to ET results, and summed difference
scores (SDS) were calculated. Relationships between changes in ST
segment [segment depression (DST) and recovery time (RT)] and SDS
were evaluated by Pearson correlation coefficient (PC), t test, Chi2, and
ANOVA, considering alpha = 0.05.
Results: Differences were not significant between groups I and II
regarding age (P = .50), sex (P = .48), BMI (P = .60), diabetes
(P = .22), smoking (P = .77), dyslipidemia (P = .52), and presence
of CAD (P = .68). As expected, hypertension was more frequent in
GII (P = .001). RT was longer in GII (P = .019), while DST and SDS
did not differ between groups (P = .09 and P = .38 respectively). In
GI, both DST and RT were positively correlated with SDS (PC = 0.43,
P \ .001 and PC = 0.25, P = .005, respectively). DST correlated with
SDS in GII (PC = 0.28, P = .043) but RT did not (PC = 0.02,
P = .86). DST C2 mm was associated with higher SDS in GI
(P \ .001, t test) but not in GII (P = .98). SDS was higher in patients
with DST B 2 mm than DST \ 2 mm in GI (P \ .001, ANOVA,
Bonferroni correction) but not in GII.
Conclusions: In patients without LVH, both DST and RT are associ-
ated with greater extent/severity of ischemia in MPS. RT is longer in
patients with LVH, but is not significantly associated with the degree
of ischemia. DST has limited correlation with ischemia in the presence
of LVH, thus supporting the lower specificity of this sign for the
diagnosis of CAD.
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Cardiac CT for the evaluation of patients prior to non
coronary cardiac surgery
F.J. Guerrero Marquez1; N. Nieves Romero Rodriguez1;
J.L. Martos Maine1; M.P. Serrano Gotarredona1;
S. Navarro Herrero1; J.M. Borrego1; A. Martinez Martinez1
1Virgen del Rocio University Hospital, Seville, Spain
Cardiac CT has an important place in the coronary study and its main
value lies in its high negative predictive value. This justifies its role in
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coronary assessment prior to valve replacement surgery instead of
coronary angiography.
Method: From December 2008 to February 2012 we included all
patients awaiting valve replacement intervention and/or intervention
on ascending aorta or tumor resection, with indication of prior cor-
onary evaluation. This was performed by coronary CT Toshiba
Aquilion 64 using standard protocol. We excluded patients with
previous ischemic disease and those with renal failure and/or diabetes
for more than 15 years of evolution and those patients who underwent
coronary angiography due to lack of availability of TAC prior to the
date of surgery (25 patients). We collected all clinical and echocar-
diographic data and they were followed after surgery and 6 months
afterwards.
Results: A total of 1025 adult patients were operated, from whom 256
were finally evaluated by Cardiac CT; 142 were male with a mean age
of 68,7 years old (SD 8.9). In 3 patients the presence of significants
lesions and in 12 patients a calcium score [500 made necessary an
invasive angiography, with the demonstration of significant lesions in 6
of them. In the rest of patients cardiac CT ruled out the presence of
significant lesions, with no complications related to the test. During the
postoperative follow-up we did not detect any acute coronary syn-
drome and 9 patients died from non-ischemic causes.
Conclusions: Coronary CT is a safe and effective technique for cor-
onary assessment prior to valve replacement surgery, although the
patient selection is crucial to indicate the test in an appropriate way.
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Transient ischemic dilation in SPECT myocardial perfusion
imaging for prediction of severe coronary artery disease in
diabetic patients
R. Assante1; W. Acampa1; S. Daniele1; E. Zampella1; C. Nappi1;
M. Tuccillo1; M. Plaitano1; P. Perrone-Filardi1; M. Petretta1;
A. Alberto Cuocolo1
1University Federico II, Napoli, Italy
Transient ischemic dilation (TID) of the left ventricle during stress
myocardial perfusion SPECT (MPS) has been shown to be a useful
marker of severe coronary artery disease (CAD). However, investi-
gations in diabetic patients with available coronary angiographic data
are still limited. We evaluated the incremental diagnostic value of TID
in identifying the presence of angiographically severe CAD in diabetic
patients.
Methods: TID ratio values were automatically derived from rest-stress
MPS in 242 diabetic patients with available coronary angiography
data. A cutoff of[1.19 was considered to represent TID. Severe CAD
([70% stenosis in the proximal left anterior descending artery or the
left main artery, or [90% stenosis in two or three vessels) was iden-
tified in 69 (29%) patients.
Results: At multivariate analysis, the best independent predictors of
severe CAD were summed stress score and TID (both P \ .001). At
incremental analysis, the addition of TID improved the power of a
model including clinical data and summed stress score, increasing the
global chi-square value from 14.3 to 28.2 (P \ .01). The best cut-off of
summed stress score for identifying patients with severe CAD was[7.
When the TID ratio was considered in patients with summed stress
score between 3 and 7, the sensitivity for diagnosing severe CAD
significantly improved from 71% to 77% (P \ .05). In the overall
study population, the net reclassification improvement by adding TID
to a model including clinical data and summed stress score in the
prediction of severe CAD was 0.40 (P \ .005).
Conclusions: TID ratios obtained from rest-stress MPS provide
incremental diagnostic information to standard perfusion analysis for
the identification of severe and extensive CAD in diabetic patients.
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Usefulness of spect myocardial perfusion in asymptomatic
patients with multiple vascular risk factors
V.D. Victor Daniel Martire1; E.R. Pis Diez1; M.V. Martire1
1CESALP. Fundacio´n Horacio Corrada, La Plata, Buenos Aires,
Argentina
Objective: To determine the incidence and magnitude of ischemia
through myocardial perfusion with SPECT as a tool for initial detec-
tion of asymptomatic patients (P) with multiple vascular risk factors
(RF).
Method: Since the incorporation of rotating gamma camera SPECT,
8965 P have been consecutively studied (1999 to 2011) among which
1611 P (18%) showed that the indication of SPECT functional imaging
study matches the objectivebefore mentioned for this study: mean age
58 ± 11 years old, 984 men, hypertension: 709 P (44%), Dyslipidemia:
918 P (57%), Diabetes mellitus (type 2): 177 P (11%), tobacco 515 P
(32%), abnormal ECG 451 P (28%), overweight/obesity: 724 P (45%),
other RF: 514 P (32%). (MS-ACCESSTM database, Graph-Pad
v5.01TM). All the P were studied with Sestamibi-99Tc SPECT, PEG-12
derivatives, according to conventional protocols.
Result: 1-PEG: 78% of P reached target maximum heart rate: negative
PEG: 1031 P (64%). Markedly positive: 129 P (8%). Doubtful: 451 P
(28%).
2-Perfusion: 1030 P (64%) evidenced normal SPECT. 581 P (36%)
evidenced abnormal SPECT, among which 275 P (17% /out of 1611)
showed low-intermediate ischemic risk, and 306 P (19%/out of 1611)
evidenced high-risk spect results (defined by the extension and mag-
nitude of ischemia on the analysis of 17 segments). As additional
datum in the ischemic high-risk group (306 P), anatomic information
of the coronary arteries was obtained in 208 of them (68%), resulting in
indication for revascularization in 172 P (83%).
Conclusion: The myocardial perfusion study is a very useful diag-
nostic tool for the detection of asymptomatic patients with multiple
high-risk factors initially considered to be of apparent low clinical risk,
discriminating sub groups with significant ischemic volume and worse
prognosis.
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Myocardial perfusion imaging in the evaluation of patients
with high risk for cardiovascular events but no cardiac
symptoms and atypical cardiac symptoms
P. Paola Smanio1; L. Machado1; J.V. Holtz1; J. Silva1;
C. Marques1; L. Ueda1; P. Cestari1; J.I. Franca1
1Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
Background: The incidence of coronary artery disease (CAD) in the
world is increasing, being also an important cause of mortality in South
America. Is there already robust evidence about the importance of
myocardial perfusion imaging (MPI) in the diagnostic evaluation of
symptomatic patients (p). However, the use of MPI in the assessment
of asymptomatic or with atypical symptoms p is not well defined.
Purposes: The primary objective was to evaluate the prevalence of
perfusion abnormalities in a high risk for CAD group of asymptomatic
or with atypical symptoms p, trying to identify clinical predictors of
risk in this group. The secondary objective was to determine the
association of ischemia on the MPI and presence of major cardiac
events in a follow up period of 12-24 months.
Methods: It was an observational and retrospective study including
503 p that performed stress MPI between 07/2010 and 06/2011. From
the total, 280 p (55.6%) male, 83.9% hypertensive, 72.4% dyslipide-
mia, 32.4% with diabetes, 49% had known CAD, 281 p (55.8%) were
asymptomatic, and 222 p (44.2%) had atypical symptoms. It was
considered atypical symptoms presence of atypical chest pain (112 p,
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22.2%) and dyspnea (110 p, 21.8%). The sestamibi-Tc-99m gated
SPECT was performed by standard technique. It was considered nor-
mal MPI if there was no perfusion defect after stress phase and
suggestive of ischemia if presence of reversible perfusion defect. It was
considered major cardiac events presence of nonfatal myocardial
infarction and cardiac death . Statistical analysis was performed using
Fisher’s exact test and logistic regression analysisbeing considered
significant P values B .05.
Results: MPI suggestive of ischemia was observed in 112 p (22.2%)
and there was no statistically significant difference between the group
of completely asymptomatic, with atypical chest pain and dyspnea
(P = .701). The clinical characteristics that were associated with the
presence of any perfusion defect on MPI were male gender (P = .007)
and the presence of known CAD (P \ .05). On logistic regression
analysis it were observed that presence of known CAD and abnormal
stress test were predictors of ischemia on MPI (P \ .05). In the
12-24 months follow up it was observed that presence of ischemia was
associated with higher rates of nonfatal MI (P = .009).
Conclusions: The obtained results may suggest high prevalence of
ischemia in the studied group. The presence of ischemia on MPI was
not statistically different in asymptomatic in comparison with atypical
symptoms p. Presence of ischemia on MPI was associated with non-
fatal MI after 12-24 months.
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Rest-dypiridamol 99mTcMIBI lower limb muscle perfusion
scintigraphy and myocardial perfusion scintigraphy in non
diabetic and diabetic patients (one-day protocol)
D. Pop Gjorceva1; M. Vavlukis2; V. Majstorov1; N. Ristevska1;
M. Zdraveska Kocovska1; I. Ahmeti3; S, Stojanoski1;
M, Zdravkovska1
1Institute of Pathophysiology and Nuclear Medicine, Skopje, Former
Yugoslav Republic; 2University Clinic of Cardiology, Medical Faculty,
Skopje, Macedonia, The Former Yugoslav Republic of; 3University
Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje,
Macedonia, Republic of the Former Yugoslav
Purpose of the Study: To establish one-day rest-Dypiridamol
99mTcMIBI protocol for lower limb muscle perfusion scintigraphy
(LLMPS), as part of myocardial perfusion scintigraphy (MPS) for
simultaneous evaluation of coronary and peripheral artery disease
(CAD/PAD), in nondiabetic (NDpts) and diabetic patients (Dpts), as
well as to evaluate diagnostic capabilities of various parameters of
LLMPS in assessment of PAD in estimated groups.
Patients and methods: 24 pts, 13 Dpts (54%) and 11 NDpts (56%)
were included in the study. No significant difference was found in
gender distribution, BMI and presence of risk factors for PAD and
CAD among the groups, except for presence of diabetes and age (Dpts
56 ± 6 vs NDpts 63 ± 10, P \ .05). At rest, LLMPS was performed as
‘‘dynamic phase of the calves’’ (0-7 minutes p.i.) followed with
acquisition of whole body scan (WBS-PA) and MPS at rest. At stress,
LLMPS (WBS-PA) was performed immediately after Dypiridamol/
99mTcMIBI application, followed by MPS.
Results: Dpts showed prolonged parameter of early arterial phase at
rest (Tmax 92/93 ± 19/19 vs 110/114 ± 24/24 seconds in NDpts,
P \ .05) and lower percentage of 1st minute-accumulation of
99mTcMIBI in the two calves (84% vs 88% in NDpts, n.s.). 3/11
NDpts (27%) and 7/13 Dpts (54%) showed pathological values of
index of asymmetry (left/right thigh and left/right calf, at rest and
stress). Perfusion reserve (PR) of thighs (LT, RT) and calves (LC, RC)
calculated as ‘‘(ROI Stress - ROI Rest) 9 100%/ROI Rest’’, non-
corrected and corrected for rest-stress doses of 99mTcMIBI and
background activity at stress-WBS were significantly lower in Dpts
compared with NDpts: LT-143 ± 35% or 23 ± 23% (Dpts) vs
183 ± 40% or 46 ± 27% (NDpts), P \ 0.01/P \ 0.05; RT-142 ± 29%
or 21 ± 17% (Dpts) vs 177 ± 35% or 42 ± 23% (NDpts), P \ 0.01/
P \ 0.05; LC-140 ± 23% or 20 ± 12% (Dpts) vs 173 ± 37% or
39 ± 22% (NDpts), P \ 0.01/P \ 0.01; RC-140 ± 23% or 23 ± 17%
(Dpts) vs 173 ± 26% or 40 ± 22 (NDpts), P \ 0.001/\ 0.05). Identi-
cally, significantly lower perfusion reserve in Dpts was obtained
comparing the D values of stress-rest ratio of: LT/L-knee, RT/R-knee,
LC/L-ankle and RC/R-ankle. PR estimated as percentage of counts
over ROI of thighs and calves at rest and stress as a part of whole body
counts, although lower in Dpts did not show significant difference
among the groups.
Conclusion: LLMPS performed simultaneously with Dypiridamol
99mTcMIBI MPS seems to be useful procedure in assessing PAD
along with CAD. Preliminary data of our study (small number of pts)
suggest the respectable role of LLMPS in estimation of tissue perfusion
by measuring the PR in lower limb muscles in patients with risk factor
for PAD, especially Dpts.
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Prognostic value of stress myocardial perfusion imaging in
female patients with low to intermediate risk for coronary
artery disease
A. Andrea Peter1; S. Lucic1; R. Jung2; M. Lucic1; S. Tadic2;
S. Stojsic2; M. Stefanovic2; J. Stojiljkovic2; J. Kmezic Grujin2
1Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia;
2Institute of Cardiovascular Diseases of Vojvodina, Sremska
Kamenica, Serbia
Introduction: Stress myocardial perfusion imaging (MPI) is one of the
major diagnostic tools in the evaluation of the presence and severity of
myocardial ischemia in patients with suspected coronary artery disease
(CAD).
Aim of the Study: To determine the impact of stress MPI in the
detection of perfusion abnormalities, their severity and to determine
the prognostic value of this diagnostic modality.
Material and Methods: In the period from June 2007 to October
2012. a total number of 222 female patients with suspected CAD and
had a low to intermediate pre test likelihood underwent a two-day
protocol, dipyridamole stress/rest Tc-99m-MIBI myocardial perfusion
imaging (MPI). After that they were followed up for the occurrence of
cardiac death or myocardial infarction over a mean follow up period of
44.77 ± 16.11 months.
Results: Average age in the group of examined women was
61.93 ± 8.83 years. Risk factors for coronary artery disease were
present in all of them and 203 women (91.44%) had arterial hyper-
tension, 20 had diabetes (9.01%), 130 had hyperlipoproteinemia
(58.56%), 54 were obese (24.32%), 10 were smokers (4.50%) and 11
had very positive family history for coronary artery disease (4.95%). In
the group of women normal MPI had 85.14%, ischemia was found in
6.31%, discrete ischemia that was considered as nonsignificant had
6.75%, borderline perfusion defects had 1.80% and perfusion defects
considered as normal for LBBB perfusion pattern had 3.60%. Average
period of follow up was 44.77 ± 16.11, with a minimum of 12 and a
maximum period of 64 months.
The values of SDS B3 were considered normal, in the group with
ischemia the values of SDS were C7, in the group with discrete per-
fusion defects it was between 3 and 5, in the group with borderline
perfusion defects between 5 and 7 and in the group with LBBB it was
between 3 and 5. The results of stress MPI and consequent follow up
showed us that the majority of the women are at low risk of nonfatal
myocardial infarction and for cardiac death.
Conclusion: Stress MPI identifies successfully patients with hemo-
dynamically significant ischemia and gives important prognostic
information toward the identification of female patients under risk for
major fatal cardiovascular incidents.
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Early detection of atherosclerosis in asymptomatic patients
with type 1 diabetes (concordance between SPECT, calcium
score and carotid ecography)
M. Mila Lopez1; E. Aguilera2; S. Serrano3; V. Vallejos Arroyo1;
J. Reverter2; N. Alonso2; E. Bernal3; S. Pellitero2; B. Soldevila2;
M. Fraile1
1Germans Trias i Pujol University Hospital, Nuclear Medicine
Department, Badalona, Spain; 2Germans Trias i Pujol University
Hospital, Endocrinology Department, Badalona, Spain; 3Germans
Trias i Pujol University Hospital, Department of Cardiology-IGTP,
Badalona, Spain
Type 1 diabetes mellitus (T1D) is associated with an increase risk of
cardiovascular disease compared to the non-diabetic population,
although there is not enough data on the prevention and screening on
these patients.
Aim of Study: To evaluate the presence of early atherosclerosis in
asymptomatic T1D patients with an evolution of more than 10 years
and without history of ischemic or macrovascular heart disease,
compared with non diabetic age and sex matched controls.
Patients and Methods: 150 T1D patients consecutively recruited from
our outpatient clinic were studied (58% males; age: 38.6 ± 8.1 years,
T1D lasting: 20.4 ± 8.1 years, BMI: 25.1 ± 3.6 kg/m2, HbA1c:
83 ± 2.3%, total cholesterol: 182.7 ± 25.1 mg/dL, 52% non-smokers,
26% retinopathy, 9% microalbuminuria) along with 55 non-diabetic
controls age and sex matched were studied. Carotid US scan was
performed to determine the mean cIMT (common carotid, bifurcation
and right and left internal) and the presence of atheroma plaques. ECG-
gated Multidetector CT scans were done for calcium analysis and
quantification. In T1D patients a two days stress-rest myocardial per-
fusion SPECT protocol was performed.
Results: In T1D patients mean cIMT value was significantly greater
than in control subjects (0.56 ± 0.14 vs 0.48 ± 0.14 mm, P = .004).
Patients with atheroma plaques (16/150) presented significantly higher
HbA1c (8.6% ± 0.6% vs 8.3% ± 2.4%), and a greater mean cIMT
values (0.74 ± 0.14 vs 0.52 ± 0.12 mm) than patients without plaques.
Patients with a Calcium Score [0 (27/150) were significantly older,
had higher HbA1c levels (8.5% ± 0.8% vs 8.2% ± 2.5%), longer
evolution of the disease (24.7 ± 5.8 vs 19.5 ± 7.6 years) and a greater
mean cIMT (0.68 ± 0.18 vs 0.52 ± 0.11 mm) than patients with score
0. In the control group, the rate of subjects with plaques (4/50:8%) and
score[0 (4/50:8%) was lower than in T1D patients. 126 patients out of
150 were evaluated with myocardial perfusion SPECT. 16/126 T1D
patients showed an abnormal SPECT (8 patients presented a typical
pattern of ischaemia and 8 a depression of systolic function suggesting
diffuse myocardial ischaemia). However, there was a low concordance
between calcium score, carotid US and SPECT (only 2 patients with
abnormal SPECT presented plaques and an score [0).
Conclusion: A small percentage of our T1D patients with more than
10 years of disease evolution presented data suggestive of atheroscle-
rosis. However, such data did not correlate with myocardial perfusion
SPECT, suggesting that SPECT can predict the appearance of ischaemic
heart disease in T1D patients without macrovascular disease. Indeed, this
might indicate the presence of microvascular pathology.
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Cardiovascular disease in women: Myocardial perfusion
SPECT in the prognostic assessment of diabetic women
V. Pubul1; M. Miguel Garrido1; M. Pombo1; S. Argibay1;
S. Nieves1; E. Pereira1; A. Martinez1; J. Cortes1;
R. Gonzalez-Juanatey1; A. Ruibal1;
1Hospital Clı´nico Universitario de Santiago de Compostela, Santiago
de Compostela, Spain
Purpose: The aim of this study is to determine the value of SPECT as
ischemia detection test performed for diagnostic purposes in diabetic
women (DM), and to evaluate whether there are differences in car-
diovascular risk profile and the prediction of adverse events compared
with nondiabetic women (NDM).
Methods: Of 1028 women attending our unit to perform a myocardial
perfusion SPECT for diagnostic purposes, we selected 196 consecutive
diabetic women. All patients underwent a two days protocol test,
performing gated acquisition at rest or effort when the images were
considered normal. Ejection fraction, diastolic and systolic volumes
indexed for body surface area were calculated. Cardiovascular risk
factors recorded were: age, smoking, diabetes, hypertension, hyper-
cholesterolemia, peripheral arterial disease and body mass index.
Positive SPECT criteria included the visualization of both reversible
and non-reversible significant perfusion defects. In the posterior fol-
low-up, we considered as events the presence of acute coronary
syndrome, revascularization surgery, development of cardiac insuffi-
ciency or cardiac death in the twelve months after the SPECT. The
average time of follow-up was 2.5 ± 2 years.
Results: Diabetic women had a higher proportion of all risk factors
studied, (hypertension 82% DM vs 62% NDM; hypercholesterolemia
72% DM vs 57% NDM; peripheral arterial disease 3% vs 0.3% body
mass index 31 vs 28 P \ .001), except smoking.
There was no significant differences in SPECT results between diabetic
and non diabetic women. Significant differences were found in EF
calculated by gated, being lower in diabetic patients (63.9 ± 13 vs
66.4 ± 10.3 P 0.007).
Diabetic women presented a higher proportion of adverse events on the
follow up (13% vs 8%, P \ 0.03). On the other hand, a positive result
on SPECT was associated with a greater number of adverse events in
both diabetic and in nondiabetic (Events in positive SPECT 34% DM
and 29% NDM vs Events in negative SPECT 8% DM and 5% NDM,
P 0.0001).
Conclusions: We observed a higher proportion of positive SPECT in
diabetic women, although the presence of diabetes itself is not sig-
nificantly related to the results of SPECT. Diabetic women had a
higher proportion of adverse coronary events during follow-up, pos-
sibly related to the presence of higher atherogenic risk profile
associated with diabetes, as well as lower values of left ventricular
ejection fraction. The positivity of SPECT in these patients remains
useful to discriminate risk subgroups.
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Relationship between patients risk profile, myocardial and
leg muscle perfusion obtained by rest-dypiridamol 99mTc
MIBI scintigraphy
M. Vavlukis1; D. Pop Gjorcheva2; V. Majstorov2; N. Kostova1;
M. Zdraveska Kocovska2; S. Stojanoski2; M. Zdravkovska2;
I. Pejovska1; N. Nevena Ristevska2
1University Clinic of Cardiology, Medical Faculty, Skopje, Macedonia,
Former Yugoslav Republic; 2Institute of Pathophysiology and Nuclear
Medicine, Skopje, Former Yugoslav Republic
Aim of the Study: To evaluate relationship between cardiovascular
risk profile, leg muscle perfusion and myocardial perfusion in car-
diovascular high risk patients.
Material and Methods: 24 pts with high cardiovascular risk profile
underwent one-day protocol of rest-dypiridamol 99mTcMIBI Leg
Muscle Perfusion (LMP) Scintigraphy and Myocardial Perfusion
Scintigraphy. Comparative analysis was performed as comparison
between diabetic and nondiabetic pts and their clinical, hemodynamic,
myocardial and leg muscle perfusion parameters as a response to
dipyridamol stress.
Results: Out of 24 pts included in the study, 17 (70.8%) were female
and 7 (29.2%) male. They were divided in diabetic and non diabetic
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group (D and ND). No significant differences in diabetes distribution
between genders (58.8% females and 42.8% males had diabetes;
P = ns) was found. Diabetic patients were significantly older 63.6 vs
56.1; P = .034. Except for presence of diabetes, two groups (D and
ND) were similarly burdened with risk factors (HTA, HLP, LVH,
obesity, cigarette smoking, except for PVD that was as expected,
more often present in D pts (OR 6.87, P = .030). Hemodynamic
response to dipyridamol revealed no significant difference in heart
rate response to dipiridamol, and significant decrease of systolic BP
(P = .033). Significant positive correlations were found for age and
presence of PVD (r = 0.442; P = .030 and r = 0.472, P = .020
respectively). As for the hemodynamic and symptom response to
dipyridamol, significant negative correlation was found for D group
and systolic BP (more pronounced drop in SBP), and more often were
asymptomatic (45.8% vs 33.3%, Fishers exact test P = .030, OR
6.875, Mantel-Haenszel P = .041). 4 (36%) ND and 7 (54%) D pts
showed pathological values of index of asymmetry (left/right thigh
and left/right calf, at rest and stress), OR 1.5, P = ns, as a parameter
of pathological leg muscle perfusion. 2 (8.3%) of ND and 4 (16.7%)
of D pts had pathological myocardial perfusion, with OR 2.0, P = ns.
50% of pts had normal myocardial and leg muscle perfusion, while
only 4 (16%) pts. had abnormal both myocardial and LMP. Patients
with pathological myocardial perfusion had OR 4.0, P = ns for
presence of impaired LMP. Using diabetes as cofounder, we found no
differences.
Conclusion: According to our data in high risk profile patients, myo-
cardial perfusion was not significantly different, but leg muscle
perfusion was significantly different in D vs ND pts. In diabetic
patients we can expect more significant drop in SBP, and absence of
dipyridamol induced symptoms, that can be due to increased vascular
stiffness and autonomic dysfunction.
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Myocardial perfusion scintigraphy in the diagnosis of
coronary artery disease in asymptomatic hemodialysis
patients
A. Sellem1; J. Souli1; W. Ajmi1; Y. Mahjoub1; H. Hammami1;
1Military Hospital of Tunis, University of Tunis Elmanar, Tunis,
Tunisia
Background: The hemodialysis population is characterized by a high
prevalence of ‘asymptomatic’ coronary artery disease (CAD), which
could be detected by nuclear cardiac imaging.
Aim: We investigated whether the absence of cardiac symptoms
may affect the diagnostic potential of gated myocardial perfusion
scintigraphy for detecting myocardial ischemia in hemodialysis
patients.
Methods: Ninety-four patients in hemodialysis for in average 3 years
(1 week-25 years) undergone stress-rest gated myocardial perfusion
scintigraphy. Depending on the presence or not of cardiac symptoms
we divided our patients into two groups. The first group (A) included
45 patients with cardiac symptoms, the second (B) included 49
asymptomatic patients.
Results: The mean age of our ninety-four patients (66 men, 28 women)
was 60 years (range, 24-82 years).
A gated myocardial perfusion scintigraphy revealed perfusion defects
in 31 patients (68.88%) from group A, and 32 (65.3%) from group B,
without statistically significant difference (P = .88).
Conclusions: Our results show that myocardial perfusion defects are
frequent even in non-symptomatic dialysis patients. This suggests that
ischemic heart disease could be more frequent than estimated by
clinical symptoms alone. Myocardial perfusion scintigraphy is a
useful non-invasive procedure in cardiological evaluation of dialysis
patients.
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Correlation between septal thickness and cardiac outcomes
among patients with chronic kidney disease with negative
myocardial SPECT studies
M. Mohamed Mandour Ali1; A.A. Sadek1; A.H. Allam1
1Al-Azhar University, Department of Cardiology, Cairo, Egypt
Background: Chronic kidney disease (CKD) is a well-known inde-
pendent predictor of cardiac events. We thought to investigate for the
correlation between increased septal thickness and cardiac outcomes
among patients with CKD.
Methods: LV dimensions were assessed by echocardiography in 188
patients with CKD and negative myocardial SPECT (to exclude sig-
nificant CAD). 66 (35.1%) had septal thickness[130 mm (group I), 81
(43.1%) were 110-130 mm (group II) and 41 (21.8%) were\0.05 and
17 (25.7%); 8 (9.8%) and 1 (2.4%) at 2 years in groups I, II and III
respectively (P values \ .005). Hard events (cardiac death, STEMI/
NSTEMI) were 4 (6.1%), 0% and 0% (P value \ .05) at one year; and
7 (10.6%), 3 (3.7%) and 1 (2.4%) at 2 years (P value \ .05). Thickness
cut-off value C130 mm correlated with significantly increased cardiac
event rate.
Conclusion: Increased septal thickness is an independent predictor of
soft and hard cardiac events at one and two years of follow up among
patients with CKD and negative SPECT scans.
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Estimated glomerular filtration rate as a predictor of
cardiovascular events in patients with renal dysfunction and
without coronary artery disease
T. Tatsuhiko Furuhashi1; M. Moroi2; M. Minakawa1; H. Masai1;
T. Kunimasa1; H. Fukuda1; K. Sugi1;
1Division of Cardiovascular Medicine, Toho University Ohashi
Medical Center, Tokyo, Japan; 2National Center for Global Health
and Medicine, Cardiology Division, Tokyo, Japan
Objectives: Patients with normal stress myocardial perfusion imaging
(MPI) have been generally warranted excellent prognosis for cardio-
vascular events which is less than 1%/year. Chronic kidney disease
(CKD) is an established risk factor for cardiovascular events and esti-
mated glomerular filtration rate (eGFR) varies widely among patients
with CKD. In CKD patients, eGFR is a poorly established predictor of
cardiovascular events. This study evaluates the prognostic value of
eGFR in CKD patients with no undergoing hemodialysis and with no
evidence of coronary artery disease (CAD) assessed by stress MPI.
Methods: Eighty-two CKD patients with no CAD (no previous CAD
and normal stress MPI which was summed stress score \4) and no
undergoing hemodialysis (49 males and mean age was 73 years) were
followed up for mean 22 months. CKD was characterized by an eGFR
of less than 60 mL/minute/1.73 m2 and/or persistent proteinuria. Car-
diovascular events included hard cardiovascular events (cardiac death,
non-fatal myocardial infarction and unstable angina) and congestive
heart failure requiring hospitalization.
Results: Total cardiovascular events were observed in 27 patients
(33%). Univariate Cox regression analysis identified diabetes, anemia,
eGFR and summed stress score of stress MPI as significant predictors
of cardiovascular events. Multivariate Cox regression analysis revealed
that only eGFR (hazard ratio = 0.97; P = .003) was an independent
significant risk factor for total cardiovascular events. Hard cardiovas-
cular events were observed in 7 patients (9%) and only eGFR could be
a significant predictor for hard cardiovascular events (hazard
ratio = 0.95; P = .035).
Conclusions: Even in CKD patients who have non-previous CAD and
normal stress MPI, we cannot warrant excellent cardiovascular prog-
nosis. Lower eGFR can be a powerful predictor of cardiovascular
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events. Nevertheless, CAD is undetected by stress MPI and clinical
history, patients with low eGFR require careful and continuous follow-
up to prevent cardiovascular events.
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Gender differences and prognostic value in the exercise
capacity and gated SPECT in patients with suspected
coronary artery disease (CAD)
V. Pubul1; M. Miguel Garrido1; S. Argibay1; M. Pombo1;
R. Agra1; S. Raposeiras1; C. Pena1; E. Abu1;
R. Gonzalez-Juanatey1; A. Ruibal1
1Hospital Clı´nico Universitario de Santiago de Compostela,
Santiago de Compostela, Spain
Purpose: The exercise EKG has a lower sensitivity and specificity for
detection of obstructive CAD in women compared with men. The
clinical limitations of the exercise-electrocardiography test included a
lower percentage of women reaching target heart rate than men and
higher false positive rate in women. Our objective was to examine
gender differences in the exercise capacity and prognostic value of
gated SPECT in patients with suspected CAD.
Methods: We selected 1959 consecutive patients, 931 men and 1028
women with suspicion of CAD, were submitted to the realization of a
myocardial perfusion SPECT for diagnostic purpose, with a two-day
stress/rest protocol study. We consider a positive result in the stress test
by obtaining a clinical response or/and a significant alteration of the
EKG. Positive SPECT criteria included the visualization of both
reversible and non-reversible significant perfusion defects. In the
posterior follow-up, we considered as events the presence of acute
coronary syndrome, revascularization surgery, development of cardiac
insufficiency or cardiac death in the twelve months after the SPECT.
The average time of follow-up was 2.5 ± 2 years.
Results: Patients obtained a high proportion of test that surpassed the
80% of the calculated target heart rate (CTHR), and there were no
differences between sexes (69%$ vs 68%#; P .5). The stress test
results showed no differences between women and men (22% vs 26%;
P .7). The SPECT, however, showed a higher percentage of positive
results in men than women (36% vs 14%; P \ .001). Positive/negative
results in the stress test were related to the number of events in the
follow-up (Registered events in 18% of patients with positive stress
test vs events in 9% patients with negative stress test; P \ .001). The
SPECT showed significant relation with the outcome in both sexes
(Events in 34% patients with SPECT+ vs 6% patients with SPECT-).
Conclusions: In our experience, there was no difference between
women and men achieving target objectives in the stress test. The
result of the stress test was related with events in both men and women.
The SPECT was more positive in men, and a positive result was
associated with more number of events.
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Value of myocardial perfusion imaging in the assessment of
ischemia in asymptomatic renal disease patients before
dialysis
P. Paola Smanio1; A. Cordeiro1; M.A. Oliveira1; L. Machado1;
J.I. Franca1; P. Cestari1; A. Thom1
1Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
Background: It is already known that cardiovascular disease (CVD) is
the leading cause of mortality in renal disease (RD) patients (p).
Studies suggest that early detection of ischemia followed by appro-
priate clinical management, improve survival. The diagnostic value of
myocardial perfusion imaging (MPI) in the evaluation of ischemia is
already known. Unfortunately, it is not yet established that RD patients
should perform an early systematic investigation of ischemia and
which group of RD p should be evaluated.
Purposes: To determine the value of myocardial perfusion imaging in
asymptomatic RD patients before start dialysis and also try to deter-
mine a clinical predictor of perfusion abnormalities.
Methods: We prospectively evaluated with dipyridamole MPI, 123
asymptomatic consecutive patients been followed in the renal failure
group in our institution between 08/2009 and 12/2011. None had
known CAD, 80 male with the mean age of 60.9 years, 97.2% were
hypertensive, 45% diabetic, 70% with dyslipidemia, 12.5% and 35.6%
of smokers and ex-smokers. The MPI was performed by the standard
dipyridamole gated SPECT technique. It was considered ischemia and
fibrosis if there were reversible and fixed decreased uptake of se-
stamibi-99mTc after pharmacological stress, respectively. The
statistical analysis was performed by Fisher’s exact test, with signifi-
cance level of P B .05.
Results: Perfusion abnormalities were found in 57 p (46%). Thirty-
four p (28%) had MPI suggestive of ischemia and 23 p (19%) had MPI
suggestive of fibrosis, respectively. The only CVD risk factor associ-
ated with ischemia was diabetes (P = 0.007). Gender (P = 0.142),
hypertension (P = 0.451), dyslipidemia (P = 0.093) and smoking
(P = 0.279) were not associated with ischemia.
Conclusion: Our results may suggest that dipyridamole MPI was very
important to identify perfusion abnormalities. It was found a high
prevalence of ischemia and fibrosis in patients with RD before dialysis
even without any cardiac symptom. Diabetes was the only CVD risk
factor associated with ischemia in the evaluated group.
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EANM/ECNC expert statement on reporting nuclear
cardiology
E. Tragardh1; B. Hesse2; L. Edenbrandt1; J. Knuuti3;
P.A. Kaufmann4; A. Flotats5
1Skane University Hospital, Clinical Physiology and Nuclear Medicine
Unit, Malmo, Sweden; 2Rigshospitalet—Copenhagen University
Hospital, Clinical Physiology, Nuclear Medicine & PET, Copenhagen,
Denmark; 3Turku PET Centre, University of Turku & Turku University
Hospital, Turku, Finland; 4University Hospital Zurich, Cardiac
Imaging, Zurich, Switzerland; 5Nuclear Medicine Department,
Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de
Barcelona, Barcelona, Spain
The report of an imaging procedure is a critical component of an
examination, since it is often the only communication from the inter-
preting physician to the referring physician. In addition the report may
become legal evidence. Few recommendations/guidelines are avail-
able, therefore a European expert statement on how to report nuclear
cardiology (myocardial perfusion, blood pool, viability, innervation,
and hybrid imaging) is currently in preparation and will be published in
spring 2013. Sections will cover demographics, study indications,
stress testing data and image acquisition, image interpretation, con-
clusion of the report, etc. An important limitation for guidelines on
reporting imaging studies is lack of evidence regarding different ways
of writing a report on clinical outcome. The current expert statement
combines existing evidence with expert consensus, previously pub-
lished recommendations as well as current clinical practices. It is
hoped this expert statement can improve the clinical value of nuclear
cardiology for physicians and patients, and eventually improve clinical
outcome.
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Comparative analysis of ischemia in the myocardial
perfusion scintigraphy in women before and after menopause
P. Paola Smanio1; D. Santos1; W. Sierraalta1; L. Machado1;
M. Oliveira1; P. Cestari1; J. Franca1
1Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
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Background: Despite of all efforts to reduce cardiovascular mortality
in recent decades, cardiovascular disease remains the leading cause of
death in females. It is already known that in postmenopausal women,
the traditional risk factors for coronary artery disease (CAD) are more
common than in men, however, is not yet fully established whether
there are differences in the prevalence of ischemia in pre and post-
menopausal women with multiple risk factors for CAD.
Purposes: To compare the prevalence of ischemia in myocardial
perfusion imaging (MPI) in pre and postmenopausal women, analyzing
also the menopause as an independent predictor of ischemia in women
with multiple risk factors for CAD.
Methods: We evaluated retrospectively 500 MPI with sestamibi-Tc-
99m of pre and postmenopausal women with high probability of CAD
due to presence of multiple risk factors. The MPI was performed by
standard technique and 1 day (rest/stress) protocol. It was considered
suggestive of ischemia if presence of reversible perfusion defect after
stress phase in at least 3 of 17 analyzed myocardial segments. We also
evaluated whether menopause or some other risk factors were inde-
pendent predictors of ischemia in MPS. Statistical analyses were
performed using Fisher exact test and multivariate analysis and it was
considered significant a P values B .05.
Results: Of the total, 55.9% were in the postmenopausal period, 83.3%
were hypertensive, 28.9% diabetic, 61.2% with dyslipidemia, 32.1%
were smokers, 25% obese and 34.3% had known CAD. It was observed
that postmenopausal women had more hypertension, diabetes, dysli-
pidemia, lower functional capacity at exercise stress test and a higher
prevalence of stress tests suggestive of ischemia (all P \ .05). The
same was not observed for the presence of ischemia on MPI (P = NS).
The only variable associated with ischemia on MPI was presence of
previous CAD (P = .001).
Conclusion: The obtained results may suggest that in the studied group
of women with high probability of CAD, menopause was not a pre-
dictor of ischemia in MPS. This information reinforces the idea that
investigation of CAD in high risk for CAD population should begin
already in premenopausal especially in patients with known CAD.
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Relation between atherosclerosis and left ventricular
hypertrophy and function in patients with chronic kidney
disease
M. Ghaleb1; Y. Baghdady1; E. Baligh1; D. Roshd2; H. Saleh1;
D. Osama1;
1Cairo University, Kasr Al-Ainy Hospital-Faculty of Medicine,
Department of Cardiology, Cairo, Egypt; 2Cairo University,
Kasr Al-Ainy Hospital-Faculty of Medicine, Department
of Nephrology, Cairo, Egypt
Background: Patients with chronic kidney disease (CKD) have an
increased risk of cardiovascular disease and mortality. Chronic kidney
disease is associated with a variety of cardiac alterations including left
ventricular hypertrophy, left ventricular dilation, and reduction in left
ventricular systolic and diastolic function. In this study, we aimed to
investigate the relation between atherosclerosis and left ventricular
hypertrophy (LVH) and left ventricular function in patients with CKD.
Methods: This is a prospective study involving 50 CKD patients
without overt cardiovascular disease (20 on hemodialysis and 30 not on
dialysis). The study was conducted in the period extending from May
2011 through February 2012 in Kasr El-Aini hospital (Cairo Univer-
sity). All patients underwent carotid and femoral ultrasonography and
echocardiography and biochemical analysis (creatinine, urea, albumin,
haemoglobin, fasting glucose and lipid profile).
Results: Atherosclerotic patients had higher left ventricular mass index
(LVMI) than non atherosclerotic patients (151.05 ± 38.68 vs
114.49 ± 42.23 g/m2, P = .001) and atherosclerotic patients had sig-
nificantly higher prevalence of LVH than non atherosclerotic patients
(91.3% vs 48.1%, P = .001). Atherosclerotic patients with CKD had
higher prevalence of left ventricular systolic and diastolic dysfunction
than non atherosclerotic patients with CKD but did not reach to sta-
tistically significant. LVH was detected in 68% of patients with CKD
(63.30% in non dialysis patients, 75% in hemodialysis patients). Left
ventricular systolic dysfunction was detected in 30% of patients with
CKD (30% in both hemodialysis and non dialysis patients). Left
ventricular diastolic dysfunction was detected in 66% of patients with
CKD (70% in non dialysis patients, 60% in hemodialysis patients).
Conclusions: Prevalence of atherosclerosis is more evident in CKD
patients with LVH. Left ventricular systolic and diastolic dysfunctions
are prevalent in patients with CKD especially in the presence of
atherosclerosis.
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Chronic kidney disease can be considered as a risk factor for
atherosclerosis
M. Ghaleb1; Y. Baghdady1; E. Baligh1; D. Roshd2; H. Saleh1;
D. Osama1
1Cairo University, Kasr Al-Ainy Hospital-Faculty of Medicine,
Department of Cardiology, Cairo, Egypt; 2Cairo University,
Kasr Al-Ainy Hospital-Faculty of Medicine, Department of
Nephrology, Cairo, Egypt, Cairo, Egypt
Background: Cardiovascular complications are the main cause of
death in patients with chronic kidney disease (CKD). As a marker of
atherosclerosis, increased carotid intima-media thickness (CIMT) has
been widely accepted as a strong predictor of cardiovascular disease
(CVD) and mortality in patients with CKD. In this study, we aimed to
investigate the prevalence of atherosclerosis in patients with CKD on
hemodialysis and not on dialysis.
Methods: This is a prospective, case-control study involving 50 CKD
patients without cardiovascular disease (20 on hemodialysis and 30 not
on dialysis) and 20 age and sex-matched healthy controls. The study
was conducted in the period extending from May 2011 through Feb-
ruary 2012 in Kasr El-Aini hospital (Cairo University). All patients and
controls underwent carotid ultrasonography and biochemical analysis
(creatinine, urea, albumin, haemoglobin, fasting glucose and lipid
profile).
Results: Prevalence of atherosclerosis was 46% in all patients with
CKD and there was no significant difference between patients on he-
modialysis and patients not on dialysis regarding the prevalence of
atherosclerosis (35% vs 53.3%, P = .203). Patients on hemodialysis
had significantly higher common carotid artery intima media thickness
(CCA IMT) than controls (0.68 ± 0.13 vs 0.5 ± 0.07; mean ± SD,
P = .001) and patients not on dialysis had significantly higher
CCAIMT than controls (0.79 ± 0.18 vs 0.5 ± 0.07; mean ± SD,
P \ .001). Patients not on dialysis had significantly higher CCA IMT
than patients on hemodialysis (0.79 ± 0.18 vs 0.68 ± 0.13;
mean ± SD, P = .024). We applied multivariate logistic regression
analysis to predict atherosclerosis, variables that we have made in this
analysis were: age, diabetes mellitus, duration of CKD, duration of
smoking and dyslipidemia. The most significant predictor was age.
Conclusions: Atherosclerosis is prevalent in patients with CKD before
and after starting hemodialysis treatment and chronic kidney disease
can be considered as a risk factor for atherosclerosis.
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Patterns of stress imaging testing after revascularization and
impact on repeat revascularization
A.N Anastasia N. Kitsiou1; S. Karas1
1Sismanoglio Hospital, Athens, Greece
Introduction: The use of stress imaging testing after revascularization
in patients without anginal symptoms is controversial. We examined
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the timing and the type of stress imaging testing after revascularization
in asymptomatic patients followed at the outpatient Cardiology Clinic.
All patients remained angina-free during the follow-up period.
Methods and Results: The patient population consisted of 72 patients
(mean age 63 ± 9 years, 53 males) who had undergone percutaneous
coronary intervention PCI (n = 55) or coronary artery bypass grafting
CABG (n = 17), 8 months to 4 years before the last stress imaging
test. The first stress imaging test after revascularization was single
photon emission tomography (SPECT) with either Thallium-201 or Tc-
99m tetrofosmin, for the majority of the patients (n = 63), whereas for
the rest of the patients (n = 9) it was dobutamine stress echocardi-
ography (DSE). Among all the patients, 34 (47%) had a total of 3 stress
imaging tests in the follow-up period, 28 (39%) had a total of 2 stress
imaging tests and 10 (14%) had one. The total number of SPECT
studies was 139 (83%) and the total number of DSE was 29 (17%)
during the follow-up period. In 28 (39%) of the patients, repeat stress
imaging testing led to repeat revascularization, based on the presence
of significant ischemia (more than 2 segments in the 17-segment
model, visual image analysis).
Conclusions: In this patient population, repeat stress imaging testing
was performed as a routine after revascularization, despite the fact that
it is considered inappropriate according to the current guidelines.
Repeat stress imaging testing demonstrated significant ischemia in a
substantial number of asymptomatic patients after revascularization.
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Exercise performance and myocardial perfusion SPECT in
patients with young myocardial infarction
\E. Emre Entok1; O. Akcay1; I. Ak Sivrikoz1; A. Birdane1
1Eskisehir Osmangazi University, Eskisehir, Turkey
Aim: There has been rise of coronary artery disease (CAD) with age
group of less than 40 years. It is unclear and in lately various studies
focused on various etiologic aspects of CAD, but could not determine
the significance of marker. We evaluated exercise capacity and other
exercise parameters in young patients with abnormal myocardial per-
fusion SPECT.
Methods: Sixty nine patients with scintigraphically abnormal coronary
arteries were evaluated in two groups according to the presence
(n = 26; 11 females, 15 males; mean age 36 ± 3 years) or absence
(n = 43; 19 females, 24 males; mean age 38 ± 5 years) of myocardial
infarction. All the patients underwent exercise treadmill testing with
the modified Bruce protocol, whereby the following variables were
determined: workload achieved in metabolic equivalents, total exercise
time, percentage of target heart rate achieved, double product, heart
rate recovery, chronotropic response and incompetence. The relation-
ships between exercise parameters and myocardial perfusion SPECT
and clinical variables were evaluated.
Results: Smoking was the most prevalent risk factor. Family history
and metabolic disease were seen in 32% patient. Ten patients had
presence of more than one risk factors. Excessive alcohol intake seen
in 65% patient. There was significant difference in lipid profile,
fibrinogen levels and CRP among the patients with myocardial
infraction. The maximum workload achieved was significantly lower
and the double product was significantly higher in patients with
myocardial infarction. Hypertensive and hyperglycemic subjects had
significantly lower maximum workload and exercise time.
Conclusion: Smoking and family history is associated with early
development of clinical atherosclerosis. In addition young patients
CRP increased significant with myocardial infarction. In patients with
abnormal myocardial perfusion SPECT and myocardial infarction is
associated with decreased exercise capacity. SPECT results define
adverse cardiac events.
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Myocardial perfusion scintigraphy in patients with
myocardial bridging over the left anterior descending artery
A. Teresinska1; J. Wnuk1; A. Dabrowski1; A. Mierzejewska1;
A. Czerwiec1
1Institute of Cardiology, Warsaw, Poland
Introduction: A myocardial bridge (MB) is a muscle atypically
overlying the intramyocardial segment of an epicardial coronary artery.
MBs are characterized by systolic compression of the tunneled seg-
ment and stay clinically silent in the majority of cases. Some MBs can
cause ischemia and associated symptoms—probably in a mechanism of
delayed diastolic relaxation.
Purpose: To investigate the incidence and the characteristics of myo-
cardial perfusion abnormalities in patients with chest pain, revealing
isolated MB over LAD (LAD-IMB) in coronary angiography (no sig-
nificant atherosclerotic changes in LAD or other main coronary artery).
Methods: 75 pts were selected retrospectively from the population of
patients after coronary angiography revealing LAD-IMB, without
previous infarction or PCI (49 males, 51 ± 12 years). The patients
were divided into 3 groups: I—27 pts with MB causing C70% con-
striction of LAD lumen, II—23 pts with\70% constriction, III—25 pts
with the constriction not defined. Perfusion of the LV was evaluated by
using Tc-99m-MIBI SPECT studies and 17-segment model with
5-grade score of MIBI uptake in each segment (0-normal, 4-no uptake).
Summed stress score (SSS), rest score (SRS) and difference score
(SDS) were used to measure perfusion deficits—globally in the LV and
in LAD territory.
Results:
1. Significant perfusion deficit (SSS C 4) was detected in 45 (60%)
pts, with at least moderate deficit (SSS C 9) in 25 (33%) pts.
2. Global perfusion deficit had ischemic character (av.SSS = 6.3 vs
av.SRS = 3.1, P = 0,00004). Also deficit in LAD territory was
ischemic (av.SSS = 3.3 vs av.SRS = 1.4, P = 0,000004).
3. There were no differences between groups I and II:
(a) in frequency of significant perfusion deficits in pts (20/
27 = 74% vs 13/23 = 57%).
(b) in average global values of SSS, SRS and SDS (6.8 vs 6.7, 2.5 vs
3.7, and 4.3 vs 2.9) as well as in average values of SSS, SRS and
SDS for LAD territory (3.5 vs 3.8, 1.1 vs 1.8, and 2.3 vs 2.0).
4. For 50 pts from groups I and II, no linear relationship between LAD
constriction by MB and global perfusion deficits SSS, SRS and SDS
was found (r = -0.01, -0.11 and 0.09); similarly, no relationship
between LAD constriction and SSS, SRS and SDS in LAD territory
was found (r = -0.11, -0.19 and -0.01).
Conclusion: Functional assessment of LAD-IMBs with myocardial per-
fusion scintigraphy is of high clinical importance, as independently of LAD
lumen constriction diagnosed in coronary angiography, significant ische-
mic perfusion defects are often (in our population in 60% of pts) and in
more than half of those cases stress perfusion defects are at least moderate.
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Peri-infarct ischemia assessed by cardiovascular magnetic
resonance imaging: Validation versus quantitative perfusion
single photon emission computed tomography imaging
E. Gerbaud1; H. Cochet2; E. Bullier\3; C. Ragot1; H. Douard1;
Y. Pucheu1; F. Laurent2; P. Coste1; L. Bordenave3;
M. Montaudon2
1CHU de Bordeaux—Service de Cardiologie, Pessac, France; 2CHU
de Bordeaux—Unite´ d’imagerie Thoracique et Cardiovasculaire,
Imaging cardiovascular disease mechanisms / Journal of Nuclear Cardiology Supplement (2013) 20 (Supplement 1) S64
Pessac, France; 3CHU de Bordeaux—De´partement de Me´decine Nu-
cle´aire, Pessac, France
Objectives: To evaluate stress adenosine cardiovascular magnetic
resonance (CMR) evaluation of peri-infarct ischemia using quantitative
perfusion single photon emission computed tomography (SPECT)
imaging as a reference.
Methods: Forty patients presenting with a peri-infarct ischemia on a
routine stress 99mTc-SPECT imaging were recruited. Within 8 days of
SPECT study, myocardial perfusion was evaluated using stress aden-
osine CMR and peri-infarct ischemia quantified by the percentage of
myocardium with stress-induced perfusion defect adjacent to and lar-
ger than the scar. This parameter was compared to both, the percent
myocardium of summed difference score (SD%) and ischemic total
perfusion deficit (ischemic TPD) assessed using SPECT. The
diagnostic performance of CMR to detect a significant coronary artery
stenosis (i.e. C75%) was determined.
Results: In addition to peri-infarct ischemia, reversible perfusion
abnormalities were detected in a remote zone in 7 patients on SPECT
imaging. In the 33 patients presenting only with peri-infarct ischemia
on SPECT imaging, the agreement between CMR peri-infarct ischemia
percentage and both, SD% and ischemic TPD was excellent
(ICC = 0.969 and ICC = 0.877, respectively). Using a cut-off value
of 8.1%, the area under the curve of peri-infarct ischemia to detect a
significant stenosis in the distribution of an infarct-related artery was
0.856 (95% CI: 0.680–0.939).
Conclusion: CMR imaging can be an alternative to SPECT for
detection and quantification of peri-infarct ischemia.
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Value of QRS width and left ventricle dyssynchrony of
myocardial perfusion imaging in predicting cardiac events
A. Alejandro Solodky1; T. Bental1; A. Gutstein1; I. Mats1;
D. Belzer1; Y. Hasid1; A. Battler1; N. Zafrir1
1Rabin Medical Center, Petah Tikva, Israel
Purpose: Recently, phase analysis software has been developed to
assess mechanical left ventricular (LV) dyssynchrony from myocardial
perfusion imaging (MPI). Prolonged QRS duration is a known index of
poor prognosis. Our aim is to examine the relation of LV dyssynchrony
detected by phase analysis and QRS width related with heart failure
(HF) hospitalization and cardiac mortality.
Methods: During 2010, in 405 consecutive patients who referred to Tc
sestamibi GSPECT MPI, we selected 143 with LVEF \ 50%. Phase
analysis software was applied. In the phase analysis, LV dyssynchrony
was measured by phase standard deviation (PSD). Patient’s charac-
teristics, risk factors of CAD, MPI, phase analysis results, LVEF and
QRS width were analyzed. The patients were followed-up for cardiac
events (HF hospitalizations and cardiac mortality) for 437 ± 75 days.
Results: Table.
Bivariate logistic regression analysis (QRS width and PSD) was used
because of the low number of events, and showed for QRS width
R = 1.013, CI 95% = 0.99-1.03 and P = .089 and for PSD
R = 1.033, CI 95% = 1.01-1.06 and P = 0 .012.
Conclusion: In addition to LVEF as a predictor of events, PSD of
phase analysis was identified to be an independent predictor for heart
failure hospitalization and cardiac mortality.
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Use of radionuclide ventriculography in the diagnosis of
cardiotoxicity in patients with breast cancer treated with
herceptin and its relationship with other clinical and hemo-
dynamic parameters
M. Garrido1; V. Pubul1; M. Pombo1; S. Argibay1; S. Nieves1;
J. Lopez-Urdaneta1; A. Bejarano1; J. Cortes1;
A. Sanchez-Salmon1; A. Ruibal1
1Hospital Clı´nico Universitario de Santiago de Compostela, Santiago
de Compostela, Spain
Objective: To assess the prevalence of cardiotoxicity measured by
radionuclide ventriculography in women with breast cancer treated
with Herceptin, and the possible relationship of the changes in LVEF
with the presence of cardiovascular risk factors or other hemodynamic
parameters (diastolic function and ventricular volumes).
Material: We selected 131 patients diagnosed with infiltrating ductal
breast carcinoma HER2 positive, with a test for estimating baseline
LVEF prior to the administration of Herceptin and at least one or more
test at least three months from the start of the treatment.
All patients had a baseline EF value greater than 50% and heart rate
values during acquisition between 50 and 100 bpm.
Hemodynamic parameters calculated by ventriculography included:
ejection fraction (LVEF), peak filling rate (PFR), time of diastole until
PFR (TPFR), end-systolic volume (ESV), end-diastolic volume (EDV).
It was considered a significant drop in LVEF to get a value of EF
below 50% during treatment or a fall of more than 10% compared to
baseline.
Results: 48 patients (36.6%) made significant drops in LVEF during
treatment.
In a study of lineal correlation between hemodynamic parameters and
the decrease of EF, it appears to establish a slight connection between
the initial values of EF (Pearson -0.1843, P .002), PFR (Pearson
-0.1396, P .044) and EDV (Pearson -0.196, P .016).
However, initial EF value was not associated with a significant
decrease in EF during treatment (initial FE significant decrease in
patients with 63.7 ± 7.7 vs 62.8 ± 5.7 in patients without significant
decrease; P .458). Diastolic function parameters did not show this
relationship (initial PFR: 3.1 ± 0.67 vs 2.9 ± 0.6, P .139—Initial
TPFR: 133.1 ± 28.9 vs 148.1 ± 76.5). In terms of volumes, only the
highest values of EDV showed relation with a significant decrease in
EF (110.3 ± 19.7 vs 100.4 ± 19.3, P .006).
Conclusions: Cardiotoxicity during treatment with Herceptin in the
treatment of breast cancer is a common adverse event—reaching in our
study a prevalence of 36%.
The diagnosis of cardiotoxicity conditioned a change in therapy and in
subsequent management of the patient.
The patient’s hemodynamic status at the beginning of the treatment
was weakly related to the presence or absence of cardiotoxicity, so we
considerextremely important the regular monitoring of LVEF during
treatment of patients with breast cancer.
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Comparison of parametric modeling of gated SPECT in
normals and patients with LBBB using gaussian and first
harmonic Fourier fitting
C.L. Christopher L Hansen1; K.B. Reist1
1Thomas Jefferson University, Philadelphia, United States of America
Purpose: Parametric modeling of gated SPECT using the first har-
monic of the Fourier transform (cosine) has been proposed as a way to
identify patients most likely to benefit from biventricular pacing. We
have previously shown that parametric modeling of the LV using a
Gaussian fit is more accurate than cosine fit in both radionuclide
ventriculography and in gated SPECT. The purpose of the present
study was to compare the accuracy of fit and differences in parameters
patients with low probability of coronary disease (nls) and patients
with left bundle branch block (LBBB) and normal ejection fraction
(EF).
Methods: We retrospectively identified 55 nls and 51 patients (pts)
with LBBB without gating artifact. Sequential radial plots were fitted
to both a Gaussian and cosine functions using a modification of the
Levenberg-Marquardt algorithm. Output of the Gaussian function was
amplitude, mean and standard deviation (SD); output of the cosine
.
Events
N 5 20
No events
N 5 123 P value
Age (years) 71 ± 12 66.3 ± 12 .1
Diabetes Mellitus 12 (60%) 43 (35%) .059
Infarct Size (1–5) 3.2 ± 2 2.25 ± 1.7 .04
QRS Width 129.8 ± 40 105.52 ± 31 .01
LVEF 26.15 ± 10 38.29 ± 10 .0001
PSD 57.18 ± 24 39.59 ± 20 .002
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function was amplitude and phase. The mean and SD of a volume-
weighted bullseye for each parameter were calculated. Accuracy of
each fit was measured by calculating the root mean square (RMS) of
the difference between the fit and the measured curves.
Results: The RMS error of the Gaussian fit was significantly lower in
both nls (10.3 ± 1.3% vs 11.3 ± 1.6%, P \ .001) and LBBB
(8.4 ± 0.9% vs 9.3 ± 1%, P \ .001). There was very high correlation
between the amplitude of the Gaussian and Cosine fits (r = 0.968,
P \ .001). As we found previously, there was very strong correlation
be the cosine phase and Gaussian mean (r = 0.945 nls, r = 0.914
LBBB, both P \ .001) and the SDs of the mean and phase (r = 0.876
nls, 0.853 LBBB, both P \ .001). The mean of the Gaussian SD,
another measure of variability, correlated with both the SDs of the
Gaussian mean (r = 0.666 nls, 0.737 LBBB, both P \ .001) and phase
(r = 0.853 nls, 0.876 LBBB, both P \ .001). Both Gaussian and
cosine showed differences between nls and LBBB by significant dif-
ferences in SDs of the Gaussian mean (0.53 ± 0.22 nls vs 0.68 ± 0.22
LBBB, P = .001) and SD of phase (0.89 ± 0.45 nls vs 1.14 ± 0.44
LBBB, P = .004). There was a trend towards a difference in the mean
of the Gaussian SD (1.37 ± 0.23 nls, 1.44 ± 0.18 LBBB, P = .10).
Conclusions: Gaussian provides a more accurate parametric fit to
gated SPECT images than does cosine. The SD of the mean of the
Gaussian is at least as powerful as cosine fit in identifying phase dif-
ferences in nls and pts with LBBB. The Gaussian SD, another measure
of variability, may prove additionally useful in identifying pts likely to
benefit from biventricular pacing.
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Prognostic value of the left ventricular dyssynchrony
determined by gated SPECT in patients with nonischemic
dilated cardiomyopathy
S. Salvador Hernandez Sandoval1; E. Alexanderson Rosas1;
H.J. Hernandez Perales1; M. Jimenez Santos1;
C.A. Guizar Sanchez1
1Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City,
Mexico
Objective: To correlate the left ventricular dyssynchrony, determined
by gated SPECT, with the morbidity and mortality in a 5-year period in
patients that have been diagnosed with nonischemic dilated
cardiomyopathy.
Methods: This is a retrospective and transversal study. It includes
patients with dilated cardiomyopathy that were treated between 2006
and 2008. They all received a gated SPECT study without evidence of
coronary disease. Also, they all had an ejection fraction of less than
40% and they were all monitored for 5 years. From the gated SPECT
analysis we obtained the indexes of left ventricular synchrony: stan-
dard deviation and bandwidth. We registered the end-diastolic and end-
systolic volumes and the ejection fraction. We divided the patients into
two groups according to the cutting points of 44 for standard deviation
and 135 for bandwidth. It’s been demonstrated that these values
indicate significant asynchrony and predict a response to the cardiac
resynchronization therapy. The gated SPECT analysis was performed
using the Emory Cardiac Toolbox software. We evaluated the mor-
tality from cardiovascular causes and the existence of at least 1
hospitalization due to decompensated heart failure during a period of
5 years.
Results: We included 32 patients, of which 20 were male and 13 were
female. The median of the ejection fraction was 27.5 ± 9%. The
median for the end-diastolic volume was 237 ± 69 mL, and the median
for the end-systolic volume was 174 ± 64 mL. The mortality was
34.3% during the 5-year period. We found correlation between the
asynchrony defined by the bandwidth (bigger than 135) and the
mortality, with a relative risk of 3.43, P = 0.027; as well as correlation
with the hospitalization, with a relative risk of 3.86, P = .050. We
didn’t find correlation between the standard deviation and the mortality
(P = .266) nor with the ejection fraction (correlation coefficient was -
0.659 with P = .000). There was also no correlation between mortality
and the end-diastolic volume (0.447 with P = .010) nor with the end-
systolic volume (0.601 with P = .000). The bandwidth was correlated
with the ejection fraction (-0.716 with P = .000), the end-diastolic
volume (0.442 with P = .011) and the end-systolic volume (0.609 with
P = .000).
Conclusions: The parameters of the left ventricular dyssynchrony are
obtained with the conventional gated SPECT study and can provide
prognostic information in addition of the other variables that have been
already studied, such as ventricular volumes and ejection fraction.
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Poststress LVEF changes in patients with normal perfusion
and function on gated MPI SPECT
A. Amelia Jimenez-Heffernan1; A. Ortega-Carpio2;
E. Sanchez De Mora1; J. Lopez-Martin1; C. Salgado1;
C. Ramos1; C. Sanchez-Gonzalez3; R. Lopez-Aguilar3
1Hospital Juan Ramo´n Jime´nez, Department of Diagnostic Imaging,
Huelva, Spain; 2Centro de Salud El Torrejon, Huelva, Spain; 3Hospital
Juan Ramon Jimenez, Department of Cardiology, Huelva, Spain
Purpose: Users of standard Anger camera technology for gated MPI
SPECT can achieve the ASNC’ goal of reducing total radiation
exposure to B9 mSv in 50% of studies by 2014 by means of fast
reconstruction algorithms coupled with dose reduction; and/or partic-
ularly with stress-only imaging in appropriately selected patients.
Poststress LVEF (PSEF) reduction has been associated with ischemia
and has shown prognostic value. We aim to evaluate the changes
between poststress and resting LVEF (RTEF) in patients with no sig-
nificant perfusion defects and PSEF C 50%, changes that would not be
observed with stress-only imaging.
Methods: A 7-year database of 2069 consecutive patients undergoing
2-day stress-rest 99mTc MPI was screened for studies with normal/
near normal perfusion (SSN B 4), PSEF C 50% and at least one year
of follow-up, retrieving 829 patients. In 148 cases follow-up was not
possible, so the study group comprised 681 patients (56.4 % female,
age: 64.5 ± 10.7 years, weight: 78 ± 14.7 kg). Mean poststress
acquisition time was 88 ± 33 minutes (r: 30-210). LVEF was calcu-
lated from well validated commercial software.
Patients were divided into three groups according to whether PSEF in
relation to RTEF was C5% higher (group A), between 4% and -4%
(group B) or C5% lower (B-5%) (group C). Groups A, B and C
comprised 158, 365 and 158 patients respectively. Follow-up was
obtained by revision of electronic medical records. Mean follow-up
was 3.5 years. Percutaneous or surgical revascularization, non-fatal
myocardial infarction and cardiac death made up the primary end-
point.
Results: The end-point was met by 9 (5.6%), 36 (9.9%) and 19 (12%)
patients from groups A, B and C respectively. Chi-square test showed
no significant differences between groups although a lineal association
was suggested (P = .054) with a growing event rate as PSEF goes
from increasing to decreasing in relation to RTEF. Kaplan Meier
survival analysis showed no significant differences in the event rate
between the three groups. Mean HR at poststress acquisition was
68.9 ± 13.9 bpm, significantly higher than at rest: 66.6 ± 12.2 bpm
but we don0t expect this to have an influence on our final results.
Conclusion: In patients with normal perfusion failure to increase or an
actual decrease in PSEF in relation to RTEF is not significantly
associated with a higher event rate, so stress-only imaging should be
safe enough. Nevertheless, if performing stress-rest studies a PSEF
reduction C5% should be carefully interpreted as 12% of such patients
in our study had cardiac events during follow-up.
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Prognostic value of gated-SPECT left ventricular shape
index in post-MI patients
E. Alexanderson Rosas1; C. Sierra-Fernandez1;
E.A. Penarrieta-Daher1; L.E. Juarez-Orozco1;
L.V. Torres-Araujo1; A. Jordan-Rios1; S. Hernandez-Sandoval1;
C.A. Guizar-Sanchez1; A. Meave1; M. Jimenez-Santos1
1Instituto Nacional de Cardiologı´a ‘‘Ignacio Cha´vez’’, Mexico City,
Mexico
Ischemic heart disease is one of the major causes of mortality and
morbidity worldwide. The objective of this study is to determine the
prognostic value of Telesystolic Left Ventricular Shape Index (TS
LVSI) in post-MI patients.
Methods: In this historic cohort study 51 post-MI patients (46 males
and 5 females, mean of age 62 years old) with 5-year follow up were
included. One-day rest-stress gated SPECT sestamibi protocol was
performed in all patients 6 to 12 months post-MI. CSI Cedar-Sinai
software was used to calculate all the gating and perfusion parameters
as well as TS LVSI. SPSS Mac v.20 was used for statistical analysis.
Results: The prognostic analysis demonstrated a global mortality of
7.8% when TS LVSI was C0.54, while there were no mortality cases at
a TS LVSI B 0.53 (P \ .01). Assessing NYHA Class deterioration,
21.6% of TS LVSI C 0.54 patients had a decrease in functional class
when compared with 3.9% of those who had a TS LVSI B 0.53
(P \ .001). Overall, we found a mortality RR of 19 (CI 95% 1.8-33.4
P = .04) and a NYHA Class deterioration RR of 12.03 (CI 95% 3.0-
48.09 P \ .01) for a TS LVSI C 0.54. Table 1 compares TS LVSI
with LVEF, SRS, SSS and SDS.
Conclusion: TS LVSI is a good prognostic parameter and allows better
determination of patients with risk of cardiac death or NYHA class
deterioration than LVEF, degree of ischemia and MI extension, when
taking 0.54 as a cutoff value. These risks increase proportionally with
this index, reaching a mortality of 100% when C0.70.
265
Diastolic function and ventricular synchrony in low
cardiovascular risk population: An assessment with
13N-Ammonia PET/CT scanning
E. Erick Alexanderson Rosas1; L.E. Juarez-Orozco2;
R.H.J.A. Slart3; E.A. Penarrieta-Daher1; L.V. Torres-Araujo1;
R.A. Tio3; A. Meave1; R.A. Dierckx3
1Instituto Nacional de Cardiologı´a ‘‘Ignacio Cha´vez’’, Mexico City,
Mexico; 2Unidad PET/CT Ciclotro´n UNAM, Mexico City, Mexico;
3University of Groningen, University Medical Center Groningen,
Groningen, Netherlands
Introduction: Cardiovascular PET/CT scanning has developed,
beyond doubt as an important adjuvant for diagnostic, prognostic and
therapeutic evaluation in cardiac disease. Nevertheless, little is known
about the significance and potential utility of the diastolic function and
phase synchrony parameters obtained by PET/CT reconstruction
algorithms due to lack of normal and low risk population studies.
Methods: We performed and analyzed eighteen 13N-Ammonia
2-phase perfusion PET/CT scans with a ‘‘list mode’’ acquisition for
static, dynamic and gated images in low cardiovascular risk patients
according to the cardiovascular risk Framingham score. Furthermore
we obtained the determination of peak filling rate (PFR) and time to
peak filling (TTPF) for diastolic function evaluation; histogram
bandwidth (HB), standard deviation (SD) and entropy (E) were
obtained for phase synchrony assessment. Resting shape index (SI) and
left ventricle ejection fraction (LVEF) was included from the gated
acquisition.
Results: We included 6 male and 12 female patients with a mean age
of 56 ± 10 years. Findings are depicted in Table 1.
Conclusions: PET/CT perfusion scans provide quantitative assessment
of diastolic function and ventricle synchrony. We found that diastolic
function parameters are close to the ones reported in SPECT scanning
but not the synchrony ones, this could be related to the automatic
border delimitation in the basal portion of the heart. Further research
for normal measurements is needed.
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Left ventricle ejection fraction: Correlation with infarct size
and myocardial perfusion reserve post-MI
R.H.J.A. Slart1; L.E. Juarez-Orozco2; E. Erick Alexanderson
Rosas3; R.A. Tio1; R.A. Dierckx1; E.A. Penarrieta-Daher3;
J. Glauche1; L.V. Torres-Araujo1
1University of Groningen, University Medical Center Groningen,
Groningen, Netherlands; 2Unidad PET/CT Ciclotro´n UNAM, Mexico
City, Mexico; 3Instituto Nacional de Cardiologı´a ‘‘Ignacio Cha´vez’’,
Mexico City, Mexico
Introduction: Left ventricular function after myocardial infarction is
considered to be determined by the size of the infarction and residual
function of the spared myocardium. Myocardial perfusion reserve
assessed by 13N-ammonia PET has been shown to be a strong pre-
dictor in patients with ischemic heart failure. Unknown is the value of
MPR in the spared myocardium in relation with infarct size and LVEF.
In the present study, the interrelationship between MPR, LVEF and
infarct size was acquainted.
Methods: In this study, 102 patients with a prior history of myocardial
infarction were included. All underwent rest—dypiridamole stress
13N-ammonia and gated FDG PET for evaluation of myocardial per-
fusion reserve and viability. FDG polar maps were used to determine
the size of the infarction. The LVEF was obtained by gated FDG PET
or another available method within 3 months of the PET scan. The
segmental MPR was obtained by dividing stress and rest myocardial
perfusion in the spared myocardium.
Results: Mean age of the subjects was 69 ± 12 years (men 78%),
global MPR was 1.65 ± 0.51. Mean LVEF was 36 ± 9.8%, mean
infarct size 23.6 ± 14.6%. Fifty patients had dyslipidemia, 41 hyper-
tension, 13 diabetes, 45 were smokers, and 35 a positive family history
Table 1. G-SPECT parameters comparison
G-SPECT
parameter
Deceased
patients
Surviving
patients P NYHA I
NYHA
deterioration P
TS LVSI
0.68 ± 0.06 0.48 ± 0.08 \.01 0.47 ± 0.08 0.60 ± 0.07 \.01
LVEF
40.5 ± 16.5 54.5 ± 13.5 .05 57.4 ± 11.9 41.8 ± 13.8 \.01
SRS
17.2 ± 6.5 13.1 ± 8.2 .33 12.1 ± 7.9 17.2 ± 7.9 .06
SSS
19.7 ± 6.2 16.9 ± 9 .54 15.6 ± 8.6 21.4 ± 8.2 .04
SDS
2.5 ± 2 3.9 ± 2.4 .41 3.7 ± 3 4.2 ± 4.0 .61
G-SPECT, Gated-single photon emission computed tomography; TS LVSI, telesystolic left ventricular shape
index; SRS, summed rest score; SSS, summed stress score; SDS, summed difference score.
Table 1. Descriptive statistics (n = 18)
Descriptive statistics (mean ± standard deviation)
n 5 18
Phase
Gated Synchrony Diastolic function
LVEF SI HB SD E PFR TTPF
Stress
69 ± 7.9 0.58 ± 0.1 133.6 ± 68.9 42.3 ± 13.9 39.1 ± 7.4 2.55 ± 0.3 194 ± 38
Rest
66.3 ± 7.6 0.55 ± 0.1 147.6 ± 56.3 44 ± 14.4 22.7 ± 23.5 2.49 ± 0.4 176.5 ± 36.5
LVEF, Left ventricular ejection fraction; SI, shape index; HB, histogram bandwidth; SD, standard deviation; E,
entropy; PFR, peak filling rate; TTPF, time to peak filling.
Left ventricular function and new insights / Journal of Nuclear Cardiology Supplement (2013) 20 (Supplement 1) S68
for cardiovascular disease. Linear regression model was applied for the
analysis considering the LVEF as an independent variable. All risk
factors, infarct size and MPR were entered as variable. The infarct size
(P \ .001) and MPR (P = .008) reached statistical significance. Of all
risk factors only diabetes mellitus (P = .030) showed a significant
correlation with LVEF.
Conclusions: In patients with a prior history of myocardial infarction,
LVEF is not just related to infarct size but also to MPR in the spared
myocardium.
S69 Left ventricular function and new insights / Journal of Nuclear Cardiology Supplement (2013) 20 (Supplement 1)
Poster Session 4
Left ventricular function and new insights
Tuesday 7 May, 2013, 14:00–18:00 Poster Area
268
Improving diagnostic yield of exercise ECG for obstructive
coronary artery disease: Integration with clinical and
bio-humoral markers
C. Caselli1; V. Lorenzoni1; G. Todiere2; M. Marinelli1;
M. Pietila3; D. Giannessi1; J. Knuuti3; D. Neglia2; D. Rovai1
1Institute of Clinical Physiology of CNR, Pisa, Italy;
2Gabriele Monasterio Foundation-CNR Region Toscana, Pisa, Italy;
3Turku University Hospital, Turku, Finland
Purpose: Exercise ECG is used in patients with suspected coronary
artery disease (CAD) to select candidates for stress imaging testing or
coronary angiography. The diagnostic accuracy of exercise ECG can
be improved by integrating clinical variables into predictive models of
CAD. We hypothesized that the diagnostic accuracy could be
improved by including bio-humoral markers in predictive models
based on clinical data and exercise ECG.
Materials and Methods: A cohort of 428 patients with angina-like
chest pain or equivalent symptoms, enrolled in the EVINCI study,
underwent clinical examination, exercise ECG test, bio-humoral
characterization and coronary arteriography. In every patient 36 bio-
markers linked to the atherosclerotic process were evaluated, and the
integrated Duke clinical score (with exercise ECG results) was cal-
culated. Independent markers of CAD were identified by logistic
regression analysis. Severe obstructive CAD, i.e. [70% coronary ste-
nosis in at least one vessel at coronary arteriography, or 30-70%
stenosis with reduced fractional flow reserve, was the diagnostic
endpoint. The diagnostic accuracy of the integrated models was eval-
uated by ROC curves analysis.
Results: The prevalence of severe obstructive CAD was 27%. The
integrated clinical model showed a predictive accuracy of 66.7%. At
multivariate analysis, HDL-cholesterol, AST, HOMA Index, IL-6, and
Osteopontin were independent predictors of CAD. Adding these vari-
ables to the clinical model, the diagnostic accuracy increased up to
74.0% (P = .001).
Conclusions: Five bio-humoral markers linked to the atherosclerotic
process are independently associated with obstructive CAD. Adding
these markers into predictive models significantly improves the diag-
nostic accuracy of clinical evaluation and exercise ECG for obstructive
CAD.
ROC curves
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Left atrial appendage volume is increased in more than half
of patients with cryptogenic stroke
M. Taina1; R. Vanninen1; M. Hedman2; P. Jakala3; P. Sipola1
1Kuopio University Hospital, Department of Radiology, Kuopio,
Finland; 2Kuopio University Hospital, Heart Center, Kuopio, Finland;
3Neuron Institute, Kuopio, Finland
Background: Ischemic stroke without a well-defined etiology is
labelled as cryptogenic, and it accounts for 30-40% of strokes in
modern stroke registries. Enlarged left atrial appendage (LAA) is the
most typical origin for intracardiac thrombus formation, when asso-
ciated to atrial fibrillation (AF). We studied whether increased LAA
volume detected with cardiac computed tomography (cCT) constitutes
a risk factor in cryptogenic stroke patients.
Methods: Consecutive stroke or TIA patients with cryptogenic etiol-
ogy for stroke after profound clinical, radiological and cardiological
investigations were selected for the study. The 1993 TOAST criteria
modified by 2010 European Association of Echocardiography (EAE)
recommendations for defining cardiac sources of embolism were used
for classification. Eighty-two patients (57 males; mean age 58 years)
were identified. Forty control subjects without cardiovascular diseases,
matched for age and gender, were selected for pair-wise comparisons
(21 males; mean age 54 years). LAA volume adjusted for body surface
area was measured three dimensionally by tracing the borders of LAA
on electrocardiogram gated CT slices.
Results: In control subjects LAA volume was 3.4 ± 1.1 mL/m2 (range
1.3=6.0 mL/m2). The upper limit for normal LAA volume was defined
as mean + 2 SD in control subjects (5.6 mL/m2). In matched pair-wise
comparisons LAA volume was 67% larger in cryptogenic stroke/TIA
patients than in control subjects (5.7 ± 2.0 mL/m2 vs 3.4 ± 1.1 mL/
m2; P \ .001). Of the all patients with cryptogenic stroke/TIA 45 (55
%) had enlarged LAA.
Conclusions: LAA is significantly enlarged in more than half of
patients with cryptogenic stroke. LAA thrombosis may contribute in
the pathogenesis of stroke in patients considered to have cryptogenic
stroke after conventional evaluation and thus do not have AF or any
other previously known risk factor for stroke.
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Prevalence and prognostic value of positive myocardial
perfusion SPECT in relation to the workload achieved
during exercise testing
V. Pubul1; S. Nieves1; M. Miguel Garrido1; S. Argibay1;
R. Vidal1; M. Vega1; A. Martinez1; J. Lopez-Urdaneta1;
R. Gonzalez-Juanatey1; A. Ruibal1
1Hospital Clı´nico Universitario de Santiago de Compostela, Santiago
de Compostela, Spain
Purpose: To evaluate the prevalence of ischemia determined by
SPECT in relation to the workload achieved during exercise testing in
patients with suspected or known coronary artery disease, and deter-
mine the frequency of adverse events in these groups.
 2013 American Society of Nuclear Cardiology
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Methods: We selected 2206 consecutive patients who underwent
myocardial perfusion SPECT for diagnosis/prognosis purpose, with a
two-day stress/rest protocol study, reaching over 80% of the maximum
age-predicted heart rate and [5 metabolic equivalents (METs) during
exercise testing. Finally, we studied 1771 patients with follow-up,
which were grouped according to the workload achieved (5-7 METs
n = 186, 7-9 METs n = 756, and [10 METs n = 824), analyzing its
relationship with perfusion defects and adverse events. Age, diabetes,
smoking, hypertension, dyslipidemia, body mass index, and peripheral
arterial disease were variables to study. At follow-up we assessed the
occurrence of adverse events such as: Coronary Revascularization,
Acute Myocardial Infarction, Hospitalization for Cardiac Causes and
Heart-Related Deaths. The average time of follow-up was
2.5 ± 2 years.
Results: Patients who achieved[10 METS, were mostly young (mean
57 years), males (71%) and a had smaller proportion of cardiovascular
risk factors such as Diabetes (17%) and obesity (12%) compared to the
other two groups.
The exercise test had more positive results in the groups of lower
workloads than the group of[10 METS (5-7 METS: 32%, 7-9: METS
32% and[10 METS 27%; P \ .05). The groups of low workload were
also associated with a higher percentage of positivity in the SPECT (5-
7 METS: 46%; 7-9 METS: 37% and [10 METS: 35%; P \ .05).
Regardless the workload, a positive result in the SPECT in each of the
three groups was related to a high prevalence of adverse events (Events
in patients with positive SPECT: 5-7 METS: 44%; 7-9 METS: 31%,
and C10 METS: 19%), compared to patients with negative SPECT.
Conclusions: Patients who achieved a lower workload had a more
atherogenic risk profile and a higher prevalence of inducible ischemia.
A positive result on SPECT is correlated with a higher percentage of
adverse events in the three groups. In our population the results of
myocardial perfusion SPECT is useful to discriminate patients with a
higher likelihood of future events even among those who reach high
workloads.
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Radiation dose and downstream testing from coronary CT
angiography compared to stress testing using high-efficiency
SPECT MPI for the evaluation of chest pain in the
emergency department
M. Milena Henzlova1; J. Savino1; E.J. Levine1; L.B. Croft1;
A.J. Einstein1; L. Hermann1; W.L. Duvall1
1Mount Sinai School of Medicine, New York, United States of America
Purpose: While recent coronary CT angiography (CTA) studies have
suggested lower radiation dose and faster study time than stress testing
and myocardial perfusion imaging (MPI), this comparison has been to
older Na-I SPECT cameras using traditional rest-stress protocols. We
compared CTA to stress testing with modern SPECT MPI using high-
efficiency CZT (cadmium-zinc-telluride) cameras and newer stress-
first protocols in an emergency department (ED) Chest Pain Unit
(CPU) population.
Methods: In a retrospective, non-randomized study all patients who
underwent CTA or stress testing [exercise treadmill testing (ETT) or
Tc-99m sestamibi SPECT MPI] as part of their ED CPU assessment in
2010-2011 driven by ED attending preference and equipment avail-
ability were evaluated for their radiation exposure and subsequent
diagnostic testing (within 3 months of ED visit). CTA was performed
on a 64-slice scanner and MPI was performed on either a CZT or Na-I
SPECT camera. Effective dose from CTA was estimated from scanner-
reported dose-length product using a published scanner-specific con-
version factor and from MPI from recorded administered activity using
separate conversion factors for stress and rest imaging provided in
ICRP Publication 80.
Results: Over the 2 year period, 1,458 patients underwent testing in
the ED with 192 CTA’s and 1,266 stress tests (327 ETT’s and 939
MPI’s). The CTA patients were a lower risk cohort based on age,
cardiac risk factors, and known heart disease. In the MPI group, 708
(75%) underwent stress-only imaging, 184 (20%) rest-stress, and 47
(5%) stress-rest with 853 (91%) imaged on a CZT camera. There were
significantly more follow-up studies in the CTA group than in the
stress testing group (13.5% vs 6.6%, P = .001), with no significant
difference in the proportion of subsequent angiograms (8.3% vs 6.2%,
P = .32), but more follow-up functional studies (5.2% vs 0.5%,
P \ .0001). There was a non-significant trend towards more revascu-
larization in those patients undergoing invasive angiography in the
CTA group than in the stress testing group (59% vs 40%, P = .16).
The mean effective dose of 13.5 ± 9.2 mSv for the CTA group was
significantly higher (P \ .0001) than 5.0 ± 4.1 mSv for the stress-
testing group and 6.4 ± 3.3 mSv for CZT SPECT MPI studies.
Conclusions: Stress testing including ETT, CZT SPECT MPI, and
stress-only imaging protocols had a significantly lower patient radia-
tion dose and less follow-up diagnostic testing than CTA. As
previously published, stress-only imaging can be completed within 90
minutes which compares favorably with the 1 hour length of a CTA.
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Automated quantitative computed tomography coronary
angiography (CTA) correlates of myocardial ischemia on
gated myocardial perfusion SPECT
M.A. Michiel De Graaf1; H.M. El-Nagger1; A. Broersen2;
J. Dijkstra2; L.J. Kroft3; I. Al-Younis4; J.H. Reiber2; J.J. Bax1;
V. Delgado1; A.J. Scholte1
1Leiden University Medical Center, Department of Cardiology, Leiden,
Netherlands; 2Leiden University Medical Center, Department of
Radiology, Division of Image Processing, Leiden, Netherlands;
3Leiden University Medical Center, Department of Radiology, Leiden,
Netherlands; 4Leiden University Medical Center, Department of
Nuclear Medicine, Leiden, Netherlands
Purpose: CTA plaque characteristics are associated with myocardial
ischemia. The current study aimed to evaluate the correlation of
quantitatively assessed CTA (QCT) plaque characteristics and the
presence of myocardial ischemia on gated myocardial perfusion single-
photon emission computed tomography (SPECT).
Methods: Patients with suspected CAD who had undergone multi-
detector row CTA and gated myocardial perfusion SPECT within
6 months were included. CTA datasets were visually assessed to
determine plaque type and stenosis degree. Consecutively, QCT was
performed per coronary lesion to assess plaque length, plaque burden
and percentage lumen area stenosis. Subsequently, the presence of
myocardial ischemia was assessed using the summed difference score
(SDS C 2) on SPECT. Using nested multivariate models, the inde-
pendent correlation of the QCT parameters and myocardial ischemia
was assessed.
Results: A total of 40 patients (mean age 58.2 ± 10.9 years, 27 men)
were included. 25 (62.5%) patients showed myocardial ischemia in 37
vascular territories. Multivariate analyses demonstrated that indepen-
dent of baseline variables and visual assessed significant stenosis, both
quantitative significant stenosis and quantitative assessed lesion length
were significantly correlated with myocardial ischemia (OR 7.72 [2.41-
24.07], P \ .001 and OR 1.07 [1.00-1.45], P = .032, respectively). As
depicted in Figure 1, both quantitative parameters have incremental
value over relevant clinical risk factors in the association with myo-
cardial ischemia.
Conclusions: Coronary lesion length and quantitative assessed sig-
nificant stenosis are significantly correlated with myocardial ischemia
on gated myocardial perfusion SPECT independent of clinical risk
factors and visual assessed stenosis.
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Predictive variables for hard cardiac events and coronary
revascularization in patients with normal left ventricular
myocardial perfusion and systolic function
J.G. Jorge Guillermo Romero Farina1; S. Aguade-Bruix1;
G. Cuberas-Borros1; G. De Leon1; J. Pinar1; J. Castell-Conesa1;
D. Garcia-Dorado1; J. Candell-Riera1
1Hospital Universitari Vall d’Hebron, Barcelona, Spain
Purpose: To investigate the impact of clinical variables to predict hard
events (HE) and coronary revascularization (CR) in patients with
normal stress-rest gated SPECT.
Methods: Two thousand and four patients (63.5 ± 12.5 years, male:
41.6%) with a normal myocardial perfusion and left ventricular ejec-
tion fraction (LVEF) [50% on gated SPECT were followed for HE
(cardiovascular death or acute myocardial infarction) and CR. Multi-
variate Cox regression analysis and Kaplan-Meier curves analysis were
used to evaluated and predict HE and CR.
Results: During a follow-up of 4.3 ± 2.4 years, 33 patients (1.6%)
(0.4%/year) had HE and 50 patients (2.5%) (0.6%/year) underwent CR.
In univariate analysis, age C 65 years, insulin-dependent diabetes
mellitus (IDDM), left bundle branch block (LBBB), and pharmaco-
logic stress were associated with HE. Independent predictors of HE
were age C 65 years (P \ .001; HR: 6.9), IDDM (P = .014; HR: 3.4),
and LBBB (P = .002; HR: 4.6). In univariate analysis, male, known
coronary artery disease (CAD), LBBB, and a positive stress test were
associated with CR. Independent predictors of CR were known CAD
(P = .016; HR:2.1), and a positive stress test (P = .006; HR: 2.3).
Conclusions: Age C 65 years, IDDM, and LBBB are HE independent
predictors in patients with normal myocardial perfusion and normal
LVEF on gated SPECT. The presence of a known CAD or a positive
stress test significantly increases the probability of CR during follow-up.
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Prognostic value of myocardial perfusion imaging in
non-stenotic coronary lesion
A. Kisko1; M. Vereb2; J. Kmec3; J. Cencarik3; P. Gazdic3;
J. Stasko3
1Cardiology Clinic, Reiman University Hospital, Sekcov Polyclinic,
Presov, Slovak Republic; 2Sekcov Polyclinic, Nuclear Medicine,
Presov, Slovak Republic; 3Cardiology Clinic, Reiman University
Hospital, Presov, Slovak Republic
Coronary angiography has diagnostic limitation in identifying non-
stenotic coronary lesion (NSCL) responsible for ischemia. Myocardial
perfusion defects in patients (pts) with NSCL have often been unrea-
sonably considered by invasive cardiologists as being ‘‘false positive’’.
We evaluated a prognostic value of gated SPECT MPI in unselected
group of the pts with NSCL over a 24 month period of follow-up.
170 pts (115 males, 67.6%; age 42-68 years; mean age 56.4 ± 9.2 years)
with NSCL (stenosis of 50% or less of LAD and 70% or less of any other
coronary artery or its major branches) were enrolled into the study.
Retrospective analysis of 86 pts with NSCL and subsequent positive
MPS performed within 6 months from the time of coronary angiography
(study group) and 84 pts with normal scan results (control group) was
performed. Follow-up period was for 24 months from the time of MPI or
up to the time of major coronary event (MCE)—first occurrence of
cardiac death or myocardial infarction.
Over a two-year follow-up, approximately 11% of the pts in study
group had MCE as compared to 3.2% in the control group (P \ .01).
Abnormal MPI, EF\35% and high levels of hs-CRP were independent
predictors for MCE in the study group. In multivariate analysis only an
abnormal MPI remained to be an independent predictor regardless of
size or severity of perfusion abnormalities (P \ .005).
Pts with NSCL on coronary angiography and myocardial perfusion
defects have relatively high event rate (11%) of MCE over a period of
24 months from the time of MPI. So, we highly recommend gated
SPECT MPI to be obligatory performed in all cases of NSCL to avoid
life-threatening coronary complications in forthcoming future.
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Left bundle branch block: Influence of septal perfusion
defects and septal dyskinesia in phase analysis of
gated-SPECT MPI
R. Cardenas Perilla1; S. Santiago Aguade-Bruix1;
G. Romero-Farina1; M.N. Pizzi1; G. De Leon1;
J. Candell-Riera1; J. Castell-Conesa1
1Hospital Vall d’Hebron, Barcelona, Spain
Introduction: Quantitative phase analysis (PhA) parameters of myo-
cardial perfusion gated SPECT (gated SPECT MPI) shows abnormal
values in all of patients with left bundle branch block (LBBB), but
relationship between septal abnormalities in perfusion and motion was
not investigated.
Objective: To compare rest PhA gated-SPECT MPI in patients with
LBBB, with and without septal defects, and with and without septal
dyskinesia.
Methods: 95 patients with LBBB (age: 71 ± 10, 67 females) and
without MI, dilated cardiomyopathy, ischemia or pacemaker were
evaluated by rest gated-SPECT MPI. PhA was performed with Sync-
tool (ECT, Emory, USA) to obtain phase peak (PhP), standard
deviation (SD), bandwidth (BD), skewness and kurtosis of phase his-
togram. Heart rate, QRS interval, left ventricular volumes, ejection
fraction and perfusion defect scores (SSS, SRS, SDS) were considered.
Results: Significant differences in phase SD (19.7 ± 8.6 vs
28.2 ± 12.5, P = .001) and histogram bandwidth (60.2 ± 23.5 vs
90.7 ± 49.9, P = .002) were observed between 21 patients with septal
dyskinesia and 74 patients without septal dyskinesia.
No significant differences in PhA parameters were observed between 56
patients with septal perfusion defects and 39 patients without septal
defects (SSS: 1.6 ± 2.1 vs 4.3 ± 2.9, P \ .001; SRS: 1 ± 1.5 vs 2.3 ± 2.3,
P = .002; SDS: 1.2 ± 1.7 vs 2.3 ± 1.9, P \ .001), and between 35
patients with septal perfusion defects and without septal dyskinesia and 21
patients without septal perfusion defects and without septal dyskinesia.
Conclusions: Septal dyskinesia, but not abnormal septal perfusion,
significantly influences PhA parameters of myocardial perfusion gated
SPECT.
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Estimation of at risk and salvaged myocardium by gated
SPECT performed one month after acute myocardial
infarction
J.G. Jorge Guillermo Romero Farina1; S. Aguade-Bruix1;
N. Pizzi1; V. Pineda1; J. Figueras1; G. Cuberas-Borros1;
G. De Leon1; C. Castell-Conesa1; D. Garcia-Dorado1;
J. Candell-Riera1
1Hospital Universitari Vall d’Hebron, Barcelona, Spain
Figure 1. Figure of the abstract 272.
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Purpose: To determine the value of late (one month) myocardial
perfusion gated SPECT (gSPECT) to estimate at risk and salvaged
myocardium in patients with acute myocardial infarction (AMI)
undergoing primary percutaneous coronary intervention (PCI).
Materials and Methods: Forty patients (mean age 61.5 years, 8
women) with a first AMI were included in the study. They underwent
two gSPECTs: the first (gSPECT-1) was performed with IV dose of
99mTc-tetrofosmine prior to PCI, and the second (gSPECT-2) was
performed during the 4th or 5th week following AMI. In gSPECT-1
myocardium at risk was quantified by measuring the perfusion defect,
and salvaged myocardium by subtracting the area of necrosis in
gSPECT-2 from the myocardium at risk area. In gSPECT-2, myocar-
dium at risk was estimated by analyzing discordance between the areas
of left ventricular wall motion and perfusion.
Results: A significant improvement in perfusion, wall motion, thick-
ening and left ventricular ejection fraction (P \ .001) was observed
between gSPECT-1 and gSPECT-2. In gSPECT-2 the mean value of
the area with abnormal wall motion was significantly greater (35.5 vs
23.1 cm2, P = .007) than the mean area with altered perfusion (mis-
match pattern wall motion-perfusion). The extent of myocardium at
risk estimated from this discordance area correlated well with myo-
cardium at risk measured in gSPECT-1 and with salvaged myocardium
between gSPECT-1 and gSPECT-2 (Pearson’s correlation coefficient:
0.78 and 0.6 respectively). The degree of concordance for correct
classification of patients with salvaged myocardium [50% was 83%.
Conclusions: Myocardial perfusion gSPECT performed one month
after early PCI in a first AMI provides useful information on at risk and
salvaged myocardium areas.
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Usefulness of gated myocardial perfusion SPECT to qualify
patients for cardiac resynchronization therapy and identify
responders through prediction of left ventricular remodeling
M. Kostkiewicz1; W. Szot2; A. Lesniak-Sobelga1;
T. Miszalski-Jamka2; P. Podolec1
1Institute of Cardiology, Jagiellonian University, John Paul II
Hospital, Department of Cardiovascular Diseases, Krakow, Poland;
2John Paul II Hospital, Krakow, Poland
Cardiac resynchronization therapy (CRT) has been accepted as a
treatment for heart failure patients refractory to conventional therapy.
However, 20-40% of the patients selected for CRT based on conven-
tional criteria—e.g. per the NewYork Heart Association (NYHA),
class III or IV severity, depressed LV ejection fraction (LVEF)
(B35%), prolonged QRS duration (C120 ms) and sinus rhythm do not
respond to CRT. Phase analysis enables gated SPECT to assess LV
dyssynchrony and has the potential for comprehensive assessment of
additional multiple parameters, such as myocardial scar burden and
location and site of latest activation, that influence response to CRT.
LV dyssynchrony measured by gated SPECT phase analysis has been
shown to correlate with that measured by 2D echocardiography, yet is
more likely to obtain reproducible results.
Aim of the study was to examine the relationship between mechanical
dyssynchrony assessed by and the outcome of patients after CRT
therapy.
Material and Methods: We studied 29 NYHA class III-IV heart
failure patients with ejection fraction (EF) B35% and QRS duration
C120 ms referred for CRT. Established optimal cutoff values for the
prediction of response to CRT, i.e. 135 for phase histogram bandwidth
(PHB) and 43 for phase standard deviation (PSD), were used. We
repeated the SPECT studies for all patients after 6 months. All images
were analyzed by a reader unfamiliar with the patient’s history.
Quantitative variables were expressed as mean ± standard deviation;
categorical variables were expressed as frequencies and percentages.
Results: SPECT identified severe LV dyssynchrony in 21 patients
with a mean PHD of 225.2 ± 36.7 and a mean PSD of
68.7 ± 11.3. Normal LV synchronicity or mild LV dyssynchrony
was found in 8 patients with a mean PHD of 83.9 ± 32.8 and a PSD
of 28.7 ± 13.1. In the post-therapy study LV mechanical dyssyn-
chrony parameters were shown to predict good responses to CRT.
Based on an improvement rate of C1 NYHA class at 6 months fol-
low-up, 19 patients were classified as responders, the other 2 as non-
responders. At 6 month follow-up both PSD (56.3 ± 19.9 vs
37.1 ± 14.4, P \ .01) and PHB (175 ± 63 vs 117 ± 51, P \ .01)
were still significantly higher in responders compared to non-
responders.
Conclusion: SPECT with phase analysis has a potential for assessing
LV dyssynchrony. This method is feasible, accurate and capable of
gathering information of dyssynchrony equally with information about
perfusion. SPECT can be a viable clinical approach to consistent
prediction of CRT response in HF patients.
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Does severity of systolic LV dysfunction predict the presence
of LV dyssynchrony in heart failure patients with narrow
QRS complex?
L. Ramaiah1; V.S. Hejjaji1; J. Selvakumar1;
G.R.K. Amancharla1; G. Nair1
1Narayana Hrudayalaya Institute of Medical Sciences, Bangalore,
India
Cardiac resynchronization therapy (CRT) has been shown to be an
efficient method of treating patients with severe heart failure. Current
selection criteria for CRT includes wide QRS ([120 ms), left ven-
tricular ejection fraction (LVEF) of B35% and NYHA symptom class
III/IV. Around 30% of patients do not experience benefits when current
selection criteria are applied. There has been a substantial interest
towards detection of mechanical dyssynchrony, as it predicts the
response to CRT. Heart failure patients with narrow QRS (B120 ms)
have also been shown to manifest mechanical dyssynchrony.
Purpose: To evaluate the relationship between left intraventricular
dyssynchrony and severity of systolic left ventricular (LV) dysfunction
in heart failure patients with narrow QRS using equilibrium gated
radionuclide ventriculography (ERNV).
Methods: 40 patients (age 53 ± 26 years, 29 males and 11 females)
with QRS duration B120 ms, NYHA symptom class III/IV and LVEF
B35% despite maximal pharmacological therapy, were enrolled in the
study. Patients underwent resting ERNV according to standard
guidelines. First harmonic phase analysis was performed on scinti-
graphic data using XT-ERNA software. A cosine curve fitted within
the cardiac cycle from 0 to 360 was obtained. It was characterized by
a phase angle and amplitude. Phase angle was converted to millisec-
onds by the formula: [phase angle/360] 9 RR interval (milliseconds).
Earliest phase angle referred to the time of onset of ventricular con-
traction, mean phase angle referred the mean time of onset of
ventricular contraction and the standard deviation was related to syn-
chrony of contraction. Standard deviation of LV phase was used to
define dyssynchrony.
Results: Left intraventricular dyssynchrony was detected in 65% (26/
40) of patients. Phase analysis result was stratified according to the
LVEF obtained by ERNV. Left intraventricular dyssynchrony was
observed in all patients with LVEF below 20%. When severity of LV
dysfunction was correlated with left intraventricular dyssynchrony, it
was found that the prevalence of left intraventricular dyssynchrony
increased with fall in LVEF (Pearson correlation coefficient r = -
0.28, P = .07).
Conclusions: Fourier phase analysis on ERNV is an effective and
operator independent method with least inter observer variability for
detecting LV dyssynchrony. A significant proportion of heart failure
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patients with narrow QRS manifest LV dyssynchrony. Heart failure
patients with severe systolic LV dysfunction and left intraventricular
dyssynchrony could be considered as potential candidates for CRT.
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Phase analysis in cardiac gated-SPECT: New possibilities
to evaluate left ventricular dyssynchrony
N. Nuno Cabanelas1; M.J. Vidigal Ferreira2; L. Santos3;
J. Correia2; M.J. Cunha2; A. Albuquerque2; A.P. Moreira2;
G. Costa2; \L.A. Providencia2
1Hospital de Santare´m, Santare´m, Portugal; 2University Hospitals of
Coimbra, Coimbra, Portuga; 3Hospital Sao Teotonio, Viseu, Portugal
Introduction: QRS width is, in present, the preferred marker of left
ventricular dyssynchrony, and the most used one when cardiac re-
synchronization therapy is hypothesized for patients with low ejection
fraction. However, the actual rate of non-responders suggests that a
better marker is needed.
Aims: In heart failure patients referred for cardiac SPECT, it’s inten-
ded to evaluate the relation between mechanical dyssynchrony (phase
standard deviation, SD, from phase histogram, FH), electrical dys-
synchrony (QRS width), left ventricular ejection fraction (LVEF),
presence of perfusion defects and prognostic end-points.
Methods: Patients referred for cardiac SPECT, between 2007 and
2008, for investigation of heart failure and in whom phase analysis was
possible to obtain using Emory Cardiac Toolbox, were retrospectively
studied (n = 41). According to previous studies a SD above 438 is
considered suggestive of dyssynchrony. Then 2 groups were estab-
lished: A, patients with SD \ 43: n = 23; and B, patients with SD343:
n = 18. They had been followed for 21.8 ± 9.9 months. The groups
were compared in terms of LVEF, QRS width, presence of ischemia,
presence of necrosis, hospitalization due to heart failure, acute coro-
nary events incidence, CRT implantation and mortality.
Results: There was not significant difference in QRS [ 120 ms
prevalence (30% vs 44%, P = .48), but patients from group B had
higher prevalence of EF \ 35% (26% vs 78%, P = .013). SPECT
perfusion images suggested ischaemia and necrosis in similar propor-
tions (ischaemia: 65% vs 61%, necrosis: 26% vs 33%). SD value had a
negative correlation with left ventricle EF (Pearson coefficient: r = -
0.59), but not with QRS width (r = 0.09). There were no deaths in
both groups. Patients from group B, showed a tendency for more CRT
implantations (0% vs 22%, P = .058), they had higher all-cause hos-
pitalizations incidence (24% vs 72%, P = .016). Incidences of acute
coronary events were similar (5% vs 8%) and although a higher inci-
dence of admissions was observed in group B no statistical difference
was found (4% vs 11%).
Conclusion: Standard deviation from phase histogram appears to be a
marker of dyssynchrony with high discriminative power. In this study,
it showed a good correlation with left ventricle EF and was related to
higher incidence of some important end-points. Using gated SPECT, it
becomes possible to identify ischaemia or necrosis and to quantify left
ventricular dyssynchrony with a single exam.
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Phase analysis of gated myocardial perfusion single-photon
emission computed in left bundle branch block patients for
the assessment of left ventricular synchrony
E.N. Aramayo G.,1; M. Daicz1; J.F. Casuscelli1; H.G. Marrero1;
C.M. Claudia Mariana Cortes1; M.A. Embon1
1Hospital Universitario Fundacio´n Favaloro, Buenos Aires, Argentina
Purpose: The aim of this study was to evaluate the left ventricular
(LV) synchrony assessed by gated myocardial perfusion single-photon
emission computed tomography (GSPECT) in left bundle branch block
(LBBB) patients, and to compare them with normal subjects.
Methods: Rest GSPECT was performed in 48 consecutive patients
with LBBB. The parameters of LV synchrony (histogram peak, his-
togram bandwidth (HB), phase Standard Deviation (SD), histogram
skewness, and histogram kurtosis were obtained by phase analysis of
rest GSPECT and were compared with our database of 130 normal
subjects. Univariate analysis was performed including clinical, elec-
trocardiographic and scintigraphic variables as well as LV function in
LBBB patients. For logistic regression model significant dyssynchrony
was defined as Phase SD C 43.
Results: The LBBB patients were older than normal subjects (65 ± 13
vs 57 ± 10 years, P \ 0.002) and 27 were men. Among coronary risk
factors, 29 presented hypertension, 28 hyperlipidemia, 6 diabetes
mellitus, and 5 were active smokers. Twelve patients showed history of
coronary artery disease (5 with myocardial infarction, 9 had previous
revascularization). Seventy percent of patients had LV ejection fraction
(LVEF) [ 50% and 23% had end systolic volume (ESV) [ 70 mL.
Comparison between phase analysis parameters of the LBBB patients
and normal subjects showed higher SD (30 ± 21 vs 12 ± 5; P \ 0.001)
and HB (98 ± 65 vs 40 ± 15; P \ 0.001). This difference remained
regardless of sex (men \ 0.001, women P \ 0.001) and radiotracer
dose (high dose \ 0.001 and low dose P \ 0.001).
In the LBBB patients, SD and HB phase analysis parameters were not
statistically different according to sex and dose.
The LBBB patients whose LVEF B 50%, ESV C 70 mL, QRS dura-
tion C 160 ms. or have a presence of abnormal rest perfusion defects,
had SD and HB statistically higher (all P \ .01). In a logistic regres-
sion model the independent predictors were ESV C 70 mL or
LVEF B 35%.
Conclusion: In our population, the phase analysis parameters in rest
GSPECT clearly differentiate patients with LBBB from normal sub-
jects according to LV synchrony.
In patients with LBBB whose LVEF \ 50%, ESV [ 70 mL
QRS [ 160 ms or have abnormal perfusion are associated with higher
LV dyssynchrony. ESV C 70 mL or LVEF B 35% were independent
predictors of LV dyssynchrony in LBBB patients.
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The predictors of cardiovascular events in hemodialysis
patients who underwent stress myocardial perfusion imaging
T. Tatsuhiko Furuhashi1; M. Moroi2; N. Joki3; H. Hase1;
M. Minakawa1; H. Masai1; T. Kunimasa1; H. Fukuda1; K. Sugi1
1Division of Cardiovascular Medicine, Toho University Ohashi
Medical Center, Tokyo, Japan; 2National Center for Global Health
and Medicine, Cardiology Division, Tokyo, Japan; 3Toho University,
Ohashi Medical Center, Department of Nephrology, Tokyo, Japan
Objectives: Patients who have normal stress myocardial perfusion
imaging (MPI) are generally warranted excellent cardiovascular
prognosis. Patients with chronic kidney disease (CKD) who underwent
hemodialysis have shown poor prognosis for cardiovascular events.
This study evaluates the prognostic factor in CKD patients with he-
modialysis who underwent stress MPI.
Methods: Eighty-four hemodialysis patients (mean age = 69,
male = 57, previous coronary artery disease = 27, hemodialysis
duration = 36 months) underwent stress MPI and followed up for
25 months. Cardiovascular events were cardiac death, non-fatal myo-
cardial infarction and unstable angina requiring hospitalization.
Results: Cardiovascular events were observed in 16 patients (19%).
Univariate Cox regression analysis revealed that peripheral artery
disease and parameters of stress MPI were significant predictors of
cardiovascular events. Multivariate Cox regression analysis revealed
that only peripheral artery disease (hazard ratio = 6.41; P = .002) and
summed stress score (SSS) [ 3 of stress MPI (hazard ratio = 7.82;
P = .009) were independent and significant predictors for total car-
diovascular events. As shown in Kaplan-Meier survival curves in
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Figure, patients with normal stress MPI (SSS B 3) had better prognosis
of cardiovascular events than in patients with abnormal stress MPI
(SSS [ 3). However in patients with normal stress MPI, cardiovascular
events were observed in 10 of 72 patients (14%).
Conclusions: In hemodialysis patients, both peripheral artery disease
and stress MPI can be powerful cardiovascular predictors. Normal
stress MPI cannot mean excellent prognosis for cardiovascular events
in hemodialysis patients.
Kaplan-Meier event-free survival curves
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The variation of left ventricular mechanical dyssynchrony
in patients with coronary artery disease
N. Takahashi1; M. Ishikawa1; A. Kikuchi1; E. Yamamoto1;
K. Amitani1; T. Uchida1; N. Sato1; K. Munakata1; S. Kumita2;
K. Mizuno3
1Nippon Medical School Musashikosugi Hospital, Department of
Cardiology, Kawasaki, Japan; 2Nippon Medical School Hospital,
Department of Radiology, Tokyo, Japan; 3Nippon Medical School,
Department of Cardiology, Tokyo, Japan
Background: Left ventricular Mechanical dyssynchrony (LVMD) has
been demonstrated to be present in patients with severe heart failure
including myocardial infarction (MI) and cardiomyopathy. However,
LVMD has not been fully clarified in stable angina pectoris (AP).
Objectives: The aim of this study was to assess the variation of LVMD
before and after stress in stable AP.
Methods: A total of 200 patients (age 69 ± 11, 137 men) with sus-
pected coronary artery disease underwent stress/rest gated myocardial
perfusion SPECT (GMPS). For the evaluation of LVMD, histogram
bandwidth (HBW) at stress and rest were determined by GMPS using
phase analysis. End-systolic volume (ESV) at stress divided by ESV at
rest was calculated as a parameter of transient ischemic dilatation
(TID) ratio in all patients. DHBW (HBW at stress—HBW at rest) was
compared among three groups: 103-normal subjects group (NG);
[summed stress score (SSS) \ 4 and LV ejection fraction C 50%],
53-ischemic group (IG); [SSS C 4 and summed difference score
(SDS) C 2 and summed rest score (SRS) \ 3], and 44-prior MI group
(pMIG); SSS C 4 and SDS B 1.
Results: The measured DHBW in NG, IG, and pMIG are summarized
in the figure (NG; 2.3 ± 27.8, IG; 18.0 ± 48.2, pMIG; 5.9 ± 37.8,
P \ .05 ANOVA). There were significant positive correlation between
DHBW and TID ratio in IG (r = 0.39, P \ .01).
Conclusions: The variation of LVMD before and after stress in stable
AP was demonstrated to be greater enhancement than those in normal
subjects. The variation of LVMD was associated with TID ratio in
stable AP.
Variation of LVMD
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Comparison of adjunctive balloon postdilatation and
intravascular ultrasound guidance during percutaneous
coronary intervention
J.B. Jae Bin Seo1; H.S. Kim2
1Boramae Hospital, Seoul, Republic of Korea; 2Seoul National
University Hospital, Seoul, Republic of Korea
Background: Intravascular ultrasound (IVUS) is helpful during per-
cutaneous coronary intervention (PCI), because we can confirm the
good apposition or optimal expansion of stents. In this study, we
compared adjunctive balloon postdilatation and IVUS-guidance during
PCI.
Methods and Results: For this study, we have divided PCI lesions for
3 years into two groups; adjunctive balloon postdilatation after stenting
vs IVUS during PCI with or without postdilatation. Among total 302
lesions (279 patients) which underwent PCI with TAXUS stent, 60
lesions underwent PCI during which adjunctive balloon postdilatation
was done without IVUS, whereas 242 lesions did underwent PCI with
IVUS. Baseline clinical features are similar between two groups. The
actual rate of adjunctive balloon postdilatation was 100% in the
postdilatation group whereas 75.6% in the IVUS-guidance group. We
analyzed serial angiographic data, pre-PCI, immediate post-PCI, and
follow-up at 6-9 months. The minimal lumen diameter at pre-PCI and
the immediate post-PCI was significantly wider in IVUS-guidance
group than in postdilatation one (0.72 vs 0.84 mm, P = .013; 2.36 vs
2.51 mm, P = .006). But the difference disappeared at follow-up
period (1.98 vs 1.93 mm, P = .327). The late loss was higher in IVUS-
guidance group (0.41 vs 0.57 mm, P = .029). Target lesion revascu-
larization at 1 year was not different between the two groups.
Conclusions: PCI with adjunctive balloon postdilatation was compa-
rable to PCI under IVUS-guidance in terms of angiographic and
clinical outcome.
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Necrosis and myocardial viability: Could gated SPECT helps
cardiac magnetic resonance?
M.N. Pizzi1; G. Cuberas-Borros2; S. Aguade-Bruix3; V. Pineda4;
G. Romero-Farina2; J. Castell-Conesa3; J. Pinar5; J. Candell-
Riera5
1Universitary Hospital Vall d’Hebron, Cardiology Department,
Nuclear Cardiology and Cardiac CT Unit, Barcelona, Spain; 2Hospital
Vall d’Hebron, Cardiology Department, Epidemiology Unit, Barce-
lona, Spain; 3Universitary Hospital Vall d’Hebron, Nuclear Medicine
Department, Barcelona, Spain; 4Universitary Hospital Vall d’Hebron,
Radiology Department, Barcelona, Spain; 5Universitary Hospital Vall
d’Hebron, Cardiology Department, Barcelona, Spain
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Introduction and Objectives: Cardiac Magnetic Resonance (CMR) is
considered one of the gold standards to determine necrosis transmu-
rality and extension, but does it has the same accuracy defining
viability? The aim of this study was to compare the concordance
between necrosis delimitation in CMR images and viability criteria of
99mTc-tetrofosmine in gated SPECT, in patients with chronic myo-
cardial infarction (MI).
Methods: CMR and gated SPECT were performed in 104 patients
(mean age: 61 ± 12 years, 87.5% men) with previous MI. Left ven-
tricular (LV) volumes and ejection fraction (EF) and classic late
gadolinium enhancement (LGE) viability criteria (\75% transmurali-
ty) were correlated with volumes, EF and viability criteria
(uptake [ 50%) of the gated SPECT in the 17 segments of the LV.
Motion, thickening and ischemia in gated SPECT were analyzed in
non-viable and LGE doubtful segments (50-75% of transmurality).
Results: A good correlation was observed between both techniques for
volumes, EF (P \ .05) and estimated necrotic mass-necrosis extension
(P \ .01). Eighty two (31%) of the 264 segments with LGE [ 75%
had SPECT tracer uptake [ 50%. From those 106 doubtful segments
in CMR, 68 (64%) had SPECT tracer uptake [ 50%, 41 (38.7%) a
preserved motion, 46 (43.4%) a conserved systolic thickening and 17
(16%) evidence of ischemia in SPECT.
Conclusions: A third of CMR non viable segments show [ 50% tracer
uptake on myocardial SPECT. Gated-SPECT can help CMR in the
evaluation of doubtful segments with the evaluation of tracer uptake,
motion and thickening analysis and the presence of ischemia.
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Late tetrofosmin-Tc-99m lung/heart ratio during exercise
gated cardiac SPECT: Correlations with left ventricle
myocardial perfusion defects and post-stress ejection fraction
T. Vieira1; A. Oliveira1; P. Oliveira1; V. Alves1; T. Faria1;
M.B. Perez1; E. Martins2; J.G. Pereira1
1Sao Joao Hospital, Department of Nuclear Medicine, Porto,
Portugal; 2Sao Joao Hospital, Department of Cardiology, Porto,
Portugal
Purpose: It has long been reported that the Tl-201 lung/heart ratio
(LHR) is a reliable marker of coronary artery disease and of left
ventricular dysfunction (LVD). Subsequent experience suggests that
sestamibi-Tc-99m LHR has a comparable role. Given the similar
biodistributions of tetrofosmin and sestamibi, it is plausible to think
that the same would also apply to tetrofosmin-Tc-99m LHR. Indeed,
recently published literature proposes that early (4-6 minutes after
radiotracer injection) post-stress tetrofosmin-Tc-99m LHR appears to
be a useful index of myocardial perfusion defects (MPD) and LVD.
We aimed to evaluate the correlations of late post-stress tetrofosmin-
Tc-99m pulmonary lung uptake with post-stress left ventricle ejection
fraction (LVEF) and MPD, obtained during exercise gated cardiac
SPECT (GSPECT).
Methods: Our study included 105 consecutive patients addressed for
myocardial perfusion scintigraphy (MPS) with cardiac stress induced
by the Bruce protocol. The stress imaging was performed by
GSPECT, 30-60 minutes after tetrofosmin-Tc-99m administration.
QGS/QPS was the software used for left ventricle (LV) perfusion
and function assessment. Subsequently, we summed all LV coronal
slices from SPECT acquisition to improve count statistics for the
purpose of LHR calculation. We manually generated ROIs in the LV
and in the left lung of the resulting summed images. The LHR was
then calculated as the simple ratio of the average pixel counts in the
lung and LV ROIs.
Results: Twenty-one patients (20%) were female. Mean age was
57 years-old. Forty-five patients (42.9%) had an abnormal MPS and 16
patients (15.2%) had a LVEF \ 45%. There was a positive correlation
of tetrofosmin-Tc-99m LHR with MPD severity (r = 0.59) and extent
(r = 0.55), and a negative correlation with LVEF (r = -0.57).
Conclusions: Late tetrofosmin-Tc-99m LHR obtained from exercise
GSPECT appears to be a useful marker of LV MPD and post-stress
LVD.
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Correlation of carotid intima media thickness and carotid
plaque prevalence with coronary artery disease
A. Anand Jeevarethinam1; S. Venuraju1; A. Lahiri1
1Wellington Hospital, Clinical Imaging and Research Centre, London,
United Kingdom
Objectives: Our aim was to evaluate the correlation between CIMT,
carotid plaque prevalence and severity of coronary artery plaque bur-
den as well coronary plaque sub-type.
Methods: One hundred and fifty patients (n = 150) with no history of
CAD, who underwent both US carotid Doppler and clinically indicated
CT coronary angiogram (CTCA) between May 2009 and May 2011
were included in the analysis. CIMT was measured in the far wall of
the common CCA 1 cm proximal to the carotid bulb using automated
edge detection software. The entire carotid system was surveyed
bilaterally for presence of plaque. CTCA was performed by a Dual
Source CT scanner.
Results: The average age was 56.34 ± 10.4 years and BMI 27.2 ± 6.7.
There were 106 (68.7%) males, 23 (15%) cigarette smokers, 70 (45%)
with hypertension, 95 (62%) with hyperlipidemia, 107 (69%) patients
had family h/o IHD and 20 (13%) with diabetes. A total of 101 (67.3%)
patients were found to have coronary plaque. The mean CIMT was
higher in patients with CAD than in those without CAD (0.76 vs
0.66 mm, P \ .003). The prevalence of carotid plaque in CAD pa-
tients was 45.5%.
CIMT measurement correlated well with prevalence of any coronary
plaque (P = .002), whereas presence of carotid plaque was a good
predictor of obstructive ([50% stenosis) coronary plaque (P = .01). In
a multi-variate analysis of, age (P .048), hyperlipidaemia (P .027),
systolic blood pressure (P .043) and IMT (P .04) were predictors of any
coronary plaque. Calcified plaque (P = .04) and mixed plaque
(P = .003) correlate well with presence of carotid plaque but not
CIMT.
Conclusion: Presence of a carotid plaque was a good predictor of
prevalence of significant coronary stenosis whereas CIMT was a strong
predictor for presence of any coronary plaque but not of severity of
plaque burden.
Carotid plaque correlation with CAD
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Left ventricular geometry indexes evaluated by preoperative
gated-SPECT in severe CAD and their correlation to
hospitalization post CABG: A five year follow up
M. Jimenez-Santos1; L.E. Rodriguez-Castellanos1;
S. Hernandez-Sandoval1; L.E. Juarez-Orozco2;
E.A. Penarrieta-Daher1; L.V. Araujo-Torres1;
C.A. Guizar-Sanchez1; E. Erick Alexanderson Rosas1
1Instituto Nacional de Cardiologı´a ‘‘Ignacio Cha´vez’’, Mexico City,
Mexico; 2Unidad PET/CT Ciclotro´n UNAM, Mexico city, Mexico
Background: Left ventricular geometry indexes approaching to
sphericity have been studied with gated-SPECT in hospital heart
failure patients. In the other hand, these indexes have also been used as
measures of ventricular remodeling and myocardial viability.
Methods: In this longitudinal retrospective study 60 patients were
included from 2005 to 2007 and were followed for 5 years.
We correlated abnormal pre-procedure left ventricular geometry
indexes (shape index (SI), eccentricity index (EI) as well as end-dia-
stolic (EDV) and end-systolic left ventricular volumes (ESV)) by
gated-SPECT in patients with severe CAD to number of hospitalization
rates due to heart failure, heart failure progression or postoperative
death in a 5 year follow-up CABG.
Results: The hospitalization rate was 16%; SI at rest was 0.717 vs
0.581 (P = .0001) and at stress was 0.544 vs 0.637 (P = .021) (hos-
pitalization); EI was not significantly different in all the cases. The rate
of cardiac death was 23%; there were non statistically significant
differences of the evaluated parameters between the groups. The rest SI
was different, in NYHA I was 0.542; NYHA II was 0.637 and NYHA
III 0.81 with P value = .0001; the stress SI was not statistically dif-
ferent between the groups.
Conclusion: in this study we demonstrate that the SI at rest was sta-
tistically different between the NYHA groups for MACE prognosis
and hospitalization. Preoperative gated-SPECT can discriminate
patients with higher probability of developing heart failure, although it
was not observed in the other values evaluated in this study.
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The use of leukocyte scintigraphy and FDG-PET in search
for a primary focus in infective endocarditis; experiences
from a single tertiary heart centre
C.H.B. Jespersen1; K. Iversen1; P. Hasbak2; A. Loft2;
H. Bundgaard1; N. Ihlemann1
1Rigshospitalet—Copenhagen University Hospital, Heart Centre,
Department of Cardiology, Copenhagen, Denmark; 2Rigshospitalet—
Copenhagen University Hospital, Clinical Physiology, Nuclear Medi-
cine & PET, Copenhagen, Denmark
Purpose: In 50% of patients with infective endocarditis (IE) extra-
cardiac infectious foci are present. Finding these foci is essential but
the optimal strategy has yet to be established. The purpose of this study
was to assess the diagnostic value of leukocyte scintigraphy (LS) and
18F-fluorodeoxyglucose (FDG) PET/CT scans in discovering extra
cardiac foci of infection in patients with IE.
Methods: Patients admitted at a tertiary referral centre from January 1,
2010 to December 31, 2011 with the diagnosis IE were studied.
Records were reviewed for information on use of LS and FDG-PET
scans; C-reactive protein (CRP) and leukocyte levels; and bacterial
aetiology.
Experienced cardiologists reviewed all journals with positive findings
on LS or FDG-PET to decide if the focus was unknown, and if the
finding changed the clinical course for the patient.
Results: A total of 165 patients were admitted. LS was performed in 95
of the cases, and FDG-PET in 29. There were no demographic baseline
differences between the groups in which LS was performed and was
not performed.
In total, 14 (14.7%) of the LS showed pathological leukocyte accu-
mulation, and 18 (62.1%) of the FDG-PET scans showed pathological
FDG uptake. CRP-levels [mg/L] were higher if an infectious focus was
found both with LS (65.36 vs 38.84, P = .137) and FDG-PET scans
(45.33 vs 34.36, P = .589), but they were not significant. In patients
with positive LS scans the examinations were performed earlier [days]
from initiation of antibiotic treatment as compared with patients with
negative LS outcome (12.6 vs 16.7, P = .540).
Journal review showed that 8 of the 14 pathological LS turned out to be
clinically insignificant or false positives, and two had inconclusive
results. The final four patients all had ostitis, and they all had clinical
signs of the final diagnosis before LS was performed. Only in two of
the 95 cases, LS resulted in altered treatment.
There was a low level of agreement between the outcomes of patients
who had both LS and FDG-PET done (j = 0.099, 95% CI [-0.040;
0.238]). Of the 26 patients who had both LS and FDG-PET performed,
only two patients had a positive finding in both LS and FDG-PET, and
in these cases the foci found with the two modalities were different.
Conclusions: This study suggests that the value of LS in the search for
extracardiac foci of infection in IE is low. Also, there was no agree-
ment between foci found with LS and FDG-PET scans.
Performing LS early in the time course of antibiotic treatment and
choosing patients with elevated CRP-levels might result in higher rates
of LS with clinically useful results.
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Evaluation of left ventricular synchrony parameters in
normal subjects by gated myocardial perfusion single photon
emission computed tomography phase analysis
E.N. Aramayo G.1; C.M. Cortes1; M. Daicz1; J.F. Casuscelli1;
H.G. Marrero1; M.A. Embon1
1Hospital Universitario Fundacio´n Favaloro, Buenos Aires, Argentina
The aim of our study was to generate reference values of phase
analysis parameters by gated myocardial perfusion single photon
emission computed tomography (GSPECT) in normal subjects
according to sex and sestamibi dose.
Method: Prospectively and consecutively were obtained phase analy-
sis LV synchrony parameters: peak, standard deviation (SD),
histogram bandwidth (HB), histogram skewness (HS) and histogram
kurtosis (HK), assessed by stress and rest GSPECT. We selected
normal subjects defined as low pre test of coronary artery disease,
without myocardiopathy and with normal electrocardiogram, stress
test, myocardial perfusion and ejection fraction (EF). We compared
these parameters in relation to sex, sestamibi dose (according to one or
two days protocol).
Results: One hundred and thirty subjects were enrolled, 84 men,
average age of 56 ± 10 years, 42% hypertensive, 42% hyperlipidemic
and 11% smokers. 92% underwent physical stress test and 17% two
Characteristic Number
Males 80%
Age (mean) 57 ± 9.43
DM (%) 48
Obesity (%) 21.7
Smoking (%) 65
Hypertension (%) 70
Dyslipidemia (%) 51
Renal Failure (%) 17
Previous MI (%) 95
LVEF (mean) 33.6 ± 8.2
S77 Left ventricular function and new insights / Journal of Nuclear Cardiology Supplement (2013) 20 (Supplement 1)
days GSPECT protocol. Phase analysis parameters of stress vs rest
were not statistically different neither in SD (12 ± 5 vs 12 ± 5) nor HB
(38 ± 14 vs 40 ± 15).
Conclusion: In our population of normal subjects, SD and HB phase
analysis parameters of LV synchrony are similar in rest and stress
images. Some phase analysis parameters are different according to sex
and sestamibi dose. These differences should be taken into account to
assess other populations.
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Value of strain imaging with low dose dobutamine stress in
detection of myocardial viability in myocardial infarction
patients: Comparison with myocardial perfusion imaging
A.M. Amal Hamdy1; M. Naeim1; S. Allam1; T. Ahmed1
1Al-Azhar University, Cairo, Egypt
Background: Detection of myocardial viability (MV) is an important
element in management of patients (pts) after myocardial infarction
(MI). The purpose of this study was to investigate the value of strain
imaging (SI) with low dose dobutamine stress echo (LDDS) for
detection of MV in pts with MI in comparison to myocardial perfusion
imaging (MPI).
Methods: 39 MI pts were subjected to both MPI using technetium-99m
Sestamibi with nitrate potentiation and SI during LDDS. Pts were
classified according to results of MPI into groups of viable and non-
viable myocardium in each of the three coronary territories. Wall
motion score index (WMSI) was calculated at rest and with LDDS in
117 territories (39 LAD, 39 LCX and 39 RCA). Strain values were
determined at rest and with LDDS in 12 segments per patient (total 468
segments). Post-systolic shortening (PSS) as a marker of MV was
investigated.
Results: MPI identified MV in a total of 92 out of the 117 territories
and in 339 out of the 468 segments. Detection of MV by reduction of
WMSI in response to LDDS was concordant with MPI results in 82 (26
in LAD, 34 in LCX and 22 in RCA) out of the 92 territories identified
as viable by MPI; and both techniques were matched in non-viability in
eight territories (4 in LAD, 1 in LCX and 3 in RCA), Fisher exact
P = .02. Positive predictive value (PPV) for LDDS-WMSI in viability
detection was 82.8%, specificity was 32% and overall accuracy was
76.9%. Strain values were lower in nonviable compared to viable
segments in LAD and LCX territories but the differences were sig-
nificant (P \ .05) in only few segments (mid anterior, basal and mid
lateral segments). Strain values increased in response to LDDS in
viable segments of LAD territory (P \ .01), with no significant
increase in nonviable segments. Responses of strain values to LDDS in
segments of RCA and LCX territories were not conclusive. PSS was
present in 98 out of the 339 (28.9%) segments identified as viable by
MPI (40 in LAD, 29 in LCX and 29 in RCA territory), and in 52 out of
129 segments (40.3%) identified by MPI as nonviable. PPV of PSS as a
marker of viability was 65.3%, its specificity was 59.7% and its
accuracy was 37.4%.
Conclusion: Strain imaging might help in detection of myocardial
viability; however, results of this study do not support its use as a
single modality for viability assessment. PSS can be detected in non-
viable as well as in viable and normal myocardium; thus, it can’t be
relied upon as a marker of viability in patients with myocardial
infarction.
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Prognostic value of 18-FDG PET myocardial viability in
ischemic left ventricular dysfunction
F. Rolfo1; G.L. Rosso2; L. Icardi1; E. Racca1; M. Feola2;
A. Terulla3; S. Chauvie3; M. Bobbio1; A. Biggi3
1Cardiology, Santa Croce e Carle Hospital, Cuneo, Italy;
2Heart Failure Unit, SS. Trinita` Hospital, Fossano, Italy;
3Nuclear Medicine, Santa Croce e Carle Hospital, Cuneo, Italy
Purpose: Patients with ischemic left ventricular (LV) dysfunction
might benefit from revascularization assuming an high risk of death or
clinical events. F-18-fluorodeoxyglucose (FDG) positron emission
tomography (PET) is used to define viable myocardium that recovers
after revascularization. Clinical outcome predicted by remaining via-
bility and coronary revascularization is still discussed. The aim of this
study was to determine whether the amount of viable myocardium or
scar detected with FDG-PET scan might predict prognosis.
Methods: This observational study reports a single-center experience.
Patients included had previous myocardial infarction and left ventric-
ular ejection fraction (LVEF)
Results: A total of 144 patients (118 males, ages 64 ± 9 years) were
studied. The LVEF was 31 ± 8 %; 71 (49.3%) suffered an anterior MI;
56 (39%) had three-vessel disease. 67 subjects (46.5%) were treated with
coronary revascularization (90% coronary artery by-pass graft). Patients
who underwent revascularization procedures had larger viable myo-
cardium (2.2 ± 2.2 vs 1.2 ± 1.3 segments, P = .0027) but similar LVEF
(30.2 ± 7.8% vs 30.4 ± 8.3%, P = .93), diabetes mellitus (33.9% vs
24.6%, P = .26) and non viable myocardium (4.3 ± 2.5 vs 4.8 ± 2.7
segments, P = .30). At 5 years follow-up, total mortality (32.8% vs
33.3%), cardiovascular death (45% vs 37%), MI (4% vs 6%) and HF
(11.3% vs 15.8%) were not different in the two groups. At multivariate
analysis, more than five non viable segments (P = .0037), diabetes
mellitus (P = .0014) and age (P = .0011) were significant predictors of
event free survival at 5 years (71.2% vs 43.5%). The amount of mis-
match (more than two segments) demonstrated a trend towards an
association with reduced risk: free survival 70.5% vs 57.3% (P = .068).
Conclusions: In patients with severe ischemic LV dysfunction, the
amount of myocardial scar evaluated by FDG-PET is a useful tool to
predict a mid-term worse clinical prognosis. Viability only demon-
strated a trend towards an association with cardiovascular events risk
reduction. A combination of FDG-PET and clinical parameters (dia-
betes, age) predicts survival.
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Simultaneous evaluation of cardiac function, aorta,
coronary, and AdamKiewicz Artery by 128 slice MDCT
H. Hiroyuki Fukuya1; M. Okada1; M. Su1
1Kobe Circulation Clinic, Kobe, Japan
Rest
Male
n 5 76
Female
n 5 43 P
High dose
n 5 88
Low dose
n 5 31 P
Peak 138 (18) 145 (15) .072 137 (17) 144 (17) .4
SD 14 (4) 10 (4) .11 12 (4) 14 (6) .003*
HB 45 (15) 32 (11) .01* 38 (12) 46 (21) .0001*
HS 3.9 (0.8) 4.9 (1.1) .008* 4.3 (0.9) 4.4 (1.3) .01*
HK 18 (9) 28 (13) .01* 22 (9) 24 (16) .0001*
Stress
Male
n 5 84
Female
n 5 46 P
High dose
n 5 52
Low dose
n 5 78 P
Peak 146 (20) 145 (15) .028* 149 (17) 144 (19) .15
SD 13 (5) 9 (3) .001* 12 (5) 12 (5) .3
HB 42 (14) 31 (12) .06 38 (16) 38 (13) .07
HS 4.2 (1) 5 (1) .33 4.5 (0.9) 4.6 (1.2) .03*
HK 22 (12) 29 (12) .31 24 (11) 25 (14) .01*
The table shows parameters and its differences according to sex, stress/
rest images and sestamibi dose: Average (SD) and *significative P
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Background: Identification of AdamKiewiczArtery (AKA) is neces-
sary to avoid spiral cord ischemia after surgery of descending aortic
aneurysm. Evaluation of coronary artery and cardiac function are also
required for safe operation. However, CT angiography of coronary
artery and AKA is performed independently, so high invasion of
radiation and contrast is problem. In this study, to minimize invasion of
contrast agent and radiation, we attempted simultaneous evaluation of
cardiac function, aorta, coronary artery and AKA as ‘‘one stop shop’’
examination by high-speed helical MDCT.
Method: We performed MDCT in nine new patients (7 males,
71.7 ± 13.7 y.o.) of aortic disease (6 abdominal aneurysm and 3 dis-
sections) by 128 slice MDCT. After CT coronary angiography (CTCA)
by nitrate administration, we injected all remaining contrast and
scanned whole aorta without ECG gating. Using reconstructed images
of coronary artery, 4D cardiac motion, aorta, and AKA, we evaluated
each images and success rate of AKA visualization.
Result: Contrast volume of CTCA was 61.6 ± 13.0 mL and addi-
tionally injected contrast volume was 33.3 ± 8.5 mL. Coronary arteries
were clearly visualized in all patients and significant stenosis was
found in three patients. LVEF was 52.4 ± 7.9%. CT value of ascending
aorta and iliac artery was 283.8 ± 61.6 HU and 269.2 ± 35.6 HU.
AKA was identified in eight of nine patients. The success rate of AKA
identification was 88.9%.
Conclusion: High spatial resolution and rapid helical pitch of MDCT,
and vasodilation by nitrate contributed successful combination scan.
Full capitalizing on MDCT modality characteristics enables less
invasive and high performance examination.
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Anthracycline and trastuzumab toxicity characterized but
not predicted with ERNA phase analysis
D. Daniel Zalkind1; A.C. Chen2; E.V. Vallejo3; L.J. Jimenez3;
R.R. Russell1
1Yale-New Haven Medical Center, New Haven, United States of
America; 2Columbia University Medical Center, New York, United
States of America; 3Nuclear Cardiology Department at the Instituto
Nacional de Cardiologia Ignacio Chavez, Chavez, Mexico
Purpose: Equilibrium Radionuclide Angiocardiography (ERNA) is
used to assess left ventricular ejection fraction (LVEF) during
anthracycline as well as trastuzumab chemotherapy. ERNA phase
analysis of LV-RV delay has been used to evaluate cardiac dyssyn-
chrony prior to implantation of biventricular pacemakers in patients
with known left ventricular systolic dysfunction (LVSD). We proposed
to use LV-RV delay to predict LVSD in chemotherapy patients.
Methods: Eighty-four consecutive patients (mean age 50.7 ±
10.2 years) with four or more ERNA studies from 2002 to 2012 who
underwent anthracycline, trastuzumab or combination therapy were
selected for this retrospective analysis. The cohort was divided into two
groups based on the development of LVSD (group A) or preservation of
normal LVEF (group B). Phase analysis was performed using the Ven-
triQuant software package. Multiple phase analysis parameters including
the LV-RV delay were analyzed. The original large cohort was subse-
quently divided by the LV-RV delay of 10 or above and below 10 (Group
C and D respectively). Similar phase analysis was performed on these
cohorts. ANOVA single-factor analysis with a P-value of .05 was used to
compare the chemotherapy specific subgroups in Group C and D.
Results: Mean period of 295.3 and 643.8 days between the baseline
LVEF and the last normal (pre-drop) in Group A and Group B,
respectively. Mean period of 506.3 and 502.2 days between the
baseline and last study in Group C and D respectively. ANOVA
analysis of patients undergoing either anthracycline alone or combi-
nation therapy in Groups B and C was not statistically significant
F(3,50) = 0.43 P = .74.
Conclusions: Although there is a trend toward significance, the LV-
RV delay does not discriminate well between patient who develop
cardiomyopathy and those who do not while receiving anthracycline,
trastuzumab or combination therapy.
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Post-stress and rest phase analysis differences in one-day and
two days gated-SPECT MPI
S. Santiago Aguade-Bruix1; R. Cardenas Perilla1; M.N. Pizzi1;
G. Romero-Farina1; J. Castell-Conesa1; J. Candell-Riera1
1Hospital Vall d’Hebron, Barcelona, Spain
Purpose: Phase analysis (PhA) of gated myocardial perfusion SPECT
(gated-SPECT MPI) leads to quantitative parameters that reports the
degree of synchronism of left ventricular myocardial contraction. The
purpose of this study was to compare post-stress and rest PhA
parameters obtained by gated-SPECT MPI performed with two
acquisition protocols (stress-rest one day vs two-days).
Methods: PhA of stress-rest gated-SPECT-MPI were prospectively
evaluated by means of PhA in 88 patients (age 65.4 ± 9.9, 66 males),
48 of them with one day protocol. The criteria for two-day protocol
was weight [90 kg. All studies use 99mTc-tetrofosmin, 300 MBq for
low dose and 880 MBq for high dose and a Infinia HK4 (GE) gamma
camera for acquisition. For any patient post-stress gated-SPECT and
rest were performed, and five phase analysisparameters were obtained:
phase peak (PhP), standard deviation (SD), bandwidth (BD), skewness
and kurtosis. Student’s t-test, Wilcoxon’s test, Mann-Whitney test and
multivariate linear regression analysis were used.
Results: Table 1.
Significant differences between post-stress and rest values for ejection
fraction (EF), PhP, DS and BD were obtained in all 88 patients. In 48
patients with one-day protocol significant differences were obtained for
EF, PhP, DS, BD and Skewness. In patients with two days protocol
significant difference was obtained only for EF. Multiple lineal
regression analysis in patients with one-day protocol, adjusted by age,
gender, and CAD, show the histogram bandwidth as the parameter with
major relation with EF.
Conclusions: There are significant differences between post-stress and
rest PhA parameters, mainly if they were obtained with one-day stress-
rest protocol gated-SPECT MPI.
Group A (qualifying LVEF decline) Group B (no LVEF decline)
Baseline Last normal Baseline Pre-drop
LVEF
64.8 ± 5.7% 62.2 ± 6.6% 60.2 ± 4.5% 59.1 ± 5.3%
LV-RV delay
10.47 ± 10.26 7.88 ± 9 4.33 ± 7.8 7.14 ± 10.2
Group C (LV-RV delay \ 10) Group D (LV-RV C 10)
LVEF baseline
62.5 ± 5.3% 63 ± 5.9%
LVEF change% (drop to last)
2.1 ± 6 7.8 ± 7.7
Table 1. Global results
N 5 88 Post-stress mean Post-stress sd Rest mean Rest sd Differences P value
EF
49.3 12.5 52.9 14.7 -3.6 \.001
PhP
135.4 27.8 126.3 20.3 9.1 \.001
SD
29.9 14.1 25.7 13.9 4.3 \.001
BD
96.1 52 82.3 53.1 13.8 \.001
Skewness
3.4 1.1 3.5 1.3 -0.17 .175
Kurtosis
14.6 5 14.9 6 -0.39 .667
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Assessment of myocardial damage and prediction of future
cardiac function in patients with acute myocardial infarction
using sestamibi early washout imaging
T. Tokuo Kasai1; R. Tanaka2; T. Nakamura2
1Jikei University Katsushika Medical Center, Tokyo, Japan;
2Kushiro Sanjikai Hospital, Kushiro, Japan
We examined the relationship between myocardial washout rate of
sestamibi and the severity of the myocardial damage in patients with
acute myocardial infarction (AMI).
Purpose: The aim of this study was to elucidate the usefulness of early
phase of washout rate of sestamibi in predicting future cardiac function.
Method: Thirty-seven AMI patients were hospitalized and underwent
successful PCI then enrolled in this study. Sestamibi SPECT was
obtained in sub-acute phase and repeated 6 months later. Images were
acquired at five minutes (0 h), 1 hour (1 h), and 6 hours (6 h) after
sestamibi (740 MBq) injection. Washout rate was calculated as wash-
out index (WI) between 0 h and 1 h, 1 h and 6 h, respectively. ECG
gated acquisition was performed at 1 h and 6 months later (6 M). The
relationships between washout rate of sestamibi and various parame-
ters, such as perfusion defect, CPK, BNP, and LVEF were investigated.
Results: There were 17 patients whose WI showed 0 from 0 h to 1 h
(group A) and 20 patients whose WI was accelerated (group B). There
were significant differences in WI from 1 h to 6 h between group A
and B (15.3 ± 5.8 vs 19.1 ± 3.7, P \ .05). No significant difference
was found in the number of perfusion defect segments (NPDS) on
SPECT among 0 h, 1 h, and 6 M in group A. On the other hand,
significant difference was found between 0 h and 1 h, 1 h and 6 M in
group B (P \ .01, P \ .05, respectively). Both groupss A and B
demonstrated significant difference in NPDS between 0 h and 6 h
(P \ .01 for each). Group B demonstrated much higher max CPK
value than that in group A (4098 ± 1695 IU/l vs 1452 ± 1006 IU/l,
P \ .001). Although BNP in sub-acute phase was not different
between group A and B (384 ± 413 pg/mL vs 319 ± 260 pg/mL) and
decreased 6 months later similarly, BNP in group B remained much
higher than that in group A in the chronic phase (181 ± 145 vs
98 ± 109 pg/mL, P \ .05). LVEF improved from 55.4 ± 12.4% in sub
acute phase to 62.7 ± 8.8% at 6 month later in group A. On the other
hand, no improvement was found in group B (from 45.7 ± 12.1% to
48.0 ± 13.1%).
Conclusion: It is suggested that in patients with AMI, early myocardial
washout rate derived from sestamibi SPECT associates with severity of
myocardial damage and predict future cardiac dysfunction.
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New results of nuclear cardiology methods monitoring the
CRT-treatment of patients with heart failure
I. Balogh1; Z. Galler1; E. Marosi2; M. Dekany2; N. Nyolczas2
1Uzsoki Municipal Hospital, Nuclear Medicine Department, Budapest,
Hungary; 2Military Hospital, Department of Cardiology, Budapest,
Hungary
Objectives: Our aim was to investigate the importance of different
nuclear cardiology methods predicting or/and measuring the efficacy of
cardiac resynchronization therapy (CRT) in severe heart failure.
Methods: In 15 patients (pts) with severe heart failure (HF)—
EF \ 30%, QRS [ 120 ms, in NYHA III-IV clinical stage—several
kinds of nuclear cardiology procedures were performed. (In 11 pts
ischemic heart disease (IHD), in 4 pts only hypertension was
responsible for HF.) (1) Before CRT gated myocardial perfusion
scintigraphy (GMPS) was performed in every case to distinguish the
viable and necrotic myocardium, to analyze the dynamic systolic
wall-thickening and to measure other functional parameters as well
(Emory Cardiac Toolbox). (2) Before and 6 months after CRT all 15
pts had (a) planar MUGA and (b) SPECT MUGA (Interview XP,
Cedars Sinai QGS) to analyze the left ventricular (LV) and right
ventricular (RV) function, phase angle (phase histogram) and syn-
chrony (S).
Results: GMPS showed small necrosis only in two cases (2/15), but
intraventricular dyssynchrony, with wide phase angle was detected in
every case. According to necrotic myocardium a separate peak
appeared on the phase angle. We could detect on planar and SPECT
MUGA—before CRT—low LVEF (10-28%) in every case (15/15), in
3/15 cases RVEF was decreased as well (20-38%). Inter and/or intra-
ventricular mechanical dyssynchrony, wide phase angle was detected
in every case. After CRT the clinical stage and LVEF improved sig-
nificantly in every case, RVEF decreased in 1 case and improved in 2
cases. In 13/15 cases both S value (as improvement) and phase angle
(as shortening) changed significantly.
Conclusions: For the prediction of effectiveness of CRT-therapy GMPS
proved to be an excellent method distinguishing the necrotic myocar-
dium—with separate peak and wide phase angle on ‘‘the dynamic
systolic wall thickening picture’’ (nonresponder to CRT)—and viable
but dyssynchronic myocardium (responder to CRT). Planar and SPECT
MUGA proved to be reliable methods to measure the functional changes
both the left and right ventricle i.e. the ‘‘response’’ to CRT.
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99mTc-sestamibi myocardial regional washout rate intensely
enhances the degree of the reperfusion injury in patients with
acute myocardial infarction receiving percutaneous coronary
intervention
K. Teramoto1; Y. Yoshihiro Akashi1; K. Ashikaga1;
M. Manabe1; T. Harada1; F. Miyake1
1St. Marianna University School of Medicine, Kawasaki, Japan
Background: Myocardial scintigraphy is widely used to assess myo-
cardium damaged by ischemia. Recently, the washout rate (WR) of
99mTc-sestamibi is used as a marker of damaged myocardium.
However, its clinical significance has not been evaluated in details. In
the present study, we evaluated the relationship between the regional
99mTc-sestamibi WR determined from myocardial scintigraphic
images and cardiac enzymes in patients with acute myocardial
infarction (AMI).
Methods: Seventy-two consecutive patients with AMI (mean age
65.7 ± 10.1 years) within 24 hours of onset who underwent primary
percutaneous coronary intervention (PCI) treatment on admission were
enrolled. A cardiac enzyme, MB isoenzyme of creatinine kinase (CK-
MB), was measured every 3 hours after PCI. 99mTc-sestamibi single
photon emission computed tomography (SPECT) images were acquired
at 30 minutes (early) and 4 hours (delayed) after tracer injection at
2 weeks after AMI onset. The left ventricular myocardium was divided
into three segments according to each coronary territory area, and the
regional WR was calculated using the cardioBull software (FUJIFILM
RI Pharma Co. Ltd., Tokyo, Japan). The left ventricular ejection frac-
tion (LVEF) was determined by the quantitative gated SPECT.
Results: (1) 29 patients had the culprit lesion in the left anterior
descending coronary artery (LAD), eight patients in the left circumflex
coronary artery (LCx), and 35 patients in the right coronary artery
(RCA). The primary PCI was performed 7.7 ± 7.5 hours after the onset
of AMI. The peak CK-MB level was 296.1 ± 194.6 IU/L (15.6 ± 5.6
hours after the onset). The initial LVEF was 50.2 ± 11.2 %. (2) The
regional WR of the culprit area was 32.4 ± 9.5% in LAD,
31.0 ± 13.6% in LCx, and 33.2 ± 6.5% in RCA.
(3) The sensitivity and specificity of the regional WR of the culprit area
in all patients for detecting mild ischemia reperfusion injury group,
defined as patients with the peak CK-MB level lower than 300 IU/L
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after PCI, were 71% (95% CI, 53.4-83.9%) and 85% (95% CI, 70.9-
92.9%), respectively, when the cutoff value was set at 40%
(AUC = 0.833).
Conclusion: These results suggest that the regional WR calculated
from 99mTc-sestamibi SPECT images reflect the degree of myocardial
injury after PCI.
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Noncompaction of left ventricular myocardium: Clinical
masks of the syndrome
O.V. Blagova1; A.V. Nedostup1; V.P. Sedov1; N.V. Gagarina1;
E.A. Kogan1; Y.U.V. Frolova2; S.L. Dzemeshkevich2;
E.A. Mershina3; A.G. Kupryanova4
1I.M. Sechenov I Moscow State Medical University, Moscow, Russian
Federation; 2B.V. Petrovsky Russian Scientific Center of Surgery of the
Russian Academy of Medical Sciences, Moscow, Russian Federation;
3Roszdrav Medical Rehabilitation Center, Moscow, Russian
Federation; 4Institute of Transplantology and Artificial Organs,
Moscow, Russian Federation
Objective: To study clinical manifestations of noncompaction of the
myocardium (NCM), especially in combination with other heart
diseases.
Methods: In 27 patients (15 men, 42.3 ± 12.9 years) blood sampling
for cardiotropic viruses (PCR and IgG/IgM, ELISA) and anti-heart
antibodies were performed, ECG, Holter monitoring, EchoCG (NCM
was confirmed in 88.9%), and cardiac CT (n = 23, 78.3%) and MRI
(n = 11, 100%), coronarography (n = 9), endomyocardial biopsy
(n = 2), intraoperative biopsy (n = 1), explanted heart examination
(n = 1), autopsy with viral PCR (n = 2). In 81.5% of patients NCM
was confirmed by 2-3 methods.
Results: Heart failure was diagnosed in 92.6% of patients (I class
[NYHA] in 8, II in 6, III in 7, and IV in 4), ventricular arrhythmias in
92.6%, atrial fibrillation in 33.3%, angina in 25.9%. The average left
ventricle diastolic diameter was 6.4 ± 0.8 cm, EF was 31.3 ± 14.0%,
systolic pulmonary artery pressure was 40.9 ± 13.8 mm Hg; intracar-
diac thrombosis was diagnosed in 22.2%. There were various clinical
syndrome masks (diagnostic scenarios): (1) NCM detected during
screening without clinical signs (3.7%); (2) NCM manifested in the
form of «idiopathic» arrhythmias (11.1%); (3) NCM masking coronary
heart disease (3.7%); (4) NCM in patients with acute or subacute
myocarditis (11.1%); (5) NCM manifested as dilated cardiomyopathy
(48.1%); and (6) NCM in patients with other primary cardiomyopa-
thies (22.3%). Three pacemakers, nine ICDs, two CRT-D were
implanted (55.6% of patients), two heart transplantations, and one
reconstructive surgery were performed; 13 patients received antiviral/
immunosuppressive therapy. The mortality was 14.8% (average fol-
low-up was 14.1 months).
Conclusions. Diagnostics of NCM should implement at least two
methods (EchoCG, CT, or MRI). Isolated NCM was found only in one
third of adult patients, usually it was combined with various heart
abnormalities (atrial and ventricular septal defect, pulmonary stenosis;
18.5%), other primary cardiomyopathies (ARVD, genetic myopathy;
7.4%), myocarditis (51.9%, including viral myocarditis in 40.7%), that
was the main cause of «unexplained» aggravation of stable NCM
requirings treatment. Signs of restrictive/hypertrophic cardiomyopathy
in 14.8% of patients with NCM can be considered as a combination of
cardiomyopathy or morphofunctional NCM variant. Morphological
diagnostics is informative both regarding verification of primary car-
diomyopathies (also NCM), and myocarditis. It is necessary to study a
possible compensatory nature of NCM in patients with severe systolic
dysfunction.
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Determination of vascular reserve of cerebral arteries during
cerebral digital angiography by introduction of sodium
nitroprusside buccal polymeric films with controlled
substance release
S. Kechyn1; I. Kechyn1; A. Materukhin2
1Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine;
2Zaporizhzhya Clinical Hospital Endovascular Surgery Department,
Zaporizhzhya, Ukraine
Introduction: Transmucosal administration of drugs can increase the
absolute bioavailability of the active substance by reducing its hepatic
biotransformation in the,it allows to reduce the dose, and therefore
reduce the risk of the development of unwanted side reactions and
toxic manifestations of active substances.
Methods and material research: A drug form for buccal application
has been developed: sodium nitroprusside (‘‘Niprutsel’’) as buccal
polymer films with controlled release of substances for 30-40 minutes
at a dose of 5 mg. Angiography performed on complex «Arcogem»
(General Electric). A total of 72 patients with transient ischemic
attacks (TIA) due to atherosclerosis, and hypoplasia of the brachi-
ocephalic arteries were studied.
Results: The result of the application of buccal polymeric form of
‘‘Niprutsel’’ has shown significant hypotensive reactions. Mean BP
decreased by 15-23% during 3-40 minutes in patients with both types
of crises. Among patients with TIA: within 10 minutes after the
application of the drug increased blood flow volume compared to
baseline against atherosclerotic remodulation of carotid and vertebral
arteries by 34% (P \ .02). In 81% of patients with pathological tor-
tuosity sonnih arteries—by 29% (P \ .05) in the carotid, and 20% in
the vertebral arteries (P \ .05) in 90% of patients. Among patients
with hypoplastic vertebral artery Niprutsel increases blood flow in the
affected artery by 31% (P \ .05); intact by 35% (P \ 002) in 83.3% of
patients.
Conclusions: Conducting contrast cerebral angiography using trans-
mucosal buccal dosage form of sodium nitroprusside is a new and safe
method allowing to indentify patients with low-capacitance cerebro-
vascular reserve bed, who are prescribed to undergo a non constructive
surgical intervention on brachiocephalic arteries.
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Myocardial bridges (MB) and myocardial perfusional
single photon emission computed tomography (SPECT) in a
clinical setting
G. Guido Valle1; A. Facciorusso2; S. Michelini3; M. Totaro1;
G. Di Stolfo2; S. Mastroianno2; G. De Luca2; M. Stanislao2
1Scientific Institute Casa Sollievo della Sofferenza, Department of
Nuclear Medicine, San Giovanni Rotondo, Italy; 2Scientific Institute
Casa Sollievo della Sofferenza, Department of Cardiology, San
Giovanni Rotondo, Italy; 3Sapienza University of Rome, 2nd Faculty of
Medicine, Rome, Italy
Background and Aim: MB is the anatomical condition characterized
by the presence of an epicardial artery that goes intramurally through
the myocardium beneath the muscle bridge. MB is largely undiagnosed
in lifetime. Symptoms, when present, simulate those of coronary ath-
erosclerosis and the diagnosis is usually performed by coronarography
and/or by angio-CT in subjects referred for the suspicion of athero-
sclerotic coronary artery disease. MB can be detected as isolated
findings but can also be observed in presence of a atherosclerotic
coronary artery disease both of the same bridged artery (usually
upstream of the MB) or of other coronary arteries. Myocardial perfu-
sional studies by SPECT offers a unique, safe and reliable way to
assess the effective myocardial perfusion downstream the bridge. Aim
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of our study has been a retrospective analysis of our series focused on
myocardial perfusional abnormalities induced by MB.
Patients and Methods: Sixteen patients (15 M) with a previously
coronarography demonstrated MB underwent myocardial perfusion
stress/rest gated-SPECT studies. MB was localized at the second
(intermediate) portion of the Left Descending Artery (LDA) in 12
cases, in the distal part of LDA in 3 cases and in the distal portion of
the Left Circumflex Artery (LCA) in one case. In eight cases the MB
was the only pathological finding at coronarography, in the other eight
patients an angiographically significant coronary artery disease was
present.
Results: None of the patients with MB in the distal portion of the LDA
nor in that with the MB at the terminal portion of the LCA demon-
strated perfusional abnormalities in the area supplied by the bridged
coronary artery. In eight out of the 12 patients with MB at the LDA
second segment the perfusional myocardial SPECT did not demon-
strated perfusional derangements of the anterior wall nor of the apex.
On the contrary the other four subjects demonstrated the presence of
significant perfusional abnormalities in the myocardial area down-
stream the MB.
Discussion and Conclusions: Our series gives a further confirmation
that MB is usually not associated to important ischemic phenomena. In
our series the dynamic stenosis represented by MB is associated to a
normal perfusional pattern in 75% of cases. However in a quarter of
cases myocardial perfusional SPECT demonstrated inducible heart
wall ischemia downstream the MB. The identification of the subjects
with significant functional stenosis is critical because these patients
will take the maximal advantage from a diastolic time lengthening
pharmacological therapy.
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In-hospital outcomes of biventricular assist devices
for high-risk percutaneous coronary intervention
V. Ganyukov1; M. Maxim Sinkov1; V. Popov1; D. Shukevich1;
L. Barbarash1
1Research Institute for Complex Issues of Cardiov. Dis.-Siberian
Branch RAMS Institution Scientific, Kemerovo, Russian Federation
Background: Revascularization by coronary artery bypass grafting
(CABG) is contraindicated in some patients with severe multivessel
coronary arterial disease (CAD). Percutaneous coronary intervention
(PCI) in this patient group also carries the risk of adverse outcomes in
case of low left ventricular (LV) function, a technically difficult pro-
cedure, or when a large area of viable myocardium is supplied by
target vessels. Currently, evidence for intraaortic balloon pump (IABP)
application in PCI is still pending due to the lack of adequate circu-
latory support and the need for a certain level of LV function. Perhaps,
biventricular assist devices supported by extracorporeal membrane
oxygenation (ECMO) can provide effective hemodynamic support for
high-risk PCI patients with multivessel CAD who have contraindica-
tions for CABG.
Methods: Eight patients with CAD contraindication for CABG were
included in the study. The average age was 62.8 ± 6.1 years, Euro-
Score 10.6 ± 2.4. Half of the patients (n = 4) had severe
comorbidities,six patients had non-STEMI. All patients underwent the
high-risk PCI facilitated by ECMO. Six patients had left main coronary
artery (LMCA) stenosis ([70%), all of them presented multivessel
CAD (SYNTAX score 32.4 ± 5.4).
The hemodynamic support in all patients was provided with venoar-
terial biventricular assist devices with perfusion index of 2.4-2.7 L/
(minutes m2). Primary end-point of the study was death, myocardial
infarction (MI), stroke, target vessel revascularization (TVR), bleeding
and stent thrombosis.
Results: The average number of implanted stents per patents was 3:1.
The average implanted stent length was 54.8 ± 16.2 mm. Seven
patients underwent bifurcation stenting, two patients underwent
chronic total occlusion revascularization and six subjects—unprotected
LMCA intervention. Angiographic success without associated in-hos-
pital major clinical complications (e.g., death, MI, stroke, TVR,
bleeding, and stent thrombosis) was achieved in all cases. Complete
revascularization was performed in 75% (n = 6) of all the patients.
Conclusions: Biventricular assist devices for the high-risk PCI facili-
tated by ECMO ensure to perform successful myocardial
revascularization in patients ineligible for CABG.
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Peptide receptor radionuclide therapy decreases
inflammation in atherosclerotic plaques, as quantified by
68Ga-DOTATATE PET/CT
I. Imke Schatka1; T. Wollenweber1; C. Haense1; F. Brunz1;
K.F. Gratz1; F.M. Bengel1
1Hannover Medical School, Department of Nuclear Medicine,
Hannover, Germany
Purpose: DOTATATE is a somatostatin receptor (SSTR) ligand which
is used with different radiolabels, for molecular imaging and targeted
therapy of tumors. SSTR subtype II is also expressed on activated
macrophages, which are an integral part of inflamed atherosclerotic
plaques. We speculated that peptide receptor radionuclide therapy
(PRRT) has beneficial effects on atherosclerotic plaque by reducing
inflammation. This hypothesis was tested in patients receiving serial
DOTATATE-based imaging and therapy for neuroendocrine tumors.
Methods: Out of a total group of 165 patients undergoing PRRT for
various tumors, we retrospectively identified 11 patients
(60 ± 13 years; 9 m, 2f) which had 3 successive 68Ga-DOTATATE
PET/CT scans, with no therapy between scans 1 and 2 (median time
between scans 347d [range 99-945]), and their first PRRT with the
beta-emitter Lu-177 DOTATATE between scans 2 and 3 (median time
between scan 2 and PRRT 28d [14-89], between PRRT and scan 3
105d [76-131]. Focal vessel wall DOTATATE uptake was measured in
six arterial segments of PET images (carotids; aortic arch; ascending,
descending, abdominal aorta; iliac arteries) as target-to-background
ratio (TBR). CT images were used to detect calcified plaque (CP).
Overall vessel uptake (OVU) was determined as the sum of TBR in all
vascular segments of a patient.
Results: Focal 68Ga-DOTATATE vessel wall uptake was detectable
in all patients. OVU of the first scan correlated with age (r = 0.76;
P \ .01), with the number of CP (r = 0.84; P \ .001) and was higher
in subjects with hypercholesterolemia (P = .04). No significant dif-
ference was found between scans 1 and 2 (43 ± 23 vs 41 ± 26;
P = .80), confirming reproducibility in the absence of treatment.
Following PRRT, there was a significant reduction in OVU of scan 3
(30 ± 19; P = .001 vs scan 1 and P = .004 vs scan 2). In each patient
the number of CPs was stable in all scans.
Conclusion: Our results support feasibility and reproducibility of
68Ga-DOTATATE PET/CT for imaging atherosclerotic plaque
inflammation via SSTR expression. In patients receiving SSTR-tar-
geted PRRT for neuroendocrine tumors, a reduction of plaque
inflammation was indicated after therapy. This initial observation may
serve as a stimulus for further exploration of radionuclide-based anti-
atherosclerotic molecular interventions.
314
RAGE imaging documents the beneficial effect of glucose
control on atherosclerotic progression in apoE null mice both
with and without diabetes
Y. Yared Tekabe1; M. Kollaros1; L. Johnson1
1Columbia University Medical Center, New York, United States of
America
Purpose: Receptor for Advanced Glycation Endproducts (RAGE)
binds AGEs and other inflammatory ligands and is expressed in ath-
erosclerotic plaques in diabetic and non-diabetic subjects. The higher
expression in diabetes mellitus (DM) corresponds with accelerated
course of the disease. We have previously shown that RAGE expres-
sion in aortic atheroma can be imaged in vivo in apoE null mice using
Tc-99m-anti-RAGE F(ab’)2 and SPECT/CT imaging and that uptake is
greater in diabetic compared to non-diabetic mice. The purpose of this
study was to show that control of blood glucose levels in diabetic mice
would lead to reduced RAGE expression and reduced atherosclerosis
compared to uncontrolled diabetics and that this difference can be
detected on in-vivo SPECT imaging.
Methods: Thirty apoE null mice (6 weeks) were given STZ, and after
6 weeks 15 began treatment with 2 insulin implants (LinBits for mice)
with weekly monitoring of blood glucose and additional implants for
blood glucose [ 200 mg/dL. At end of 15 weeks, all mice were
injected with Tc-99m-anti-RAGE F(ab’)2 (15.14 ± 1.23 MBq) and CT
contrast agent (eXIA 160XL) and underwent SPECT/CT imaging
(Bioscan nano-SPECT/CT). Animals were sacrificed, the proximal
aorta removed and counted to calculate the percentage of injected dose
per gram (%ID/g) RAGE uptake, followed by histological and
immunohistochemical characterization. ROIs were drawn over uptake
of radiotracer in the aorta and neck vessels using the contrast angio-
gram to identify vessels and quantified in mCi using InVivoScope
software.
Results: Radiotracer uptake in the proximal aorta, arch, and neck
vessels was visibly less in the treated compared to non-treated and
supported by the quantitative results for %ID: 0.45 ± 0.34 9 10-4 vs
0.78 ± 0.28 9 10-4 (P = 0.007). The mean blood glucose levels for
the duration in treated mice were 144 ± 14 mg/dL and for the controls
348 ± 60 mg/dL. RAGE uptake correlated with quantitative RAGE
staining in the atheroma and there was a significant correlation
between %ID from scans vs %ID/g (R = 0.60, P = 0.023). The lesion
size as percent cross sectional area was significantly smaller in the
treated (14.3 ± 7.8%) vs untreated (29.5 ± 10.9%) (P = 0.03).
Conclusion: These data further support the important role of RAGE
expression in atherosclerosis in diabetes, the value of in-vivo imaging
of RAGE expression in atherosclerosis, and the value of glucose
control to reduce atherosclerotic burden.
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In vivo diagnosis of experimental infective endocarditis:
Comparison between 99mTc-labeled HYNIC-Annexin A5
and Annexin A5-128 for
K. Khadija Ben Ali1; F. Rouzet1; R. Ben Azzouna1; A. Petiet2;
L. Louedec2; D. Chicco3; A. Filannino3; L. Sarda-Mantel1;
M. Jean-Baptiste2; D. Le Guludec1
1AP-HP—Hospital Bichat-Claude Bernard, Department of Nuclear
Medicine, Paris, France; 2Inserm U698—Hospital Bichat-Claude
Bernard, Paris, France; 3Advanced Accelerator Applications,
Colleretto Giacosa, Italy
Objectives: AnnexinA5 (AnxA5) is a ligand of phosphatidylderines
exposed by activated platelets and apoptotic cells. 99mTc-HYNIC-
annexinA5 (HYNIC-Anx) has already been shown to be sensitive for
in vivo detection of platelet activation in animal models. Anx A5-128
is a new mutant of AnxA5 which possess an endogenous peptidic
chelation site at its N terminus. We compared biodistribution and
diagnostic value of HYNIC-Anx and Anx A5-128 in rat model of
infective endocarditis (IE).
 2013 American Society of Nuclear Cardiology
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Methods and Results: Blood clearance and tissue biodistribution was
assessed in 12 control rats. Anx A5-128 was rapidly cleared from the
blood according to a 2-compartment model (rapid component: 83%;
1/2-life 10 minutes) with less than 10% of the injected dose remaining
in blood at 30 minutes (vs 23% for HYNIC-Anx). Tissue biodistri-
bution at 60 minutes was similar between both forms of AnxA5 except
for kidney uptake which was fivefold lower with Anx A5-128. IE was
induced in 12 rats and SPECT/CT performed 1 hour after injection of
the tracer (HYNIC-Anx, n = 6; Anx A5-128, n = 6). On visual
analysis, all animals presented a focal uptake in the aortic valve area
with both tracers. The uptake to background ratio was similar for both
tracers (median and range): 8.7 [5.6-9.7] and 5.0 [2.1-8.1] for HYNIC-
Anx and Anx A5-128 respectively, P = .10. On autoradiography, the
uptake matched with platelets (P-selectin/Annexin A5 positivity on
immunostaining) valvular vegetations and platelets immunostaining.
Conclusions: Blood clearance and tissue biodistribution of Anx A5-
128 is quite similar to that of HYNIC-Anx except for kidney uptake
which is much lower. Its diagnostic value in a rat model of IE is good
and comparable to that of HYNIC-Anx. These results support the
evaluation of Anx A5-128 as a tracer in the diagnosis of IE in humans.
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Myocardial uptake and tetention mechanisms of novel F-18
sympathetic nerve imaging tracer LMI1195
T. Higuchi1; B.H. Yousefi2; F. Kaiser1; F. Gaertner2;
M. Beschorner2; R. Reder2; Y. Ming3; S. Robinson3;
M. Schwaiger2; S. Nekolla2
1Wu¨rzburg University, CHFC/Nuclear Medicine, Wu¨rzburg, Germany;
2Technical University of Munich, Department of Nuclear Medicine,
Munich, Germany; 3Lantheus Medical Imaging, Departments of
Discovery Chemistry and Discovery Biology, North Billerica,
United States of America
Background: A novel 18F-labeled tracer, LMI1195 is being developed
for sympathetic nerve terminal PET imaging of the heart. Its high
specificity for neural uptake-1 mechanism has previously been dem-
onstrated in cell associative studies and in rabbit and non-human
primate in-vivo studies assessing heart uptake. The aim of this study is
to further characterize the mechanisms of LMI1195 cardiac uptake and
retention utilizing isolated perfused rabbit heart to avoids systemic
recirculation of tracer and radiolabeled metabolites.
Methods: Cardiac first pass tracer extraction fraction and retention of
the LMI1195 were measured by a pair of bismuth germanate detectors
interfaced to coincidence detection circuitry of whole isolated rabbit
hearts perfused with the Langendorff method (n = 6). Effect of neural
uptake-1 blocker desipramine 40 nM added to the perfusion media was
monitored during first pass extraction and tracer retention (n = 4).
Results: LMI1195 first pass extraction fraction was calculated as
23.4 ± 3.4% in the isolated rabbit heart using a flow of 40 mL/minutes.
Desipramine decreased the extraction fraction to 7.7 ± 3.2%
(P \ .001). There was a minimal tracer washout with a rate of
0.39 ± 0.05%/minutes during the initial 10 minutes, but from thereon,
tracer retention remained stable in the hearts. The washout rate did not
change under the 40 nM desipramine additive during the early washout
phase (0.51 ± 0.12%/minutes, n.s.).
Conclusion: Utilizing the isolated rabbit heart system, cardiac first
pass extraction fraction of LMI1195 was determined. The extraction
fraction was decreased significantly by desipramine indicating highly
specific uptake mechanism for norepinephrine uptake in nerve termi-
nals consistent with previous cellular and in-vivo studies. High tracer
retention indicated minimal metabolism in the heart, and it was not
influenced by desipramine suggesting stable tracer storage into the
nerve terminals. Thus, LMI1195 is promising for the cardiac nerve
terminal PET imaging.
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GSAO-based molecular targeting of myocardial necrosis in
acute ischemic insult
H.J. Hans De Haas1; H.R. Zandbergen2; N. Tahara3;
A.D. Petrov1; R.H.J.A. Slart4; H.H. Boersma4;
C.P. Reutelingsperger2; J. Narula1
1The Zena and Michael A. Wiener Cardiovascular Institute, Mount
Sinai School of Medicine, New York, United States of America;
2Maastricht University, Cardiovascular Research Institute Maastricht
(CARIM), Maastricht, Netherlands; 3Kurume University, Kurume,
Japan; 4University Medical Center Groningen, Department of Nuclear
Medicine and Molecular Imaging, Groningen, Netherlands
Purpose: GSAO has an arsenic group that binds to dithiols on various
intracellular proteins that are upregulated during cellular stress
including HSP90, PDI, which plays a role in the unfolded protein
response and apoptosis, and Beclin-1, which drives autophagy.
Extracellular dithiols are uncommon. As 111In-GSAO is membrane
impermeable, intracellular uptake shows membrane disruption, a
hallmark of necrotic cell death. It is proposed that information about
preferential protein binding other than HSP90 would determine the
likely initial cell death pathway. The current study sought to show
feasibility of GSAO imaging in animal models of acute and chronic
myocardial infarction and to evaluate the relation between myocardial
apoptosis and necrosis.
Methods: Chronic and acute myocardial infarction were induced by
persistent occlusion and by 30 minutes occlusion + release of the LAD
in rabbits and mice. In acute MI rabbits, in vivo and ex vivo SPECT
imaging using GSAO (n = 6), GSAO + sestamibi (n = 4),
GSAO + AA5 (n = 3) and control compound GSCA (n = 5) were
performed, followed by gamma-counting and immunohistochemistry.
In mice, ex vivo imaging and gamma-counting using GSAO was
performed after acute MI (n = 6), after chronic MI at 2 (n = 6), 4
(n = 6) and 12 (n = 8) weeks and in controls (n = 5). GSCA was
employed at 2 (n = 6) weeks. Six mice received fluorescently labeled
AA5 and GSAO after acute MI.
Results: In rabbits, myocardial GSAO uptake was high
(1.1 ± 0.43%ID/g), localized in the perfusion defect and was signifi-
cantly higher than in the remote area (0.07 ± 0.03%ID/g, P \ 0.001).
GSAO and AA5 uptake were observed in the same region and showed
a strong correlation (0.75, P \ .001). IHC revealed correlation with
apoptosis markers TUNEL (r = 0.54 P \ .001) and Caspase-3
(R = 0.27 P \ .001); no significant correlation was observed with
Beclin or PDI. In mice, high GSAO uptake was observed in acute MI
(2.56 ± 2.51 %ID/g) and significantly reduced over time in chronic MI
to level of controls (0.13 ± 0.02%) paralleling apoptosis as shown by
TUNEL. No specific uptake of GSCA was seen in mice or rabbits.
Fluoro-microscopy in acute MI mice showed that all GSAO-positive
cells were AA5-positive, GSAO-negative Annexin-positive cells were
seldomly seen. Extracellular GSAO was not observed.
Conclusions: GSAO SPECT is feasible after acute MI. Colocalization
of GSAO and AA5 shows that necrosis after acute MI is secondary to
apoptosis. The lack of correlation of GSAO with Beclin-1 or PDI, and
the correlation of GSAO with AA5, and TUNEL and Caspase-3 show
that necrosis following apoptosis is a dominant cell death mode in this
setting.
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Correlation between calcium score on attenuation correction
CT and gated non-contrast computed tomography
M. Al-Mallah1; H. Alziady1; I. Suleiman1; M. Alharthi1;
A. Alsaileek1
1National Guard Hospital, King Abdulaziz Cardiac Center (KACC),
Riyadh, Saudi Arabia
Introduction: Quantification of coronary artery calcification with non-
contrast gated cardiac CT has been well validated using Agatston
method. While visual estimation of CCS using attenuation correction
CT (CTAC) images obtained during positron emission tomography
(PET) appears to agree with CAC scans, the quantification of CCS by
CTAC has not been extensively studied. The aim of this analysis is to
determine the correlation between coronary artery calcium score (CCS)
using a low dose radiation non ECG gated CTAC and a dedicated ECG
gated non contrast Cardiac CT (CAC).
Methods: We included 147 patients (mean age 62 years, 52% male)
who underwent myocardial perfusion positron emission tomography
(PET) and coronary calcium score in the same setting. Calcium score
was calculated twice on both non-contrast gated CT (120 Kvp,
200 mA, 2.5 mm slice thickness), and computed tomography attenu-
ation correction CTAC (120 Kvp, 20 mA, 3.8 mm slice thickness)
using Agatston method by two physicians blinded to the results of the
other study. A threshold of 130 HU was used to define detected
calcium.
Results: Nearly half of the patients included in the study were obese
(median BMI [ 31 kg/m2). 92 cases (63%) had CCS [ 0. There was a
strong statistical correlation between calcium score obtained from the
two scans at patient level (R = 0.897, P \ .0001) and at vessel level.
(r = 0.827, P \ .001). However, compared to CAC, calcium score on
CTAC was overestimated in five cases and underestimated in 86 (59%)
patients with median difference of 88 (range 1-1468). Of the 92
patients with detected calcium on CAC, 39 (42%) patients had no
detected calcium on CTAC.
Conclusion: A very low radiation attenuation correction computed
tomography scan underestimates calcium score often. A total of 42%
of patients with coronary calcifications were missed on the CT atten-
uation correction.
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Can we achieve a benefit in all-cause mortality by coronary
computed tomographic angiography routine screening in
asymptomatic diabetic patients?
B.-H. Byung-Hee Hwang1; M.-K. Kang1; C.-J. Kim1; J.-J. Kim1;
M.-O. Jang1; K.-Y. Chang1; S.-M. Yim1; I.-J. Choi1; T.-H. Kim1
1The Catholic University of Korea, St. Mary’s Hospital, Seoul,
Republic of Korea
Background: Coronary computed tomography angiography (CCTA) is
a noninvasive imaging test that demonstrates high diagnostic perfor-
mance for the detection and exclusion of CAD, with recent multicenter
studies demonstrating a robust prognostic utility to CT angiographic
findings for the prediction of mortality and other major adverse cardiac
events (MACE).
But till now, only few studies are aimed at the prediction of mortality
and other MACE in asymptomatic diabetic patients. Since diabetes is
already known as a coronary artery disease equivalent, there might be a
benefit in all-cause mortality by performing coronary CT routinely in
diabetic patients.
Methods: We have enrolled 2866 asymptomatic, adult diabetic
patients from 2005 to 2011. CCTA scans were performed in 955
patients, and 1910 patients were enrolled as control group with no
CCTA scans. Control group was matched with CCTA scan group in
age, gender with 2:1 ratio. All patients had a follow-up for death, MI,
stroke with a median duration of 31 months.
Results: CCTA scan group had a longer DM duration (12.45 ± 9.5 vs
10.19 ± 8.98, P \ .001), higher HbA1c (8 ± 1.94 vs 7.59 ± 1.8,
P \ 0.001), BUN (18.42 ± 9.14 vs 17.13 ± 7.32, P \ .001), Cr
(1.03 ± 0.56 vs 0.92 ± 0.22, P \ .001) level, and lower Hb
(13.52 ± 1.67 vs 13.27 ± 1.82, P = .01), AST (27.25 ± 35.82 vs
23.71 ± 9.89, P \ .001), premeal C-peptide (2.12 ± 2.31 vs
1.8 ± 1.26, P \ .001) level. Univariate hazard ratio in CCTA scan
group for all death in 5-year landmark analysis had statistical signifi-
cance (HR 0.610, 95% CI 0.424-0.876, P = .008). After adjusting for
multivariables, CCTA scan group still showed statistical significance
(HR 0.670, 95% CI 0.457-0.982, P = .040).
Conclusion: Performing CCTA scans in asymptomatic diabetic
patients as a routine screening study has a benefit in all-cause mortality.
Cumulative hazard between 2 groups
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Prognostic value of MDCT in diabetes: Excellent long-term
prognosis in patients with normal coronary arteries
S. Mushtaq1; D. Andreini2; G. Pontone1; E. Bertella1; E. Conte1;
A. Baggiano1; S. Cortinovis1; M. Pepi1; G. Ballerini1;
C. Fiorentini2
1Cardiology Center Monzino (IRCCS), Milan, Italy; 2Cardiology
Center Monzino (IRCCS), Department of Cardiovascular Sciences,
University of Milan, Milan, Italy
Purpose: To assess the prognostic role of multidetector computed
tomography coronary angiography (MDCT-CA) in diabetics with
suspected coronary artery disease (CAD). Use of MDCT-CA is
increasing in patients with suspected CAD. However, data supporting
its prognostic value in diabetics are limited.
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Methods and Results: Between January 2006 and September 2007, 429
consecutive diabetic patients were prospectively studied with MDCT-CA for
detecting presence and assessing extent of CAD (disease extension and
coronary plaque scores). Patients were classified according to the presence of
normal coronaries, non-obstructive (\50%) and obstructive ([50%) coro-
nary lesions. The composite rates of hard cardiac events (cardiac death, non-
fatal myocardial infarction, unstable angina) and all cardiac events (includ-
ing revascularization) were the end points of the study. Twenty-four patients
were excluded because MDCT-CA data were uninterruptable. Of the
remaining 405 patients, clinical follow-up (mean 62 ± 9 months) was
obtained in 390 (98%). By multivariate analysis, predictors of hard and all
events were obstructive CAD, 3-vessel CAD and left main coronary artery
(LMCA) disease. Cumulative event-free survival was 100% for hard and all
events in patients with normal coronary arteries, 78% for hard events and
56% for all events in patients with non-obstructive CAD, and 60% for hard
events and 16% for all events in patients with obstructive CAD. Three-vessel
CAD and LMCA disease was associated with higher rate of hard cardiac
events.
Conclusion: MDCT-CA provides long-term prognostic information in
diabetics with suspected CAD, showing excellent prognosis when there
is no evidence of atherosclerosis and allowing risk stratification when
CAD is present.
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Automatic quantification and characterization of coronary
atherosclerosis with computed tomography angiography
(CTA): Cross-correlation with intravascular ultrasound
virtual histology (IVUS VH)
M.A. De Graaf1; A. Broersen2; P.H. Kitslaar2; J. Dijkstra2;
M.J. Schalij1; J.H. Reiber2; J.J. Bax1; V. Delgado1; A.J. Scholte1
1Leiden University Medical Center, Department of Cardiology, Leiden,
Netherlands; 2Leiden University Medical Center, Department of
Radiology, Division of Image Processing, Leiden, Netherlands
Purpose: Plaque constitution on CTA is associated with prognosis. At
present only visual assessment of plaque constitution is possible. An
accurate automatic, quantitative approach for CTA plaque constitution
assessment would improve reproducibility and allows higher accuracy.
The present study assessed the feasibility of a fully automatic and
quantitative analysis of atherosclerosis on CTA. Clinically derived CTA
and IVUS VH datasets were used to investigate the correlation between
quantitatively automatically derived CTA parameters and IVUS VH.
Methods: A total of 57 Patients underwent CTA prior to IVUS VH.
First, quantitative CTA (QCT) was performed. Per lesion stenosis
parameters and plaque volumes were assessed. Using predefined HU
thresholds, CTA plaque volume was differentiated in four different
plaque types (necrotic core (NC), dense calcium (DC), fibrotic (FI) and
fibro-fatty tissue (FF). At the identical level of the coronary, the same
parameters were derived from IVUS VH. Bland-Altman analyses were
performed to assess the agreement between QCT and IVUS VH.
Results: Assessment of plaque volume using QCT in 108 lesions
showed excellent correlation with IVUS VH (r = 0.928, P \ .001)
(Figure 1). The correlation of both FF and FI volume on IVUS VH and
QCT was good(r = 0.714, P \ .001 and r = 0.695, P \ .001 respec-
tively) with corresponding bias and 95% limits of agreement of 24 (-42;
90) and 7.7 (-54; 70). Furthermore, NC and DC were well-correlated in
both modalities (r = 0.523, P \ .001) and (r = 0.736, P \ .001).
Conclusion: Automatic, quantitative CTA tissue characterization is
feasible using a dedicated software tool.
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Absence of coronary calcification is associated with a low
long term revascularization rate
M. Al-Mallah1; W. Qureshi2; K. Nour2
1National Guard Hospital, King Abdulaziz Cardiac Center (KACC),
Riyadh, Saudi Arabia; 2Henry Ford Hospital, Detroit, United States of
America
Background: The absence of coronary artery calcification (CAC) is
associated with excellent long term survival. However, some data sug-
gest that the absence of coronary calcification does not rule out the need
for revascularization. The aim of this analysis is to determine the long
term need for revascularization among patients with zero calcium score.
Methods: CAC measurement was performed in 1255 consecutive
patients without known coronary artery disease (CAD). (Mean age
58 ± 12 years, 49% males, and 78% symptomatic) Patients were fol-
lowed up for future angiography and revascularization using medical
records review and insurance claims data.
Results: A total of 497 (37%) patients had zero calcium score. Patients
with zero CAC were more often females (64% vs 42%, P \ .001), more
often symptomatic (78% vs. 71%, P = .012) with higher prevalence of
hypertension and diabetes. After a median follow-up duration of 47
months (25-75th percentile 32-63 months, range up to 101 months), 218
(17.4%) patients underwent clinically indicated coronary angiography
and 75 (6.1%) patients underwent clinically indicated revascularization,
5 patients (1%) with zero CAC vs 70 patients (9%) with non-zero CAC
(P \ .001) (Figure). In multivariable Cox regression, coronary calcifi-
cation was the strongest predictor of the need of long term
revascularization. [Hazard ratio (HR) 8.3, 95% CI 3.2-21.5, P \ .001].
Other predictors were symptoms (HR 2.4) and male gender (HR 2.1).
Conclusions: In an up to 8 years of follow-up, the absence of coronary
calcification excludes the need for coronary revascularization.
.
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Quantitative cardiac SPECT and coronary calcium score in
the detection of coronary artery disease: Validation of
findings by coronary angiography
M. Kaminek1; I. Metelkova1; M. Budikova1; E. Buriankova1;
R. Formanek1; L. Henzlova1; P. Koranda1; E. Sovova1;
V. Kincl2
1University Hospital Olomouc, Olomouc, Czech Republic;
2CMI, ICRC-FNUSA, Brno, Czech Republic
Purpose: To analyse sensitivity and specificity of SPECT and to assess
the diagnostic potential of quantitative parameters of perfusion, left
ventricular function and coronary artery calcium (CAC) score to
identify high risk patients with multivessel coronary artery disease.
Methods: 702 patients underwent stress gated SPECT study and then
coronary angiography. We quantified summed difference score (converted
to % of ischemic myocardium), left ventricular ejection fraction (LVEF),
end-diastolic/end-systolic volumes, transient ischemic dilatation (TID)
ratio. In patients with a dilated left ventricle, we measured CAC score.
Results: Sensitivity and specificity of SPECT were 91% (456/502) and
76% (151/200), respectively. There was not significant difference
between sensitivity in men and women (91% vs 90%, P = NS).
Sensitivity was significantly higher in patients with multivessel dis-
ease (87% in 1-vessel disease vs 95% and 94% in 2- and 3-vessel
disease, respectively, P \ 0.05). In quantitative analysis, % of ische-
mic myocardium rose with a number of diseased vessels: 11% ± 11%,
15% ± 12% and 19% ± 14% in patients with 1-, 2- and 3-vessel dis-
ease, respectively. The sign of postischemic left ventricular stunning
(poststress worsening of the LVEF [ 5% and/or TID ratio [ 1.17) was
observed in 46%, 49%, and 63% of patients with 1-, 2- and 3-vessel
disease, respectively. In the subgroup of 81 patients with a dilated left
ventricle, combining SPECT with CAC score (at a cutoff of 1000)
improved sensitivity from 80% to 91% and negative predictive value
from 66% to 81% (P \ .05), in association with not significant change
in specificity and positive predictive value.
Conclusions: Quantitative SPECT enables identification of high risk
patients with a large ischemia and postischemic stunning with probable
multivessel disease. In patients with a dilated left ventricle, the accu-
racy of SPECT has been improved by combination with CAC score.
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Simultaneous evaluation of myocardial perfusion imaging
(MPI) and coronary calcium score (CCS) in patients with
intermediate likelihood of CAD: A 5 year follow-up study
C. Cittanti1; E. Succi Leonelli2; D. Mele3; S. Panareo1;
I. Santi1; C. Peterle1; V. De Cristofaro1; I. Rambaldi1;
V. Rossetti1; L. Feggi1
1Nuclear Medicine Unit—University Hospital, Ferrara, Italy;
2Cardiology Unit—Delta’s Hospital, Lagosanto, Italy;
3Cardiology Unit—University Hospital, Ferrara, Italy
Aim: Hybrid SPECT-CT tomographs offer the opportunity to simul-
taneously evaluate both functional (MPI) and morphoanatomical
(CCS) aspects of the atherosclerosis. The aim of this study is to assess
the additional prognostic value of CCS in adjunct to MPI in the
evaluation of patients with intermediate-risk of CAD.
Materials and Methods: Study population consisted of 367 prospec-
tive patients who were clinically scheduled for MPI and classified at
intermediate risk on the basis of the Framingham Risk Score. All
subjects underwent contextual rest sestamibi MPI and CCS evaluation
as a part of a standard two-days stress-rest MPI protocol. Studies were
acquired with an hybrid Symbia T2 tomograph (Siemens). Summed
Stress Scores (SSS) and Agatston data were calculated for all patients
and MPI studies were considered ‘‘positive’’ (+) if SSS [ 3. Subjects
were divided into four groups on the basis of tests results: MPI- and
CCS \ 400 (group A); MPI- and CCS C 400 (group B); MPI+and
CCS \ 400 (group C); and MPI+ and CCS C 400 (group D).
Results: Fifteen patients were excluded because of sub-optimal quality
of imaging and other 22 subjects did not complete the follow-up. The
remaining 330 patients (216 men, mean age 67 ± 12 years) were
prospectively followed for an average of 63 ± 9 months and the out-
come events considered were: cardiac death, non-fatal myocardial
infarction, hospitalization for unstable angina and late ([90 days)
coronary revascularization. Group A consisted of 126 patients, group B
of 58, group C of 32 and group D of 114. The cardiac event rate in the
study population was 2.7%/year. Annual event rates for overall cardiac
events in group A, B, C and D were 0.3, 1.4, 4.4 and 5.6%/year
respectively. Patients with a normal MPI had higher survival free of
cardiac events (P \ .01); additionally an increase in global chi-square
in predicting all cardiac events occurred when CCS data were added to
MPI information. Kaplan-Meier curves showed a significant difference
in event-free survival at 5 years in the four groups.
Conclusions: Although this study suffers from several limitations it
outlines that an ‘‘hybrid’’ approach, combining an anatomic assessment of
coronary atherosclerotic plaque burden (which probably better estimates
longer-term prognosis) with a functional evaluation of myocardial ische-
mia (more closely related to a ‘‘short-term risk’’) may contribute to refine
temporal risk stratification among subjects at intermediate likelihood of
CAD. Multicenter trials are mandatory to confirm these preliminary
findings and to assess their potential impact in larger clinical settings.
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More anatomy and more physiology: Hybrid SPECT-CT
images as the gold standard of a culprit lesion
M.N. Pizzi1; A. Roque2; S. Aguade-Bruix3; G. Cuberas-Borros4;
H. Cuellar-Calabria2; B. Garcia Del Blanco4; G. Romero-Farina4;
J. Castell-Conesa3; D. Garcia-Dorado4; J. Candell-Riera4
1Universitary Hospital Vall d’Hebron, Cardiology Department,
Nuclear Cardiology and Cardiac CT Unit, Barcelona, Spain;
2Universitary Hospital Vall d’Hebron, Radiology Department,
Barcelona, Spain; 3Universitary Hospital Vall d’Hebron, Nuclear
Medicine Department, Barcelona, Spain; 4Universitary Hospital Vall
d’Hebron, Cardiology Department, Barcelona, Spain
Introduction and Objectives: The anatomic extension and severity of
the coronary disease have routinely used in the prognosis evaluation of
patients and the decision of revascularization. However, this is a uni-
dimensional viewpoint of a multi-dimensional problem. We have now
the possibility of integrating non-invasively function and anatomic
images to improve our understanding of the coronary artery disease,
especially helpful in the determination of the culprit lesion.
Methods: We analyzed 30 patients (mean age: 65.5 ± 6.77 years, 90%
men, pre-test prevalence of 63.3% ± 21.88%) with known significant
coronary artery disease ([50% stenoses) in at least one vessel who had
undergone a gated SPECT, a coronary computed tomography angiography
(CTA) and an invasive angiography (IA). We looked for the ability of the
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different techniques in the determination of the culprit lesion (the most
stenotic lesion in the anatomic explorations and the most severe perfusion
defect in the functional test) using the hybrid imaging as the gold standard.
In the hybrid images we considered the culprit vessel the one with a
significant stenosis causing the most severe perfusion defect.
Results: In 3 of 30 CTA (10%), in 4 of 30 IA (13%), and in 3 of 30
SPECT (10%) we could not determine only one culprit vessel-region
due to the presence of two similar stenoses or two similar perfusion
defects. In all these cases SPECT-CTA hybrid images could determine
culprit lesion. After the exclusion of these doubtful cases, we observed
an 81% (22/27) concordance (kappa: 0.692) between SPECT and
hybrid images, 85% (23/27) of concordance (kappa: 0.776) between
CTA and hybrid images, and 88% (23/26) concordance (kappa: 0.817)
between IA and hybrid images. Concordance between SPECT and
hybrid images was 100% for left anterior descending artery (LDA) but
only 64% (9/14) for right coronary-left circumflex artery. Concordance
between anatomic explorations was 80% (20/25) for LDA and 93%
(26/28) for right coronary-left circumflex artery.
Conclusions: When analyzed separately, SPECT, CTA and IA could
not determine the culprit vessel-region in 10-13% of patients while
hybrid images could do it in all cases. There is 80-85% of concordance
between SPECT, CTA, IA and hybrid images for the diagnosis of the
culprit lesion. SPECT was more accurate in the LDA territory while
anatomic explorations did it better in the inferior territory.
353
Prevalence and morphologic features of myocardial
bridging: A coronary computed tomography angiographic
study from Northern Greece
C. Christos Graidis1; T. Christoforidou1; D. Dimitriadis1;
V. Karasavvidis1; V. Psifos1; K. Gourgiotis1; G. Karakostas1;
M. Giannadaki1; I. Neroladakis1; G. Dimitriadis1
1Euromedica-Blue Cross Hospital, Thessaloniki, Greece
Background: Myocardial bridging (MB) is a congenital structural
variant in which a segment of the epicardial coronary artery tunnels
into and is surrounded by the myocardium. The depiction rate of MB
varies significantly between catheter coronary angiography and
autopsy studies. Conventional coronary angiography is the gold stan-
dard for detection, but it is invasive and may not be sensitive enough to
detect a thin bridge.
Purpose: The aim of this study was to assess the depiction rate of MB
by coronary computed tomographic angiography in Northern Greece
and to determine the anatomical features of the tunneling vessels.
Methods: Between January 2009 and March 2012, a total of 1884
consecutive patients who underwent 64-row MDCT coronary angiog-
raphy in our institution, were retrospectively reviewed to identify the
presence and the location of MB and determine morphologic features
and relation to atherosclerosis.
Results: A total of 338 (226 males, 44 females; mean age,
55.4 ± 12.6 years; age range 24-90 years) out of 1,884 (17.9%)
patients showed 353 cases of MB. One hundred ninety-one tunneling
segments (54.2%) were situated in the middle portion of the left
anterior descending coronary artery (LAD), 103 segments (29.2%)
were in the distal portion of the LAD, 38 segments were in the
proximal part of the LAD (10.8%), 6 (1.7%) in the first diagonal
branch, 6 (1.7%) in the ramus intermediate, 3 (0.8%) in the second
diagonal branch, and 3 (0.8%) in the Right coronary artery. Depth
ranged from 0.1 to 4.1 mm. Intramuscular segment length ranged from
9 to 38 mm. All intramuscular segments were without evidence of
atherosclerosis. We found proximal intima to be without atheroscle-
rosis in 44.1% of patients (149/338) and with atherosclerosis in 55.9%.
Distally atherosclerosis was absent in 95.9% of cases.
Conclusions: Our study showed that MDCT is a reliable and nonin-
vasive tool for diagnosing coronary myocardial bridging, since it
accurately determines the location, depth, and length of MB. We found
the incidence of myocardial bridging in this patient group to be 17.9%,
higher than the depiction rate of MB by catheter CAG reported in the
literature and in concordance with other studies using MDCT. The
most common location of MB was in the LAD. We also observed that
most atherosclerotic plaques in the ‘‘host’’ vessel were located at the
segment proximal to the tunneled segment there was no evidence of
atherosclerosis within any intramuscular segment.
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Cost-effectiveness of performing coronary computed
tomography angiography in patients with mild ischemia by
SPECT-MPI
M. Zapparoli1; J. Vitola1; F.R. Farias1; S.S. Zier1; C. Cunha1;
J.J. Cerci1; O.J. Kormann1; A. Stier Jr1; O. Franca Neto1;
R.J. Cerci1
1Quanta Diagnostico e Terapia, Curitiba, Brazil
Purpose: To determine the cost effectiveness of performing coronary
CT angiography (CCTA) as a gatekeeper for invasive angiography
(ICA) in patients with suspected coronary artery disease and mild
ischemia on SPECT-MPI.
Methods: Data from patients without known coronary artery disease
(CAD), with mild ischemia (SSS ranging from 4 to 8) detected on
SPECT-MPI and submitted or not to CCTA between 12/2011 and
08/2012, were retrospectively analyzed from Quanta database (Curitiba,
Brazil). We modeled two diagnostic scenarios in which patients would
be: (1) submitted directly to ICA (U$ 800.00 per procedure) after the
abnormal SPECT; (2) submitted to CCTA (U$ 500.00 per procedure),
followed by ICA only when obstructive disease was detected. For cost
analysis purposes, the CCTA frequencies of normal, non-obstructive
(\50% stenosis) and obstructive (C50% stenosis) CAD results of the
subgroup submitted to CCTA were extrapolated to the whole cohort.
Results: During the observation period of 9 months, 5,345 patients
were referred for SPECT-MPI. Of these, 1,450 had mild ischemia on
SPECT-MPI, but 564 had previous history of CAD. From the
remaining 886 patients suitable for analysis, CCTA was performed in
only 75 (8.5%). The clinical and SPECT characteristics of the groups
submitted or not to CCTA are presented in the Table. There were 36
(48%) normal, 26 (34.7%) non-obstructive and only 13 (18.3%)
obstructive results by CCTA. The CCTA first strategy would avoid an
unnecessary ICA in 82.7% of patients. Applying the procedures costs
in each strategy, the total cost would be U$ 708,800.00 on the direct
ICA group and U$ 566,200.00 on the CCTA first strategy, with a net
economy of 20.1%.
Conclusion: A CAD diagnostic strategy in which CCTA is applied as a
gatekeeper to ICA in patients with mild ischemia by SPECT is very
cost-effective, but still remains highly underused in Curitiba, Brazil.
Clinical and SPECT variables by group
Clinical and SPECT
variables
CCTA group
(N 5 75)
Non-CCTA group
(N 5 811) P value
Age [mean (SD)] 61.6 (11.8) 65.1 (12.1) .02
Female (%) 57.3 61.9 .43
Diabetes (%) 28.0 32.5 .43
Hypertension (%) 64.0 69.8 .29
Ejection fraction
[mean (SD)]
63.0 (10.6) 61.8 (11.4) .34
Summed stress score
[mean (SD)]
4.7 (1.2) 5.3 (1.5) .0003
CCTA, Coronary computed tomography angiography; SD, standard
deviation.
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Integration of single-photon emission computed tomography
(SPECT) and cardiac computed tomography (CCT) for the
triage of patients with equivocal stenoses in clinical practice
L. Luigi Di Serafino1; G. Toth1; S.A. Pyxaras1; F. De Vroey1;
J. Geraedts2; H. Declercq2; P. Vanhoenacker1; B. De Bruyne1;
W. Wijns1; C. Van Mieghem1
1OLV Hospital Aalst, Cardiovascular Center, Aalst, Belgium;
2St Blasius Hospital, Dendermonde, Belgium
Purposes: The aim of this study was to evaluate the diagnostic
accuracy of sequential CCT and SPECT imaging in the evaluation of
patients with CAD and at least one equivocal stenosis detected at CCT,
in comparison with invasive coronary angiography (ICA) and FFR.
Methods: All consecutive patients with stable angina and at least one
equivocal stenosis (% diameter stenosis between 30% and 70%)
detected at CCT (Dual source CT), underwent SPECT followed by
ICA and FFR measurement. At CCT, an equivocal stenosis was
assessed as being significant (50-70%) by visual estimation. Intrave-
nous (IV) adenosine infusion was used as stressor for SPECT. At
quantitative coronary angiography, a lesion was considered significant
when the %DS was [50%. FFR was measured for all equivocal ste-
noses detected by CCT using a 0.014’’ pressure guide wire system (St
Jude Medical Systems). Maximum hyperemia was induced by IV
adenosine infusion. An FFR B 0.80 was used as threshold to define a
functionally significant stenosis.
Results: A total of 51 patients were prospectively enrolled and 121
stenoses were evaluated. At CCT, 60 stenoses (49%) in 43 patients
(84%), were considered anatomically significant. Using SPECT,
inducible myocardial ischemia was detected in only 30 patients. At
ICA, 45 stenoses (37%), in 29 patients (57%), were found to be ana-
tomically significant. Using FFR, only 36 stenoses (30%), in 28 patients
(55%), were determined as being functionally significant: these patients
subsequently underwent revascularization. In comparison with ICA,
CCT showed high sensitivity (90%) and lower specificity (77%), when
assessing anatomical severity of CAD. In comparison with FFR, CCT
was suboptimal for determining the functional significance of a stenosis
(sensitivity: 89%, specificity: 22%). Combining CCT with SPECT
imaging (hybrid imaging), as compared with FFR, did not improve
diagnostic accuracy (sensitivity: 64%, specificity: 48%). In addition,
hybrid imaging was significantly less sensitive (64% vs 89%, P = .05)
as compared with CCT alone. Considering patient management, the
FFR result was used as decisive to proceed with revascularization. The
noninvasive hybrid approach resulted in appropriate patient triage in
65% of the patients: 17 of the 22 patients who underwent revasculari-
zation were correctly identified, 16 of the 29 patients who were treated
medically had a normal CCT-SPECT result.
Conclusions: In patients with equivocal stenoses at CCT, the combi-
nation with SPECT imaging did not improve diagnostic accuracy to
detect ischemia-provoking CAD. This combination of tests did not
result in reliable patient management.
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Pre-operative CT coronary angiography in patients with
mitral valve prolapse referred for surgical repair:
Comparison of accuracy, radiation dose and cost versus
invasive coronary angiography
G. Gianluca Pontone1; D. Andreini1; E. Bertella1; S. Mushtaq1;
S. Cortinovis1; A. Baggiano1; A.D. Annoni1; A. Formenti1;
G. Ballerini1; M. Pepi1
1University of Milan, Foundation Monzino (IRCCS), Center Cardiol-
ogy, Department of Cardiology, Milan, Italy
Purpose: To evaluate the accuracy of low dose multidetector computed
tomography coronary angiography (MDCT) vs invasive coronary
angiography (ICA) in ruling out CAD in patients with mitral valve
prolapse and severe mitral regurgitation (MVP) before cardiac surgery
and to compare the overall effective radiation dose (ED) and cost of a
diagnostic approach in which conventional ICA should be performed
only in patients with significant CAD as detected by MDCT.
Materials and Methods: Eighty patients with MVP and without his-
tory of CAD were randomized to MDCT (Group 1) or ICA (Group 2)
to rule out CAD before surgery. However, ICA was also performed as
gold standard reference in Group 1 to test the diagnostic accuracy of
MDCT. A diagnostic work-up A in whom all patients underwent low-
dose MDCT as initial diagnostic test and those with positive findings
were referred for ICA was compared with work-up B in which all
patients were referred for ICA according to the standard of care in
terms of ED and cost.
Results: The two groups were homogeneous in terms of gender, age
and body mass index. The overall feasibility and accuracy in a patient-
based model were 99% and 93%, respectively. The overall ED and
costs were significantly lower in diagnostic work-up A compared to
diagnostic work-up B.
Conclusions: The accuracy of low dose MDCT for ruling out the
presence of significant CAD in patients undergoing elective valve
surgery for mitral valve prolapse is excellent with a reduction of
overall radiation dose exposure and costs.
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Association of atherosclerosis of the descending thoracic
aorta with coronary artery disease on multi-detector row
computed tomography in patients with suspected coronary
artery disease
C.J. Cornelis Jacobus Roos1; A.J. Witkowska-Grzeslo1;
V. Delgado1; M.A. De Graaf1; C.E. Veltman1; J.J. Bax1;
A.J. Scholte1
1Leiden University Medical Center, Department of Cardiology, Leiden,
Netherlands
Purpose: The association between atherosclerosis in the descending
thoracic aorta (DTA) visualized on CTA and CAD has not been
extensively explored. Therefore, we assessed the presence, severity and
extent of DTA atherosclerosis and evaluated the association of DTA
atherosclerosis with CAD in patients with suspected CAD who
underwent CTA.
Methods: A total of 345 patients (54 ± 12 years, 54% men) with
suspected CAD underwent a non-contrast enhanced scan for calcium
scoring and a CTA to evaluate CAD. CTA scans were classified as
non-significant CAD or significant CAD, based on \50% or C50%
luminal stenosis, respectively. The DTA was divided into segments
according to the posterior intercostal arteries. Per segment maximal
wall thickness was measured and the presence of plaque (C2 mm wall
thickness) was determined. In addition, plaque composition was scored
as non-calcified or mixed and mean wall thickness was calculated.
Results: Significant CAD was present in 152 (44%) patients. DTA
atherosclerotic plaque was identified in 279 (81%) patients. Differ-
ences in DTA atherosclerosis between patients with and without CAD
are presented in the table. Multivariate linear regression analysis cor-
rected for age and other risk factors demonstrated independent
associations of DTA wall thickness (OR 2.3, 95% CI 1.4-3.8,
P = .001) and presence of DTA plaque (OR 6.8, 95% CI 1.4-32.6,
P = .017) with significant CAD.
Conclusions: The presence, severity and extent of DTA atherosclerosis
were independently related with significant CAD on CTA in patients
with suspected CAD.
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Cardiac CT and non-invasive electrocardiographic imaging
of chronic myocardial infarction arrhythmia substrates
F. Fady Dawoud1; K.H. Schuleri1; R. Beinart1; M. Horacek2;
H. Halperin1; A.C. Lardo1
1Johns Hopkins University, Baltimore, United States of America;
2Dalhousie University, Halifax, Canada
Introduction: Chronic myocardial infarction (MI) constitutes a sub-
strate for ventricular tachyarrhythmias (VT) and its delineation is
important to facilitate catheter ablation procedures. While MI can be
delineated with cardiac CT, electrical propagation can only be iden-
tified with electrophysiological techniques. We investigated the
feasibility of cardiac CT combined with a novel non-invasive electrical
imaging technique (ECGI) to delineate scar and gain insight into VT
reentry mechanism.
Methods: MI was induced in three pigs by LAD occlusion. Whole
body ECG mapping was performed during native rhythm and VT
induction 6 months post MI. Delayed-enhancement CT (DE-CT) was
acquired 7.5-minutes post contrast injection. Inverse electrograms were
reconstructed according to previously developed methodology utilizing
CT-segmented torso- and heart geometries. Regional electrical acti-
vation times were computed and Q-wave integral maps were used to
estimate scar from inverse electrograms.
Results: Figure 1 shows an example of DE-CT volume-rendered
image showing the MI (pink outline, AHA segments 2, 7, 8, 13, 14 in
panel A) and Q-wave integral map from ECGI in pig 1 showing scar
(values \ 0, pink outlined shadowed with black, segments 2, 7, 6, 8,
12, 13, 14 in panel B top) over extending to lateral segments while the
inferior/infero-lateral segments show viable tissue (values [ 0, green
to red, panel B bottom). The reconstructed VT activation map shows
early antero-apical activation at the scar border implying an exit site of
the reentrant VT. Similar patterns were observed in other animals.
Conclusion: We demonstrated a promising application of CT in
combination with ECGI to delineate the location of MI and reconstruct
activation times during VT which can greatly guide planning of
catheter ablation procedures.
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Influence of calcium channel blocker usage on results of
123I-mIBG myocardial scintigraphy in heart failure
patients: Diagnostic and prognostic implications
A. Arnold Jacobson1
1GE Healthcare, Princeton, United States of America
Background: Previous studies have suggested that calcium (Ca)
channel blockers may interfere with stimulation of neuronal cell bodies
and may also inhibit release of meta-iodobenzylguanidine (mIBG).
The present analysis examined the influence of Ca channel blocker
usage on 123I-mIBG imaging results and clinical outcomes during
2 years follow-up of HF subjects in the ADMIRE-HFX study.
Methods: Of the 961 HF subjects in ADMIRE-HFX (LVEF B 35%;
83% NYHA II, 17% NYHA III), 78 (8%) were using Ca channel
blockers at the time of 123I-mIBG imaging. Cardiac 123I-mIBG
uptake was quantified as the heart/mediastinum ratio (H/M) on early
(15 minute) and late (4-hour) anterior planar (p) images, background-
corrected washout (WO) rate between the two planar images, and H/M
on OSEM-reconstructed SPECT (s) images. Outcomes determined
during median 2 years follow-up were cardiac death, and all-cause
mortality. Summary statistics were compared using t-tests, while sur-
vival was compared using Kaplan Meier analyses and log-rank tests
(P \ .05 considered significant).
Results: During follow-up, there were 64 cardiac (7%) and 101 total
deaths (11%). In the total population, there was no difference in baseline
123I-mIBG parameters between subjects who were and were not using Ca
channel blockers (With vs without Ca blockers: Mean Early H/Mp: 1.55 vs
1.57 (P = .38); Mean Late H/Mp: 1.41 vs 1.45 (P = .16); Mean WO
Rate: 39.2% vs 37.3% (P = .36); Mean H/Ms: 2.19 vs 2.19 (P = .99)).
However, when subjects were categorized as having either reduced (late
H/Mp \ 1.60) or preserved (late H/Mp C 1.60) myocardial innervation,
those using Ca blockers had lower 2 year all-cause mortality rates (With
vs without Ca blockers: 8.3% vs 16.8% for late H/Mp \ 1.60, 0 vs 3.2%
for late H/Mp C 1.60; P = .002) and lower 2 year cardiac mortality rates
(With vs without Ca blockers: 6.7% vs 11.5% for late H/Mp \ 1.60, 0 vs
3.2% for late H/Mp C 1.60; P = .013).
Conclusions: Although Ca channel blockers had no effect on popu-
lation-based measures of myocardial 123I-mIBG uptake, HF subjects
using these medications had lower cardiac and all-cause mortality rates
during 2-year follow-up. In light of the higher mortality rate among
subjects with reduced myocardial innervation, the potential value of
addition of Ca channel blockers to the therapeutic regimen of such
subjects may warrant further investigation.
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Epicardial fat volume on cardiac computed tomography as a
marker of high risk patients with subclinical coronary artery
disease
I. Vassiliadis1; E. Despotopoulos2; O. Kaitozis3; C. Tekedis4;
S. Koropouli4
1Euroclinic Hospital, Institute Euromedica-Encephalos, Athens,
Greece; 2Institute Euromedica-Encephalos, 251 Hellenic Airforce
Hospital, Athens, Greece; 3Institute Euromedica-Encephalos, Athens,
Greece; 4251 Hellenic Airforce Hospital, Athens, Greece
Epicardial fat volume (EFV) measurement, using cardiac computed
tomography (CT) has been shown to be a reliable marker of coronary
atherosclerosis, and greater EFV is associated with coronary artery
disease (CAD). However, little is known on the relation between the
DTA atherosclerosis
DTA variable
All
patients
n 5 345
Non-
significant
CAD
n 5 193
Significant
CAD
n 5 152 P value
Max wall
thickness (mm)
2.7 ± 1 2.3 ± 0.7 3.2 ± 1.1 \.001
Atherosclerotic
plaque [n (%)]
279 (81%) 130 (67%) 149 (98%) \.001
Mean wall
thickness (mm)
2.4 ± 0.7 2.1 ± 0.5 2.7 ± 0.7 \.001
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Figure 1. DE-CT and inverse ECGI scar and VT maps.
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amount of EAT and the severity of coronary atherosclerosis in iden-
tifying high risk patients with subclinical CAD.
Purpose: The aim of this study was to investigate the relationship
between EFV and severity of coronary artery disease measured by CT.
Methods: We retrospectively analyzed data of 600 individuals who
were referred for evaluation of CAD with cardiac CT from 2007 to
2012. Subjects who had history of primary coronary intervention or
coronary artery by-pass graft were excluded. Thickness of epicardial
adipose tissue (EAT cm3), was measured on noncontrast multiplanar
reformat images with parasternal short axis view at basal, mid-ven-
tricular and apical levels and horizontal long axis view as the sum of
the EAT areas with 2 mm thick from the whole heart. CAD severity
was determined by, the presence of significant coronary stenosis
([50% luminal narrowing of at least one major coronary artery), high
coronary artery calcium score (CACS [ 100) and plaque characteris-
tics (any plaque causing significant stenosis and/or vulnerable plaques),
in the subsequent CT angiography.
Results: In the finally studied population of 434 individuals, 155
(35.7%) had atherosclerotic coronary artery disease and 279 (64.3%) of
them were normal. Overall, 75.2% were male; mean age was
58 ± 18 years with a mean EAT 155.54 cm3. Patients with coronary
atherosclerosis had significantly greater mean EAT compared to nor-
mals (P = .011). Linear regression analysis revealed that the incidence
of significant stenosis, atherosclerotic plaque and high calcium score
increased with EFV (P \ .01).
Conclusion: EFV measured by 64-slice CT scanning, was closely
associated with significant CAD and its measurement might be used in
addition to CT angiography as an early indicator of increased risk of
coronary atherosclerosis.
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Incidence of coronary artery disease at CT coronary
angiography in patients with hypertrophic cardiomyopathy
presenting with chest pain or angina-equivalent symptoms
M. Shariat1; A.M. Crean1
1University Health Network, Toronto, Canada
Incidence of coronary artery disease at CT coronary angiography in
patients with hypertrophic cardiomyopathy presenting with chest pain
or angina-equivalent symptoms.
Background: Angina is a frequent symptom in patients with hyper-
trophic cardiomyopathy (HCM). Many of these patients will present
with exertional chest pain or angina-equivalent symptoms, such as
effort-related breathlessness, which appear indistinguishable from
symptoms in the arteriopathic population.
CT coronary angiography (CTCA) is often regarded as the non-inva-
sive test of choice to rule out significant coronary artery disease in the
low and medium risk patient group category—into which many of
these patients fall.
Objectives: To describe the prevalence of severe coronary artery
disease in patients with HCM referred to CTCA for investigation of
anginal symptoms.
Patients and Methods: We retrospectively reviewed CTCA studies of
93 patients who were known to have HCM or in whom the diagnosis
was unequivocally present based on the CTCA images.
CTCA studies were done on 320 slice CT scanner. Volumetric data
acquisition was done at 0.5 mm slice thickness and 0.25 mm gap. The
coronary arteries were carefully evaluated and any luminal narrowing
more than 70% was labeled ‘severe’. Any narrowing less than 50%
was labeled mild and between 50% and 70% was called moderate.
Cases were reviewed by two blinded observers. Disagreements were
arbitrated by a third reader.
Results: The indications for the CTCA included chest pain in 87
patients (93.5%) and shortness of breath in 6 patients (6.5%). Out of 93
patients, 14 (15.1%) had apical HCM, 13 (14%) had concentric
hypertrophy and 66 (70.9%) had asymmetric septal hypertrophy.
54 patients (58%) had completely normal coronary arteries, 31 (33.3%)
had mild disease and 6 (6.5%) had moderate disease. Only 2 patients
(2.2%) had severe disease in at least one segment of the coronary
arteries. The left anterior descending artery was the most commonly
involved vessel. It showed mild disease in 28 patients, moderate dis-
ease in five patients and severe disease in 1 patient. Myocardial
bridging was present in 34 patients (36.6%) and it involved the LAD in
31 patients (33.3%).
Conclusion: Although angina is a common symptom in patients with
HCM, in our study, only 2.2% of these symptomatic patients had
severe coronary artery disease on CTCA. Coronary CTA may be useful
for preventing inappropriate treatment of HCM patients with anti-
anginal and lipid lowering therapies.
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A quantitative computed tomography angiography
(QCT) derived risk score for automatic risk stratification of
patients with suspected coronary artery disease (CAD):
Preliminary results
M.A. Michiel De Graaf1; A. Broersen2; P.H. Kitslaar2;
J. Dijkstra2; B.P. Lelieveldt2; J.H. Reiber2; J.J. Bax1;
A.J. Scholte1
1Leiden University Medical Center, Department of Cardiology, Leiden,
Netherlands; 2Leiden University Medical Center, Department of
Radiology, Division of Image Processing, Leiden, Netherlands
Purpose: Computed tomography coronary angiography (CTA) has
important prognostic value. Additionally, QCT provides a more detailed,
accurate assessment of CAD on CTA. Potentially, a score incorporating
all quantitative stenosis parameters allows for accurate risk stratification.
Therefore, the purpose of this study was to determine if a detailed
automatic assessment of coronary atherosclerosis using QCT combined
into a single risk score allows automatic risk stratification of patients.
Methods: In 300 consecutive patients QCT was performed. First, using
an automatic tree labeling algorithm, segments were labeled according
to the AHA 17-segment model. Second, vessel wall and lumen were
automatically segmented. Finally, an automatic lesion detection algo-
rithm identified all lesions in the coronary tree. Using QCT, patients
risk was calculated based on plaque extent, severity, composition and
location on a segment basis and integrated into a single score (0-42).
During follow-up, the composite endpoint of all cause mortality, PCI
and non-fatal infarction was recorded.
Results: At present, results are available for 65 of the 300 patients.
Event rate was 12%. In all eight patients with events an automatic,
quantitative assessed significant stenosis was present. Furthermore, in
these patients the median risk score was higher compared to patients
without events (median 8.6 (IQR 4.7-12.8) vs median 0 (IQR 0-4.8)
respectively) (P = .007).
Conclusion: Integration of detailed plaque characteristics on QCT into
a single risk score could provide accurate risk stratification.
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Evaluation of nonculprit vulnerable plaque with 64-Slice
multidetector computed tomography in comparison to
intravascular ultrasound
K. Kunihiko Makino1; T. Takagi2; Y. Tajiri2; J. Yamaguchi2;
Y. Kusunose2; T. Lee2; M. Nakamura1; K. Sugi1
1Toho University, Ohashi Medical Center, Department of
Cardiovascular Medicine, Tokyo, Japan; 2Toshiba Hospital, Tokyo,
Japan
Background: Coronary atherosclerotic plaque composition plays an
important role in the progression of future coronary event. Espe-
cially, coronary atherosclerotic plaque with intravascular ultrasound
(IVUS) attenuation might be related to the deterioration of coronary
flow and worse long-term outcomes after coronary artery disease
(CAD) and interventions. Noninvasively characterizing vulnerable
plaque is an important method in risk stratification and following
the progression of coronary plaques. Multidetector computed
tomography (MDCT) is most reliable method to evaluate coronary
plaque composition. The aim of this study is to evaluate possibility
of 64-slice MDCT to detect nonculprit IVUS attenuated plaque
and identification of atherosclerotic plaque with future coronary
events.
Methods and Results: Fifty-seven patients (15 with ACS, 42 with
stable CAD) and 240 plaques were evaluated by 64-slice MDCT. One
hundred sixty-eight nonculprit plaques of the 240 plaques were eval-
uated by IVUS. Of the 168 plaques, 59 (47 calcified and 12 mixed
plaques) were excluded from the present analysis. The remaining 109
plaques (40 soft plaques, 30 attenuated plaques, 39 fibrous plaques)
represent the present analysis. In the attenuated plaques, CT density
had significantly higher than soft plaques (70 ± 9 HU vs 40 ± 6 HU;
P \ .001) and lower than fibrous plaques (70 ± 9 HU vs 94 ± 6 HU;
P \ .001). Spotty calcification with lipid pool was more common
(37% vs 13%; P \ .05) in the attenuated plaques compared to the soft
plaques. The attenuated plaques were present significantly more fre-
quently in patients with lower high-density lipoprotein cholesterol
levels than those without attenuated plaques (40 ± 9 vs 48 ± 9 mg/dL;
P \ .001, 40 ± 9 vs 47 ± 11 mg/dL; P \ .005).
Conclusions: Nonculprit plaque analysis by MDCT would be a useful
method for predicting atherosclerotic plaque with high risk of future
coronary events.
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Prevalence and characteristics of coronary artery anomalies
in an adult population undergoing multidetector-row
computed tomography for the evaluation of coronary artery
disease
C. Christos Graidis1; T. Christoforidou1; D. Dimitriadis1;
V. Karasavvidis1; K. Gourgiotis1; M. Giannadaki1;
I. Neroladakis1; G. Karakostas1; N. Karadimitras1;
G. Dimitriadis1
1Euromedica-Blue Cross Hospital, Thessaloniki, Greece
Background: Congenital coronary anomalies are uncommon with an
incidence ranging from 0.17% in autopsy cases to 1.2% in angio-
graphically evaluated cases. The recent development of ECG-gated
multi-detector row computed tomography (MDCT) coronary angiog-
raphy allows accurate and noninvasive depiction of coronary artery
anomalies.
Purpose: The aim of this study was to evaluate the prevalence of
anomalous origin, course and termination of coronary arteries in
consecutive symptomatic patients, who underwent cardiac 64- slice
MDCT coronary angiography.
Methods-Results: This retrospective study included 2572 patients who
underwent coronary 64-slice MDCT coronary angiography from Jan-
uary 2008 to March 2012. Of the 2572 patients, 60 (2.33%) were
diagnosed with coronary artery anomalies (CAAs), with a mean age of
53.6 ± 11.8 years. High take-off of the RCA was seen in 16 patients
(0.62%), of the left main coronary artery (LMCA) in 2 patients
(0.08%) and both of them in 2 patients (0.08%). Separate origin of the
LAD and Cx from Left Sinus of Valsalva (LSV) was found in 15
patients (an incidence of 0.58%). In 9 patients (0.35%) the RCA arose
from the opposite sinus of Valsalva with a separate ostium. In 6
patients (0.23%) an abnormal origin of LCX from the right sinus of
Valsalva (RSV) was found. A single coronary artery was seen in 3
patients (0.12%). In 2 patients (0.08%) left coronary trunk was found
to originate from the RSV with separate ostium from the RCA. LCA
from the pulmonary artery was seen in one patient (0.04%). A coronary
artery fistula was detected in 4 patients (0.15%).
Conclusion: The results of this study support the use MDCT coronary
angiography as a safe and effective noninvasive imaging modality for
defining CAAs in an appropriate clinical setting, providing detailed
three-dimensional anatomic information that may be difficult to obtain
with invasive angiography.
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Association of cardiac calcification and coronary artery
disease detected by 64-multislice detector computed
tomography coronary angiography in a juvenile Albanian
population
N.X.H. Xhabija1; I.A. Allajbeu1; A.D. Duni1; M.H. Heba2;
E.P. Petrela3
1American Hospital, Balkan Alliance Group, Tirana, Albania;
2University Hospital ‘‘Nene Teresa’’, Tirana, Albania; 3Medicine
Faculty, Department of Biostatistics, Tirana, Albania
Aortic valve sclerocalcification (AVSC) and mitral annulus calcifica-
tion (MAC) is common with aging and have been considered as a
manifestation of generalized atherosclerosis in elderly population.
However, the significance of these calcifications in younger popula-
tions has not been previously determined. AVSC and MAC can be
easily detected by transthoracic echocardiography (TTE). Recently,
Coronary CT angiography (CTA) has become widely available in
detecting occult coronary atherosclerosis disease (CAD).
Purpose: We hypothesized that in subjects age \ 60 years, AVSC and
MAC would be associated with a higher prevalence of positive CCTA.
Methods: In a prospective, cohort study, we identified patients
younger that 60 years, who all underwent both CCTA and TTE for
various clinical indications. We utilized positive CTA as a surrogate
for angiographically CAD. All known risk factors for atherosclerosis
including age, gender, hypertension, smoking, dyslipidemia, diabetes
and family history were also investigated.
Results: The mean age of our study population included 155 patients
(109 men and 46 women) was 50 ± 4.2 years. When the cohort was
divided by the presence of atherosclerosis, we found that 81 patients
had CAD and 74 had normal coronary arteries (75.8% vs 24.2%). Of
the 81 patients with CAD, 69 had AVSC compared with 22 in the non-
CAD group (P \ .001).Hypertension and MAC were found signifi-
cantly more prevalent in the CAD group than in non-CAD group,
respectively (61% vs 39%, with P = .006 and 70.4 vs 29.6, with
P = 0,042). Multivariate analysis identified only AVSC and age as
independent predictors of coronary atherosclerosis. The sensitivity,
specificity, positive and negative predictive values for AVSC in
diagnosing CAD were 72.2.1%, 60%, 81% and 50%, respectively.
Although AVS is highly associated with CAD, it has only modest
sensitivity and specificity (72% and 60%), respectively. Despite a low
negative predictive value (50%), it has a high positive predictive value
(81%) for the presence of significant CAD.
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Conclusion: Our study demonstrates that aortic valve sclerocalcifica-
tion and coronary atherosclerosis are significantly associated with
each-other, even in a juvenile population. The presence of aortal
sclerocalcifications may help in predicting CAD and should be added
to conventional risk factors.
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The correlation between the major adverse cardiac events
and coronary plaque characteristics
J. Jingjing Gai1; L.Y. Gai1; H.Y. Qiao1; S.Y. Zhang1;
Z.W. Guan2; L. Yang3; Y.D. Chen1
1China PLA General Hospital, Department of Cardiology, Beijing,
People’s Republic of China; 2China PLA General Hospital,
Department of Nuclear Medicine, Beijing, People’s Republic of China;
3China PLA General Hospital, Department of Radiology, Beijing,
People’s Republic of China
Objective: Major adverse cardiac events (MACE) often occur sud-
denly resulting in high mortality and morbidity. Analyzing the
characteristics of coronary plaque by Coronary Computed Tomogra-
phy Angiography (CCTA) may help forecasting the MACE.
Methods: The patients who underwent CCTA from Jan 2008 to Feb
2010 were consecutively enrolled in the study. The hospital data base
was screened for patients who later developed acute ST elevated
myocardial infarction (STEMI) or non ST elevated acute myocardial
infarction (NSTEMI) or cardiac death. The definition of the plaque
score as follow: 1. Minor plaque, 1 point; 2. Moderate plaque, 2 points;
3. Severe localized stenosis, 3 points; 4. The erosive plaque, 5 points;
5. Calcification, 1 point; 6. DES, 5 points; 7. Plaque with positive
remodeling, 3 points; 8. Complete occlusion, 3 points; 9. Diffused
moderate lesions, 2 points. Two-way analysis of variance was
performed.
Results: A total of 8557 consecutive cases of CCTA were performed in
the institution. Among them 1055 were hospitalized during which 25
patients developed MACE, including 6 cases of deaths, 2 cases of heart
failure, 11 cases of STEMI and 6 cases of NSTEMI. One way ANOVA
analysis showed that advanced age, AF, past history of PCI, low Hb,
tachycardia and high Grace Score contributed to death and heart failure.
The differences were significant, P \ .05. The plaque characteristics of
the plaques were analyzed. The patients who had erosion plaques and
high degree localized lesions had high likelihood of developing MACE,
95% CI: 0.6472-1.538, P = .000. The death and heart failure had the
highest plaque score, 95% CI: 0.4882-1.379, P = .000.
Conclusion: The plaque characteristics identify high risk patients.
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Comparation of agatston coronary artery calcium score
using contrast-enhanced CT coronary angiography,
framingham score and multiple blood biomarkers
as predictors of coronary artery stenosis
A. Ana Lanca1; Z. Madzar1; D. Javoran1; V. Bursic1;
V. Pehar-Pejcinovic1; V. Persic1; M. Boban1
1Clinical Hospital Thalassotherapia Opatija, Opatija, Croatia
Purpose: To analyze efficiency of Agatston score, Framingham risk
score, and multiple blood biomarkers as predictors of coronary artery
stenosis in patients with nonspecific chest pain.
Methods: The study included 161 patients (mean age 63 ± 7.7, 70% of
females) with atypical chest pain and unknown coronary heart disease,
who underwent coronary multi detector computed tomography coro-
narography and obtained Agatston score. Scanning was done with the
Definition Flash 2 9 128 slice CT scanner by dual source technique,
and the mean received amount radiation was 4.6 ± 1.2 mSv. The mean
heart rate during scanning was 68 ± 9.3/minute, and patients body
mass index (BMI) 27.4 ± 4.3. Patients with known cardiovascular risk
factors, including hypertension (77%), diabetes mellitus (25%), dysl-
ipidemia (77%) or smoking (28%) and various Framingham risk score
values (0.6-59.9, mean 22.3 ± 12.7) were considered. Blood bio-
markers included glucose, C-reactive protein (CRP), total cholesterol,
LDL-cholesterol, HDL-cholesterol, triglycerides, creatinine, eGFR and
uric acid. Participants were divided in two groups, based on coronary
artery stenosis greater than 50% (40 of participants), and the other with
stenosis smaller than 50% (121 of participants). Frequency of demo-
graphic and clinical characteries, blood biomarkers and risk factors
were tested between the groups by using Chi square test and Student T
test as appropriate. To test for factors associated with predicting cor-
onary artery stenosis, Likelihood Ratio, and Receiver Operating
Characteristics (ROC) analyses were used. Relative Risk was calcu-
lated in context of developing coronary artery stenosis greater than
50% in participants with Agatston score above 100.
Results: The most accurate predictor of coronary artery stenosis
greater then 50% was Agatstone score (AUC 0.99, P \ .0001). A-
gatstone score higher than 100, had relative risk for developing of
coronary stenosis over 50%, 17 times higher than values under 100.
CRP (AUC 0.76), glucose (AUC 0.59), uric acid (AUC 0.61) and
Framingham risk score (AUC 0.57) had high sensitivity but low
specificity for coronary artery stenosis.
Conclusion: Among all considered demographic and clinical charac-
teristics, blood biomarkers and risk factors, Agatstone score was the
most accurate predictor for developing of coronary artery stenosis.
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A diagnostic/therapeutic proposed approach to the
myocardial bridge
G. Scrima1; G. Giovanni Bertuccio2
1UOA Cardiologia, Moncalieri, Italy; 2UOA Medicina Nucleare,
Moncalieri, Italy
Myocardial ‘‘bridge’’ is the most frequent congenital coronary
anomaly (about 1.5% of patients already undergone to coronary
angiography).
Prognosis is quite variable: a negative prognosis could be related to the
so-called type III ‘‘bridges’’ (deep intra-myocardial course; [ 10 mm
length; [ 75% systolic ‘‘milking’’) with myocardial ischemia and
major ventricular arrhythmias (0,6% among Patients pertaining to our
department).
We have considered consecutively all symptomatic patients with type
III myocardial ‘‘bridge’’ afferent to our department from 01/’08 to 01/
’11. All of them were submitted to coronary angiography.
We selected 22 patients out of them, 13 with stable angina symptoms
(angina CCS II-III): 11/13 with exercise test positive for ischemia; 2/13
had a positive SPECT with mild/moderate amounts of anterior ische-
mia in the absence of specific medical therapy.
The remaining 9 Patients exhibited a clinical SCA (2 antero-lateral
STEMI; 7 anterior/UA NSTEMI) related to the myocardial ‘‘bridge’’
on IVA.
All Patients with stable angina symptoms were treated with beta-
blockers, followed by myocardial SPECT resulted negative for
inducible ischemia in the same site. All of them were asymptomatic to
the clinical follow-up (22 months).
All Patients, with ‘‘bridge-related’’ SCA, were treated with PTCA and
medicated stent (DES). This procedure in 8/9 Patients was guided by
intracoronary ultrasound (IVUS) that allowed the diameter’s optimi-
zation and the length of the implanted stent (in-flow and out-flow of the
stent at least 3 mm before and after the intra-myocardial stretch), as
well its final relaxation.
Only the patient submitted to PTCA without IVUS was hospitalized
again for a SCA recurrence 7 months after first procedure, secondary
to the re-stenosis of the medicated stent. The IVUS control demon-
strated an evident under-sizing of the implanted stent compared to the
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native vessel; it was solved with a simply re-PTCA using an adequate
diameter NC balloon.
Finally we could affirm that: Patients with myocardial ‘‘bridge’’ on
IVA with stable angina symptoms have indication to medical therapy
with Beta-blockers or, if not indicated, Ca-antagonist. They should be
subjected to a myocardial SPECT with full therapy to evaluate the
residual functional significance of the ‘‘bridge’’ during medical ther-
apy. PTCA is useful with persisting ischemia despite medical treatment.
In SCA ‘‘bridge-related’’, IVUS guided percutaneous treatment with
medicated stent appears to be safe and effective because it isn’t related
to late thrombotic events (no patient in our casistic) and it’s associated
with a very low restenosis rate.
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Additional value of myocardial perfusion imaging after
coronary calcium score in low to intermediate risk of
coronary artery disease patients
P. Smanio1; P. Filippi1; M.A. Oliveira1; L. Machado1;
P. Cestari1
1Grupo Fleury, Sao Paulo, Brazil
Background: Cardiovascular disease is the leading cause of mortality
in the world. An early investigation and management can improve
survival. The non-invasive diagnostic methods in the evaluation of
coronary artery disease have been widely used even those that submit
patients (p) to radiation. If the association of myocardial perfusion
imaging (MPI) and coronary calcium score (CAC) is important in the
management of low to intermediate risk of coronary artery disease
(CAD) patients (p) is not yet well established.
Purpose: The aim of this study was to evaluate if the information of MPI
add value to CAC in a low to intermediate risk of CAD group of patients.
Methods: It was analyzed 212 p that performed CAC and MPI
between 01 and 07 of 2012 without any cardiac procedure in between.
From the total, 166 p (78.3%) were male, mean age of 47 years, 49 p
(23.1%) with diabetes, 122 p (57.5%) with dyslipidemia, 48 p (22.6%)
with hypertension, and none p had known CAD or cardiac symptoms.
The CAC and the sestamibi-Tc-99m MPI were performed by standard
techniques. CAC were divided in zero (101 p), \100 (27 p), 100-400
(44 p) and [400 (40 p). MPI was considered normal if no perfusion
defect and suggestive of ischemia if reversible perfusion defect after
stress phase. Statistical analysis was performed by Fisher exact test,
being considered significant P values B 0.05.
Results: In the group of CAC zero 2 p (1.9%) had presented ischemia on
MPI. In the other groups with CAC \ 100, CAC 100-400 and
CAC [ 400, 1 p (3.7%), 6 p (13.6%) and 14 p (35%) had presented
ischemia on MPI, respectively (P B 0.05). The three patients who pre-
sented ischemia on MPI and had CAC zero or\100 had suggestive of
soft plaque on coronary tomography. Male gender and presence of
diabetes were associated with ischemia in the group of patients with
CAC 100-400 (P \ 0.05). In the group with CAC [ 400 only diabetes
was associated with presence of ischemia on the MPI (P \ 0.05).
Conclusion: The obtained results may suggested that MPI can add
diagnostic information to CAC in a low to intermediate risk of CAD group
of patients because of the detection of ischemia in p with soft plaques.
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Calcified coronary arteries in patients with giant coronary
artery aneurysms caused by Kawasaki disease
K. Kenji Suda1; Y. Kudo1; H. Yoshimoto1; M. Iemura1;
T. Matsuishi1
1Kurume University School of Medicine, Kurume, Japan
Aim: To characterize coronary artery calcification in patients with
giant coronary aneurysms (GAA) caused by Kawasaki disease (KD)
using multi-detector x-ray computed tomography (MDCT).
Methods: Subjects were 25 pediatric and young adult patients (19 male
and 6 female) with history of KD who had GAA with [8.0 mm of
coronary artery diameter confirmed by coronary angiography (CAG).
Using MDCT, calcification of the coronary arteries was identified and
classified according to the degree of circumferential calcification; Type
A, \90; B 90–180; C, 180-359; D, 360; E, luminal occlusion and
internal lumen was evaluated at these calcified segments.
Results: Patient’s age at onset and at study were 2.6 ± 2.8 and
23.5 ± 7.1 (10.8-40.4) years old, with median of 20.8 (9.8-40.1) years
after the onset. In these 25 patients, 11 (44%) underwent either catheter
or surgical interventions for coronary stenosis.
On MDCT, all 25 patients showed calcification of the coronary arteries
in total of 47 segments (1.9, range 1-4 segments for each patient). In
these 47 segments, GAA presented in 36 (77%) segments, small to
moderate aneurysms with diameter \8.0 mm in 11 (23%). Calcifica-
tion was located at #1 in 15, #2 in 5, #3 in 5, #5 in 5, #6 in 12, and #11
in 15 patients. Degree of calcification was calcified as Type A, 28%; B,
6%; C, 17%; D, 34%; E, 15%. Among 29 segments where calcification
presented with patent coronary lumen, we could evaluate the degree of
stenosis in 18 of 19 (95%) segments of Type A, B, and C, but it was
possible only 3 of 10 (30%) segments of Type D with complete cir-
cumferential calcification.
Conclusions: All patients with GAA after KD showed calcification at
more than 10 years after the onset at proximal coronary segments, even
at segments with small to moderate coronary aneurysms. Complete
circumferential calcification present in one third of segments and
preclude accurate evaluation of the internal lumen with current setting
of the MDCT, hence other modalities including CAG or cardiac
magnetic resonance imaging must be the choice of diagnostic test in
these patients.
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Visualization of coronary sinus and left circumflex coronary
artery in computed tomography before percutaneous mitral
annuloplasty
A. Mlynarska1; R. Mlynarski2; M. Sosnowski1
1Medical University of Silesia, Katowice, Poland; 2Upper Silesian
Cardiology Center, Katowice, Poland
Multi-slice computed tomography (MSCT) offers possibility to visu-
alize the relations between left circumflex artery (LCx) and coronary
sinus (CS) before percutaneous mitral annuloplasty (PMA) to exclude
patients with potentially dangerous relations LCx/CS. There are no
data available showing quality of visualization both vessels in MSCT.
Methods: MSCT (Aquilion64) in 196 pts. (109 M; aged 56 ± 11) with
suspected CAD was performed using retrospective scan with ECG-
gating. In each case 3D VR and 2D MPR reconstructions were created
(0.5 mm). A subjective assessment of the quality of visualization to
find the optimal phases of visualization for LCx, CS and both vessels
together (relations) was used. The quality of visualization was graded
by 2 experts on 6-points scale: 0 = lack of vessel; 1 = image not
diagnostic; 5 = smoothly bordered vascular structure. Independent
2 mm reconstructions optimized for the LCx (diastolic 70-80-90% RR)
and CS (systolic 30-40-50% RR) were also performed.
Results: In parallel visualization of LCx and CS optimal image quality
(score 5 and 4) was obtained in diastolic phases (70-80%)—72 cases
(36.7%). Exact scoring for independent visualization in optimal phases
is presented in the table below (n; %). Optimal score was achieved in
85 cases (43.4%) for LCx and in 133 cases (67.9%) for CS. Not
diagnostic images (score 1) was obtained in 7 (3.6%) cases (LCx: 2;
1.0% CS: 5; 2.5%).
Conclusions: Quality of parallel as well as independent visualization
of LCx and CS confirm potential role of MSCT before PMA proce-
dures. Parallel visualization should be performed in diastolic phases as
an addition for independent visualization.
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A new algorithm for image post-processing to fulfill
percutaneous mitral annuloplasty requirements image
preparation
R. Mlynarski1; A. Mlynarska2; M. Sosnowski3
1Upper-Silesian Cardiology Center, Katowice, Poland;
2Medical University of Silesia, Katowice, Poland;
3Medical University of Slesia, Katowice, Poland
Cardiac imaging is almost mandatory in techniques like percutaneous
mitral annuloplasty (PMA). During PMA the relationship between
coronary sinus (CS) and circumflex artery (Cx) in relations to mitral
valve (MV) is of special importance. In such circumstances, a new
image reconstruction algorithm might be potentially useful.
Methods: In 46 pts (24 M) a 64 slice computed tomography (Aquilion
64) was performed. Pts with critical changes in LCx were excluded. A
scan with ECG-gating was performed using: slice 0.5 mm, helical pitch
12.8 and tube voltage 135 kV (380 mA). 100 ml of non-ionic contrast
agent at a rate of 4.5 mL/second was given. In each case 3D VR and 2D
MPR reconstructions were created (Vitrea 2). In all pts various visu-
alization modes were tested (MPR measurements and visualizations) to
create optimal visualization LCx/CS/MV, defined as a consensus
between 2 experienced observers to fulfill PMA requirements.
Results: The following stages in post-processing were recognized as
optimal: 3DVR visualization of lateral view of the heart (Figure A); 3x
(±10) virtual cutting of the of the heart (Figure B); digital analysis
(own project—Figure C) of the relations LCx/CS/MV. Examples of
image preparation are presented on the figures below. Presented
method was applicable in all patients. Selected 2D measurements
vessels of interest (Figure C) were as follow: LCx diameter
3.7 ± 0.7 mm, CS diameter 4.9 ± 1.5 mm, LCx-MVd diameter
44.5 ± 7.9 mm, and CS-MVd diameter 42.8 ± 6.6 mm. In 26 pts
(56.5%) the LCx run closer to the MV—it potentially cause problems
(LCx occlusion) after PMA device implantation.
Conclusions: Presented method may be useful for visualization of
LCx/CS/MV in cardiac CT in patients before PMA, however appli-
cability of this method requires verification in further clinical studies.
Scheme of CT image post-processing
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Usefulness of computed tomography coronary angiography
in screening patients in the presence of atypical chest pain
and risk factors for coronary disease
R. Moran1; O. Rana1; R. Patel1; R. Swallow1; J. Kingston1;
T. Levy1
1Royal Bournemouth Hospital, Bournemouth, United Kingdom
Purpose: Assessment of patients with chest pain and risk factors for
coronary artery disease (CAD) in the presence of atypical symptoms
can be difficult. Such patients often have equivocal exercise tolerance
tests or cannot perform one. Consequently they undergo quantitative
coronary angiography to exclude significant CAD, with normal results
in up to 25%. Non-invasive imaging modalities such as computed
tomography coronary angiography (CTCA) have emerged as alterna-
tives. We performed a retrospective review to assess the hypothesis
that CTCA is diagnostically useful in this cohort.
Methods: We examined the referral pathway of 168 consecutive
patients (58.4 ± 11.3 years) over 14 months who had been referred to
3 cardiologists for possible CAD. All had atypical chest pain with co-
existing risk factors (see table) and either had an equivocal exercise
tolerance test or were unable to perform one. The cohort had an
intermediate pre-test probability of CAD (52.1% ± 26.4) derived from
the United Kingdom national guidelines. All patients underwent CTCA
(Aquilion 1 Toshiba, Japan) and proceeded to invasive coronary
angiography only if CTCA showed significant CAD (defined as at least
one moderate lesion, [50% stenosis).
Results: Of 168 patients, 123 (73.2%) were normal (63, 37.5%) or had
non-significant CAD (60, 35.7%) based on CTCA. The remaining 45
patients (26.8%) underwent quantitative coronary angiography,
revealing severe CAD ([70% stenosis) in only 13 patients (7.7%). All
13 had been correctly identified by CTCA. Moderate CAD (50-70%
stenosis) was seen in the other 32 (19%), CTCA being concordant with
this in 28 patients (88%). CTCA overestimated CAD severity in the
other 4 (12%).
Conclusions: Our data suggest CTCA is an alternative to quantitative
coronary angiography in screening patients with atypical chest pain
and equivocal exercise tolerance tests, despite the presence of risk
factors for CAD. Risk scores appear to overestimate the true incidence
of significant CAD.
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Cardiac CT angiography in patients with inconclusive
functional stress fest, a follow up clinical study
M.J. Moncy Jacob Oommen1; L. Nazar1
1Division of Cardiology, RIPAS Hospital, Brunei, BANDER SERI
BEGAWAN, Brunei Darussalam
Introduction: Patients with inconclusive stress tests and suspected
CAD often present a diagnostic challenge in a non interventional
cardiac centre. In deed the yield of invasive CAG in this group of
patients is not significant. Coronary CTA in patients with equivocal
stress test is considered as an appropriate indication.
Quality of visualization
Score 5 Score 4 Score 3 Score 2 Score 1
Quality of visualization LCx
Phase 70% 17; 9.7% 12; 6.8% 10; 5.7% 1; 0.6% 0
Phase 80% 25; 14.2% 23; 13.1% 7; 3.8% 7; 3.8% 1; 0.6%
Phase 90% 5; 2.8% 3; 1.7% 2; 1.1% 0 1; 0.6%
Quality of visualization CS
Phase 30% 19; 10.8% 9; 5.1% 2; 1.1% 3; 1.7% 3; 1.7%
Phase 40% 61; 34.6% 31; 17.6% 18; 10.2% 6; 3.4% 2; 1.1%
Phase 50% 8; 4.5% 5; 2.8% 9; 5.1% 1; 1.7% 0
LCx, Left circumflex artery; CS, coronary sinus.
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Frequency of CAD risk factors (%)
Smoking history 42
Family history 42
Hyperlipidaemia 37
Hypertension 36
Diabetes mellitus 13
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Objectives: We attempted to determine the clinical events of the
patients who had the inconclusive stress tests and CTA, tried to classify
these a patients based on the risk factors, severity of CAD by CTA and
tried to find the significance of the risk factors and CTA results with
the clinical events during this period.
Methods: We studied 175 patients who had suspected CAD and
inconclusive stress tests done from April 2007 to December 2009. All
these patients had 64 slice cardiac CTA. Patients are classified based
on age, sex risk profile, CCS and CTA results of the CAD severity.
Patients are reviewed for the cardiac events in the followup clinic. The
primary outcome of the study was all cause mortality, cardiac admis-
sions for ACS or for CAG and PCI. However only 139 patients were
followed up in the clinic and by telephonic interview till date.
Results: 43% of the patients were in the age group 50 to 69, 53% were
females, 69% has hypertension 44% hyperlidaemia. 40% had atypical
chest pain, 70% had CCS less than 100. CTA results showed no CAD
in 54% patients. Follow up of these patients with significant CAD once
in six months till date showed 69% of these patients had no cardiac
events, there was one death (0.7%, 8 (5.6%) admissions for ACS, 34
(24%) patients had CAG and PCI.
Conclusion: Among patients with inconclusive stress tests, a signifi-
cant number did not show any obstructive CAD by CTA. During the
follow up study, clinical events are higher in patients with increasing
severity of CAD by CTA. This clinical approach based on CTA is
useful for short term prognostic assessment in this group of patients
especially in a non interventional cardiac centre.
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Assessment of functional severity of borderline coronary
artery lesions using noninvasive computed fractional flow
reserve
L. Velicki1; N. Cemerlic-Adjic1; R. Jung1; N. Tomic1; O. Adjic1;
D. Nikolic2; I. Saveljic2; D. Milasinovic2; N. Filipovic2
1Institute of Cardiovascular Diseases of Vojvodina, Sremska
Kamenica, Serbia; 2University of Kragujevac, Kragujevac, Serbia
Purpose: Fractional flow reserve (FFR) is an easily obtained index of
the physiologic significance of coronary stenosis that can optimize
treatment strategy. The purpose of this work was to compare diagnostic
performance of noninvasive computed FFR (FFRct) with standard
invasive FFR angiogram patient data and to assess the impact of FFRct
on diagnostic improvement in borderline coronary lesions.
Methods: Three patients admitted for coronary artery disease under-
went coronary CT angiography (Siemens 256-slice SOMATOM
Definition CT scanner) and cardiac catheterization with FFR assess-
ment. Internally designed software was used for computer simulation
of FFR based on the coronary CT angiogram. The 3D blood flow was
described by the Navier-Stokes equations, in conjunction with the
continuity equation. A parabolic flow waveform was applied at the
location of aortic root, while outlet boundary conditions were config-
ured to an inverse resistance of the corresponding diameter.
Results: Coronary CT angiography discovered that two patients had
single vessel CAD with significant stenosis ([50%) observed on ACD
and LAD respectively, and one patient had triple vessel CAD. There
was no difference between the FFR and FFRct values (P [ .22).
Coronary CT angiogram designated 2 (66%) lesions as significant and
after performing FFRct none of these lesions proved to be hemody-
namically significant. Coronary CT angiogram tended to overestimate
the degree of stenosis but with no statistical difference compared to
coronary angiography (P = .75).
Conclusions: We found a solid correlation between standard FFR and
FFRct results. Computer simulation may offer distinct advantage due
to non-invasive nature of the analysis, and as such may prove to be of
particular benefit when assessing borderline cardiac patients.
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Presence of stenosis in the left circumflex artery
influence the anatomy of coronary sinus: Lesson from
cardiac CT
R. Mlynarski1; A. Mlynarska2; M. Sosnowski2
1Upper-Silesian Cardiology Center, Katowice, Poland; 2Medical
University of Silesia, Katowice, Poland
Assessment of coronary vessels surrounding left ventricle in the
atrioventricular sulcus is an important step before percutaneous mitral
annuloplasty (PMA). There are no research evidencing whether and
how the presence of flow-limiting stenosis in the left circumflex artery
(LCx) influence the venous circulation of the heart.
Methods: In 66 consecutive patients (41 M, aged 61.7 ± 10.4), a
64-slice CT (Aquilion 64) was performed due to a CAD suspicion. Pts
were divided into two groups according to the presence of stenosis in
LCx: 38 pts with LCx stenosis (stenosis) and 28 pts without changes in
LCx (control). A scan with ECG-gating was performed using: slice
0.5 mm; helical pitch: 12.8; rotation time: 0.4 seconds and average
tube voltage: 135 kV at 380 mA. 100 mL of non-ionic contrast agent
at a rate of 4-5 mL/second was given. All measurements were per-
formed on 2D MPR and VR reconstructions. Following measurements
were made: CS ostium diameter (mm), angle of entrance CS to RA (8),
average LCx diameter (mm), average CS diameter (mm), max distance
between CS and LCx (mm), minimal distance between CS and LCx
(mm), distance between LAD and CS/LCx intersection (mm)—
examples Fig below.
Results: A significant reduction of angle of entrance CS to the right atrium
was observed in the group with LCx stenosis: 102.3 ± 8.5 (stenosis) vs
110.5 ± 8.3 (control); P \ .001. In this group, a significant increase of the
maximum distance between CS and LCx was also observed: 16.9 ± 4.9
(stenosis) vs 13.6 ± 4.4 (control); P \ .01. Differences in the other ana-
lyzed parameters did not reach statistical significance.
Conclusions: Presence of stenosis in the left circumflex branch of left
coronary artery influence the anatomy of coronary sinus, however
further studies are necessary to explore clinical significance of our
findings.
Example of measurements
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Comparative results angio CT versus CG to non-obese
patients
S. Huidu1; D. Dimulescu1; A. Popescu1; S. Lacau1; S. Barsan1;
L. Ionescu1; I. Stanca1; L. Arama1
1Elias Emergency Universitary Hospital, Bucharest, Romania
Purpose: We evaluated the feasibility and image quality of coronary
CT to 120 patients screening for CT angiography in Elias-Prolife
Hospital between 2010 and 1012.
Method: All patients were symptomatic with low or intermediate
probability of having severe coronary stenosis. Other patients had
known coronary heart disease and CT were performed to check for
patency of coronary stents or by-passes.
120 patients were screen.
Were excluded those who had renal insufficiency or allergy to contrast
substance.
Inclusion criteria were: age over 29 years, weight less than 100 kg,
heart rate below 60 bpm after administration of premedication beta-
blockers.
It is known that about 60 bpm heart rate allows a better image quality
in CT angiography.
It influences body weight and image quality.
Of the 120 patients, 11 were excluded by the inability to obtain a heart
rate below 60/minute after 100 mg of atenolol ± 10-20 mg metoprolol
IV, 5 were excluded by the presence of renal insufficiency, 4 because
of marked obesity. To 100 patients were performed CT angiographies.
Among patients who carried angio CT all 100 images were good
results without having no interpretable.
32% of patients were women and 68% men;
46 patients were aged below 60 years.
Results: Calcium score was 0 in 26% patients.
9% had PCI with stent in one or two coronary arteries prior CT and 2%
CABG 2, 3 coronary arteries.
All the stenosis more than 50% was considered significant stenosis.
One patient had a significant lesion on LM segment, 18 cases had LAD
stenosis, 8 cases CD and 13 cases—circumflex artery. 11 patients had
two or more coronary arteries with stenosis.
76% patients had insignificant coronary stenosis. Of all patients, 24
were sent for coronary lesions confirmation to CG, and one single false
positive result was found. 12 patients had confirmed the lesions
through CG. 11 patients had indication to perform CG because of
significant stenosis but did not complete it.
Conclusion: Angio CT remains a noninvasive method for assessing
coronary stenosis that is recommended to patients with low or mod-
erate probability of significant coronary stenosis and provides excellent
image quality for non-obese patients with AV below 60/minute.
381
Guidance by computed tomographic angiography for ad hoc
PCI. Lesson from a registry
W. Wilson Pimentel1; W. Custodio1; J. Buchler1; S. Assis1; M.
Macedo Soares1; E. Bocchi1
1Beneficeˆncia Portuguesa Hospital, Sao Paulo, Brazil
Aims: The aim of this study was to evaluate the diagnostic perfor-
mance of coronary computed tomographic angiography (CCTA) and
its influence on modification of percutaneous coronary interventions
(PCI) strategies that means, we discuss the potential application of
CCTA for the guidance of PCI.
Methods and Results: The study included two groups of patients: a
main group (MG), including 200 patients screened with a suspect of
severe CAD by CCTA and indication for coronary cineangiography
(CINE), and a control group (CG) for comparison, including 200
patients selected during the same period, with indication for CINE
according to clinical criteria or by positive functional tests. We eval-
uated the performance of CCTA for the diagnosis of lesions[50% in
coronary segments, arteries and patients and the revascularization
strategies adopted.
Results: The sensitivity, specificity and positive and negative predic-
tive values of CCTA were 85%, 85%, 71% and 98% for the coronary
segments, 90%, 91%, 82% and 100% for the coronary arteries and
100%, 88%, 96% and 98% for patients, respectively. In the MG,
percutaneous coronary intervention (PCI) was performed in 90% of the
patients, whereas in the CG, percutaneous coronary intervention was
performed in 43% of the patients (P = .01).
Conclusions: CCTA had a high diagnostic performance in detecting
CAD and allowed ad hoc PCI to be performed in 90% of the patients.
This strategy, however, must await randomized studies to confirm
these results.
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Superiority of CT coronary angiography over catheter
angiography in detection of variants/anomalies/disease of the
coronary arteries: A problem solver
A. Abhishek Bansal1; M.M. D’souza1; H. Wardhan2;
R. Sharma1; P.K. Chugh1; R.P. Tripathi1
1Institute of Nuclear Medicine and Allied Sciences, New Delhi, India;
2Dr. Ram Manohar Lohia Hospital, New Delhi, India
Purpose: To describe various coronary artery variants/ anomalies and
diseases that were identified on coronary CT angiography (CCTA), and
better delineated and characterized than on the catheter angiography
(CAG), thus, emphasizing the increasing role of CCTA in accurately
diagnosing such conditions which went unnoticed previously.
Methods: We retrospectively studied 94 patients who had undergone
CCTA at our institute. Out of these, we identified 10 patients showing
variations/anomalies/disease of the coronary arteries, which were not
adequately assessed on CAG. The CCTA was then performed on a
40-slice MDCT scanner (SOMATOM Sensation, Siemens Medical
Systems). Informed consent was taken from each patient.
Results: Patients ranged in age from 22-64 years. Out of 10 patients, 4
were females and 6 were males. In 2 patients, the right coronary artery
(RCA) showed an intra-atrial course in the right atrium for variable
lengths, which was not identified on CAG. A patient with Tetralogy of
Fallot demonstrated markedly tortuous and dilated coronary arteries
with multiple coronary-cameral fistulae. CCTA also depicted all the
characteristic abnormalities namely, ventricular septal defect, over-
riding of aorta, infundibular pulmonary stenosis and right ventricular
hypertrophy. 1 patient with single coronary artery arising from the
right coronary sinus was identified. The exact course of all the bran-
ches was delineated accurately on CCTA only. In another patient, the
RCA was seen arising from the ascending aorta anteriorly, which was
not identified on the CAG. 1 patient had the left main coronary artery
(LMCA) arising from the non-coronary sinus. In another patient, CAG
showed complete occlusion of the RCA in its proximal part, the cause
of which- an intra-luminal thrombus and its exact extent was identified
on CCTA only. In another patient the LAD had an aberrant course on
CAG, the cause of which was identified as marked dilatation of the
right atrium and ventricle exerting pressure effects over the LAD on
CCTA. 1 patient showed a non-enhancing mass in the left ventricular
cavity, diagnosed as a cystic thrombus on CCTA. In 1 patient the RCA
showed focal long segment ectatic dilatation.
Conclusions: This study illustrates the utility of CCTA in depiction of
coronary artery anomalies/variants and its superiority over CAG. It is
highly likely that such anomalies/variants of the coronary arteries were
missed in the past due to the availability of only CAG. CCTA allows
simultaneous depiction of coronary arteries, surrounding tissue and
cardiac chambers and comprehensive evaluation of the arterial course
in multiple planes.
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Multidetector ct angiography as a noninvasive tool to assess
graft patency of surgically reconstructed diffusely diseased
coronary arteries
A. Rezk1; M. Bazid1; Z. Saad2
1King Fahad Military Hospital, Southern Region, Kamis Mushyat,
Saudi Arabia; 2Aseer Central Hospital, Abha, Saudi Arabia
Background: Long reconstruction of the diffusely diseased vessel may be
a useful surgical option for patients with diffuse coronary artery disease.
Close and careful follow up of such subgroup of patients is mandatory.
Invasive graft angiography serves as the diagnostic standard for follow up
of graft patency for such extensive procedure; however, because of the
risks, discomfort, and costs of a hospital stay, a noninvasive diagnostic
tool is desirable. The purpose of current study is to evaluate the results of
extensive reconstruction of the diffusely diseased left anterior descending
coronary artery (LAD) using an left internal thoracic artery (LITA) graft
and assess the reliability of multidetector computed tomography (MDCT)
angiography as a noninvasive and safe alternative to assess graft patency
in asymptomatic patients after (coronary artery bypass surgery (CABG)
with reconstructed diffusely diseased vessels.
Methods: 25 patients with the diffusely diseased LAD underwent a
long-segmental reconstruction procedure with a LITA graft. The dif-
fusely diseased LAD was extensively incised, additional
endarterectomy was performed if necessary, and then the LAD was
reconstructed with an ITA graft in a long on-lay fashion. Postoperative
MDCT angiography as a non-invasive single tool was performed in 25
asymptomatic patients to assess graft patency.
Results: The cohort consisted of 23 men (92%) and 2 women (8%).
The mean age was 58.5 ± 9.2 years. The mean length of the arteriot-
omy incision was 3.5 ± 1.2 cm. Endarterectomy was performed in 3
patients (12%). Preoperative MI was recorded among 1 patient (4%).
While all arterial grafts 27 (100%) were classified as patent, 51 venous
grafts (89%) were considered as patent where 11% of venous grafts
were considered as non patent. All the significant stenosis were found
in the body of venous graft.
Conclusion: Extensive reconstruction of the diffusely diseased LAD
using an ITA graft could be performed safely with very encouraging
results. MDCT angiography is an excellent non invasive tool not only
to evaluate graft patency in the reconstructed LAD but also to detect
other findings in asymptomatic patients with diffuse coronary artery
disease for better and more close follow up.
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Non-invasive assessment by Cardiac CT of bypass grafts and
native coronary versus invasive coronary angiography
N. Nieves Romero Rodriguez1; F.J. Guerrero Marquez1;
P. Cristobo Sainz1; S. Navarro Herrero1; M.P. Serrano
Gotarredona1; J.L. Martos Maine1; A. Martinez Martinez1
1Virgen del Rocio University Hospital, Seville, Spain
Introduction: Cardiac CT has proven usefulness in the study of cor-
onary patients, especially with low and intermediate risk profile.
However there are few published studies on its usefulness in the
diagnosis of patients who have underwent coronary bypass graft. This
study attempts to determine its diagnostic accuracy in this area.
Methods: From October 2008 to January 2012 a total of 632 coronary
CT have been performed in our center of which 12 occurred in patients
with coronary bypass. Finally 9 of them underwent coronary angiog-
raphy, on which this study is based. We analyzed the diagnostic
accuracy in the evaluation of both types of grafts and in the assessment
of segments distal to the anastomosis.
Results: A total of 8 males were included with 23 aortocoronary grafts
(12 arterial and 11 venous). 18 were visualized by CT angiography
with a sensitivity of 100% and specificity of 90.9% and with positive
and negative predictive values of 75% and 100% respectively. We also
analyzed the 18 vessels distal to the anastomosis detected (11 anterior
descending, 5 circumflex and 3 right coronary artery), with a sensitivity
of 100%, specificity of 91.6%, negative predictive value of 66.7% and
positive predictive value of 100%.
Conclusions: Cardiac CT has a high sensitivity in the assessment of
coronary grafts and native arteries in this setting.
385
Does the pre-test probability of CAD improve prediction of
coronary artery calcification and stenosis on CTA?
M.C. Maria Cecilia Ziadi1; R.L.V. Villavicencio1
1Diagnostico Medico Orono, Rosario, Argentina
Objective: Computed tomography angiography (CTA) is mainly
applied to patients (pts) with low to intermediate risk of coronary
artery disease (CAD). Our goal was to assess how the clinical pre-test
categorization impacts on the coronary calcium score (CCS) and the
presence of severe CAD evaluated with non-invasive CTA.
Methods: We identified 133 consecutive adult pts with suspected
CAD, who underwent CTA. According to the pre-test likelihood of
CAD, pts were divided into 3 groups: I (low), II (intermediate) and III
(high). CCS was categorized as follows: 0, 1-100, 101-400 and [400.
Coronary artery lumen was classified into normal = 0%, mild = 1-
49%, moderate = 50-69% and severe C70% stenosis.
Results: Mean age was 57 (±14) years old, 56% were males.
A CCS = 0 was present in 43 of 65 (66%) and in 15 of 48 (31%) pts
from groups I and II, respectively. Conversely, none of the pts from
group III had a CCS = 0, but 70% (14/20) presented with CCS [ 400
(P \ .05). The prevalence of severe obstructive CAD was 3.1%
(n = 2) in group I, 8.3% (n = 4) in group II and it was significantly
higher in pts from group III, 65% (n = 13), (P \ .05) (Figure). CTA
ruled out obstructive CAD in 95.4% of pts in group I and in 79.2% of
pts in group II. Regardless of the pre-test likelihood of CAD, C70%
stenosis was present 1 of 58 (1.7%) pts with CCS = 0, in 2 of 33
(6.1%) pts with CCS B 100, in 5 of 16 (31.2%) pts with CCS = 100-
400 and in 11 of 26 (42.3%) pts with CCS [ 400, (P \ .05).
Conclusions: There is a direct correlation between the clinical prob-
ability of CAD and the calcified atherosclerotic burden. Pre-test
likelihood assessment facilitates prediction of severe coronary stenosis
with non-invasive CTA. These findings underscore the role of clinical
categorization for appropriate selection of pts referred for CTA.
Pre-test probability vs CTA lumen
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Predictors of significant coronary lesions in patients with
abnormal myocardial single photon emission computed
tomography
V.A. Vadim Kuznetsov1; E.I. Yaroslavskaya1;
D.V. Krinochkin1; G.V. Kolunin1; E.A. Gorbatenko1
1Tyumen Cardiology Center, Tyumen, Russian Federation
Background: It is difficult often to detect coronary artery disease
(CAD) without coronary angiography (CAG) in atypical patients by
clinical and echocardiography and single photon emission computed
tomography (SPECT) data.
Purpose: The present study aimed to reveal predictors of significant
coronary lesions in patients with myocardial perfusion abnormalities
by SPECT.
Methods: From 13,283 consecutive patients suspected CAD we
selected patients after (99)Tc(m)-methoxyisobutylisonitrile (MIBI)
gated SPECT and CAG who had no more than 3 months between the
tests. There were 47 patients among them who had abnormal SPECT.
We divided these patients in two groups: with significant coronary
lesions (C50% of lumen) on CAG and without.
Results: In 16 patients (34%) with abnormal SPECT and CAD com-
pared to patient without CAD we observed more often acute
myocardial infarction (37.1% vs 6.5%, P = .005) and higher level of
serum glucose (6.9 ± 2.5 vs 5.3 ± 0.8 mmol/L, P = .007). Reduced
left ventricular (LV) systolic function (LV ejection fraction \ 50%)
was more frequent in these patients (17.4% vs 7.4%, P \ .001), as well
as mild, moderate or severe mitral regurgitation (81.3% vs 59.4%,
P = .026). They had higher extent and index of LV wall motion
abnormalities (20.8% ±18.0% vs 2.0% ±5.5%, 20.8% ±18.0% vs
2.0% ±5.5%, respectively), and only patients of this group had signs of
myocardial scars detected by echocardiography (31.3%, all P \ .001).
According to the results of discriminant analysis, CAD was associated
with index of LV wall motion abnormalities and mitral regurgitation.
The obtained sensitivity, specificity, and positive predictivity were
80.6%, 81.8%, and 80.9%, respectively.
Conclusion: An extent of LV wall motion abnormalities and mitral
regurgitation are independent predictors of CAD in patients suspected
CAD with abnormal SPECT.
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Stress myocardial perfusion imaging in the evaluation of
functional significance of coronary artery disease verified on
CT coronarography
A. Andrea Peter1; S. Lucic1; M. Lucic1; R. Jung2; S. Tadic2;
S. Stojsic2; M. Stefanovic2
1Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia;
2Institute of Cardiovascular Diseases of Vojvodina, Sremska
Kamenica, Serbia
Introduction: Noninvasive coronary angiography (CTA) using mul-
tidetector computed tomography is used to detect anatomical coronary
artery stenosis in patients who are suspected to have coronary artery
disease (CAD) with an intermediate to high pretest likelihood. Stress
myocardial perfusion imaging (MPI) is an important diagnostic tool
since it provides information about the functional severity of the
detected coronary artery lesion.
Aim of the Study: To evaluate the findings of MPI after CTA detected
coronary artery lesions and follow up of these patients in terms of
therapeutic decision making and potential cardiac events.
Material and Methods: In 25 patients MPI was performed after CT
coronarography detected coronary artery stenoses. A two-day protocol,
dipyridamole stress/ rest Tc-99m-MIBI myocardial perfusion imaging
(MPI) was performed. Myocardial perfusion images were analyzed
quantitatively, perfusion scores (Summed Stress Score—SSS and
Summed Difference Score—SDS), ejection fraction (EF) and the
percentage of affected left ventricle myocardium was calculated using
4DMSPECT commercial software package.
Results: Average age in the examined group was 67.78 ± 8.22 years.
A total number of 46 coronary stenoses were verified during CT cor-
onarography and the majority had two or mutlivessel coronary artery
disease. The percentage of coronary stenoses detected on CT corona-
rography ranged from a minimal of 30% to a maximal narrowing of
98%. The findings of stress MPI showed normal perfusion of the left
ventricle in 22 patients (88%) and reversible ischemia was detected in
3 patients (12%). The group with normal MPI finding had an average
follow up period of 29.20 ± 9.75 month and out of this group only one
patient was admitted to the hospital because of suspected acute coro-
nary syndrome and coronarography was performed, non-significant
narrowings were found on the coronary arteries. Out of the group with
reversible ischemia all of them underwent coronarography and have
been treated with stent implantation on coronary arteries that had
functionaly significant stenosis on stress MPI. The average follow up
period in this group was 18.20 ± 3.65 months and during this period
they had no symptoms and were without any major cardiovascular
incidents.
Conclusion: The evaluation of functional significance of coronary
artery lesions with stress MPI is a very important tool in the diagnostic
algorithm of stenoses verified on CT coronarography. Stress MPI
successfully identifies patients with coronary artery lesions that need
revascularization.
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The reproducibility of coronary calcium scoring on multiple
software platforms
M. Al-Mallah1; N. Abukhaled1; A. Alskaini1; H. Alziadey1;
I. Suleiman1; E. Ficaro2; A. Al Saileek1
1National Guard Hospital, King Abdulaziz Cardiac Center (KACC),
Riyadh, Saudi Arabia; 2University of Michigan, Ann Arbor,
United States of America
Introduction: The aim of this analysis is to evaluate the reproduc-
ibility of CAC calculated on different commercial softwares.
Methods: We included 159 patients who underwent CAC scoring with
use of 64-slice multidetector computed tomography (CT) with pro-
spective electrocardiographic gating for clinical reasons. The data sets
were evaluated on two different commercially available softwares
(4DM from INVIA, Ann Arbor, MI (software A) and Smart score from
General Electric, Milwaukee, WI (software B)) by two blinded inde-
pendent readers using the method of Agatston with a threshold of 130
Hounsfield units. Comparative analysis of CAC scores between the
different software was performed by using Spearman rank correlation
and Bland Altman analysis.
Results: Each software produced different absolute numeric results for
Agatston score. CAC was detected on 107 scan on both softwares. A
total of 59 scans (37%) had the same reading of which 50 patients are
without detected calcium. In contrast, CAC reading were within 10
units in 86 scans (52%) There was excellent statistical correlation
between the two softwares (r = 0.948, p400), 132 (87%) of the scans
were in the same group by both softwares.
Conclusion: Our analysis shows that there is a close correlation
between the different software calculation of CAC although the dif-
ferent CAC software different absolute CAC scores. The two softwares
concordantly classified 87% of the study population prognostically.
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Coronary artery calcium scores on admission trauma CT
scans and their Association with in-hospital survival
H.D. De’ath1; K. Oakland1; C. Davies1; K. Brohi1
1Royal London Hospital, London, United Kingdom
Purpose: The presence of coronary artery calcium on Computerised
Tomography (CT) scans is indicative of Coronary Heart Disease
(CHD). Formal scoring of coronary artery calcium in patients with
heart disease is a useful prognostic tool, and is predictive of future
adverse cardiac events and survival. The ability to estimate coronary
artery calcium scores (CACS) on CT scans undertaken in trauma
patients has not been explored. The purpose of this study was to
determine the feasibility of estimating CACS on trauma triage scans,
and thereby determine the incidence of heart disease in injured
patients. Finally, the study aimed to explore the relationship
between coronary artery calcium and in-hospital mortality following
injury.
Methods: A single centre retrospective cohort study of all injured
patients aged 45 years or over presenting to a trauma centre between
2009 and 2011. Two observers estimated and graded CACS (none,
mild, moderate, severe and extensive) on admission CT scans of the
thorax, and the relationship with in-hospital mortality was
determined.
Results: Four hundred and seventy four trauma patients had a CT scan
of the thorax, of which the calcium scores of 432 (91%) were inter-
pretable. No coronary artery calcium on CT was found in 137 (32%),
whilst 292 (68%) patients had evidence of calcium. Patients with
coronary calcium were older (60 years vs 50, P \ .001) and had more
co-morbidities (132 vs 46, P = .03, respectively). Of the patients with
calcium, 139 (32%) had a mild score, 75 (17%) moderate, 64 (15%)
severe and 17 (4%) had evidence of extensive coronary artery calcium.
Only patients with severe coronary artery calcification had higher
death rates (OR 2.4, 95% CI 1.1-4.9), whilst patients with mild,
moderate and extensive calcium scores had similar death rates to those
without evidence of calcification. Inter-observer agreement for calcium
grading was substantial (j = 0.74).
Conclusions: Admission trauma CT scans of injured patients may be
used to determine CACS. These estimates demonstrated that the
incidence of CHD approaches 70% in trauma patients aged C45 years.
Only evidence of severe coronary artery calcium placed patients at an
increased risk of in-hospital death following injury.
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Coronary artery disease among patients with low coronary
calcium score: A call for definition of low coronary artery
calcium score-Multi-Detector Computed Tomography ANIN
Registry
E. Edyta Kaczmarska1; C. Kepka1; Z. Dzielinska1; R. Pracon1;
K. Kryczka1; J. Pregowski2; M. Kruk1; M. Demkow1
1National Institute of Cardiology, Department of Coronary Heart
Disease, Warsaw, Poland; 2Department of Interventional Cardiology
and Angiology Institute of Cardiology, Warsaw, Poland
Objectives: The prospective study was conducted to find the cut-off
point for low CAC score and evaluated the incidence of CAD in
relation to the low CAC score among patients with intermediate
probability of CAD.
Methods: Consecutive patients (n = 1132) were included to the
analysis (58.7 ± 10.9 years, 46.7% males). Coronary computed
tomography (CCT) angiography was performed by multi-detector
computed tomography scanner. CAC score was calculated by Agatston
method. CAD was defined as presence of coronary artery stenosis
C50% on CCT angiography.
Results: CAD was diagnosed in nearly one-fourth of patients
(n = 272, 24%). CAD in subjects with CAC score B10 and B100 were
detected in 4.9% (56 patients) and 12.4% (140 patients), respectively.
In the ROC curve analysis, CAC score of 10 presented as optimal cut-
off point for the discriminating the CAD (sensitivity 0.79, specificity
0.75, P \ .0001). Whereas for CAC score of 100, the sensitivity and
specificity was 0.48 and 0.92, respectively.
Conclusions: The cut-off point of 10 for CAC score with the best
sensitivity and specificity determined patients with CAD. Furthermore,
CAC score \ 10 better defined patients with high risk obstructive
plaque prone to rupture (non- or low calcified obstructive plaque) than
CAC score 100. CAC score \ 10 should be classified as ‘‘low’’.
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Quantitative assessment of extracoronary calcification using
Coronary CT angiography may be helpful in predicting
coronary artery disease
N.X.H. Xhabija1; I.A. Allajbeu1; E.P. Petrela2; M.H. Heba3
1American Hospital, Balkan Alliance Group, Tirana, Albania;
2University of Tirana, Faculty of Medicine, Department of Public
Health, Division of Biostatistics, Tirana, Albania; 3University Hospital
‘‘Nene Teresa’’, Tirana, Albania
Several studies have been suggested that the presence of multiple
extracoronary sites with calcium deposits would infer a greater risk for
CAD. But, most of them are based in echocardiographic studies that
used categorical variables with poor reproducibility and does not
quantify calcium. Cardio-vascular calcium screening with the use of
EBCT is emerging as a potentially useful test to diagnose atheroscle-
rotic burden.
Purpose: The aim of this study was to determine whether there is a
significant association between calcification of the aortic/mitral annu-
lus and/or thoracic aortic calcified plaques and coronary artery disease
(CAD) in patients undergoing 64-slices angio-CT scan. If an associa-
tion could be established between cardiovascular calcifications and
CAD, their presence might be used as a marker of coronary
atherosclerosis.
Methods: We identified the presence, absence and amount of calcifi-
cation in each of the three extracoronary calcification (ECC) sites:
aortic root, mitral annulus and ascending aorta, using Agatston calcium
score. We applied a digitized method to quantify ECC so we had a
good reproducibility in identifying them. All known cardiac risk
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factors for atherosclerosis including age, gender, hypertension, smok-
ing, dyslipidemia, diabetes and family history were investigated.
Results: The mean age of our study population included 305 patients
(184 men and 121 women) was 57 ± 11.28 years. These patients were
divided in two groups, age and sex-matched 166 (58.7%) in the ECC
group and 139 (41.3%) in the control group. The ECC group had a
higher prevalence of positive CT for the presence of CAD (75.8 vs
19%, with P \ .001). Multivariate analysis identified only ECC and
age as independent predictors of coronary atherosclerosis. Logistic
regression analysis showed also that ECC was strongly and signifi-
cantly associated with CAD after adjusting for all coronary risk factors,
except age (OR = 6.637; 95% CI 2.5-7.464, P \ .001), hence patients
with ECC had a sixfold higher risk for CAD than those without. The
sensitivity, specificity, positive and negative predictive values for ECC
in diagnosing CAD were 85.1%, 70%, 76% and 91%, respectively.
Conclusion: Calcium deposits at two or more sites may help in
identifying patients with atherosclerosis. Their absence is a stronger
predictor for absence also of CAD. Measuring extracoronary calcifi-
cation using CTA is accurate, reproducible and may be clinically
relevant.
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Coronary calcification is superior to exercise stress testing in
predicting significant coronary artery stenosis in
symptomatic patients
T.M. Tarek Mohamed Bengrid1; R. Nicoll1; A. Schmermund2;
M.Y. Henein1
1Heart Centre & Department of Public Health & Clinical Medicine,
Umea University, Umea, Sweden; 2Bethanien Hospital, Frankfurt,
Germany
Coronary calcification is generally recognised as a form of subclinical
atherosclerosis and has been found, in various severities, in asymp-
tomatic populations. Its relevance in predicting significant coronary
artery (CA) stenosis in symptomatic patients remains uncertain. We
retrospectively studied 360 patients, mean age 65, 58% males, who
presented with angina-like symptoms and who underwent CT coronary
calcium scoring CAC, conventional angiography and exercise toler-
ance testing (ETT). A CAC score [ 0 was superior to ETT for
prediction of significant coronary artery stenosis (C50% narrowing),
with sensitivity 97% vs 39% (P \ .001) but specificity was only 26%
vs 70% (P \ .001). Patients aged C70 had higher sensitivity of
CAC C 400 in predicting CA stenosis C 50% compared to those aged
\70 (62% vs 26%, P = .018) and in predicting single vessel disease
(SVD) (65% vs 28%, P = .008) and multivessel disease (MVD) (74%
vs 28%, P = .039). The respective specificities for CAC [ 0 were
significantly lower in those aged C70 compared to age \ 70 for SVD
(9% vs 60%, P = .052) and MVD (5% vs 26%, P = .018). ROC curve
analysis showed a CAC score of 46.5 as having the highest sensitivity
and specificity (83% and 62%, respectively, P \ .001) for predicting
[50% CA stenosis with area under the curve (AUC) of 76%.
Conclusion: In symptomatic patients, coronary artery calcium score is
more accurate in predicting the presence of significant stenosis but
exercise tolerance testing is more specific in excluding significant
multivessel disease.
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